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Definitions, History and General Considerations 
Related to the Aortic Aneurysms 
Guillermo Careaga-Reyna 
Chief of the Cardiothoracic Surgery and Cardiopulmonary Support Department,  
UMAE, Hospital General "Dr. Gaudencio González Garza" 
Centro Médico Nacional "La Raza", IMSS 
Mexico 
1. Introduction 
The objective of this chapter is to present the definitions, history and general considerations 
related to the aortic aneurysm as an introduction to the other chapters of this book. 
The aorta can be affected by a variety of pathological conditions as the aneurysms. 
Aneurysms are areas of dilation local or diffuse from the aorta. This aneurysms are 
developed in places of congenital or acquired weakness of the middle wall. Some of them 
have a clear genetic component and affect young patients. Most pathology is however 
encountered in the grown-up population and is caused by degenerative diseases (Risberg & 
Lönn, 2007)  
2. History 
2.1 Classic descriptions 
Even when the aortic disease was described in the Egyptian papyri, the term aneurysm 
probably comes from the Greek aneurysma, which means enlarged or dilated (Cooley, 1999). 
The first description of an arterial aneurysm is attributed to Galen in the 2nd century. He 
wrote,”when arteries are enlarged, the disease is called an aneurysm”. If the aneurysm is 
damaged, the blood drips into quarters, and is difficult to contain. In addition he described 
the difference between aneurysm caused by trauma and those caused by degenerative 
disease.  
In the same 2nd century, Antyllus, developed and described a technique to treat these 
injuries. He believed that the clot seals the defect when there were dissection of the wall as 
well as try to ligation of artery above and below in thoracic aortic aneurysm and evacuated 
the clot.  
In 1542, Fernelius told that the aneurysm originates as a result of thinning of the arterial 
wall, but is recognized that Vesalius made the first clinical diagnosis of an aneurysm in 1557 
(Cooley, 1999; Kouchoukos NT, 1996). 
In 1728, Lancisi published De Motu Cordis et Aneurysmatibus. In this paper it was proposed 
the etiology of abdominal aortic aneurysms. Later John Hunter showed that peripheral 
arteries can surely be ligated and Astley Cooper, one of his pupils, ligated an aneurysm of 
the aorta. These researchers believed that the ligature could decrease or stop the movement 
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of blood within the aneurysmal sac, which could cause thrombosis and eventually 
obliteration. Surgeons applied the ligature to the artery on the proximal side, the distal side, 
or both sides of the aneurysm. Ligation of aneurysms, however, returned to the extremities 
vulnerable to ischemic damage. Thus, the treatment of aortic aneurysms remained 
frustrating even for the best doctors. (Cooley, 1999) 
In 1864, Moore inserted a wire of silver in a thoracic aneurysm to induce clot formation, and 
in 1879, Corradi applied a galvanic current through the wire. For 40 years, the method of 
combined electrolysis Moore-Corradi was adopted by other researchers. Blakemore and 
King, created a thermal coagulation device of aneurysms. The next step in the treatment of 
aneurysms was the stimulation of periarterial fibrosis. With this procedure,  the cellophane 
or other types of plastic film were used as an irritant to cause occlusion of the vessel by 
tissue production. Harrison and Chandy applied this method to treat of the subclavian 
artery aneurysm, Poppe and De Oliveira used cellophane or plastic polyethylene films for 
wrapping aneurysms of the thoracic aorta produced by syphilis. In 1888, Dr. Rudolph 
Matas, developed a method for internal repair of aneurysms in which continuity of blood 
flow was restored by a simple intravascular suture of the artery opening directly the 
aneurysm sac. He described two procedures of aneurismorraphy. One called it the 
restorative, used for sacular aneurysms. In another technique -the reconstructive-, he  
excised the sick or injury portion of the vessel and created a tunnel through the remaining 
normal portion.  
2.2 The twentieth century 
In 1900, sir William Osler said, “There is no greater illness that leads to the clinical humility 
than aneurysms of the aorta” by the complexity and the limited treatment options and the 
outcome of the same. 
In 1944, Alexander and Byron successfully resected an aneurysm of the descending aorta 
associated with aortic coarctation, but did not try to restore the aortic continuity.  
In the same year, Ochsner treated a small sacular aneurysm of the descending aorta with 
good results. 
On 28 April 1950, Denton A. Cooley conducted its first surgical treatment of aortic 
aneurysm, and in 1951, reported a work entitled "Surgical considerations of intrathoracic 
aneurysms of the aorta and large vessels". Gross and his colleagues, began the modern era 
of vascular grafts and employed preserved homografts to treat aortic coarctation (Cooley, 
1999). 
Those aneurysms that appears large in radiological studies, thin-walled and adhesions to 
the posterior side of the sternum recommended that before doing the surgical approach via 
median sternotomy, a left lateral thoracotomy was conducted to put a cannula to 
decompress the left ventricle. This maneuver to empty the heart, decreases the tension 
within the aorta, and in case of rupture when the sternum was opened, represents support 
in aspiration and control of bleeding. 
In 1956, Cooley and DeBakey described a technique for the replacement of the ascending 
aorta with a synthetic graft distal to the coronary arteries ostia. In 1960, Mueller et al. 
combined the replacement with a supracoronary graft and the bicuspidization of an 
incompetent aortic valve. In 1963, Starr and collaborators described a replacement with a 
supracoronary graft and replacement of the valve. 
In 1964, Wheat and colleagues described a radical technique of resection of the aortic wall, 
carrying the small buttons of adjacent tissue to the coronary ostium, replacement of the 
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aorta with a graft, and prosthetic aortic valve replacement. In 1968, Bentall and Bono 
described a technique for replacement of the ascending aorta and aortic valve with a tubular 
graft containing a valve prosthesis with latero-terminal reimplantation of the ostium of the 
coronary artery graft. This technique reduces the risk of recurrent proximal aortic aneurysm. 
(Kouchoukos, 1996; Gelsomino et al., 2003).  
In the following decades (1970s, and early 1980s), the results of thoracoabdominal aortic 
aneurysm and descending thoracic aortic aneurysm repair were extremely different from 
center to center. (Safi, 2007). 
Until the development of vascular grafts, prosthetic valves and the improvement of 
extracorporeal circulation techniques, surgical treatment of aneurysms of the ascending 
aorta was limited to the plication of the aorta or aneurismorraphy (Gelsomino et al., 2003)  
Graft prosthetic, valved conduits or procedures with placement of an endovascular graft 
within the site of the aneurysm are currently used. (Cooley 1999; Gelsomino et al,  2003; 
Saiki et al., 2003; Girardi et al., 2002) 
Traditionally the gold standard treatment has been surgery with a short-term treatment 
mortality incidence of 10-20% for elective procedures. In recent years, endovascular aortic 
repair of descending aneurysms has shown great promise. In 1991 Volodos and his group 
published the first report on endovascular stent grafting for a thoracic aortic lesion (Volodos 
et al, 1991), while the clinical first series was published by the Stanford group in 1994 (Dake 
et al, 1994)  
The first endovascular thoracoabdominal aneurysm operation using branched grafts was 
reported by Chuter in 2001 (Chuter et al, 2001)  
3. Classification 
In the last decade, the descending thoracic aneurysms were classified only based in the 
aortic extension they affect:  The upper half, lower half, or entire thoracic aorta, named as 
types A, B, and C, respectively. During the clamp-and-sew technique, it was showed that 
the maximum incidence of neurological deficit involved types B and C. Safi and coworkers 
consider these using the modified "Crawford classification," (table 1) (Safi, 2007). 
 
Type Description 
Extent I from the left subclavian artery to above the renal arteries 
Extent II from the left subclavian artery to below the renal arteries 
Extent III from the 6th intercostal space to below the renal arteries 
Extent IV involves the total abdominal aorta from T12 to below the renal arteries 
Extent V from the upper extent of the 6th intercostal space to the lower extent above the renal arteries 
Table 1. Modified crawford classification 
It was found that the extent of the aneurysm correlated with a high incidence of 
neurological deficit (31%), the highest being in extent II. In the clamp-and-sew technique, 
the clamp time and the extent of the aneurysm correlated to neurologic deficit (Svensson et 
al. 1993). 
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In regards to the aortic dissections present the classification of DeBakey (table 2), and in 
table 3 the Stanford proposed by Daly et al in 1970 (Kouchoukos, 1996; David TE, 1997; Kato 




The tear of the intimate usually originates in the proximal ascending aorta and 
extends to the ascending aorta, aortic arch, and variable-length to the thoracic 
aorta descending and abdominal. 
(II) The dissection is limited to the ascending aorta. 
(III) Dissection can be limited to the descending thoracic aorta (type IIIa) or extended proximally and affect the ascending aorta and aortic arch. 
Table 2. DeBakey’s classification for aortic dissection. 
 
Type Description 
A. It includes all the dissections involving the ascending aorta, regardless of their place of origin and its extension, corresponds to the types I and II of De Bakey. 
(B) It includes the dissections in the ascending aorta is not affected, this corresponds to the type De Bakey III 
Table 3. Stanford classification for the aortic dissections. 
4. General concepts 
Aneurysms are characterized by degeneration of the media resulting in a weakness of all the 
layers of the aortic wall. Its recognized that 50% of the thoracic aneurysms are originated in 
an aortic dissection. These are truly pseudoanurysms since not all layers of the aortic wall 
are engaged. (Bickerstaff et al. 1982).  
Once expressed, the formation of the aneurysm is progressive because some level of 
intraluminal pressure and tangential wall tension, increases with the square of the radius 
and are described as the aneurysms sac.  
The risk of rupture is related to the largest diameter of aorta with a fatal outcome in 33-50% 
of the patients, while comorbidities are responsible for the remaining deaths (Bickerstaff et 
al. 1982; McNamara et to 1978).  
In many cases, based in clinical findings and comorbidities, regular observation and medical 
management are indicated, but surgical treatment has been recommended if the sac 
diameter of the aneurysm reaches 5.5 cm even for asymptomatic cases (Lederle et al., 2007), 
but the criteria has been modified due to the higher risk of rupture with a great diameter; 
and in symptomatic aneurysms, immediate treatment is required, regardless of diameter.  
If we find an aneurysm with a diameter of over 3 cm it must be monitored with 
ultrasonography every 12 months. When the diameter of the aneurysm has reached 5 cm in 
a man or 4.5 cm in a woman the ultrasonographic checks are carried out every 6 months 
(Powell & Greenhalgh, 2003).  
Hypertension and other cardiovascular risk factors should be treated effectively. The 
systolic blood pressure should be lowered quickly to around 100- 120 mmHg. First aid 
treatment includes chewed antihypertensive drugs (i.e nifedipine), nitrate (or nitroprusside) 
infusion to beta-blocker, and effective analgesia.  
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The mortality from a ruptured aneurysm is 90%. Also, the surgery is a priority in patients 
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The aim of endovascular aortic repair is to prevent rupture of the aneurysm sac by its 
exclusion and decrease of the pressure on the wall of the aneurysmal sac stress, or to reduce 
the pressure in the false lumen with subsequent obliteration. Now with the new improved 
stent grafts for thoracic use. The endovascular procedure may increase its application as  
less invasive than standard operative repair and patients who were previously not eligible 
for surgery may now be considered for treatment, with lower risk than open surgery.  
4.1 Thoracic aorta aneurysms 
About 20% of the aortic aneurysms are located in the thoracic aorta (Bickerstaff et al. 1982).  
The etiology for the thoracic aneurysms do not differ in any segments of the aorta. They can 
be due to degeneration, medial noninflammatory atherosclerotic degeneration, chronic 
dissections, trauma or infectous diseases (mycotic or syphilitic). The most common 
connective tissue disorder associated with aneurysm is the hereditary disorder Marfan's 
Syndrome. More rarely, Klipper-Feil syndrome or Turner’s syndrome among other 
syndromes may involve the aorta (Kouchoukos, 1996; David, 1997; Greenberg & Rischer, 
1998) 
Aneurysms of the thoracic aorta are typically those that affect the aortic ring and ascending 
aorta (Figure 1), aortic arch or descending aorta. (Von Fricken, 2002). 
 
 
Fig. 1. Aneurysm of ascending aorta without extension to supraaortic branches. 
There is a pathological disorder which precedes the formation of an aneurysm in the 
thoracic aorta in 60% of the cases is the dissection. (Kouchoukos, 1996; Von Fricken, 2002; 
Kato et al., 2002) 
In regards to our experience, the frequency by gender was higher in the male than the 
female, similar to that reported in the literature. (Ramirez-Vargas et al., 2003; Miyairi et al, 
2002; Colombi et al, 1983; Cabrol et al, 1986; David & Feindel, 1992) 
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In regards to the aortic dissections present the classification of DeBakey (table 2), and in 
table 3 the Stanford proposed by Daly et al in 1970 (Kouchoukos, 1996; David TE, 1997; Kato 
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Early population-based studies have been demonstrated to 5-year survival rate for 
untreated thoracic aneurysms of only 13 per cent (Bickerstaff et al. 1982), and for patients 
with degenerative aneurysm 3-year survival was 35% (McNamara et al. 1978). 
Usually thoracic aortic aneurysms are asymptomatic. So if pain appears, suggests 
expansion, equal as tracheal or bronchial compression. Sometimes the neck veins are dilated 
due to the compression caused by the aneurysm. 
The thoracic aortic aneurysms may be visible as an incidental finding on a chest x-ray film, 
but improved diagnostic accuracy and more frequent use of CT and echocardiography 
accounts for the relative increase in the frequency of aortic aneurysms. Transoesophageal 
echocardiography is a good primary investigation. Computed tomography, magnetic 
resonance imaging (MRI), or angiography is often needed for final diagnosis. 
The risk for rupture during a 5-year period for thoracic aneurysms was near 20%; and in 
women was greater than men with a 7:1 ratio (Johansson et al, 1995; Meszaros et al, 2000). 
However this pattern may differ as Johansson et al. demonstrated when in Scandinavia 
found an equal sex distribution in ruptured thoracic aneurysms (Johansson et al. 1995).  
Aortic valve insufficiency is of particular concern in the ascending aorta aneurysms. This 
risk is proportional to the increase in size of the aneurysm and on this basis, are new 
recommendations for an earlier surgical treatment with lower diameters than previously 
accepted.  
The preoperative assessment of coronary mouths or the aortic valve disease is very 
important to choose the appropriate surgical procedure. The decision to treat an aneurysm 
should be based on the risk of rupture and the life expectancy of the patient (Greenberg & 
Rischer, 1998) 
On the other side the aneurysms of the descending aorta have an incidence of 
approximately 30-50/million inhabitants/year (Joyce et al. 1964).  
Repair for the ascending aorta aneurysms is an open standard replacement of the diseased 
segment of the aorta and if needed combined with a new valve insertion and reattachment 
of the coronary arteries with a synthetic valved aortic graft as shown in figure 2 (Gelsomino 
et al., 2003; Cabrol et al, 1986; Carias de Oliveira et al., 2003).  
 
 
Fig. 2. Surgical treatment of an aneurysm of the ascending aorta with a mechanical valved 
graft. 
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Although important progress in surgical methods, brain preservation and myocardial 
protection and the postoperative care, often the surgical treatment of thoracic aortic 
aneurysms remains a challenge for the cardiothoracic surgeon (Greenberg & Rischer, 1998).  
The surgical treatment of aortic aneurysm may be associated to another procedures: 
myocardial revascularization, implant for mitral valve prosthesis, correction of coarctation 
of the aorta or closure of an atrial septal defect, as we reported (Ramirez-Vargas et al., 2003). 
Other publications have also referred surgical procedures combined with the treatment of 
aneurysms of the thoracic aorta as tricuspid valve surgery and closure of the 
interventricular septal defect (Schulte et al, 1983; Massih et al, 2002; Levine et al. 1968). 
In our experience, the time of aortic cross clamping and cardiopulmonary bypass give a 
similar average result compared to other series (Ramirez-Vargas et al., 2003; Kouchoukos, 
1996; Gelsomino et al., 2003; David & Feindel, 1992; Tominaga et al., 2003). 
The main type of cardioplegic solution was  St. Thomas in 88.5% and only 11.5% was used  
HTK solution. Oster and cols, employed HTK for myocardial protection in a study with 
good results (Oster et al, 1983).  
Several options have been used to reduce the incidence of neurological and renal 
complication which include: circulatory arrest with deep hypothermia, selective anterograde 
cerebral perfusion, retrograde cerebral perfusion, drainage of cerebrospinal fluid, placement 
of ice on the head in patients undergoing aortic arch surgery mainly (Ramirez-Vargas et al., 
2003; Girardi et al, 2002; Oster et al, 1983; Di Eusanio et al., 2003; Griepp, 2003; Bachet et al, 
1999; Deeb et al, 1999; Dossche et al., 1999). 
The most commonly used approaches include the median sternotomy for  treatment of 
aneurysm in the aortic arch. There are others such an “L” incision, with an incomplete 
median sternotomy and a previous thoracotomy is performed giving a greater advantage in 
the visualization of the surgical field and all the advantages that this leads well as its main 
disadvantage is the pain of the wound. For the approach of the distal aortic arch and 
descending aorta is preferred a postero-lateral thoracotomy (Gelsomino et al., 2003; Kay et 
al, 1986; Colombi et al, 1983; Tominaga et al, 2003; Kazui et al, 2002; Levine et al, 1968) 
Femoral cannulation for cardiopulmonary bypass, remains the standard option for surgical 
repair of acute aortic dissection type. However, the retrograde perfusion has the potential 
risk of embolization of detritus of atheroma, extension of the dissection and poor perfusion 
(David & Feindel, 1992; Ergin et al., 1999). We use in 20.5% of this pathology femoral artery 
canulation (Ramirez-Vargas et al., 2003). Other sites for canulation have been described. One 
of this is the axillary artery which has the advantage for heart operations performed with 
cardiopulmonary bypass in the presence of occlusive peripheral disease, atherosclerosis of 
the femoral vessels, or distal extension of dissection (Careaga et al, 2001; Oberwalder et al., 
2003; Murray & Young, 1976; Ergin et al, 1999; Galajda et al., 2003; Minatoya et al., 2003; 
Karmy-Jones et al, 2001)  
Hospital-acquired early postoperative mortality has been reported by 4% to 20%. We had an 
early postoperative mortality of 7.7%. The main causes were perioperative myocardial 
infarction, left ventricle failure with low cardiac output, acute dissection, shock, hemorrhage 
(Ramirez-Vargas et al, 2003; Kouchoukos, 1996; Gelsomino et al., 2003; Girardi et al, 2002; 
Cabrol et al, 1986; Di Eusanio et al., 2003; Bell et al., 2003; Kay et al, 1986). 
Other consideration is the association of aortic aneurysm and coarctation is a known entity. 
Aortic artery may become occlusive in the site adjacent to who has the greater narrowing as 
a result mainly of haemodynamic effects, dissection or aneurysm inflammatory or 
infectious. (Kouchoukos et al, 2003) 
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It is rare in children because the total of aneurysms prevalence increases as the individual 
grows, so that it approaches 20% when the patient is in the final stages of the third decade of 
life (Schuster & Gross, 1962) 
The formation of aneurysms may be a late complication of a surgical repair or endovascular, 
but is less frequent in the absence of corrective procedures. Aneurysms are most frequent in 
intercostal arteries and can be isolated or multiple and followed in order of frequency by the 
aortic segment located after a coarctation, aortic and finally into the left subclavian artery 
isthmus (Kouchoukos et al, 2003). 
Coarctation of the aorta-surgical treatment has provided successful mostly in the last 
decade. (Kouchoukos et al, 2003; Schuster & Gross, 1962; Parks et al, 1995; Bell et al., 2003). 
The formation of aortic aneurysms associated with coarctation of the aorta is rare (Parks et 
al, 1995; Bell et al., 2003) 
There are currently endovascular techniques for the correction of aortic aneurysms 
associated or not to aortic coarctation. However, in this association the recommended 
procedure is open surgery (Bell et al., 2003; Knyshov, 1996) 
4.2 Abdominal aneurysms 
The incidence of rupture of abdominal aortic aneurysms is estimated to be 9.2 cases per 
100,000 person-years (Bengtsson & Bergqvist, 1993). Ruptured aortic aneurysms remain the 
13th leading cause of death in the United States with an increasing prevalence (Coady et al., 
1999); This may be attributable to improved imaging techniques, increasing mean age of the 
population, and overall heightened awareness (LaRoy et al, 1989).  
Due to the age profile of the patients, atherosclerotically damaged vessels in one or several 
organs increase the risk of complications for surgical treatment of this patients as pulmonary 
disease, reduced FEV 1, renal, abdominal and cardiovascular complications, which 
contribute to a significantly increase of  morbidity. However all symptomatic patients need 
immediate surgery. We must remember that about 30% of the patients have clinically 
significant cardiovascular, stroke, renal, or peripheral atherosclerotic disease. 
The mean age of this population is between 59 and 69 years with a male to female ratio of 3: 
1 (Bickerstaff et al. 1982). Branched devices have incorporated side branches and their use is 
for those aneurysms with no neck/proximal landing zone at all. These advanced devices can 
be classified according to target region (abdominal or thoracic or thoracoabdominal) and 
subdivided into fenestrated or branched stent-graft systems (Melissano et al, 2004; 
Verhoeven et al., 2005).  
4.3 Thoracoabdominal aortic aneurysms 
On the other side the thoracoabdominal aortic aneurysms (TAA) constitute about 10-15% of 
all aortic aneurysms. This type of aneurysms are probably the most difficult to treat. Chronic 
dissection is the cause of these aneurysms in approximately 20% of the cases (Svensson et al. 
1993).  
Women seem affected as often as men which is at variance with abdominal aneurysms 
which predominantly are to male disorder. So, the 85% of the patients are men for the 
abdominal aneurysms and 10 per cent of men are aged 75 years or more.  
In the table 1, present the Crawford classification for the thoracoabdominal aneurysms 
according to their size. Type II aneurysms are the most extensive and difficult to treat. They 
also have the highest morbidity and mortality. 
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Modern treatment of TAA was pioneered by Stanley Crawford who introduced the "inlay" - 
technique (Crawford, 1974).  
 
Type0 Description 
(I) Descending aorta + part of visceral branch 
(II) Descending aorta + abdominal aorta 
(III) Distal part of descending aorta + abdominal aorta 
(IV) Visceral branches 
Table 1. Crawford classification of thoracoabdominal aortic aneurysm 
By using motor evoked potential to monitor motor function of the spinal cord during 
surgery the risk for paraplegia can be reduced further to around 2% (Jacobs & Mess, 2003). 
Preventive measures must be largely preoperatively, such as coronary artery by-pass 
grafting or percutaneous coronary interventions, and a proper risk assessment must be 
performed.  
The most frequent risk factors of aortic dissection are degenerative disease of the middle 
and high blood pressure (Oberwalder et al., 2003). 
In the pathology added in our series of patients with aneurysm, the most frequent were: 
Aortic valvular disease, chronic smoking, systemic arterial hypertension and Marfan 
syndrome, coarctation of the aorta, coronary artery disease similar to that reported in world 
literature. (Ramirez-Vargas et al., 2003; Kouchoukos, 1996; Gelsomino et al., 2003; Miyairi et 
al, 2002; Tominaga et al., 2003; Kazui et al., 2002) 
The complications that have been reported early as ventricular failure, ventricular 
arrhythmias and hemorrhage are similar to that reported in our series. In addition other 
authors report paraplegia, stroke, renal failure, myocardial infarction, and respiratory 
failure. (Gelsomino et al, 2003;  Girardi et al, 2002; Tominaga et al, 2003). 
The ejection fraction of the left ventricle in our series was from 20% to 78%, varying with the 
reported in another series with a greater average 65%. (Kouchoukos, 1996) 
Probably due to the risks involved in elective repair, a large proportion of patients, 
approximately 25% are treated urgent due to acute symptoms (Coselli et al, 2000). 
On this basis its very recommended the diagnose of aortic aneurysm rupture, monitor 
before a small aneurysm, found incidentally or through screening, until it reaches in size 
where the benefit of surgical repair outweighs the risks associated with such surgery. 
Always remember the possibility of aortic dissection in a patient with severe pain 
suggestive of acute myocardial infarction (AMI) but without clear electrocardiogram (ECG) 
findings. All patients with aortic dissection must be referred to a hospital immediately. 
Finally, in the decision of surgical intervention we must consider the age of the patient, his 
state of health, their symptoms and the size of aneurysm (McKneally, 2001), or the reason 
why surgery is required. As an example to the above mentioned, in our experience there 
was need to operated a septuagenarian patient who had been treated with the placement of 
a mechanical valved graft by thrombosis of the same. This was an emergency procedure and 
was only made the thrombectomy with a good result and recovery for the patient (Careaga-
Reyna et al., 2006). 
Is very important to define the diagnosis of aortic dissection vs acute myocardial infarction 
in aortic dissection because thrombolysis is contraindicated. 
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On this basis its very recommended the diagnose of aortic aneurysm rupture, monitor 
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With this brief presentation, we can conclude that  aortic artery aneurysms are not a recent 
pathology. The frequency of cases has increased by the greater care of the physician in the 
clinical evaluation and the availability of technological resources. The aortic aneurysm is a 
complex pathology, current therapeutic options allow to offer more secure procedures, with 
less morbidity and even patients than before were not considered candidates for treatment 
by the presence of other diseases now after a complete evaluation can be included for open 
or endovascular surgical procedures. 
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1. Introduction 
Patients with abdominal aortic aneurysms (AAA) may present with musculoskeletal pain 
patterns (Bassano, 2006). In approximately 7% to 8% of patients with low back pain (LBP), 
the cause is due to non-mechanical spinal conditions or visceral disease (Jarvik & Deyo, 
2002). A contained retroperitoneal rupture of AAA is very rare, but  may have a long history 
of less apparent clinical signs (Al-Koteesh et al., 2005). Approximately half of diagnosed 
AAAs are detected clinically; these are usually >5 cm in diameter (Beck et al., 2005). 
Accidental discovery is common when plain film radiographs are taken for evaluation of 
back pain. Ultrasonography of the abdomen is accurate and reliable in detecting AAAs 
(Fleming et al., 2005), but there needs to be a clinical reason before deciding to do these 
evaluations. This stresses the importance of a thorough history and physical examination. 
2. Clinical history  
It can be quite challenging to recognize the symptoms found in clinical history that support 
the need for a screening abdominal exam. Patients that do have an abdominal aortic 
aneurysm can present in three different categories. These categories consist of patients 
without significant symptoms, patients with symptoms due to a bulging AAA, and patients 
with symptoms due to a chronic contained ruptured AAA where the containment of the 
rupture keeps the leak slow enough as to not cause immediate death (Cates, 1997).   
2.1 Aortic aneurysms without significant symptoms 
The first category is obviously the most difficult to discover in clinical practice. Although 
most patients with AAA present with symptoms, 66%-75% of the cases of AAA are 
asymptomatic (Beck et al., 2005; Crawford et al., 2003, de Boer et al., 2010). What is even 
more disturbing is the fact that there is a considerable amount of patients with a chronic 
AAA rupture that have less than apparent clinical symptoms signifying the need for a 
screening for abdominal aortic aneurysms (Al-Koteesh et al, 2005). It is also unfortunate that 
most patients that have an asymptomatic AAA will remain asymptomatic until it finally 
ruptures. If they are fortunate, the size of the aneurysm draws the attention of the patient 
and physician prior to rupture (Crawford et al., 2003). Mass screening will benefit this group 
since this is the only way to detect these. 
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2.2 Symptomatic aortic aneurysm 
In the second category, it is also difficult to discern between a patient that has an AAA and a 
patient that has another cause for the same complaint. Compared with non-inflammatory 
AAA, 65% to 90% of patients with inflammatory AAA are symptomatic (Ahlawat & 
Cuddihy, 2002). Some of these patients do present as patients having typical 
musculoskeletal problems and/or abdominal pain (Crawford et al, 2003). A feeling of 
fullness or heavy pulsations in the abdomen may be an early symptom (Crawford et al, 
2003). Often, patients with this condition present with epigastric pain radiating into the 
flank/back region (Patel & Kettner, 2006). Sometimes patients with this sort of  condition 
find it difficult to achieve a position which eases the pain (Mechelli et al, 2008). Other 
symptoms that a patient with AAA may have, include costovertebral angle pain, suprapubic 
pain, groin pain or leg pain (Hadida & Rajwani, 1998). Other patients may present with a 
dull constant aching pain paired with weight loss and occasional night sweats. These 
symptoms are generally considered “red flags” (Ahlawat & Cuddihy, 2002).  
2.3 Chronic contained ruptured aneurysm 
The third category is an emergency situation. Here again the symptoms are still the same, 
except there are added symptoms from the hypotension due to loss of blood. Depending on 
the rate of leaked blood from the rupture, the severity of the symptoms can differ. In 
general, the pain is severe in most patients, but atypical presentations are just as common. 
The symptoms can also vary depending on where the rupture is and what structures are 
compromised by the haematoma. For instance, a retroperitoneal haematoma that places 
stress on a iliopsoas muscle can very well cause irritation of the femoral nerve, making it 
appear a femoral neuropathy. This may imply that a patient presenting with a sensory 
deficit of the anterior thigh could be someone who is in need of an immediate medical 
referral (Ramasamy et al, 2001; Al-Koteesh et al, 2005). Symptoms can result from 
compression (e.g. ureter), erosion of vertebral bodies, or occlusion of blood supply (Hadida 
& Rajwani, 1998; Yokomuro et al, 2008). 
These three categories demonstrate that in many cases the history alone gives no reliable 
information about a potential AAA. Many of these patients may very well end up 
presenting with low back pain and try various therapies to help lessen these conditions. It is 
also probable that there could be actual musculoskeletal symptoms at the same time as 
symptoms from an AAA. Other differential diagnoses include any abdominal pathology 
related to the structures compressed. It is suggested that the atherosclerotic plaques from 
someone with an AAA can increase risk of ischemia and thus lead also to disc degeneration 
(Al-Koteesh et al, 2005). This means that anyone presenting with degenerative disc disease 
symptoms could also have an underlying AAA that was the initial cause. Evaluating the risk 
factors in history is, therefore, very important. 
3. Risk factors  
In the clinical history, the presenting complaint gives information on the signs and 
symptoms. Since patients in primary contact practices do not necessarily present with 
symptoms that point directly to an abdominal aortic aneurysm (AAA), the review of 
systems and social history is of value in ‘case finding’. This is the consideration of unrelated 
or intercurrent illness in presenting patients due to the presence of the risk factors associated 
with, in this case, an abdominal aneurysm (Crawford, 2003). 
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Age, gender, smoking and family history are the most significant risk factors for developing 
an AAA (Brown & Powell, 1999; Lederle et al., 2000; Kuivaniemi et al., 2003). These alone 
are a reason to pay attention to abdominal palpation and auscultation in the physical 
examination (Mechelli et al., 2008). Apart from these risk factors, there are other 
characteristics that may be of significance, namely cardiovascular disease and its associated 
complicating factors like hypertension, hyperlipidemia and atherosclerosis (Patel & Kettner, 
2006; Hadida & Rajwani, 1998; Mechelli et al., 2008). COPD, trauma, infectious and 
inflammatory conditions and autoimmune diseases causing cystic medial necrosis, have also 
been implicated (Van der Velde, 1998; Weston, 1995). Black race and diabetes have a 
negative association with AAA. (Lederle et al., 2000). 
3.1 Age, gender and race  
Most AAA deaths occur in men over 65 years of age (Mechelli et al., 2008; Fleming et al., 
2005). AAA is considered uncommon under the age of 50 (Van der Velde, 1998). With aging, 
the aorta may be less able to withstand the force of the pulsatile blood flow, in which case 
dilatation can occur (Crawford et al, 2003). The prevalence increases with age. The 
prevalence rates in men range from 2-9.5% (Cates, 1997; Van der Velde, 1998). Lederle et al. 
(2000) found that the likelihood of discovering an AAA of 4 cm or larger increases for every 
7 year interval of age (OR 1.71; 95% CI: 1.61-1.82). 
There is a difference in age-related deaths between men and women. Whereas in men, it 
occurs mostly over the age of 65, in women this occurs on average around 10 years later 
(Scott 2002), with a peak approximately at the age of 80 (Mechelli et al., 2008). This may be 
because of the protective effect of oestrogen, which may delay the process leading to AAA 
until after the menopause (Van der Velde, 1998). Overall prevalence is 5 to 6 times greater in 
men than in women (Scott et al., 2002). The inflammatory variant of AAA has male-to-
female ratios ranging from 30:1 to 6:1 (Ahlawat & Cuddihy, 2002). Aneurysms occur more 
often in Caucasian men (Karkos et al., 2000). Even though the prevalence is many times 
lower in women than in men, it is surprising to note that the risk of rupture is threefold 
higher in women than in men. This difference is independent of age, initial AAA diameter, 
and body mass index or height. The mean AAA diameter at rupture was 5 cm in women 
and 6 cm in men (Brown & Powell, 1999). 
3.2 Smoking and lung function 
Smoking is a primary risk factor for AAA: it increases AAA growth rates by 15% to 20% 
(Brady et al., 2004). A history of smoking in this context is defined as lifetime consumption 
of more than 100 cigarettes in a lifetime. Deaths associated with AAA have increased since 
the 1950s. Part of this can be explained by improved diagnostic methods, better surgical 
techniques and general aging of the population, but this does not explain the increase 
completely. The deaths parallel the increase of tobacco use in those decades (Crawford et al, 
2003; Van der Velde, 1998). The excess prevalence associated with smoking accounts for 
approximately 75% of all AAA of 4.0 cm or greater (Lederle et al., 2000). There is a 
significant association between the amount of cigarettes currently smoked and the depth of 
inhalation and the risk of AAA. This risk increases with an increasing amount of cigarettes 
and deeper inhalation into the lungs (Franks et al., 1996). There is, however, no association 
for any blood marker of smoking.  
Smoking is also the only modifiable factor in AAA. It increases the risk for AAA, but 
abstaining from smoking can slow the growth of the aneurysm (Brady et al., 2004). 
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Age, gender, smoking and family history are the most significant risk factors for developing 
an AAA (Brown & Powell, 1999; Lederle et al., 2000; Kuivaniemi et al., 2003). These alone 
are a reason to pay attention to abdominal palpation and auscultation in the physical 
examination (Mechelli et al., 2008). Apart from these risk factors, there are other 
characteristics that may be of significance, namely cardiovascular disease and its associated 
complicating factors like hypertension, hyperlipidemia and atherosclerosis (Patel & Kettner, 
2006; Hadida & Rajwani, 1998; Mechelli et al., 2008). COPD, trauma, infectious and 
inflammatory conditions and autoimmune diseases causing cystic medial necrosis, have also 
been implicated (Van der Velde, 1998; Weston, 1995). Black race and diabetes have a 
negative association with AAA. (Lederle et al., 2000). 
3.1 Age, gender and race  
Most AAA deaths occur in men over 65 years of age (Mechelli et al., 2008; Fleming et al., 
2005). AAA is considered uncommon under the age of 50 (Van der Velde, 1998). With aging, 
the aorta may be less able to withstand the force of the pulsatile blood flow, in which case 
dilatation can occur (Crawford et al, 2003). The prevalence increases with age. The 
prevalence rates in men range from 2-9.5% (Cates, 1997; Van der Velde, 1998). Lederle et al. 
(2000) found that the likelihood of discovering an AAA of 4 cm or larger increases for every 
7 year interval of age (OR 1.71; 95% CI: 1.61-1.82). 
There is a difference in age-related deaths between men and women. Whereas in men, it 
occurs mostly over the age of 65, in women this occurs on average around 10 years later 
(Scott 2002), with a peak approximately at the age of 80 (Mechelli et al., 2008). This may be 
because of the protective effect of oestrogen, which may delay the process leading to AAA 
until after the menopause (Van der Velde, 1998). Overall prevalence is 5 to 6 times greater in 
men than in women (Scott et al., 2002). The inflammatory variant of AAA has male-to-
female ratios ranging from 30:1 to 6:1 (Ahlawat & Cuddihy, 2002). Aneurysms occur more 
often in Caucasian men (Karkos et al., 2000). Even though the prevalence is many times 
lower in women than in men, it is surprising to note that the risk of rupture is threefold 
higher in women than in men. This difference is independent of age, initial AAA diameter, 
and body mass index or height. The mean AAA diameter at rupture was 5 cm in women 
and 6 cm in men (Brown & Powell, 1999). 
3.2 Smoking and lung function 
Smoking is a primary risk factor for AAA: it increases AAA growth rates by 15% to 20% 
(Brady et al., 2004). A history of smoking in this context is defined as lifetime consumption 
of more than 100 cigarettes in a lifetime. Deaths associated with AAA have increased since 
the 1950s. Part of this can be explained by improved diagnostic methods, better surgical 
techniques and general aging of the population, but this does not explain the increase 
completely. The deaths parallel the increase of tobacco use in those decades (Crawford et al, 
2003; Van der Velde, 1998). The excess prevalence associated with smoking accounts for 
approximately 75% of all AAA of 4.0 cm or greater (Lederle et al., 2000). There is a 
significant association between the amount of cigarettes currently smoked and the depth of 
inhalation and the risk of AAA. This risk increases with an increasing amount of cigarettes 
and deeper inhalation into the lungs (Franks et al., 1996). There is, however, no association 
for any blood marker of smoking.  
Smoking is also the only modifiable factor in AAA. It increases the risk for AAA, but 
abstaining from smoking can slow the growth of the aneurysm (Brady et al., 2004). 
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Inflammatory AAA represents 3% to 10% of all AAAs. A significant percentage of patients 
with inflammatory AAA are active smokers, when compared to non-inflammatory AAA  
(Ahlawat & Cuddihy, 2002). There is an 8:1 preponderance of smokers compared to non-
smokers (Cates, 1997).  
Poor lung function and smoking go hand in hand; both influence the rate of rupture of an 
aneurysm. Smokers are considered to be less healthy in general than non-smokers: they 
exercise less and exercise reduces the risk for cardiovascular disease (Kawachi et al., 1993). 
Several studies have shown an association between poor lung function (lower mean FEV1) 
and AAA rupture (Brown & Powell, 1999; United Kingdom Small Aneurysm Trial 
Participants, 2002). Other studies report that after correction for number of years smoked, 
the connection between AAA rupture and COPD was lost and is not a risk factor (Lederle et 
al., 2000). Overall, patients that were former smokers after AAA surgery had a lower risk of 
death than those who reported that they were current smokers. 
The mechanism by which smoking influences the development of an AAA is not known. It 
is thought that smoking influences the aortic elasticity negatively, which promotes AAA 
formation (Lederle et al., 2000). Increased amounts of the proteolytic enzymes collagenase 
and elastase have been observed in individuals that smoke as well as people with chronic 
obstructive pulmonary disease. This causes degradation of the aortic wall and 
atherosclerosis, thereby slowly weakening the aortic wall (Crawford et al., 2003; Lederle et 
al., 2000; Van der Velde, 1998; Cates, 1997). 
3.3 Family history  
Family history is an important issue. When considering patient history, special issues that 
require attention during a physical examination are easier to identify (Donahue, 1997). The 
probability of a patient having AAA is nearly twice that of someone without a (male) 
relative with a history of AAA (Lederle et al., 2000). It is found that a significantly higher 
percentage of patients with inflammatory AAA have a family history of AAA compared 
with patients with non-inflammatory AAA (Ahlawat & Cuddihy, 2002). Men who are first-
degree relatives of a known aneurysm patient are especially at risk. Studies have reported 
prevalence rates of 12% to 33% in first-degree relatives (Crawford et al., 2003; Kuivaniemi et 
al., 2003; Van Vlijmen-van Keulen et al., 2002; Patel & Kettner, 2006). 
The exact mode of inheritance is not known, but thought to be multifactorial with more than 
one environmental and genetic risk factor (Kuivaniemi et al., 2003). Defects are found in 
collage type I and III or other components of the connective tissue matrix, elastin and 
fibrillin, the inflammatory cell-derived matrix metalloproteinase, their inhibitors, 
autoimmune components and components related to atherosclerosis. Some say there may be 
autosomal dominant inheritance; however, others say that the sex-chromosome linked 
susceptibility is thought to account for male predisposition (Van Vlijmen-van Keulen et al., 
2002; Cates, 1997). Association of certain collagen diseases, such as Marfan’s syndrome and 
Ehler-Danlos type IV syndrome do seem to suggest a gene defect (Van der Velde, 1998). 
3.4 Other risk factors 
Coexisting conditions like cardiovascular disease can have an influence on the elasticity of 
the arteries, thereby causing weakening of the aortic wall. In the case of inflammatory AAA, 
10-47% of patients have been reported to have arterial occlusive disease (Ahlawat & 
Cuddihy, 2002). Several authors have reported the presence of cerebral arterial disease, 
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peripheral aneurysms or claudication as a sign in the clinical history demanding further 
questioning and examination. At least a third of patients with femoral or popliteal 
aneurysms will have an AAA (Karkos et al, 2000; Crawford et al., 2003; Patel & Kettner, 
2006). Suspicion is raised when a patient comes in with low back pain and mentions a 
history of myocardial infarction (Crawford et al., 2003). A history of coronary artery disease 
also carries an increased risk (OR 1.52; 95% CI: 1.37 to 1.68)(Lederle et al., 2000). 
Hypertension and older age are more strongly associated with AAA than with coronary 
artery disease even though risk factors of coronary artery disease show overlap with those 
of AAA (Kishi et al., 1997). Hypertension is associated both with increased risk of rupture as 
well as increased prevalence of AAA. It is a continuing haemodynamic burden on the aortic 
wall, which may further weaken the aortic wall (Crawford et al., 2003; Brown & Powell, 
1999). Higher systolic as well as diastolic blood pressure has been found in aneurysm 
patients. When combined with a history of smoking and a positive family history, the 
association becomes even stronger (Franks et al., 1996; Kishi et al., 1997). With 
uncomplicated hypertension, screening is generally not indicated, but in the case of low 
back pain, especially when no apparent cause is found, careful physical examination is 
indicated (Crawford et al., 2003). Since hypertension can be influenced, it is especially 
important to regulate blood pressure in patients with smaller AAAs.  Hyperlipidemia and 
atherosclerosis generally increase the risk of complications within the cardiovascular 
system, and with this increases the risk of AAA (United Kingdom Small Aneurysm Trial 
Participants, 2002; Mechelli et al., 2008; Patel & Kettner, 2006). Medication is said to be 
necessary to reduce the rate of expansion of aneurysms, even though no medical treatment 
has shown to influence this rate over time (Thompson et al., 2009). 
Diabetes actually decreases the risk for AAA, even though it increases the risk for 
atherosclerosis (Lederle et al., 2000; Brady et al., 2004). Its effect is not yet fully understood, 
but the release of proteolytic enzymes and cytokines is implicated and the inhibitory effect 
of diabetes on this process may be a factor in the pathogenesis of AAA (Golledge et al., 
2008). Certain infectious and inflammatory conditions are known to weaken the aortic wall. 
Diseases like Takayasu’s disease and Marfan’s syndrome can cause cystic medial necrosis, 
also causing weakening of the aortic wall, which predisposes to aneurysms (Hadida & 
Rajwani, 1998). 
4. Signs in clinical examination  
The usefulness of the clinical examination to detect AAA is limited. However, abdominal 
palpation and auscultation are important, especially when there is a suspicion of a non-
mechanical or abdominal pathology for low back pain or when patients do not respond to 
the treatment. Most non-ruptured AAAs are asymptomatic, apart from a pulsating mass in 
the abdomen (Engel, 1996). There is a difference in chronic and acute rupture. Chronic is 
often misdiagnosed as back pain, spinal cord compression or more unusual presentations 
(Al-Koteesh et al, 2005). Acute rupture more often gives pain as described in the history 
findings. 
Blood pressure in most cases will be either normal or high (Crawford et al., 2003; Hadida & 
Rajwani, 1998; Ahlawat & Cuddihy, 2002; Yokomuro et al, 2008; Cates, 1997). Pulse rate and 
rhythm are generally normal. In case of a ruptured aneurysm, there is often hypotension 
with a high pulse rate (Van der Velde, 1998). 
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2002; Cates, 1997). Association of certain collagen diseases, such as Marfan’s syndrome and 
Ehler-Danlos type IV syndrome do seem to suggest a gene defect (Van der Velde, 1998). 
3.4 Other risk factors 
Coexisting conditions like cardiovascular disease can have an influence on the elasticity of 
the arteries, thereby causing weakening of the aortic wall. In the case of inflammatory AAA, 
10-47% of patients have been reported to have arterial occlusive disease (Ahlawat & 
Cuddihy, 2002). Several authors have reported the presence of cerebral arterial disease, 
 
Presentation of Abdominal Aortic Aneurysm in Clinical Practice, a Review 
 
19 
peripheral aneurysms or claudication as a sign in the clinical history demanding further 
questioning and examination. At least a third of patients with femoral or popliteal 
aneurysms will have an AAA (Karkos et al, 2000; Crawford et al., 2003; Patel & Kettner, 
2006). Suspicion is raised when a patient comes in with low back pain and mentions a 
history of myocardial infarction (Crawford et al., 2003). A history of coronary artery disease 
also carries an increased risk (OR 1.52; 95% CI: 1.37 to 1.68)(Lederle et al., 2000). 
Hypertension and older age are more strongly associated with AAA than with coronary 
artery disease even though risk factors of coronary artery disease show overlap with those 
of AAA (Kishi et al., 1997). Hypertension is associated both with increased risk of rupture as 
well as increased prevalence of AAA. It is a continuing haemodynamic burden on the aortic 
wall, which may further weaken the aortic wall (Crawford et al., 2003; Brown & Powell, 
1999). Higher systolic as well as diastolic blood pressure has been found in aneurysm 
patients. When combined with a history of smoking and a positive family history, the 
association becomes even stronger (Franks et al., 1996; Kishi et al., 1997). With 
uncomplicated hypertension, screening is generally not indicated, but in the case of low 
back pain, especially when no apparent cause is found, careful physical examination is 
indicated (Crawford et al., 2003). Since hypertension can be influenced, it is especially 
important to regulate blood pressure in patients with smaller AAAs.  Hyperlipidemia and 
atherosclerosis generally increase the risk of complications within the cardiovascular 
system, and with this increases the risk of AAA (United Kingdom Small Aneurysm Trial 
Participants, 2002; Mechelli et al., 2008; Patel & Kettner, 2006). Medication is said to be 
necessary to reduce the rate of expansion of aneurysms, even though no medical treatment 
has shown to influence this rate over time (Thompson et al., 2009). 
Diabetes actually decreases the risk for AAA, even though it increases the risk for 
atherosclerosis (Lederle et al., 2000; Brady et al., 2004). Its effect is not yet fully understood, 
but the release of proteolytic enzymes and cytokines is implicated and the inhibitory effect 
of diabetes on this process may be a factor in the pathogenesis of AAA (Golledge et al., 
2008). Certain infectious and inflammatory conditions are known to weaken the aortic wall. 
Diseases like Takayasu’s disease and Marfan’s syndrome can cause cystic medial necrosis, 
also causing weakening of the aortic wall, which predisposes to aneurysms (Hadida & 
Rajwani, 1998). 
4. Signs in clinical examination  
The usefulness of the clinical examination to detect AAA is limited. However, abdominal 
palpation and auscultation are important, especially when there is a suspicion of a non-
mechanical or abdominal pathology for low back pain or when patients do not respond to 
the treatment. Most non-ruptured AAAs are asymptomatic, apart from a pulsating mass in 
the abdomen (Engel, 1996). There is a difference in chronic and acute rupture. Chronic is 
often misdiagnosed as back pain, spinal cord compression or more unusual presentations 
(Al-Koteesh et al, 2005). Acute rupture more often gives pain as described in the history 
findings. 
Blood pressure in most cases will be either normal or high (Crawford et al., 2003; Hadida & 
Rajwani, 1998; Ahlawat & Cuddihy, 2002; Yokomuro et al, 2008; Cates, 1997). Pulse rate and 
rhythm are generally normal. In case of a ruptured aneurysm, there is often hypotension 
with a high pulse rate (Van der Velde, 1998). 
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On visual inspection, a pulsatile mass may be visible at or slightly above the umbilicus in 
the epigastrium (Patel & Kettner, 2006; Hadida & Rajwani, 1998). Ecchymosis may be 
present as an atypical finding. This may be somewhere over the abdomen, but can appear as 
low as the scrotum or popliteal fossa (Dargin & Lowenstein, 2008). 
Palpation of the lower extremity pulses is also important, even though it is often 
unremarkable (Thorkeldsen, 1993; Yochum, 1994; Yokomuro et al, 2008; Donahue, 1997; 
Engel, 1996). Peripheral aneurysms increases suspicion of AAA; absent pulses may indicate 
atherosclerosis: another risk factor for AAA (Patel & Kettner, 2006; Pierce, 1998). The 
abdominal aorta can be palpated at or slightly above the umbilicus in the epigastrium in the 
supine position with the knees bent. In the case of AAA, a prominent and often nontender, 
mass with pulsations or thrills is felt in the coronal as well as the sagittal plane (Ahlawat & 
Cuddihy, 2002; Patel & Kettner, 2006; Hadida & Rajwani, 1998; Pierce, 1998). Pulsations of 
an AAA tend to push more laterally than anteriorly (Cates, 1997).  
In thin people, an abdominal pulse can easily be felt. But the accuracy of detecting AAA is 
dependent upon the patient's girth as well as the size of the aneurysm. When the patient's 
girth is 100 cm or greater, very few AAAs are palpable. However, as aneurysm size 
increases, the chance of clinical detection increases. The sensitivity of detecting an AAA 
with a diameter greater than 5cm in a patient with an abdominal girth of less than 100cm is 
100%, but this percentage decreases quickly with a smaller aneurysm (Fink et al., 2000). 
Karkos et al. (2000) found that physical examination missed more than a third of those 
detected radiologically, but they also say that clinical examination still plays a paramount 
role in the detection of AAAs. Physical examination cannot be relied upon to exclude AAA. 
If the history has enough signs and risk factors present, a referral for an ultrasound 
evaluation may be warranted (Lynch, 2004). 
Another screening tool for AAA that is always mentioned is auscultation for an abdominal 
or femoral bruit. Lederle et al. found that it does not contribute to the diagnosis of AAA. It 
is, however, part of the routine in many case reports. A negative physical exam in a patient 
with a girth of more than 100 cm with risk factors of AAA present still warrants referral for 
ultrasound evaluation (Ahlawat & Cuddihy, 2002; Mechelli et al., 2008; Hadida & Rajwani, 
1998; Pierce, 1998). 
5. Implications for treatment of the accompanying musculoskeletal 
complaints  
The significance of AAA to the therapist treating the patient is the potential for rupture 
during treatment (Beck et al., 2005). In the case of a large AAA, lumbar spinal manipulative 
therapy is an absolute contra-indication.  It is, however, likely that patients with smaller 
AAAs and mechanical low back pain are receiving spinal manipulative therapy. Knowing 
the prevalence of AAA, it seems reasonable to assume that many patients have been treated 
without detrimental effect. It is, however, important to modify the techniques for patients 
who are considered at high risk after history taking. It is advised to minimize torsional 
stress to the lumbar spine and use more graded mobilisation or manipulation during 
exhalation, to decrease the intra-abdominal pressure (Weston, 1995). In the clinical setting, 
management of patients with AAA is limited (Pierce, 1998). A delay in referral in order to 
offer a trial of spinal manipulative care is unacceptable (Crawford et al., 2003). Table 1 gives 
an outline of the steps to be taken in clinical practice. 
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history                
of low back or 
abdominal pain 




check for risk factors*








yes  ↓  yes ↓     
possible symptomatic 









refer for further 
investigation 
  
no ↓  no ↓     
physical examination~ no   
→




AAA not excluded 
as differential 




yes ↓  no ↓     
possible AAA: refer for 
further investigation 
 AAA not likely     
       
~ physical examination includes: blood pressure, pulsating mass in abdomen, peripheral aneurysm 
* risk factors include: age over 50, male gender, Caucasian, smoking, positive family history, co-
existing cardiovascular disease 
Table 1. Flow sheet Aortic Abdominal Aneurysm in clinical practice 
6. Conclusion 
Abdominal aortic aneurysms can be very difficult to identify. Careful history taking and 
case finding is important to decrease the chance of missing the diagnosis. Presentation can 
vary from totally asymptomatic to excruciating pain. Combining these with the risk factors 
gender, age, history of smoking and family history of AAA will furnish a good indication 
for the physical examination and possible referral for further screening. 
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ultrasound evaluation (Ahlawat & Cuddihy, 2002; Mechelli et al., 2008; Hadida & Rajwani, 
1998; Pierce, 1998). 
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1. Introduction 
A fast-growing body of literature is providing evidence in favor of screening men for 
abdominal aortic aneurysm (AAA). Several large, randomized trials published in the past 
few years have consistently shown that screening reduces AAA-related mortality.18 
2. Cost-effectiveness of screening 
Longer-term mortality benefit and cost-effectiveness for abdominal aortic aneurysm (AAA) 
screening are uncertain.18 
In addition to the mortality benefit, evidence indicating that screening is highly cost-
effective is increasing.2, 34 In light of this evidence, national screening programs are now 
being considered in many countries.47, 46 
However, there is little evidence regarding long-term outcomes after AAA screening; almost 
all of the evidence from randomized trials is limited to the first 4 years after screening.18 
It is therefore expected that cost-effectiveness of screening will improve over time.18 
It is expected that the lifetime cost-effectiveness of screening will be highly favorable. 
Furthermore, these results show that the mortality benefit of an approximate 50% reduction 
in AAA-related death in patients invited to be screened is maintained at 7-year follow-up. 
The risk for AAA rupture remains low in patients with normal results on initial screening.18 
Patients with AAA detected in selective screening at the vascular laboratory had a high level 
of morbidity and inferior long-term survival when compared with the general population. 
Elective AAA repair rate was lower in this group than in patients with AAA detected in 
general screening programmes, with an acceptable perioperative mortality rate. Despite 
these factors, selective screening for AAA among patients referred to the vascular laboratory 
for suspected arterial disease was cost-effective under most assumptions with an estimated 
ICER at base-case of 11 084 Euro/LYG compared with non-screening.28 
Screening appears to reduce hospital AAA mortality and to be cost-effective.25 
The benefit of inviting men aged 65-74 to screening for abdominal aortic aneurysm 
continues at about the same rate 7-10 years after screening, as observed in previous years. 
The reduction in number of deaths related to abdominal aortic aneurysm in MASS is 
estimated as 42% at four years34, 47% at seven years18, and now 48% at 10 years. This is 
surprising as it might be expected that ruptures of the aneurysm in those originally screened 
as normal and incidental detection of abdominal aortic aneurysm in the control group 
would erode the benefit over time.45 
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A crucial problem is the extent to which those screened as normal will go on to develop an 
aneurysm that ruptures and whether rescreening of participants after a normal scan is 
justified at any stage.45 
Women are generally not considered a suitable target population for abdominal aortic 
aneurysm (AAA) screening. The main reason is not only the low prevalence of AAA but 
also a development of the disease later in life and an inferior relative long-term survival in 
women with AAA. However, other aspects of the disease, such as the higher rupture rate, 
indicate that AAA in women may be more severe than in men. Screening reduced the AAA 
rupture incidence by 33% and the AAA-related death rate by 35%. The cost per life year 
gained was estimated at $5911. The incremental cost-effectiveness ratio was similar to that 
found for screening men, which reflects the fact that the lower AAA prevalence in women is 
balanced by a higher rupture rate. Screening women for AAA may be cost-effective, and 
future evaluations on screening for AAA should include women.50 
Cost-effectiveness was rather insensitive to variations in prevalence >1%. Below this level, 
however, the cost per life year gained increased rapidly.50 
The rupture rate has a large impact on the cost-effectiveness of a screening program,10 and 
the higher rupture rate among women compensates for the lower prevalence and reduces 
the cost per life year saved by 64%.49 
The sensitivity analysis showed, however, that the incremental cost per life year gained was 
lower than what is generally considered cost-effective, even if the rupture rate among 
women with AAA was assumed to be the same as for men.50 
The life expectancy of the screened individuals is a key variable for the cost-effectiveness 
ratio.49 
The incremental cost per life year gained for screening all 65-year-old women for AAA was 
lower than what is generally considered cost-effectiveand was similar to that for screening 
men at the same age.This reflects the fact that in women, a low prevalence is balanced by a 
high rupture rate.50 
3. Treatment decisions  
The major problem with AAAs is the risk of rupture. AAA is often asymptomatic and if left 
undetected they will continue to expand and may eventually rupture.11 
Decisions about the treatment of AAAs are traditionally based upon the maximum cross-
sectional diameter. If the AAA diameter is 5.5 cm or larger then intervention is generally 
deemed appropriate.11 The diameter of an AAA is a well established objective criterion for 
selecting patients for treatment and when assessing the results following endovascular 
repair.11 
New treatments for abdominal aortic aneurysm may impact on a national screening 
programme and increase its effectiveness. Endovascular repair of aneurysms rather than 
conventional open repair is now used more widely for elective surgery but was used for 
only 9% of the elective procedures in MASS. In patients who are fit for open repair, and 
anatomically suitable for endovascular repair, endovascular repair has lower operative 
mortality than open repair and fewer deaths related to abdominal aortic aneurysm in the 
longer term10, 12, 13, 21; it may therefore be preferred by both patients and surgeons. Reliable 
evidence comparing endovascular repair of abdominal aortic aneurysms with open repair is 
currently available only up to four years of follow-up; it shows no difference in all cause 
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mortality21 but a substantial incidence of graft problems (for example, leaks around the graft 
or movement of the graft) and need for reinterventions after endovascular repair.13, 10 
The quality of life data collected in the trial around the time of screening showed no clear 
adverse or beneficial effects of screening or any long term effects after surgery.34, 29 
Patients with a detected AAA have yearly revisits to follow the expansion of the aneurysm. 
They are offered elective open surgery, if they are healthy enough, when the AAA has 
grown to >55 mm, has expanded rapidly, or has caused symptoms. Some patients with 
detected AAA fulfill the criteria for elective surgery at the time of screening and will be 
offered surgery as soon as possible.50 
4. Age and screening 
The prevalence also depends on the age of the screened population. However, the present 
lack of age-specific prevalence data in women makes a more precise analysis of the optimal 
screening age difficult.50 
The results suggest that aortic screening may be worthwhile extending to a wider age band. 
By focusing follow-up, this should give greater value for younger men in terms of 
community productivity and allows for selective intervention in the elderly.32 
The United States Preventative Services Task Force (USPSTF) recommends one-time 
screening for AAAs in men 65 to 75 years of age who have ever smoked and recommends 
against routine screening in women, and the Screening Abdominal Aortic Aneurysms Very 
Efficiently Act supports only a screening program for AAA in male ever- smokers when 
they turn 65 years old.5 
The mortality benefit of screening men aged 65-74 for abdominal aortic aneurysm is 
maintained up to 10 years and cost effectiveness becomes more favourable over time. To 
maximise the benefit from a screening programme, emphasis should be placed on achieving 
a high initial rate of attendance and good adherence to clinical follow-up, preventing delays 
in undertaking surgery, and maintaining a low operative mortality after elective surgery. 
On the basis of current evidence, rescreening of those originally screened as normal is not 
justified.45 
The reduced benefit of screening elderly males is due to the reduced life expectancy and to 
the demonstrated increased mortality after AAA repair.30 
5. Sex and screening 
Among men, the rupture risk of an AAA was estimated at 0.8% per year among those with 
an AAA attending a screening and 1.9% among those with an AAA not attending a 
screening or not invited to a screening.49 Women were estimated to have a threefold higher 
rupture risk than men.37 Thus, the corresponding annual rupture risks were 2.4% and 5.7%, 
respectively, for women with AAA. Sixty-five percent of men with ruptured AAA die before 
surgery, and an additional 14% die during surgery, corresponding to an operative mortality 
of 40%.49The rate of surgery for ruptured AAA was lower for women50 and the operative 
mortality was higher. Thus, the total mortality for AAA rupture was estimated at 86.3% for 
women compared with 79% for men.50 
The Chichester screening trial is the only published evaluation of screening for AAA in 
women. Some 9342 women aged 65 to 80 years (mean age, 72 years) were randomized, with 
no difference in rupture rate between the screened and the control groups after 10 years 
Diagnosis and Treatment of Abdominal and Thoracic Aortic  
Aneurysms Including the Ascending Aorta and the Aortic Arch 
 
26
A crucial problem is the extent to which those screened as normal will go on to develop an 
aneurysm that ruptures and whether rescreening of participants after a normal scan is 
justified at any stage.45 
Women are generally not considered a suitable target population for abdominal aortic 
aneurysm (AAA) screening. The main reason is not only the low prevalence of AAA but 
also a development of the disease later in life and an inferior relative long-term survival in 
women with AAA. However, other aspects of the disease, such as the higher rupture rate, 
indicate that AAA in women may be more severe than in men. Screening reduced the AAA 
rupture incidence by 33% and the AAA-related death rate by 35%. The cost per life year 
gained was estimated at $5911. The incremental cost-effectiveness ratio was similar to that 
found for screening men, which reflects the fact that the lower AAA prevalence in women is 
balanced by a higher rupture rate. Screening women for AAA may be cost-effective, and 
future evaluations on screening for AAA should include women.50 
Cost-effectiveness was rather insensitive to variations in prevalence >1%. Below this level, 
however, the cost per life year gained increased rapidly.50 
The rupture rate has a large impact on the cost-effectiveness of a screening program,10 and 
the higher rupture rate among women compensates for the lower prevalence and reduces 
the cost per life year saved by 64%.49 
The sensitivity analysis showed, however, that the incremental cost per life year gained was 
lower than what is generally considered cost-effective, even if the rupture rate among 
women with AAA was assumed to be the same as for men.50 
The life expectancy of the screened individuals is a key variable for the cost-effectiveness 
ratio.49 
The incremental cost per life year gained for screening all 65-year-old women for AAA was 
lower than what is generally considered cost-effectiveand was similar to that for screening 
men at the same age.This reflects the fact that in women, a low prevalence is balanced by a 
high rupture rate.50 
3. Treatment decisions  
The major problem with AAAs is the risk of rupture. AAA is often asymptomatic and if left 
undetected they will continue to expand and may eventually rupture.11 
Decisions about the treatment of AAAs are traditionally based upon the maximum cross-
sectional diameter. If the AAA diameter is 5.5 cm or larger then intervention is generally 
deemed appropriate.11 The diameter of an AAA is a well established objective criterion for 
selecting patients for treatment and when assessing the results following endovascular 
repair.11 
New treatments for abdominal aortic aneurysm may impact on a national screening 
programme and increase its effectiveness. Endovascular repair of aneurysms rather than 
conventional open repair is now used more widely for elective surgery but was used for 
only 9% of the elective procedures in MASS. In patients who are fit for open repair, and 
anatomically suitable for endovascular repair, endovascular repair has lower operative 
mortality than open repair and fewer deaths related to abdominal aortic aneurysm in the 
longer term10, 12, 13, 21; it may therefore be preferred by both patients and surgeons. Reliable 
evidence comparing endovascular repair of abdominal aortic aneurysms with open repair is 
currently available only up to four years of follow-up; it shows no difference in all cause 
 
Screening for Abdominal Aortic Aneurysm 
 
27 
mortality21 but a substantial incidence of graft problems (for example, leaks around the graft 
or movement of the graft) and need for reinterventions after endovascular repair.13, 10 
The quality of life data collected in the trial around the time of screening showed no clear 
adverse or beneficial effects of screening or any long term effects after surgery.34, 29 
Patients with a detected AAA have yearly revisits to follow the expansion of the aneurysm. 
They are offered elective open surgery, if they are healthy enough, when the AAA has 
grown to >55 mm, has expanded rapidly, or has caused symptoms. Some patients with 
detected AAA fulfill the criteria for elective surgery at the time of screening and will be 
offered surgery as soon as possible.50 
4. Age and screening 
The prevalence also depends on the age of the screened population. However, the present 
lack of age-specific prevalence data in women makes a more precise analysis of the optimal 
screening age difficult.50 
The results suggest that aortic screening may be worthwhile extending to a wider age band. 
By focusing follow-up, this should give greater value for younger men in terms of 
community productivity and allows for selective intervention in the elderly.32 
The United States Preventative Services Task Force (USPSTF) recommends one-time 
screening for AAAs in men 65 to 75 years of age who have ever smoked and recommends 
against routine screening in women, and the Screening Abdominal Aortic Aneurysms Very 
Efficiently Act supports only a screening program for AAA in male ever- smokers when 
they turn 65 years old.5 
The mortality benefit of screening men aged 65-74 for abdominal aortic aneurysm is 
maintained up to 10 years and cost effectiveness becomes more favourable over time. To 
maximise the benefit from a screening programme, emphasis should be placed on achieving 
a high initial rate of attendance and good adherence to clinical follow-up, preventing delays 
in undertaking surgery, and maintaining a low operative mortality after elective surgery. 
On the basis of current evidence, rescreening of those originally screened as normal is not 
justified.45 
The reduced benefit of screening elderly males is due to the reduced life expectancy and to 
the demonstrated increased mortality after AAA repair.30 
5. Sex and screening 
Among men, the rupture risk of an AAA was estimated at 0.8% per year among those with 
an AAA attending a screening and 1.9% among those with an AAA not attending a 
screening or not invited to a screening.49 Women were estimated to have a threefold higher 
rupture risk than men.37 Thus, the corresponding annual rupture risks were 2.4% and 5.7%, 
respectively, for women with AAA. Sixty-five percent of men with ruptured AAA die before 
surgery, and an additional 14% die during surgery, corresponding to an operative mortality 
of 40%.49The rate of surgery for ruptured AAA was lower for women50 and the operative 
mortality was higher. Thus, the total mortality for AAA rupture was estimated at 86.3% for 
women compared with 79% for men.50 
The Chichester screening trial is the only published evaluation of screening for AAA in 
women. Some 9342 women aged 65 to 80 years (mean age, 72 years) were randomized, with 
no difference in rupture rate between the screened and the control groups after 10 years 
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follow-up. The authors concluded that it was neither clinically indicated nor economically 
rational to screen women.40 However, a possible limitation that is likely to counteract the 
possible benefits of screening women is the biased mortality data based on official statistics. 
With a low autopsy rate, the reliability is limited in determining mortality rate from 
ruptured AAA. The autopsy rate has decreased to an overall 11% in Sweden, and is almost 
nonexistent among women >80 years old.1 
Among 2257 AAA patients enrolled in the UK Small Aneurysm Trial (UKSAT) or Small 
Aneurysm Study, the risk of rupture was, independently of age and initial AAA diameter, 
associated with female sex. The rupture rate was three times higher in women compared 
with men. 37 
Only one RCT, the Chichester trial, included women (n = 9342) aged 65–80 years old. In this 
trial, the prevalence of AAA >3 cm among women (1.3%) was substantially lower than in 
men (7.6%). The subgroup analysis addressing the effect of screening in women concluded 
that screening followed by surgery did not reduce mortality.41 
In women, the incidence of ruptured AAA was similar in the control and screening groups, 
and in general the incidence of death from ruptured aneurysm increased with age, since 
more than 70% of ruptures occurred among women > 80 years.41 
On the basis of the low prevalence of AAA in women and the unfavorable RR, screening of 
women may not be beneficial or cost effective.41 
The evidence available from the Chichester trial regarding the effect of population screening 
in women should be considered with caution because of the possibility of confounding 
factors or biases. The gender analysis was a subgroup analysis and, as expected, the number 
of participating women was considerably lower than men. Since the risk factors associated 
with increased risk for surgery are the same as those associated with increased incidence of 
AAAs, it is possible that many women were excluded, giving a falsely lower incidence of 
AAAs (ascertainment bias).5 
Before making a final decision on the effectiveness of AAA screening in women, a number 
of features unique to women should be considered. The lower prevalence of AAA in women 
is most likely due to their lower burden of risk factors compared with men. The evidence 
supports that like in men, for women the probability of AAAs is increased among smokers 
(odds ratio (OR) 3.8), those aged >70 years (OR 1.8), family history (OR 2.6), and pre-existing 
cerebrovascular disease (OR 3.20).20 
Like coronary heart disease, the increase in prevalence of AAA among women appears to 
occur approximately one decade after men. Because of this 10-year delay in onset, and lower 
burden of AAAs likely due to the currently more favorable cardiovascular risk factor profile 
of women, the cost effectiveness of screening and repair of AAA to prevent death does not 
favor screening at present.5 
However, we must also consider the observation that although women have a lower 
incidence of AAA, when they are found to have an AAA > 3 cm the risk of rupture is greater 
than that of men, 33, 6 and mortality associated with surgery for ruptured aortic aneurysms is 
higher compared with that in men.41 
This higher risk of rupture in women may be because the prevalence of the disease was 
defined as an aorta with a diameter >3 cm, which is the usual threshold used for men, and it 
does not take into account the smaller size of a normal aorta in women. Thus, an aneurysm 
of 5 cm in a woman may have a higher rupture rate because it is equivalent to an aneurysm 
of 6 cm in a man. Given the state of the evidence, a number of outstanding issues should be 
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considered for the screening of AAA in women. First, the evidence does not support 
population-based screening over 65 years of age, due to the low incidence of AAA. 
However, it would be reasonable to recommend targeted screening of ‘higher risk 
women’, including those of an older age, who are current or had a long history of 
smoking, as well as those with co-existing vascular disease.5 
In men, an AAA diameter of 55 mm generally justifies elective repair, whereas it has been 
suggested that women may benefit from a lower threshold for surgery. A lower threshold 
diameter for surgical repair in women (≤50 mm) may reduce the difference in surgery rate 
and the likelihood of an AAA to rupture. In the UKSAT, the mean AAA diameter at rupture 
was 50 mm for women and 60 mm for men. They concluded that different thresholds should 
apply to women than men when AAA repair is being considered.37 In the Chichester trial, 
however, a threshold diameter of 60 mm did not result in higher rupture rate.40 
The relative long-term survival after surgery for AAA was found to be better in men than in 
women, although the crude long-term survival was similar between men and women, 
because women in general have a longer life expectancy. The assumed additional relative 
mortality in women with AAA compared with men increased the cost per life years saved 
by 30%.50 
the decrease in AAA-specific mortality among women invited to screening was only 32% 
compared with 50% among men. The explanation lies in the complex relations between 
mortality, risk of rupture, and risk of elective surgery. If women had an identical 
compliance and rupture rate as men, the model would generate a decrease in AAA-specific 
mortality of 43%.50 
6. Size of aneurysm 
Within group of detected aneurysms, surveillance involved rescanning: annually for those 
with diameters of 3.0-4.4 cm and every three months for those of 4.5-5.4 cm. Patients were 
referred to a hospital outpatient clinic for possible elective surgery when the aneurysm 
reached 5.5 cm, the aneurysm had expanded by 1.0 cm or more in one year, or symptoms 
attributable to the aneurysm were reported.45 
The prevalence of the disease is, however, highly dependent on the definition used.26 In 
most population-based screening studies including women, an AAA was defined as the 
maximum infrarenal aortic diameter being ≥30 mm, as proposed by McGregor.31 Because 
the normal aortic diameter differs by gender,44 a fixed diameter may not be an optimal 
definition of AAA and may partly explain the differences seen in prevalence between men 
and women. 
In the Chichester trial, four of the 10 women from the screened group who had AAA 
rupture or emergency repair  initially had a normal scan.40 This may be the result of how an 
AAA was defined, where a fixed diameter may result in false-negative findings, or a 
consequence of the natural history of AAA development among women. 
7. Rescreening 
Two of the RCTs looked at the need for rescreening in individuals with <3 cm AAA: the 
Viborg trial repeated an ultrasound examination (USE) 3 to 5 years after the first one and 
found that new AAA > 3 cm occurred in 28% (95% CI 21-35), but none were clinically 
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follow-up. The authors concluded that it was neither clinically indicated nor economically 
rational to screen women.40 However, a possible limitation that is likely to counteract the 
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ruptured AAA. The autopsy rate has decreased to an overall 11% in Sweden, and is almost 
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trial, the prevalence of AAA >3 cm among women (1.3%) was substantially lower than in 
men (7.6%). The subgroup analysis addressing the effect of screening in women concluded 
that screening followed by surgery did not reduce mortality.41 
In women, the incidence of ruptured AAA was similar in the control and screening groups, 
and in general the incidence of death from ruptured aneurysm increased with age, since 
more than 70% of ruptures occurred among women > 80 years.41 
On the basis of the low prevalence of AAA in women and the unfavorable RR, screening of 
women may not be beneficial or cost effective.41 
The evidence available from the Chichester trial regarding the effect of population screening 
in women should be considered with caution because of the possibility of confounding 
factors or biases. The gender analysis was a subgroup analysis and, as expected, the number 
of participating women was considerably lower than men. Since the risk factors associated 
with increased risk for surgery are the same as those associated with increased incidence of 
AAAs, it is possible that many women were excluded, giving a falsely lower incidence of 
AAAs (ascertainment bias).5 
Before making a final decision on the effectiveness of AAA screening in women, a number 
of features unique to women should be considered. The lower prevalence of AAA in women 
is most likely due to their lower burden of risk factors compared with men. The evidence 
supports that like in men, for women the probability of AAAs is increased among smokers 
(odds ratio (OR) 3.8), those aged >70 years (OR 1.8), family history (OR 2.6), and pre-existing 
cerebrovascular disease (OR 3.20).20 
Like coronary heart disease, the increase in prevalence of AAA among women appears to 
occur approximately one decade after men. Because of this 10-year delay in onset, and lower 
burden of AAAs likely due to the currently more favorable cardiovascular risk factor profile 
of women, the cost effectiveness of screening and repair of AAA to prevent death does not 
favor screening at present.5 
However, we must also consider the observation that although women have a lower 
incidence of AAA, when they are found to have an AAA > 3 cm the risk of rupture is greater 
than that of men, 33, 6 and mortality associated with surgery for ruptured aortic aneurysms is 
higher compared with that in men.41 
This higher risk of rupture in women may be because the prevalence of the disease was 
defined as an aorta with a diameter >3 cm, which is the usual threshold used for men, and it 
does not take into account the smaller size of a normal aorta in women. Thus, an aneurysm 
of 5 cm in a woman may have a higher rupture rate because it is equivalent to an aneurysm 
of 6 cm in a man. Given the state of the evidence, a number of outstanding issues should be 
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considered for the screening of AAA in women. First, the evidence does not support 
population-based screening over 65 years of age, due to the low incidence of AAA. 
However, it would be reasonable to recommend targeted screening of ‘higher risk 
women’, including those of an older age, who are current or had a long history of 
smoking, as well as those with co-existing vascular disease.5 
In men, an AAA diameter of 55 mm generally justifies elective repair, whereas it has been 
suggested that women may benefit from a lower threshold for surgery. A lower threshold 
diameter for surgical repair in women (≤50 mm) may reduce the difference in surgery rate 
and the likelihood of an AAA to rupture. In the UKSAT, the mean AAA diameter at rupture 
was 50 mm for women and 60 mm for men. They concluded that different thresholds should 
apply to women than men when AAA repair is being considered.37 In the Chichester trial, 
however, a threshold diameter of 60 mm did not result in higher rupture rate.40 
The relative long-term survival after surgery for AAA was found to be better in men than in 
women, although the crude long-term survival was similar between men and women, 
because women in general have a longer life expectancy. The assumed additional relative 
mortality in women with AAA compared with men increased the cost per life years saved 
by 30%.50 
the decrease in AAA-specific mortality among women invited to screening was only 32% 
compared with 50% among men. The explanation lies in the complex relations between 
mortality, risk of rupture, and risk of elective surgery. If women had an identical 
compliance and rupture rate as men, the model would generate a decrease in AAA-specific 
mortality of 43%.50 
6. Size of aneurysm 
Within group of detected aneurysms, surveillance involved rescanning: annually for those 
with diameters of 3.0-4.4 cm and every three months for those of 4.5-5.4 cm. Patients were 
referred to a hospital outpatient clinic for possible elective surgery when the aneurysm 
reached 5.5 cm, the aneurysm had expanded by 1.0 cm or more in one year, or symptoms 
attributable to the aneurysm were reported.45 
The prevalence of the disease is, however, highly dependent on the definition used.26 In 
most population-based screening studies including women, an AAA was defined as the 
maximum infrarenal aortic diameter being ≥30 mm, as proposed by McGregor.31 Because 
the normal aortic diameter differs by gender,44 a fixed diameter may not be an optimal 
definition of AAA and may partly explain the differences seen in prevalence between men 
and women. 
In the Chichester trial, four of the 10 women from the screened group who had AAA 
rupture or emergency repair  initially had a normal scan.40 This may be the result of how an 
AAA was defined, where a fixed diameter may result in false-negative findings, or a 
consequence of the natural history of AAA development among women. 
7. Rescreening 
Two of the RCTs looked at the need for rescreening in individuals with <3 cm AAA: the 
Viborg trial repeated an ultrasound examination (USE) 3 to 5 years after the first one and 
found that new AAA > 3 cm occurred in 28% (95% CI 21-35), but none were clinically 
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significant (the largest <48 mm); and the Chichester trial rescreened patients with aortic 
diameter <3 cm every 2 years and identified 4.1% AAA, which were all <3.8 cm in 
diameter.30  
Recommending rescreening those with an initial normal scan would only become justified 
in subsequent years if future analyses show that there is a further noticeable increase in 
ruptures in this group that is not sufficiently offset by the reduction in number of deaths 
related to abdominal aortic aneurysm for those with an aneurysm detected (or rendered 
unimportant by the overall toll of mortality from all causes).45 
8. Psychological effects of screening 
The offer of screening causes transient psychological stress in subjects found not to have 
AAA. However, diagnosis of an AAA seems to impair QL permanently and progressively in 
conservatively treated cases. This impairment seems reversible by operation. Nevertheless, 
the impairment seems considerable, and must be considered in the management of AAA 
and in the final evaluation of screening for AAA. 26 
Several concerns have been raised about the utility of population-based screening for AAA. 
It has been proposed that patients who are found to have “small” aneurysms will experience 
a diminished quality of life related to concern about rupture.17 
For strategies toward other target groups, and management of small AAAs, prediction 
models and cost-effectiveness analyses are needed to provide guidance.14 
9. Family history  and screening 
The ADAM study found that a family history positive for presence of AAA is associated 
with a two-fold increase in the risk of having an AAA with no difference between men and 
women.30 
Familial AAA do not expand faster nor are they associated with unusual locations, but they 
may occur earlier in life. Screening causes psychological side effects, and it could therefore 
be offered to male first-degree relatives from the age of 60, and be confined to 
ultrasonographic scanning of the infrarenal abdominal aorta at five-year intervals. 23 
Aging brothers of patients with known abdominal aortic aneurysm have the highest risk for 
developing the disease; the prevalence of the disease in siblings older than 60 years of age is 
18%.39 
Ultrasonographic screening is recommended in brothers (50 years) of patients with 
aneurysms of the abdominal aorta.4 
10. Screening methods 
10.1 Physical examination 
A focused physical examination has been investigated as a screening tool to identify AAA. 
Sensitivity has been reported in the range of 76% to 85% and specificity 85% for AAA >5 cm 
with moderate interobserver agreement (kappa = 0.5).31 The diagnostic properties of 
physical examination require further investigation.30 
10.2 Ultrasonography 
Ultrasonography is the detection method of choice for AAA screening: it is cheap and 
noninvasive and can be used easily in a community setting.36 
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Results from a large, pragmatic randomized trial show that the early mortality benefit of 
screening ultrasonography for AAA is maintained in the longer term and that the cost-
effectiveness of screening improves over time.18 
Ultrasound screening to identify abdominal aortic aneurysms (AAA) >5cm followed by 
surgery reduces cause-specific mortality among individuals older than 65 years. This benefit 
is not apparent among men older than 75 years, 5 and there is some controversy regarding 
the benefit of screening for AAA among women.5 
The United Kingdom Multicentre Aneurysm Screening Study (MASS) 18,46 has provided most 
of the worldwide randomised evidence for the mortality benefit after ultrasound screening 
for abdominal aortic aneurysm.8, 16 The UK screening programme for men aged 65 is based 
closely on the protocol and procedures in MASS. Some uncertainties relating to screening 
remain, however, including its long term benefit in terms of mortality and cost effectiveness, 
whether rescreening those with a previously normal scan is warranted, and the extent to 
which incidental detection of abdominal aortic aneurysm erodes the benefit of a systematic 
screening policy over time. It might be expected that the mortality benefit seen in the early 
years after one-off screening would decrease over time. MASS, started in 1997, runs more 
than 10 years ahead of the UK national screening programme and is uniquely positioned to 
tackle these uncertainties and to inform the development of the national programme.45 
The neck of the aneurysm and suprarenal aorta might be more difficult to visualize with 
ultrasonography, and most ultrasound screening studies report only the maximum anterior-
posterior diameter. However, ultrasonography also can provide information about the size 
and shape of the luminal thrombus in an AAA and the presence of iliac aneurysms.36 
It is able to define the diameter of the infrarenal aorta in 98% (95% CI 92-94) of individuals, 
with a sensitivity and specificity of 100% and 98%, respectively. The correlation between 
observers for ultrasound measurements of the abdominal aorta is high (Spearman 
coefficient = 0.99), but abdominal girth reduces the precision of the measurement.30 
Abdominal palpation has only moderate overall sensitivity for detecting AAA, but appears 
to be highly sensitive for diagnosis of AAAs large enough to warrant elective intervention in 
patients who do not have a large girth. Abdominal palpation has good sensitivity even in 
patients with a large girth if the aorta is palpable.15 
Many large AAAs currently remain undetected until rupture, and many small AAAs that 
will never rupture are detected incidentally and repaired, with some resulting morbidity 
and mortality. Both scenarios contribute to aortic aneurysms remaining a leading cause of 
death. Recent randomized trials have demonstrated a substantial reduction in AAA-related 
mortality from ultrasonographic screening and resulting elective repair. If the U.S. 
Preventive Services Task Force recommends AAA screening, health plans, including 
Medicare, will probably follow with coverage and the era of AAA screening will begin. 
Meanwhile, it is reasonable to offer 1-time ultrasonographic screening to men 65 to 79 years 
of age who have ever smoked, especially if elective repair can be reserved for AAAs 5.5 cm 
or larger. If screening is accompanied by prudent use of elective repair, the mortality 
associated with AAA may at last be reduced. 19 
10.3 Computed tomography (CT) scan 
The accuracy of radiographers in performing AAA CT measurements is encouraging. 
Variability exists for both professions, and in some instances may be clinically significant. 
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in subsequent years if future analyses show that there is a further noticeable increase in 
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related to abdominal aortic aneurysm for those with an aneurysm detected (or rendered 
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the impairment seems considerable, and must be considered in the management of AAA 
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It has been proposed that patients who are found to have “small” aneurysms will experience 
a diminished quality of life related to concern about rupture.17 
For strategies toward other target groups, and management of small AAAs, prediction 
models and cost-effectiveness analyses are needed to provide guidance.14 
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The ADAM study found that a family history positive for presence of AAA is associated 
with a two-fold increase in the risk of having an AAA with no difference between men and 
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Familial AAA do not expand faster nor are they associated with unusual locations, but they 
may occur earlier in life. Screening causes psychological side effects, and it could therefore 
be offered to male first-degree relatives from the age of 60, and be confined to 
ultrasonographic scanning of the infrarenal abdominal aorta at five-year intervals. 23 
Aging brothers of patients with known abdominal aortic aneurysm have the highest risk for 
developing the disease; the prevalence of the disease in siblings older than 60 years of age is 
18%.39 
Ultrasonographic screening is recommended in brothers (50 years) of patients with 
aneurysms of the abdominal aorta.4 
10. Screening methods 
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A focused physical examination has been investigated as a screening tool to identify AAA. 
Sensitivity has been reported in the range of 76% to 85% and specificity 85% for AAA >5 cm 
with moderate interobserver agreement (kappa = 0.5).31 The diagnostic properties of 
physical examination require further investigation.30 
10.2 Ultrasonography 
Ultrasonography is the detection method of choice for AAA screening: it is cheap and 
noninvasive and can be used easily in a community setting.36 
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Results from a large, pragmatic randomized trial show that the early mortality benefit of 
screening ultrasonography for AAA is maintained in the longer term and that the cost-
effectiveness of screening improves over time.18 
Ultrasound screening to identify abdominal aortic aneurysms (AAA) >5cm followed by 
surgery reduces cause-specific mortality among individuals older than 65 years. This benefit 
is not apparent among men older than 75 years, 5 and there is some controversy regarding 
the benefit of screening for AAA among women.5 
The United Kingdom Multicentre Aneurysm Screening Study (MASS) 18,46 has provided most 
of the worldwide randomised evidence for the mortality benefit after ultrasound screening 
for abdominal aortic aneurysm.8, 16 The UK screening programme for men aged 65 is based 
closely on the protocol and procedures in MASS. Some uncertainties relating to screening 
remain, however, including its long term benefit in terms of mortality and cost effectiveness, 
whether rescreening those with a previously normal scan is warranted, and the extent to 
which incidental detection of abdominal aortic aneurysm erodes the benefit of a systematic 
screening policy over time. It might be expected that the mortality benefit seen in the early 
years after one-off screening would decrease over time. MASS, started in 1997, runs more 
than 10 years ahead of the UK national screening programme and is uniquely positioned to 
tackle these uncertainties and to inform the development of the national programme.45 
The neck of the aneurysm and suprarenal aorta might be more difficult to visualize with 
ultrasonography, and most ultrasound screening studies report only the maximum anterior-
posterior diameter. However, ultrasonography also can provide information about the size 
and shape of the luminal thrombus in an AAA and the presence of iliac aneurysms.36 
It is able to define the diameter of the infrarenal aorta in 98% (95% CI 92-94) of individuals, 
with a sensitivity and specificity of 100% and 98%, respectively. The correlation between 
observers for ultrasound measurements of the abdominal aorta is high (Spearman 
coefficient = 0.99), but abdominal girth reduces the precision of the measurement.30 
Abdominal palpation has only moderate overall sensitivity for detecting AAA, but appears 
to be highly sensitive for diagnosis of AAAs large enough to warrant elective intervention in 
patients who do not have a large girth. Abdominal palpation has good sensitivity even in 
patients with a large girth if the aorta is palpable.15 
Many large AAAs currently remain undetected until rupture, and many small AAAs that 
will never rupture are detected incidentally and repaired, with some resulting morbidity 
and mortality. Both scenarios contribute to aortic aneurysms remaining a leading cause of 
death. Recent randomized trials have demonstrated a substantial reduction in AAA-related 
mortality from ultrasonographic screening and resulting elective repair. If the U.S. 
Preventive Services Task Force recommends AAA screening, health plans, including 
Medicare, will probably follow with coverage and the era of AAA screening will begin. 
Meanwhile, it is reasonable to offer 1-time ultrasonographic screening to men 65 to 79 years 
of age who have ever smoked, especially if elective repair can be reserved for AAAs 5.5 cm 
or larger. If screening is accompanied by prudent use of elective repair, the mortality 
associated with AAA may at last be reduced. 19 
10.3 Computed tomography (CT) scan 
The accuracy of radiographers in performing AAA CT measurements is encouraging. 
Variability exists for both professions, and in some instances may be clinically significant. 
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Observers should be aware of measurement variability issues and have an understanding of 
the factors responsible. Careful and repeat measurements of AAAs around 5.5 cm are 
recommended in order to define treatment.11 
A good level of agreement exists between radiologists and radiographers in performing CT 
measurements of maximum AAA diameter. Variability for both professions does exist and 
can be significant in certain situations, observers should be aware of the existence of 
variability especially when making treatment decisions. It is technically feasible for 
radiographers to perform such measurements, whether this area of role extension should be 
explored needs further investigation. Understanding the factors which play a role in 
observer variability is paramount; variability may be decreased if using standardised 
measurement protocols, 3D techniques and computer-assisted measurements. If the latter is 
to be accepted then these measurements will require validation and clinical checking before 
prescribing treatment.11 
10.4 Magnetic Resonance Images (MRI) 
It seems that MRI screening of older men with LBP for AAA, especially in smokers or 
patients with a recent history of smoking, is advantageous. Further studies are needed to 
determine the best modality and the most feasible method of screening.42 
10.5 Plasma levels of plasmin-antiplasmin-complexes 
Three proteolytic systems seem involved in the aneurysmal degradation of the aortic wall. 
Plasmin is a common activator of the systems and could thus be predictive for the 
progression of abdominal aortic aneurysms (AAAs).24 
The levels of elastase have been found elevated in the circulation and aneurysmal walls 
compared with those with aortic occlusive atherosclerosis.3, 7, 9Furthermore, circulating 
levels of Cystatin C B, the major inhibitor of cysteine proteases, have been reported 
decreased in aneurysmal cases compared with a sex-matched and age-matched control 
group.43 Finally, the levels of various metallodependent proteases (MMPs), especially 
MMP2 and MMP9, have been found elevated in aneurysmal aortic walls compared with 
aortic walls of occlusive atherosclerosis35, 38, and we have earlier reported a positive 
significant correlation between the plasma level of MMP9 and the expansion of small 
AAAs.27The progression of AAA is correlated with the PAP level, which seems to have a 
predictive value similar to the best serologic predictor known, serum-elastin-peptides.24 
10.6 Genetic screening 
Nine functional positional candidate genes on AAA1 locus on chromosome 19 were 
investigated. Two of the genes, CD22 and PEPD showed modest level of evidence of being 
involved in AAA pathogenesis. This evidence came from a nominal association of SNPs 
residing in these genes to AAA, identification of novel sequence changes and expression of 
these proteins in aneurysmal tissue. If replicated in independent studies, the findings 
provide important information about AAA pathogenesis. Association testing of the 
functional positional candidate genes on the AAA1 locus on chromosome 19q13 
demonstrated nominal association in three genes. PEPD and CD22 were considered the 
most promising candidate genes for altering AAA risk, based on gene function, association 
evidence, gene expression, and protein expression. 22 
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Observers should be aware of measurement variability issues and have an understanding of 
the factors responsible. Careful and repeat measurements of AAAs around 5.5 cm are 
recommended in order to define treatment.11 
A good level of agreement exists between radiologists and radiographers in performing CT 
measurements of maximum AAA diameter. Variability for both professions does exist and 
can be significant in certain situations, observers should be aware of the existence of 
variability especially when making treatment decisions. It is technically feasible for 
radiographers to perform such measurements, whether this area of role extension should be 
explored needs further investigation. Understanding the factors which play a role in 
observer variability is paramount; variability may be decreased if using standardised 
measurement protocols, 3D techniques and computer-assisted measurements. If the latter is 
to be accepted then these measurements will require validation and clinical checking before 
prescribing treatment.11 
10.4 Magnetic Resonance Images (MRI) 
It seems that MRI screening of older men with LBP for AAA, especially in smokers or 
patients with a recent history of smoking, is advantageous. Further studies are needed to 
determine the best modality and the most feasible method of screening.42 
10.5 Plasma levels of plasmin-antiplasmin-complexes 
Three proteolytic systems seem involved in the aneurysmal degradation of the aortic wall. 
Plasmin is a common activator of the systems and could thus be predictive for the 
progression of abdominal aortic aneurysms (AAAs).24 
The levels of elastase have been found elevated in the circulation and aneurysmal walls 
compared with those with aortic occlusive atherosclerosis.3, 7, 9Furthermore, circulating 
levels of Cystatin C B, the major inhibitor of cysteine proteases, have been reported 
decreased in aneurysmal cases compared with a sex-matched and age-matched control 
group.43 Finally, the levels of various metallodependent proteases (MMPs), especially 
MMP2 and MMP9, have been found elevated in aneurysmal aortic walls compared with 
aortic walls of occlusive atherosclerosis35, 38, and we have earlier reported a positive 
significant correlation between the plasma level of MMP9 and the expansion of small 
AAAs.27The progression of AAA is correlated with the PAP level, which seems to have a 
predictive value similar to the best serologic predictor known, serum-elastin-peptides.24 
10.6 Genetic screening 
Nine functional positional candidate genes on AAA1 locus on chromosome 19 were 
investigated. Two of the genes, CD22 and PEPD showed modest level of evidence of being 
involved in AAA pathogenesis. This evidence came from a nominal association of SNPs 
residing in these genes to AAA, identification of novel sequence changes and expression of 
these proteins in aneurysmal tissue. If replicated in independent studies, the findings 
provide important information about AAA pathogenesis. Association testing of the 
functional positional candidate genes on the AAA1 locus on chromosome 19q13 
demonstrated nominal association in three genes. PEPD and CD22 were considered the 
most promising candidate genes for altering AAA risk, based on gene function, association 
evidence, gene expression, and protein expression. 22 
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1. Introduction 
The introduction of endovascular stent-graft repair for aortic aneurysm has engendered 
considerable enthusiasm and interest from vascular specialist. With progressive 
improvement in imaging, clinical experience, and stent-graft design, and the use of adjuvant 
procedures, a substantial number of patients are now candidates for endovascular repair of 
an aortic aneurysm. Endoluminal aneurysm repair, however, currently is at a critical point. 
Unquestionably, endoluminal aneurysm repair can reduce substantially the need for 
intensive care and length of hospital stay, and survival is reportedly improved when 
compared with open repair. Although the use of stent-grafts for the treatment of thoracic 
and abdominal aneurysms has increased dramatically there is little midterm or long-term 
proof of its efficacy. Endovascular aortic aneurysm repair (EVAR trial participants, 2005) has 
an initial postoperative benefit versus open AAA repair as a result of decreased early 
morbidity and mortality (EVAR trial participants. 2005; Lederle et al., 2007). However, as 
shown in EVAR trial 1 (EVAR trial participants, 2005), stent-graft-related complications are 
observed in approximately 40% of patients within 4 years after EVAR, resulting in a 20% 
reintervention rate to reduce the ongoing rupture risk. Persistent blood flow into the 
aneurysm sac and outside the graft lumen (endoleak) represents the most frequent 
complication after EVAR and is considered a procedural failure, since it is associated with 
aneurysm enlargement and possible rupture. The reported incidence of endoleaks ranges 
from 10% to 45%, and lifelong surveillance is required for early detection and treatment. 
As with the entire field of endovascular surgery, imaging techniques and recommendations 
regarding their use are changing rapidly. Only long-term follow-up data determine which 
methods will become standard. Currently, the imaging modalities best suited to achieve the 
above goals are plain film radiographs of the abdomen (chest) and CT angiography with 
specialized 3D reconstruction protocols (Fig. 1). In centers of excellence, color or power-
Doppler ultrasound is a useful adjunctive modality and ultimately may decrease the 
required frequency of more expensive studies such as CT. The modalities for postoperative 
imaging of endoleak may be surrogate or direct (May et al., 2005). The surrogate modalities 
include plain abdominal x-ray and measurement of AAA diameter by B-mode ultrasound or 
CT. Because the majority of endografts have a radio-opaque metallic frame, a plain 
abdominal x-ray is a useful investigation (Fig. 2). It may demonstrate faulty fixation more 
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include plain abdominal x-ray and measurement of AAA diameter by B-mode ultrasound or 
CT. Because the majority of endografts have a radio-opaque metallic frame, a plain 
abdominal x-ray is a useful investigation (Fig. 2). It may demonstrate faulty fixation more 
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clearly and earlier than contrast CT, and it may lead to the detection of endoleaks. The 
accuracy of detecting migration can be improved by following a protocol of performing A-P, 
lateral, and oblique views at the level of the umbilicus. Studies have confirmed that the 
presence of an endoleak is usually associated with an increase in the size of the aneurysm 
sac. Measurement of AAA diameter by B-mode ultrasound can therefore be used as a 
surrogate method of detecting endoleaks. CT may also be used for a similar purpose, with 
the option of monitoring an increase in volume of the sac in addition to the diameter of the 
sac. The direct methods of imaging for endoleaks include CDU, contrast-enhanced CT, and 
angiography. Contrast-enhanced CT has been accepted as the gold standard for detecting 
the presence of an endoleak. Once an endoleak has been detected, however, carefully 
planned arteriography is more useful in characterizing the origin and nature of the 
endoleak. CDU has the advantage of imaging type II endoleaks in real time, as distinct from 
contrast CT and arteriography, both of which have to ray on accurate timing to image the 
contrast arriving in the sac via collateral circulation (Prinssen, 2004). 
 
 
Fig. 1. CT angiography with 3D reconstruction. Left: Excluder bifurcated endoprosthesis 
(W.L. Gore and Associates Inc, Flagstaff, Ariz). Right: Talent aortouniiliac endoprosthesis 
(Medtronic Ave, St. Rosa, Cal), left common iliac occluder and femoro-femoral crossover 
bypass. 
The goals of postprocedural imaging are to confirm and redocument the appropriate 
placement of the stent-graft, to assess better the effectiveness of the stent-graft in initially 
excluding the AAA (detecting flow in the sac), to follow the long-term fate and size of the 
AAA sac and ensure its stability, to detect remote stent-graft failure (structural or 
functional) and to better characterize and possibly treat any endoleaks. Increase in 
aneurysm size after EVAR is associated with an increased risk of AAA rupture and may 
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require reintervention or conversion to open repair to prevent AAA rupture. Imaging 
evaluation should be able to show aneurismal size, changes in aneurysm size, position of 
stent-graft, evidence of change in position of the endoprosthesis, structural integrity of the 
device, endoleaks and change in the characteristics of the endoleak. 
 
 
Fig. 2. Plain abdominal x-ray. Left: Anaconda bifurcated endoprosthesis (Vascutek Inc., a 
Terumo Company, Renfrewshire, Scotland, UK). Right: Zenith bifurcated endoprosthesis 
(Cook Medical Inc., Bloomington, Ind). 
2. Endoleak after EVAR 
In addition to preoperative imaging, adequate surveillance imaging modalities capable of 
detecting complications and treatment effects, are necessary. Follow-up imaging is directed 
toward repeated assessment of the aneurysm size, detection of endoleaks, and monitoring of 
the structural and positional integrity of the stent-graft. 
An endoleak is a condition associated with endovascular stent-grafts, defined by persistent 
blood flow outside the lumen of the stent-graft but within the aneurysm sac or adjacent 
vascular segment being treated by the stent-graft. Endoleaks are usually associated with 
nonregresion or even expansion of the AAA. An endoleak is evidence of incomplete 
exclusion of the aneurysm from the circulation. There is evidence that an endoleak may 
resolve spontaneously, but a proportion of those that do persist are associated with late 
aneurysm rupture. Although intrasac pressure may approach systemical arterial pressure in 
the presence of an endoleak, some type II endoleaks have been associated with a decrease in 
aneurysm volume and intrasac pressures that are substantially less than systemic pressures 
(Van Sambeek, 2004). With or without an endoleak, an aneurysm that does not decrease size 
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the presence of an endoleak, some type II endoleaks have been associated with a decrease in 
aneurysm volume and intrasac pressures that are substantially less than systemic pressures 
(Van Sambeek, 2004). With or without an endoleak, an aneurysm that does not decrease size 
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during follow-up cannot be considered to be adequately treated. Under these conditions, 
regular monitoring is required until definitive exclusion of the AAA is achieved. An 
endoleak can be classified according to the time of occurrence. An endoleak first observed 
during the perioperative (<30 days) period is defined as a “primary endoleak”, and 
detection thereafter is termed a “secondary endoleak”. Further categorization requires 
precise information regarding the course of the blood flow into the aneurysm sac (Table 1). 
CDU could enable a better understanding of the mechanisms underlying some endoleaks 




Fig. 3. Left: CT angiography with 3D reconstruction. Endurant bifurcated endoprosthesis 
(Medtronic Ave, St. Rosa, Cal) with a type II endoleak originated from the inferior 
mesenteric artery, yellow arrow. Right: Arteriography. Anaconda bifurcated endoprosthesis 
(Vascutek Inc., a Terumo Company, Renfrewshire, Scotland, UK) with a type II endoleak 
originated from a left lumbar artery. 
A type I endoleak is indicative of a persistent perigraft channel of blood flow caused by 
inadequate seal at either the proximal (Ia) or distal (Ib) stent-graft end or attachment zones. 
In the case of an aorto-mono-iliac prosthesis, a type I endoleak may also refer to blood flow 
around an iliac occlude plug (Ic). A type II endoleak is attributed to retrograde flow from 
the inferior mesenteric artery (IIa), lumbar arteries (IIb), or other collateral vessels (Fig. 3). 
Origin and outflow sources of a type II endoleak could be specified, such as lumbar-lumbar, 
lumbar-inferior mesenteric artery (IMA), accessory renal-lumbar/IMA, hypogastric-
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lumbar/IMA, or undefined. It should be emphasized that any connection with a proximal or 
distal attachment zone will classify the endoleak as a type I endoleak. Flow hemodynamics 
of type II endoleaks affect the endoleak´s persistence and treatment outcome. Therefore, a 
new, more detailed classification of leaks, particularly type II endoleak, is required that is 
based on Doppler waveforms and flow velocities (Fig. 4). 
A type III endoleak is caused by a component disconnection (IIIa) or fabric tear, fabric 
disruption, or graft disintegration (IIIb). Type IIIb endoleak can be further stratified as 
minor (<2mm) or major (>2mm). A type IV endoleak is caused by blood flow through an 
intact but otherwise porous fabric, observed during the first 30 days after stent-graft 
implantation. This definition is not applicable to fabric-related endoleaks observed after the 
first 30-day period. Type V endoleaks are those in which bloodflow can be visualized within 
the aneurysm sac but the source cannot be identified. If an endoleak is visualized in imaging 
studies but the precise source cannot be determined, the endoleak is categorized as an 
endoleak of undefined origin. It is recognized that an AAA can continue to enlarge after 
endovascular repair, even in the absence of a detectable endoleak, and that this enlargement 
may lead to aneurysm rupture. This phenomenon is currently defined as “endotension”. 
Explanations for persistent or recurrent pressurization of an aneurysm sac include blood 
flow that is below the sensitivity limits of detection with current imaging modalities or 
pressure transmission through thrombus or stent-graft material. 
 
Type Cause of perigraft flow 
I Inadequate seal at proximal end of endograft 
Inadequate seal at distal end of endograft 
Inadequate seal at iliac occluder plug 
II Flow from a collateral vessel (lumbar, IMA, accessory renal, hypogastric) 
without attachment site connection. 
III Flow from a modular disconnection 
Flow from an inadequate seal at modular junction 
Flow from a fabric disruption 
IV Flow from porous fabric (less than 30 days after graft placement) 
V Flow visualized but source unidentified 
Table 1. Classification of endoleak. Modified from Chaikof et al., 2002. 
The origins of the endoleaks were also correctly identified with duplex. Sac refilling by a 
lumbar artery or the IMA is readily visualized by color coding, which also determines flow 
direction. It is then relatively easy to differentiate a type I proximal endoleak from a type II 
endoleak. One difficulty, however, remains with distal attachment sites where reverse flow 
can also be demonstrated without aneurysm sac reperfusion and be labeled as a distal type I 
endoleak. CDU appears to be an excellent tool for the evaluation of high-flow endoleaks 
within the aneurysm sac; however, it appears limited in making the distinction between 
type I and type III endoleaks. 
3. Ultrasound surveillance after endovascular aneurysm repair 
The most reliable diagnostic alternative to CTA in post-EVAR life-long surveillance is still 
heavily debated. CDU imaging is routinely used in vascular screenings because it is easy to 
perform, inexpensive, portable, safe, and widely available. This technique performs poorly 
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endoleak of undefined origin. It is recognized that an AAA can continue to enlarge after 
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may lead to aneurysm rupture. This phenomenon is currently defined as “endotension”. 
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in endoleak detection, with high false-negative and false-positive results, principally due to 
echo reflection by the metallic portion of stent-graft, presence of calcifications, meteorism, 
obesity, and slow endoleak flow, which does not allow distinction of color signals coming 
from vessel walls and surrounding tissue from those derived from corpuscular hematic 
components. 
The use of CDU as the preferred imaging modality in the follow-up of patients can reduce 
the biologic hazards associated with CT angiography (Carrafiello et al., 2008). The EVAR 
procedure and lifelong annual CT follow-up carry a substantial ionizing radiation burden. 
Patients receive a total effective dose of approximately 60mSv within the first year after 
EVAR, taking into account procedure-related fluoroscopy and follow-up CT angiography. 
The mean effective dose of CT angiography for EVAR follow-up is approximately 15 mSv. 
The stochastic risk of a fatal radiation-induced tumor is estimated to be 5%/Sv radiation. 
Therefore, the risk of cancer induction of one CT angiography procedure is approximately 1 
in 1,500 (International Commission on Radiological Protection, 2007), indicating the 
relevance of reliable alternatives to annual CT angiography for post-EVAR follow-up, 
particularly in younger patients. Second, CT angiography requires the administration of 
iodinated contrast agents, which are associated with nephrotoxic effects. Renal dysfunction 
is a comorbidity found in 80% of patients with aneurysms, and is the most important risk 
factor for contrast agent-induced nephrotoxicity. No major side effects, including 
nephrotoxic effects, have been reported for ultrasound contrast agents, which favors the use 
of contrast enhanced untrasound (CEUS) for post-EVAR follow-up. 
The advantages of duplex ultrasound in the follow-up of patients with aortic endografts 
include the ability to collect accurate residual aortic sac diameter measurements serially 
over time. It is a very sensitive method for endoleak detection with adequate time and 
when a protocol is used. Ultrasound can often identify the source for endoleak 
classification and can readily evaluate for limb dysfunction or any other hemodynamic 
impairment. It is inexpensive and reproducible and requires no contrast and there may be 
an additive effect of CT with ultrasound in the follow-up of patients with these devices 
placed. The disadvantages of using duplex ultrasound may be the time commitment 
involved in a busy vascular laboratory. Additionally, there is a need for high-resolution 
equipment for the adequate performance of this examination. It is a technically 
challenging, subjective study that is highly dependent on the examiner and interpreter but 
it can be a valuable tool in the assessment of patients with aortic endografts. Ultrasound 
data are often influenced by the ability of the technologist as well as the quality of the 
equipment available. Therefore the results obtained with ultrasounds are much harder to 
reproduce from center to center, while CT can be easily standardized using a 
reproductible protocol for obtaining the scan. Unfortunately, interrogation of aortic 
endografts by either methodology can be challenging, with many subtleties to the images 
obtained. As a result, the best methodology for surveillance may not be one or the other, 
but a combination of the two. The unique ability of ultrasound to look at flow allows 
interrogation of the residual aneurysm sac around the endograft in ways that are likely 
not possible using conventional CT scans. The important aspects of endograft surveillance 
are the detection of endoleaks, changes in the endograft limbs, routine measurement of 
maximum aneurysm size and device migration. 
The benefits of CT scan as an imaging modality compared with CDU imaging include that 
it is highly reproducible, less influenced by body habitus and offers faster image 
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acquisition. However, among the limitations of CT scans is repeated radiation exposure, 
potential contrast-related complications, including allergy and renal insufficiency, and 
high cost. CDU imaging is more accurate than CT in detecting problems that threaten 
graft patency, such as migration, kinking, and stenosis. Color-flow images give 
physiologic as well as anatomic information that CT does not. CDU imaging accurately 
predicted all seven cases where graft patency appeared threatened. The ability to quantify 
and compare serial examination in a cost-effective, contrast-free, and radiation-safe 
manner suggests that CDU imaging should be the gold standard for EVAR limb patency 
follow-up. CDU imaging can almost always accurately determine if structural defects are 
causing a flow-related problem and graft migration. The safety of routine triphasic CT 
scanning for all patients undergoing follow-up post EVAR must be questioned. Although 
late type II endoleaks are more likely to be picked up in the delayed post-contrast phase, 
there is little evidence to suggest that this translates to a clinically significant advantage, 
in a group of patients in whom most aneurysms remain stable or shrink following 
treatment. Beeman et al. (2009), showed that cost savings is substantial when CDU 
imaging alone is used for midterm follow-up vs the accepted approach that required 
multiple CT scans. Bendick et al. (2003a), reported that eliminating CT as a surveillance 
tool after EVAR would represent a 3-year cost savings of >$16,000 per patient. In fact, new 
surveillance paradigms have already been suggested to reduce the charges associated 
with EVAR. Kim et al. (2008), estimated that current reimbursement for long-term EVAR 
surveillance and secondary procedures using traditional protocols average a net loss of 
$2,235 per patient. 
A systematic review by Sun in 2006 was undertaken to investigate the diagnostic value of 
CDU compared with CT angiography for the detection of endoleaks and measurement of 
the aneurysm sac (the most commonly used criteria to assess the success of endovascular 
AAA repair). Twenty-one studies met the criteria and were included for analysis. The 
results are showed in table 2. The sensitivity in the detection of endoleaks was significantly 
improved with contrast material-enhanced CDU compared with unenhanced CDU; 
however, no significant difference was found regarding the specificity, PPV, NPV, and 
accuracy between unenhanced and enhanced CDU. CDU was insensitive in measurement of 
aneurysm diameter compared with CT angiography in most situations. These results 
showed that CDU has not reached the diagnostic accuracy necessary to be a reliable 
alternative to CT angiography in the follow-up of endovascular AAA repair. 
Iezzi et al. (2009), in the only prospective study to address this issue, shows CEUS imaging 
significantly improves the diagnostic performance of CDU imaging in endoleak detection in 
patients with endovascular aortic stent-grafts. Reported no significant difference in 
sensitivity for endoleak detection between analysis of arterial phase image alone, 
unenhanced and arterial phase images, and arterial and delayed phase images, after the 
initial follow-up at 1 month. Its sensitivity and negative predictive value are similar to 
multislice CTA (97.5% and 97.3%, respectively), and its specificity and accuracy are 
satisfactory (81.8% and 89.3%) but not ideal because the false-positive rate is nearly 10%. 
These findings support previous studies evaluating aortic stent-grafts by CEUS imaging vs 
CTA, where sensitivity for endoleak detection was 50% to 100%, with many false-positive 
results. Furthermore, CEUS imaging seems to be more sensitive than CTA in diagnosing 
low-flow endoleaks, CTA failure may have resulted from shorter imaging duration than 
with CEUS imaging. 
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Table 2. CDU compared with CT angiography (Sun, 2006; Iezzi 2009). PPV: positive 
predictive value; NPV: negative predictive value. 
Type 2 endoleaks are the most common endoleak following EVAR. Arko et al. reported 
that type 2 endoleaks intrasac flow velocities (IFV) <80 cm/second were likely to resolve 
without treatment and that those with velocities >100 cm/second were related to large 
branch vessel diameter and multiple endoleaks. They also suggested that higher velocity 
endoleaks were more resistant to transarterial embolization. Beeman et al. in 2010, found 
that IFV did not correlate with likelihood of closure of type 2 endoleaks, nor did high IFV 
predict sac enlargement. In addition, the velocity and multiplicity of type 2 endoleaks was 
not additive for AAA sac expansion. In other words, those with multiple branch 




Fig. 4. An example of a type II endoleak as demonstrated on CTA. Intravenous contrast is 
seen outside stent-graft and within aneurysm sac. This was shown to originate from the 
inferior mesenteric artery, and was not associated with an increase in aneurysm sac size, 
and so was managed conservatively. CDU scan demonstrates the same endoleak. 
Meier et al. (2001), suggested that spectral Doppler waveform (SDW) patterns can 
differentiate endoleaks that spontaneously seal from those that persist. They suggested that 
bidirectional to-from waveforms in endoleaks type 2 may precede occlusion, while 
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waveforms that remain biphasic with characteristics similar to normal peripheral arterial 
flow appear to predict persistent endoleaks. The findings of Beeman et al. (2010) contradict 
their results. Bidirectional to-from waveforms could be predictive of AAA sac enlargement 
due to the following mechanism: if an endoleak can connect a higher pressure inflow source 
(lumbar or IMA) with an outflow vessel such as another nearby lower pressure lumbar 
vessel we would see biphasic SDWs much as normal peripheral arteries. However, if the 
lumbar or IMA has only an inflow source into the AAA sac and no nearby lumbar or other 
feeding vessel, the SDW would reveal the to-and-from SDW. The to-and-from SDW reflects 
the lack of an outflow source vessel and thus increases the diastolic pressure in the AAA sac; 
the net effect is to increase the mean pressure in the AAA sac. The presence of multiple type 
2 endoleaks and bidirectional SDW may be the strongest predictive factors of increased sac 
diameter (Beeman et al., 2010). A to-from signal was associated with spontaneous sealing 
and a mono-biphasic waveform was associated with endoleak persistence (Parent et al., 
2002). 
4. Imaging protocol 
The CDU is performed according to a protocol, which included the evaluation of the flow 
through the endograft, the perigraft flow, the renal and the iliac arterial flow, the maximum 
diameter of the aneurysm, and the presence of branch vessel flow. Because of the anatomy 
of the aneurysm stent-graft repair and the location of the endoleaks, we feel that several 
important aspects are essential to a complete examination of the aneurysm sac with duplex 
scan imaging. On the basis of the study of Sato et al., the following 4 criteria were developed 
to determine whether an adequate study had been performed to evaluate endoleaks: 
1. A satisfactory B-mode image of the AAA sac and the stent-graft. 
2. The satisfactory use of color Doppler (CD) scan imaging without an excessive overgain 
or undergain. 
3. A CD scan assessment of the entire AAA sac outside the graft in both the transverse 
and the longitudinal views to screen for endoleaks. 
The use of spectral Doppler scan waveform analysis outside the graft and within the AAA 
sac to confirm or reject potential endoleaks suggested with CD scan assessment. 
All studies should be performed on a high resolution duplex ultrasound scan system with 
color-flow capability with technologists who are cognizant of the stent-graft structure, 
implantation site (aortobiiliac grafts, aortouniiliac graft with femorofemoral bypass 
grafting), and potential sites for endoleaks (Fig. 5). Low frequency (range, 2.25 to 5 MHz), 
curved array, phased array or mechanical sector, and pulsed Doppler scan transducers are 
used. Patients are studied after an overnight fast in the supine position. The graft, proximal 
and distal stents, and the abdominal aortic aneurysm (AAA) sac are imaged in B-mode, and 
size measurements of the AA sac are performed. The CD scan is added, and the settings are 
optimized to avoid excessive overgain (ie, color artifact that completely fills the entire color 
box) or undergain (ie, absence of color flow within the aortic graft). The color box size is 
adjusted to completely encompass the AAA sac but not made so large as to encourage 
artifact. The entire AAA sac outside the graft is assessed systematically by CD scan imaging 
in both sagittal and transverse views. Perigraft leaks are suspected with reproducible, 
pulsatile, CD scan flow images outside the graft and within the AAA sac. The focus is 
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grafting), and potential sites for endoleaks (Fig. 5). Low frequency (range, 2.25 to 5 MHz), 
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used. Patients are studied after an overnight fast in the supine position. The graft, proximal 
and distal stents, and the abdominal aortic aneurysm (AAA) sac are imaged in B-mode, and 
size measurements of the AA sac are performed. The CD scan is added, and the settings are 
optimized to avoid excessive overgain (ie, color artifact that completely fills the entire color 
box) or undergain (ie, absence of color flow within the aortic graft). The color box size is 
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artifact. The entire AAA sac outside the graft is assessed systematically by CD scan imaging 
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directed at the following potential leak sites: the superior and inferior stent attachments; the 
anterior mid-AAA sac (inferior mesenteric artery); and the posterior mid-AAA sac (lumbar 
arteries). A power Doppler scan may be added to assist in the detection of perigraft flow. 
Because spectral Doppler scan waveform will differentiate true endoleaks from color 
artifacts, all suspected endoleaks are evaluated by spectral Doppler scan waveform analysis. 
The presence of an arterial signal confirms the presence of an endoleak. Color artifacts may 
result from low color sensitivity settings so that pulsatility of the adjacent tissue is imaged as 
color signals. For all endoleaks, location, flow direction, and extent of AAA sac involvement 
are determined. An attempt is made to identify the origin and direction of the flow in the 
inferior mesenteric artery. In cases without evidence of endoleak or inadequate CD scan 
visualization, a systematic sampling of the AAA sac should be performed with spectral 
Doppler scan waveform signals to evaluate for possible endoleaks (Sato). 
 
 
Fig. 5. Ultrasound scan imaging, main body endograft. Longitudinal view (a,b) and cross-
sectional view (c,d) with no evidence of endoleak. 
Endoleak surveillance is best performed with sensitive color-flow Doppler scale settings 
to show low-flow channels. These lower scale settings may produce color reverberation 
artifacts that obscure low-flow endoleak signals posterior to the stent-graft. Coronal views 
with the patient in a decubitus position may improve image quality in this posterior 
region. Endoleaks can be distinguished from artifacts by their reproducibility, uniform 
nature, and persistence during diastole when artifacts usually recede. Pulsed Doppler 
spectral waveform sampling of extrastent flow is used to document flow direction. Gray-
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scale images of some endoleaks are characterized by pulsatile lucencies adjacent to the 
stent-graft. Some, low-flow leaks may be seen as a small color spot at the stent wall 
during diastole. Reproducibility and persistence help differentiate these leaks from scale-
related artifacts. 
A Power Doppler (PD) instrument can be helpful when the proper angle of insonation is 
difficult to achieve with certainty, because it is insensitive to angle considerations (Fig. 6). 
PD also can be helpful in low-flow situations, but care must be taken not to overinterpret 
artifacts caused by motion of the graft wall, which is more common in endografts that are 
not fully supported throughout their length. Lastly, duplex or PD can aid in the acquisition 
of a Doppler waveform for the flow within a suspected endoleak to analyze the direction of 
flow, to provide an estimate of the “resistance” of the endoleak from a nearby collateral 
vessel. In most cases, however, the latter information will not be of critical importance. All 
endoleaks related to endograft attachment sites or endograft perforations will flow from the 
attachment site toward a branch vessel and will have relatively low resistance and high 
flow. Most branch-to-branch endoleaks (ie, lumbar artery to lumbar artery), will have “to 
and from” waveforms. Nevertheless, any endoleak should be taken seriously no matter 
what the Doppler information suggests regarding its flow characteristics. 
The keys to optimizing the yield of duplex ultrasonography are: have the patient prepared 
properly for an abdominal study; employ an experienced technologist educated about 
endovascular grafts, endoleaks, etc; have a physician who knows the specific endograft 




Fig. 6. Cross-sectional duplex ultrasound scan image of aortic bifurcated stent-graft with no 
evidence of endoleak with power-doppler imaging. 
5. Contrast-enhanced ultrasound 
A number of studies have indicated that CDU may be used for EVAR (Wolf et al., 2000; 
Manning et al., 2009). Non-contrast enhanced ultrasound correlates with CT angiography in 
determining change in AAA size over time, but has low sensitivity and positive predictive 
value in endoleak detection compared with conventional CT angiography (Manning et al., 
2009; Elkouri et al., 2004; Raman et al., 2003). CEUS may be an alternative to CT 
angiography in the follow-up of patients after EVAR. As ultrasound reduces exposure to the 
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biologic hazards associated with lifelong annual CT angiography, including cumulative 
radiation dose and nephrotoxic contrast agent load, CEUS might be considered as a 
substitute for CT angiography in the surveillance of patients after EVAR (Ten Bosch et al., 
2010). CEUS utilizes a non-nephrotoxic contrast agent offering safer post-EVAR 
surveillance. However, to replace the current gold-standard for endoleak detection, any 
alternative imaging modality must accurately identify endoleaks with high sensitivity and 
specificity. In this technique, harmonic imaging is used rather than conventional grayscale. 
Since the ultrasound beam entrains the microbubbles to resonate at a certain frequency, 
imaging at that harmonic frequency results in dramatic improvements in blood flow 
imaging. What is sacrificed is grayscale quality; harmonic imaging loses grayscale quality as 
blood pool imaging is improved. Therefore the ability to evaluate blood flow is improved 
while the imaging of the endograft and aneurysm sac is degraded. For endoleaks, the 
advantage is a shortened examination with more certainty as to the presence or absence of 
perigraft blood flow. The combination of conventional CDU with contras-enhanced imaging 
when appropriate may ultimately prove to be the new standard in aortic endograft 
surveillance. 
In this year, Mirza et al. (2010), have published a systematic review and bivariate meta-
analysis about duplex ultrasound and CEUS versus computed tomography for the detection 
of endoleaks after EVAR. Twenty-one studies provided sufficient data for inclusion in the 
meta-analysis about unenhanced ultrasound. Overall, unenhanced duplex ultrasound was 
compared to the gold-standard of contrast-enhanced CT in 2601 patients. From the bivariate 
analysis, the pooled sensitivity was 0.77 and pooled specificity was 0.94. The summary ROC 
curve plotted using fixed-effects meta-analysis had an area under the curve of 0.91. 
Whatever, seven studies about enhanced ultrasound (285 patients), provided sufficient data 
for inclusion in this analysis. From the bivariate meta-analysis, the pooled sensitivity was 
0.98. The pooled specificity was 0.88. The summary ROC curve plotted using fixed-effects 
meta-analysis had an area under the curve of 0.96. 
There might be a relationship between blood flow characteristics and CT angiography and 
duplex ultrasound leakage detectability. In fact, in all patients with a nonvisualized leakage 
with CT angiography and CDU, the perigraft flow visualized at CEUS was characterized by 
very slow flow dynamics, with diffuse and delayed aneurysm enhancement. The contrast 
medium did not concentrate in a confined part of the sac, but it spread into the thrombus. 
The delayed appearance of the leak, its spreading throughout the sac, and its very slow flow 
could be the key factors in the explanation for the undetectability of endoleaks with CT 
angiography. It would be interesting to investigate whether performance of CT scanning 
with longer delay (>3-4 minutes after contrast agent administration) increases CT sensitivity 
in the detection of endoleaks in patients with enlarging aneurysms and no evidence of other 
complications (Napoli et al., 2004). 
CEUS imaging is more specific than CTA in endoleak classification thanks to longer 
duration of enhancement, lack of metallic artifacts, and angio-dynamic evaluation of the 
leak during the dynamic phase (Fig. 7). CEUS advantages include minimal invasiveness, 
rapidity, good tolerability and no adverse events have been registered. On the other hand, 
CEUS imaging also has some limitations. Patient habitus (obesity) and bowel gas can 
interfere with imaging, and the patient must cooperate. The results of the ultrasound are 
operator-dependent, and obtaining quality images requires training and specific skills. 
Color-Doppler Ultrasonography  
in the Monitoring of Endovascular Abdominal Aortic Aneurysm Repair 
 
49 
Furthermore, CTA provides superior information related to graft anchoring and integrity, 
aneurysm morphologic changes, or visceral vessel patency (renal arteries). 
5.1 Sonographic constrast agents 
Sonographic contrast agents enhance the capability of color duplex imaging to detect 
endoleaks (McWilliams et al., 2002; Napoli et al., 2004). Are typically microbubbles of a 
perfluorocarbon gas encapsulated within a thin lipid or human albumin shell for stability 
while circulating in the blood pool. The microbubbles have a range of diameters from 2 to 5 
microns, with a suspension of approximately 5 x 108 microbubbles per mL of fluid. The 
microbubbles slowly dissolve as the shell is metabolized, and the perfluorocarbon gas is 
eliminated through the lungs with normal respiration; a 1 mL bolus injection of the contrast 
agent will allow approximately 3 to 4 minutes of enhanced visualization and scanning time. 
At diagnostic ultrasound scan frequencies of 3 to 5 Mhz, the reflectivity of the microspheres 






Fig. 7. CEUS demonstrating a type II endoleak. 
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An additional advantage of the contrast agent is the nonlinear behavior when insonated 
with the ultrasound scan beam; the returning signal has strong components of both the 
fundamental transmitted frequency and the second harmonic, at twice the transmitted 
frequency. This allows imaging with the technique of tissue harmonics, which further 
suppresses returning echoes from stationary structures and effectively enhances the blood 
flow signal in the image. As applied to the surveillance of stent-grafts, it is hypothesized 
that increased ultrasound scan signal will arise from wherever blood is flowing, including 
the aneurysm sac in the case of an endoleak, with suppression of the stationary echo from 
the thrombus within the sac with tissue harmonic imaging to improve the contrast between 
these two in the resulting image (Bendick et al., 2003b). Ultrasound scan contrast agents and 
tissue harmonic imaging appeared less susceptible to the presence of patient obesity or 
bowel gas. System default settings for harmonic imaging of the contrast agent may also help 
eliminate some of the operator dependence in acquiring technically adequate ultrasound 
scans. In addition, imaging with contrast may make it easier to evaluate the position of the 
proximal attachment site of the stent-graft relative to an anatomic reference point, such as 
the origin of the real arteries, because imaging of these vessels is also enhanced with the 
contras agent. 
Second generation sonographic contrast agents consist of stabilized microbubbles of sulphur 
hexafluoride gas, which is eliminated through the respiratory system, surrounded by a 
phospholipid shell. These microbubbles improve blood flow echogenicity by resonating 
with low-intensity ultrasound, which enhances backscatter and thereby increases the 
detected signal (Carrafiello et al., 2008). Bubble destruction during imaging is minimized, 
allowing real-time scanning for several minutes. No adverse events, such nephropathy, have 
been reported for ultrasound contrast agents. The clinical applicability of ultrasound 
investigation may be operator-dependent variability as well as by patient-related limitations 
such as obesity. There is the potential for hypersensitivity or an allergic reaction to the 
albumin shell of the contrast agent, which can be treated with antihistamines.  
5.2 Technique 
a. SonoVue (Bracco, Milan, Italy): A diluted sonographic contrast solution is administered 
by continuous intravenous infusion (240 mL/h) for a period of 15 minutes. Sonographic 
contras solution is obtained by mixing 5 mL SonoVue containing 8 µl sulfur 
hexafluoride microbubbles per millimeter with 55 mL saline solution. Continuous real 
time tissue harmonic imaging for endoleak detection was performed for 15 minutes 
during sonographic contrast agent infusion at a mechanical index for 0.4-0.5 at low 
acoustic power (Ten Bosch et al., 2010). According to the package insert 
recommendation of the manufacturer, in which the optimal dose for vascular 
examination was fixed at 2.4 mL, in which a lower dose (1.5 mL) appeared to be 
sufficient for endoleak detection in the majority of patients. The agent is administered 
into an antecubital vein at a dose of 1.5-2.4 mL, followed by a flush of 5mL saline 
solution.  
b. Levovist (Schering Company, Berlin, Germany): which contains 99.9% D-galactose 
and 0.1% palmitin acid, is a crystalline powder that is mixed with injectable water. In 
this suspension, the microparticles bind tiny air bubbles, enhancing the Doppler 
signal quality when injected intravenously by up to 25 dB without increasing 
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background noise. This is a clear improvement in the signal-to-noise ratio (Heilberger 
et al., 1997). 
c. Optison (Mallinckrodt, Saint Louis, Missouri): a 1 mL bolus of ultrasound scan contrast 
agent is given via injection into an antecubital vein, followed by a flush of 5 mL of 
normal saline solution. The contrast agent is allowed to circulate in the blood pool for 
approximately 1 minute, and then the aortic stent-graft and aneurysm sac were again 
scanned from the level of the diaphragm to below iliac limb attachment points in 
longitudinal and cross-sectional scanning modes (Bendick et al., 2003b). 
6. Color duplex ultrasound limitations 
The major disadvantages of the CDU are related to the proper instrumentation and to 
technologist dependency. In addition, satisfactory images cannot be obtained in some 
patients because of technical inability (ie, obesity or excessive intestinal gas). A review of the 
CDU studies from multiple centers for the EnACT stent-graft trial (Sato et al., 1998), 
revealed that most of the studies were suboptimal in the evaluation for endoleaks. Although 
approximately 90% of the studies were technically possible, as indicated with satisfactory B-
mode images, complete evaluation for endoleaks as outlined in the methods described was 
obtained in only 19% of the studies. The most glaring deficiencies were the failure to assess 
the entire AAA sac with CD scan imaging and the failure to use spectral Doppler scan 
waveform analysis outside the graft but within the AAA sac to confirm suspected 
endoleaks. Errors in technical settings could be identified in some cases (ie, poor gain or 
focal zone settings). Most of the incomplete CDU studies for endoleaks appeared to be the 
result of a lack of a standardized protocol for the technologist to improve the accuracy for 
endoleak diagnosis with CDU technology. Others have shown improved sensitivity of CDU 
in identifying endoleaks when intravenous ultrasound scan contras agents are added to the 
study. 
Ultrasound examinations may carry a number of well known limitations. First, operator 
dependency might limit reproducibility of the results. It is clearly true that assessment of a 
CT scan is less operator-dependent. Unfortunately, interobserver variability for endoleak 
detection by CEUS could not be assessed because this would require repetitive sonographic 
contrast agent infusions. Second, patient habitus may interfere with ultrasound imaging, as 
patient obesity or bowel gas. CDU imaging with contrast may prove to be especially useful 
for obese patients but is not necessarily any better in most patients, especially considering 
the extra cost and more difficult technique required to use this method.  
A potential drawback of CEUS is the inability to detect kinking and migration of the stent-
graft. Plain abdominal radiography may be used for the detection of graft migration and 
structural failure. In addition, sonographic contrast agents are not available worldwide yet, 
which may limit the applicability of CEUS techniques. Interobserver variability in technical 
factors can be another important limitation in the diagnostic value of CDU imaging. 
Furthermore, ultrasound scanning measurements have been noted to underestimate the true 
size of the AAA when compared with CT. Nevertheless, there is a good correlation between 
CDU and CT in determining aneurysm size changes over time. 
Even if the technologists are very experienced, the use of relatively older equipment and 
short scan times may be the main culprit in an inadequate correlation between CDU and CT 
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An additional advantage of the contrast agent is the nonlinear behavior when insonated 
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during sonographic contrast agent infusion at a mechanical index for 0.4-0.5 at low 
acoustic power (Ten Bosch et al., 2010). According to the package insert 
recommendation of the manufacturer, in which the optimal dose for vascular 
examination was fixed at 2.4 mL, in which a lower dose (1.5 mL) appeared to be 
sufficient for endoleak detection in the majority of patients. The agent is administered 
into an antecubital vein at a dose of 1.5-2.4 mL, followed by a flush of 5mL saline 
solution.  
b. Levovist (Schering Company, Berlin, Germany): which contains 99.9% D-galactose 
and 0.1% palmitin acid, is a crystalline powder that is mixed with injectable water. In 
this suspension, the microparticles bind tiny air bubbles, enhancing the Doppler 
signal quality when injected intravenously by up to 25 dB without increasing 
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background noise. This is a clear improvement in the signal-to-noise ratio (Heilberger 
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agent is given via injection into an antecubital vein, followed by a flush of 5 mL of 
normal saline solution. The contrast agent is allowed to circulate in the blood pool for 
approximately 1 minute, and then the aortic stent-graft and aneurysm sac were again 
scanned from the level of the diaphragm to below iliac limb attachment points in 
longitudinal and cross-sectional scanning modes (Bendick et al., 2003b). 
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The major disadvantages of the CDU are related to the proper instrumentation and to 
technologist dependency. In addition, satisfactory images cannot be obtained in some 
patients because of technical inability (ie, obesity or excessive intestinal gas). A review of the 
CDU studies from multiple centers for the EnACT stent-graft trial (Sato et al., 1998), 
revealed that most of the studies were suboptimal in the evaluation for endoleaks. Although 
approximately 90% of the studies were technically possible, as indicated with satisfactory B-
mode images, complete evaluation for endoleaks as outlined in the methods described was 
obtained in only 19% of the studies. The most glaring deficiencies were the failure to assess 
the entire AAA sac with CD scan imaging and the failure to use spectral Doppler scan 
waveform analysis outside the graft but within the AAA sac to confirm suspected 
endoleaks. Errors in technical settings could be identified in some cases (ie, poor gain or 
focal zone settings). Most of the incomplete CDU studies for endoleaks appeared to be the 
result of a lack of a standardized protocol for the technologist to improve the accuracy for 
endoleak diagnosis with CDU technology. Others have shown improved sensitivity of CDU 
in identifying endoleaks when intravenous ultrasound scan contras agents are added to the 
study. 
Ultrasound examinations may carry a number of well known limitations. First, operator 
dependency might limit reproducibility of the results. It is clearly true that assessment of a 
CT scan is less operator-dependent. Unfortunately, interobserver variability for endoleak 
detection by CEUS could not be assessed because this would require repetitive sonographic 
contrast agent infusions. Second, patient habitus may interfere with ultrasound imaging, as 
patient obesity or bowel gas. CDU imaging with contrast may prove to be especially useful 
for obese patients but is not necessarily any better in most patients, especially considering 
the extra cost and more difficult technique required to use this method.  
A potential drawback of CEUS is the inability to detect kinking and migration of the stent-
graft. Plain abdominal radiography may be used for the detection of graft migration and 
structural failure. In addition, sonographic contrast agents are not available worldwide yet, 
which may limit the applicability of CEUS techniques. Interobserver variability in technical 
factors can be another important limitation in the diagnostic value of CDU imaging. 
Furthermore, ultrasound scanning measurements have been noted to underestimate the true 
size of the AAA when compared with CT. Nevertheless, there is a good correlation between 
CDU and CT in determining aneurysm size changes over time. 
Even if the technologists are very experienced, the use of relatively older equipment and 
short scan times may be the main culprit in an inadequate correlation between CDU and CT 
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in the detection of endoleaks. Most large hospital laboratories have not uniformly upgraded 
to newer equipment. Therefore, it is essential that clinical decisions based on CDU be 
undertaken only after a review of local results indicates equivalent or superior results with 
this modality when compared to CT scanning. Congested waiting lists for vascular studies 
and an inability to attract enough trained technologists have limited the ability of hospital 
laboratories to devote longer time periods to each study. The lack of additional diagnostic 
utilities of CDU over CT scanning under these conditions has led to abandon CDU as a 
routine test for EVAR surveillance. Based on literature, conditions in which ultrasound 
imaging alone can be proposed for EVAR follow-up can be listed as follows (Long et al., 
2005).: 
 High quality of technical conditions of ultrasound imaging: such examination requires 
at least from medium- to high-end ultrasound scanner. 
 High quality of medical conditions of ultrasound imaging: it must be performed by a 
trained senior operator really involved in AAA follow up and having an accurate 
knowledge of AAA endovascular treatment. Precise data concerning preoperative 
AAA diameter, nature of stent-graft, operative report, and events before discharge 
and during follow-up, such as complementary procedures, must be clearly 
communicated. 
 Previous ultrasound imaging evaluation: evaluation of ultrasound performance for 
AAA diameter measurement and endoleak detection (especially type I) compared with 
CT remains essential in each ultrasound laboratory. A common protocol for 
measurements of AAA diameter with ultrasound and CT is highly recommended. 
 Selection of patients: patients must be good candidates for ultrasounds. Poor 
echogenicity may represent a transient or definitive contraindication for ultrasound 
follow-up; it should be determined by the operator himself; a score of ultrasound image 
quality as proposed by Sato could be established. 
 Absence of type I endoleak: a type I endoleak at discharge or during follow-up is a 
definitive contraindication for ultrasound follow-up, until the real utility is proven for 
ultrasound performance; 
 Retraction of AAA: a clear decrease in AAA diameter diagnosed with ultrasound or 
unenhanced CT studies allows for ultrasound alone follow-up until suspicion of 
regrowth. 
7. Conclusions 
The use of endovascular techniques to repair AAAs has gained wide acceptance in the 
surgical community. Disadvantages of endovascular repair include late complications and 
the need for long-term surveillance to monitor possible sequelae, such as endoleaks, 
migration, aneurismal dilatation, or possible graft thrombosis. The optimal follow-up of 
patients after EVAR is still unknown and the repeated exposure to radiation, inconvenience 
for patients, and cost involved are important. The modality for long-term follow-up has 
been debated and there is a need for accurate, cost-effective means of postoperative 
surveillance. 
Ultrasound offers the advantages of low cost and lack of radiation exposure. High-quality 
ultrasound reliably excludes endoleaks in patients after stent-grafting of AAA. Although 
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duplex ultrasound is often used to augment CT scanning in post-EVAR follow-up, evidence 
suggest it is unsuitable for sole use in endoleak detection after EVAR. As ultrasound 
precludes the risks of contrast-induced nephropathy and ionizing radiation load, CEUS 
might be considered as a substitute to CT angiography as the primary imaging modality in 
the surveillance of patients after EVAR, provided those patients are suitable for 
abdominal/pelvic ultrasound and highly trained ultrasound operators are available. CEUS 
offers promise as a safe and sensitive modality for endoleak detection, potentially obviating 
the need for patient exposure to high radiation doses and nephrotoxic agents in recurrent 
CT imaging. Combining CDU scan with a noncontrast CT and abdominal x-ray is a useful 
strategy in patients who cannot have radio-contrast. Using both test permits assessment 
about endoleaks along with aneurysm size, seal zone, and possible graft migration. CEUS 
imaging is a fast, noninvasive, reliable, and valid alternative to multislice CTA for endoleak 
detection in endovascular aortic stent-graft patients, and is superior to unenhanced 
ultrasound imaging.  
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undertaken only after a review of local results indicates equivalent or superior results with 
this modality when compared to CT scanning. Congested waiting lists for vascular studies 
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laboratories to devote longer time periods to each study. The lack of additional diagnostic 
utilities of CDU over CT scanning under these conditions has led to abandon CDU as a 
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imaging alone can be proposed for EVAR follow-up can be listed as follows (Long et al., 
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quality as proposed by Sato could be established. 
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ultrasound reliably excludes endoleaks in patients after stent-grafting of AAA. Although 
Color-Doppler Ultrasonography  
in the Monitoring of Endovascular Abdominal Aortic Aneurysm Repair 
 
53 
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CT imaging. Combining CDU scan with a noncontrast CT and abdominal x-ray is a useful 
strategy in patients who cannot have radio-contrast. Using both test permits assessment 
about endoleaks along with aneurysm size, seal zone, and possible graft migration. CEUS 
imaging is a fast, noninvasive, reliable, and valid alternative to multislice CTA for endoleak 
detection in endovascular aortic stent-graft patients, and is superior to unenhanced 
ultrasound imaging.  
8. References 
Arko, F.R.; Filis, K.A.; Siedel, S.A.; Johnson, B.L.; Drake, A.R.; Fogarty, T.J. & Zarins, C.K. 
(2003). Intrasac flow velocities predict sealing of type II endoleaks after 
endovascular abdominal aortic aneurysm repair. Journal of Vascular Surgery, Vol. 37, 
No. 1 (January 2003), pp. 8-15, ISSN 0741-5214. 
Beeman, B.R.; Doctor, L.M.; Doerr, K.; McAfee-Bennett, S.; Dougherty, M.J. & Calligaro, K.D. 
(2009). Duplex ultrasound imaging alone is sufficient for midterm endovascular 
aneurysm repair surveillance: A cost analysis study and prospective comparison 
with computed tomography scan. Journal of Vascular Surgery, Vol. 50, No. 5, 
(November 2009), pp. 1019-1024, ISSN 0741-5214. 
Beeman, B.R.; Murtha, K.; Doerr, K.; McAfee-Bennett, S.; Dougherty, M.J. & Calligaro, K.D. 
(2010). Duplex ultrasound factor predicting persistent type II endoleak and 
increasing AAA sac diameter after EVAR. Journal of Vascular Surgery, Vol. 52, No. 5, 
(November 2010), pp. 1147-1152, ISSN 0741-5214. 
Bendick, P.J.; Bove, P.G.; Long, G.W.; Zelenock, G.B.; Brown, O.W. & Shanley, C.J. (2003). 
Efficacy of ultrasound scan contrast agents in the noninvasive follow-up of aortic 
stent-grafts. Journal of Vascular Surgery, Vol. 37, No. 2, (February 2003), pp. 381-385, 
ISSN 0741-5214. 
Bendick, P.J.; Zelenock, G.B.; Bove, P.G.; Long, G.W.; Shanley, C.J. & Brown, O.W. (2003). 
Duplex ultrasound imaging with an ultrasound contrast agent: the economic 
alternative to CT angiography for aortic stent-graft surveillance. Vascular and 
Endovascular Surgery, Vol. 37, No. 3, (May-June 2003), pp. 165-170, ISSN 1538-
5744. 
Carrafiello, G.; Recaldini, C.; Laganà, D.; Piffaretti, G. & Fugazzola, C. (2008) Endoleak 
detection and classification after endovascular treatment of abdominal aortic 
aneurysm: value of CEUS over CTA. Abdominal Imaging, Vol. 33, No. 3, (May-June 
2008), pp. 357-362, ISSN 0942-8925. 
Chaikof, E.L.; Blankensteijn, J.D.; Harris, P.L.; Zarins, C.K.; Bernhard, V.M.; Matsumura, J.S.; 
May, J.; Veith, F.J.; Fillinger, M.F.; Rutherford, R.B. & Kent, K.C. Ad Hoc 
Diagnosis and Treatment of Abdominal and Thoracic Aortic  
Aneurysms Including the Ascending Aorta and the Aortic Arch 
 
54
Committee for Standarized Reporting Practices in Vascular Surgery of the Society 
for Vascular Surgery/American Association for Vascular Surgery. (2002) Reporting 
standards for endovascular aortic aneurysm repair. Journal of Vascular Surgery, Vol. 
35, No. 5, (May 2002), pp. 1048-1060, ISSN 0741-5214. 
Elkouri, S.; Panneton, J.M.; Andrews, J.C.; Lewis, B.D.; McKusick, M.A.; Noel, A.A.; 
Rowland, C.M.; Bower, T.C.; Cherry, K.J. Jr & Glovicki, P. (2004). Computed 
tomography and ultrasound in follow-up patients after endovascular repair of 
abdominal aortic aneurysm. Annals of Vascular Surgery, Vol. 18, No. 3, (May 2004), 
pp. 271-279. 
EVAR trial participants. (2005). Endovascular aneurysm repair versus open repair in 
patients with abdominal aortic aneurysm (EVAR trial 1): randomized controlled 
trial. Lancet, Vol. 365, No. 9478, (June-July 2005), pp. 2179-2186, ISSN 0140-6736. 
Heilberger, P.; Schunn, C.; Ritter, W.; Weber, S. & Raithel D. (1997). Postoperative color flow 
duplex scanning in aortic endografting. Journal of Endovascular Surgery, Vol. 4, No. 
3, (August 1997), pp. 262-271, ISSN 1074-6218. 
Iezzi, R.; Basilico, R.; Giancristofaro, D.; Pascali, D.; Cotroneo, A.R. & Storto, M.L. (2009). 
Contrast-enhanced ultrasound versus color duplex ultrasound imaging in the 
follow-up of patients after endovascular abdominal aortic aneurysm repair. Journal 
of Vascular Surgery, Vol. 49, No. 3, (March 2009), pp. 552-560, ISSN 0741-5214. 
Kim, J.K.; Tonnessen, B.H.; Noll, R.E. Jr; Money, S.R. & Sternbergh, W.C. 3rd. (2008). 
Reimbursement of long-term postplacement cost after endovascular abdominal 
aortic aneurysm repair. Journal of Vascular Surgery, Vol. 48, No. 6 (December 2008), 
pp. 1390-1395, ISSN 0741-5214. 
Lederle, F.A.; Kane, R.L.; MacDonald, R. & Wilt, T.J. (2007) Systematic review: repair of 
unruptured abdominal aortic aneurysm. Annals of Internal Medicine, Vol. 146, No. 
10, (May 2007), pp. 735-741, ISSN 0003-4819. 
Long A, Louail B, Turmel-Rodrigues L, Julia P, Sapoval M. (2005). EVAR surveillance: is 
ultrasound imaging alone reliable in routine practice? In: Controversies and updates 
in vascular surgery, Becquemin JP, Alimi YS, Wateletbe J, pp. (8-16), Edizioni 
Minerva Medica, 88-7711-488-6, Turin. 
Manning, B.J.; O’Neill, S.M.; Haider, S.N.; Colgan, M.P.; Madhavan, P. & Moore, D.J. (2009). 
Duplex ultrasound in aneurysm rurveillance following endovascular aneurysm 
repair: a comparison with computed tomography aortography. Journal of Vascular 
Surgery, Vol. 49, No. 1, (January 2009), pp. 60-65, ISSN 0741-5214. 
May J, Harris JP, Kidd J, White GH. (2005). Imaging modalities for the diagnosis of 
endoleak, In: Vascular diagnosis, Mansour MA, Labropoulos N, pp. (407-19), 
Elsevier, 0-7216-9426-8, Philadelphia. 
McWilliams, R.G.; Martin, J.; White, D.; Gould, D.A., Rowlands, P.C.; Haycox, A.; Brennan, 
J.; Gilling-Smith, G.L. & Harris, P.L. (2002). Detection of endoleak with enhanced 
ultrasound imaging: comparison with biphasic computed tomography. Journal of 
Endovascular Therapy, Vol. 9, No. 2, (April 2002), pp. 170-179. 
Meier, G.H.; Parker, F.M.; Godziachvili, V.; Demasi, R.J.; Parent, F.N. & Gayle, R.G. (2001). 
Endotension after endovascular aneurysm repair: the Ancure experience. Journal of 
Vascular Surgery, Vol. 34, No. 3, (September 2001), pp. 426-427, ISSN 0741-5214. 
Color-Doppler Ultrasonography  
in the Monitoring of Endovascular Abdominal Aortic Aneurysm Repair 
 
55 
Mirza, T.A.; Karthikesalingam, A.; Jackson, D.; Walsh, S.R.; Holt, P.J.; Hayes, P.D. & Boyle, 
J.R. (2010). Duplex ultrasound and contrast-enhanced ultrasound versus computed 
tomography for the detection of endoleak after EVAR: systematic review and 
bivariate meta-analysis. European Journal of Vascular and Endovascular Surgery, Vol. 
39, No. 4, (April 2010), pp. 418-428, ISSN 1078-5884. 
Napoli, V.; Bargellini, I.; Sardella, S.G.; Petruzzi, P.; Cioni, R.; Vignali, C.; Ferrari, M. & 
Bartolozzi, C. (2004) Abdominal aortic aneurysm: contrast enhanced US for missed 
endoleaks after endoluminal repair. Radiology, Vol. 233, No. 1, (October 2004), pp. 
217-225, ISSN 0033-8419. 
Parent, F.N.; Meier, G.H.; Godziachvili, V.; LeSar, C.J.; Parker, F.M.; Carter, K.A.; Gayle, 
R.G.; DeMasi, R.J.; Marcinczyk,  M.J. & Gregory, R.T. (2002). The incidence and 
natural history of type I and II endoleak: a 5-year follow-up assessment with color 
duplex ultrasound scan. Journal of Vascular Surgery, Vol. 35, No. 3, (March 2002), pp. 
474-481, ISSN 0741-5214. 
Prinssen, M.; Verhoeven, E.L.; Buth, J.; Cuypers, P.W.; van Sambeek, M.R.; Balm, R.; 
Buskens, E.; Grobbee, D.E. & Blankensteijn, J.D.; Dutch Randomized Endovascular 
aneurysm Management (DREAM) Trial Group. (2004) A randomized trial 
comparing conventional and endovascular repair of abdominal aortic aneurysms. 
New England Journal of Medicine, Vol. 351, No. 16, (October 2004), pp. 1607-1618, 
ISSN 0028-4793. 
Raman, K.G.; Missig-Carroll, N.; Richardson, T.; Muluk, S.C. & Makaroun, M.S. (2003). 
Color-flow duplex ultrasound scan versus computed tomographic scan in the 
surveillance of endovascular aneurysm repair. Journal of Vascular Surgery, Vol. 38, 
No. 4, (October 2003), pp. 645-651, ISSN 0741-5214. 
Sato, D.T.; Goff, C.D.; Gregory, R.T.; Robinson, K.D.; Carter, K.A.; Herts, B.R.; Vilsack, H.B.; 
Gayle, R.G.; Parent, F.N. 3rd; DeMasi, R.J. & Meier, G.H. (1998). Endoleak after 
aortic stent graft repair: diagnosis by color duplex ultrasound scan versus 
computed tomography scan. Journal of Vascular Surgery, Vol. 28, No. 4, (October 
1998), pp. 657-663, ISSN 0741-5214. 
Sun Z. (2006). Diagnostic value of color duplex ultrasonography in the follow-up of 
endovascular repair of abdominal aortic aneurysm. Journal of Vascular Interventional 
Radiology, Vol. 17, No.5, (May 2006), pp. 759-764, ISSN 1051-0443. 
Ten Bosch, J.A.; Rouwet, E.V.; Peters, C.T.; Jansen, L.; Verhagen, H.J.; Prins, M.H. & Teijnk, 
J.A. (2010). Contrast-enhanced ultrasound versus computed tomographic 
angiography for surveillance of endovascular abdominal aortic aneurysm repair. 
Journal of Vascular Interventional Radiology, Vol. 21, No. 5, (May 2010), pp. 638-643, 
ISSN 1051-0443 
The 2007 Recommendations of the International commission on Radiological Protection. 
ICRP publication 103. Annals of the ICRP, Vol. 37, No. 2-4, (2007), pp. 1-332, ISSN 
0146-6453. 
Van Sambeek, MRHM. (2004). Abdominal Aneurysms – EVAR, In: Comprehensive Vascular 
and Endovascular Surgery, Hallett JW, Mills JL, Earnshaw JJ, Reekers JA, pp. (409-
423), Mosby, 0-7234-3232-5, Edinburgh. 
Diagnosis and Treatment of Abdominal and Thoracic Aortic  
Aneurysms Including the Ascending Aorta and the Aortic Arch 
 
54
Committee for Standarized Reporting Practices in Vascular Surgery of the Society 
for Vascular Surgery/American Association for Vascular Surgery. (2002) Reporting 
standards for endovascular aortic aneurysm repair. Journal of Vascular Surgery, Vol. 
35, No. 5, (May 2002), pp. 1048-1060, ISSN 0741-5214. 
Elkouri, S.; Panneton, J.M.; Andrews, J.C.; Lewis, B.D.; McKusick, M.A.; Noel, A.A.; 
Rowland, C.M.; Bower, T.C.; Cherry, K.J. Jr & Glovicki, P. (2004). Computed 
tomography and ultrasound in follow-up patients after endovascular repair of 
abdominal aortic aneurysm. Annals of Vascular Surgery, Vol. 18, No. 3, (May 2004), 
pp. 271-279. 
EVAR trial participants. (2005). Endovascular aneurysm repair versus open repair in 
patients with abdominal aortic aneurysm (EVAR trial 1): randomized controlled 
trial. Lancet, Vol. 365, No. 9478, (June-July 2005), pp. 2179-2186, ISSN 0140-6736. 
Heilberger, P.; Schunn, C.; Ritter, W.; Weber, S. & Raithel D. (1997). Postoperative color flow 
duplex scanning in aortic endografting. Journal of Endovascular Surgery, Vol. 4, No. 
3, (August 1997), pp. 262-271, ISSN 1074-6218. 
Iezzi, R.; Basilico, R.; Giancristofaro, D.; Pascali, D.; Cotroneo, A.R. & Storto, M.L. (2009). 
Contrast-enhanced ultrasound versus color duplex ultrasound imaging in the 
follow-up of patients after endovascular abdominal aortic aneurysm repair. Journal 
of Vascular Surgery, Vol. 49, No. 3, (March 2009), pp. 552-560, ISSN 0741-5214. 
Kim, J.K.; Tonnessen, B.H.; Noll, R.E. Jr; Money, S.R. & Sternbergh, W.C. 3rd. (2008). 
Reimbursement of long-term postplacement cost after endovascular abdominal 
aortic aneurysm repair. Journal of Vascular Surgery, Vol. 48, No. 6 (December 2008), 
pp. 1390-1395, ISSN 0741-5214. 
Lederle, F.A.; Kane, R.L.; MacDonald, R. & Wilt, T.J. (2007) Systematic review: repair of 
unruptured abdominal aortic aneurysm. Annals of Internal Medicine, Vol. 146, No. 
10, (May 2007), pp. 735-741, ISSN 0003-4819. 
Long A, Louail B, Turmel-Rodrigues L, Julia P, Sapoval M. (2005). EVAR surveillance: is 
ultrasound imaging alone reliable in routine practice? In: Controversies and updates 
in vascular surgery, Becquemin JP, Alimi YS, Wateletbe J, pp. (8-16), Edizioni 
Minerva Medica, 88-7711-488-6, Turin. 
Manning, B.J.; O’Neill, S.M.; Haider, S.N.; Colgan, M.P.; Madhavan, P. & Moore, D.J. (2009). 
Duplex ultrasound in aneurysm rurveillance following endovascular aneurysm 
repair: a comparison with computed tomography aortography. Journal of Vascular 
Surgery, Vol. 49, No. 1, (January 2009), pp. 60-65, ISSN 0741-5214. 
May J, Harris JP, Kidd J, White GH. (2005). Imaging modalities for the diagnosis of 
endoleak, In: Vascular diagnosis, Mansour MA, Labropoulos N, pp. (407-19), 
Elsevier, 0-7216-9426-8, Philadelphia. 
McWilliams, R.G.; Martin, J.; White, D.; Gould, D.A., Rowlands, P.C.; Haycox, A.; Brennan, 
J.; Gilling-Smith, G.L. & Harris, P.L. (2002). Detection of endoleak with enhanced 
ultrasound imaging: comparison with biphasic computed tomography. Journal of 
Endovascular Therapy, Vol. 9, No. 2, (April 2002), pp. 170-179. 
Meier, G.H.; Parker, F.M.; Godziachvili, V.; Demasi, R.J.; Parent, F.N. & Gayle, R.G. (2001). 
Endotension after endovascular aneurysm repair: the Ancure experience. Journal of 
Vascular Surgery, Vol. 34, No. 3, (September 2001), pp. 426-427, ISSN 0741-5214. 
Color-Doppler Ultrasonography  
in the Monitoring of Endovascular Abdominal Aortic Aneurysm Repair 
 
55 
Mirza, T.A.; Karthikesalingam, A.; Jackson, D.; Walsh, S.R.; Holt, P.J.; Hayes, P.D. & Boyle, 
J.R. (2010). Duplex ultrasound and contrast-enhanced ultrasound versus computed 
tomography for the detection of endoleak after EVAR: systematic review and 
bivariate meta-analysis. European Journal of Vascular and Endovascular Surgery, Vol. 
39, No. 4, (April 2010), pp. 418-428, ISSN 1078-5884. 
Napoli, V.; Bargellini, I.; Sardella, S.G.; Petruzzi, P.; Cioni, R.; Vignali, C.; Ferrari, M. & 
Bartolozzi, C. (2004) Abdominal aortic aneurysm: contrast enhanced US for missed 
endoleaks after endoluminal repair. Radiology, Vol. 233, No. 1, (October 2004), pp. 
217-225, ISSN 0033-8419. 
Parent, F.N.; Meier, G.H.; Godziachvili, V.; LeSar, C.J.; Parker, F.M.; Carter, K.A.; Gayle, 
R.G.; DeMasi, R.J.; Marcinczyk,  M.J. & Gregory, R.T. (2002). The incidence and 
natural history of type I and II endoleak: a 5-year follow-up assessment with color 
duplex ultrasound scan. Journal of Vascular Surgery, Vol. 35, No. 3, (March 2002), pp. 
474-481, ISSN 0741-5214. 
Prinssen, M.; Verhoeven, E.L.; Buth, J.; Cuypers, P.W.; van Sambeek, M.R.; Balm, R.; 
Buskens, E.; Grobbee, D.E. & Blankensteijn, J.D.; Dutch Randomized Endovascular 
aneurysm Management (DREAM) Trial Group. (2004) A randomized trial 
comparing conventional and endovascular repair of abdominal aortic aneurysms. 
New England Journal of Medicine, Vol. 351, No. 16, (October 2004), pp. 1607-1618, 
ISSN 0028-4793. 
Raman, K.G.; Missig-Carroll, N.; Richardson, T.; Muluk, S.C. & Makaroun, M.S. (2003). 
Color-flow duplex ultrasound scan versus computed tomographic scan in the 
surveillance of endovascular aneurysm repair. Journal of Vascular Surgery, Vol. 38, 
No. 4, (October 2003), pp. 645-651, ISSN 0741-5214. 
Sato, D.T.; Goff, C.D.; Gregory, R.T.; Robinson, K.D.; Carter, K.A.; Herts, B.R.; Vilsack, H.B.; 
Gayle, R.G.; Parent, F.N. 3rd; DeMasi, R.J. & Meier, G.H. (1998). Endoleak after 
aortic stent graft repair: diagnosis by color duplex ultrasound scan versus 
computed tomography scan. Journal of Vascular Surgery, Vol. 28, No. 4, (October 
1998), pp. 657-663, ISSN 0741-5214. 
Sun Z. (2006). Diagnostic value of color duplex ultrasonography in the follow-up of 
endovascular repair of abdominal aortic aneurysm. Journal of Vascular Interventional 
Radiology, Vol. 17, No.5, (May 2006), pp. 759-764, ISSN 1051-0443. 
Ten Bosch, J.A.; Rouwet, E.V.; Peters, C.T.; Jansen, L.; Verhagen, H.J.; Prins, M.H. & Teijnk, 
J.A. (2010). Contrast-enhanced ultrasound versus computed tomographic 
angiography for surveillance of endovascular abdominal aortic aneurysm repair. 
Journal of Vascular Interventional Radiology, Vol. 21, No. 5, (May 2010), pp. 638-643, 
ISSN 1051-0443 
The 2007 Recommendations of the International commission on Radiological Protection. 
ICRP publication 103. Annals of the ICRP, Vol. 37, No. 2-4, (2007), pp. 1-332, ISSN 
0146-6453. 
Van Sambeek, MRHM. (2004). Abdominal Aneurysms – EVAR, In: Comprehensive Vascular 
and Endovascular Surgery, Hallett JW, Mills JL, Earnshaw JJ, Reekers JA, pp. (409-
423), Mosby, 0-7234-3232-5, Edinburgh. 
Diagnosis and Treatment of Abdominal and Thoracic Aortic  
Aneurysms Including the Ascending Aorta and the Aortic Arch 
 
56
Wolf, Y.G.; Johnson, B.L.; Hill, B.B.; Rubin, G.D.; Fogarty, T.J. & Zarins, C.K. (2000). Duplex 
ultrasound scanning versus computed tomographic angiography for postoperative 
evaluation of endovascular abdominal aortic aneurysm repair. Journal of Vascular 
Surgery, Vol. 32, No. 6, (December 2000), pp. 1142-1148, ISSN 0741-5214. 
5 
Abdominal Aortic Aneurysm (AAA):  
The Decision Pathway in Ruptured  
and Non-Ruptured AAA 
Saeid Shahidi 
Department of vascular surgery Slagelse university hospital 
Denmark 
1. Introduction 
Abdominal aortic aneurysm (AAA) derives from Greek ανєυρυσμα (aneurusma), meaning 
widening, and can defined as a permanent and irreversible dilatation of a vessel. In 1991 the 
Society for vascular Surgery proposed as a criterion that the infra renal aorta diameter 
should be 1.5 times the expected normal diameter. In Europe it is defined as an abdominal 
aorta greater than 30mm. AAA is assumed to be prevalent in about 4% of males over the age 
of 65 although variation exists across countries and cause 1.3% of all deaths among men 
aged 65-85 years in developed countries (Best VA et al.2000). Whether detected incidentally 
or by screening patients with an AAA ≥ 50 mm will be referred for surgical evaluation in 
Denmark. Patients detected with aneurysms below the threshold value for referral to 
surgery will be followed regularly and referred for surgery if their aneurysm grows or if 
they develop symptoms. Patients with symptomatic or ruptured AAA will be referred for 
acute surgery where, in some cases of rupture, the patient will die before reaching the 
hospital (vascular department). A proportion of patients will be unfit for surgery for 
anatomical or physiological reasons while another proportion will decline to have surgical / 
endovascular treatment. Until recent years, open surgery was primarily performed but the 
technique of endovascular aortic repair (EVAR) has now become a part of standard practice 
in many countries. The availability of EVAR is an important alternative for two reasons: it is 
less invasive and it is provides a treatment opportunity for a proportion of these patients 
who are ineligible for open surgery. The natural disease history is progressive and may 
result in rupture with an associated mortality risk of up to 80%.If an AAA on the other hand 
is detected at an earlier, asymptomatic state there will be treatment modalities reducing the 
mortality risk dramatically. An increased awareness of the characteristics of AAA by first 
contact practitioners might reduce the risk of a fatal outcome with this disorder. In this 
chapter, we aim to provide and update review of the decision making in regard to elective 
and rupture treatment of AAA.  
2. Indication for elective treatment 
Although surgical treatment of non-rupture AAA relies on specific rare indications, such as 
distal embolisation, urethral compression, contain rupture, mycotic aneurysm, treatment of 
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intact AAA is essentially prophylactic and aimed at prevention of fatal rupture. The 
expected functional form of the relationship between risk of rupture and size, it would be 
appropriate to model relatively small size-intervals for larger aneurysms. Data availability 
on growth and rupture rates remain limited due to patients being repaired once their 
aneurysm reaches 55 mm, unless they are unfit or unwilling to receive surgical treatment. It 
was decided by Morkov  model, that  the disease process using starting states: definitely no 
AAA (0-25mm), probably no AAA (25-29mm), small or medium –sized AAA with 
essentially no risk of rupture (30-49mm), medium–sized AAA close to the iatrogenic 
threshold (50-54 mm) and four states of large AAAs above the iatrogenic threshold (55-59 
mm., 60-69 mm., 70-79 mm. and 80+ mm.). Figure 1 shows the proposed model structure for 
which the underlying decision pathways and structural assumptions are detailed in the 
following. The choice of Markov model implies two overall assumptions. First, the so-calls 
Markova property states that individuals starting in a given state can be modelled in the 
same way. This means that the route to arriving in a state or time spend in a state has no 
influence on subsequent parameters. For example, when individuals arrive at acute open 
surgery their probability for a successful outcome is independent on whether symptoms 
arose from 30 mm or a 70 mm AAA. Second, the so-called stationary assumption states that 
parameters are time–homogeneous, and do not vary from one cycle to another. There are 
limited opportunities for relating assumption, which in the present context were taken 
advantage of to allow increasing mortality rates as population age. 
 
 
Note: Blue ovals represent starting states. All numbers refer to abdominal diameter in millimetres. The 
model structure was applied equally for a scenario with and a scenarario without screening EVAR= 
elective endovascular vascular aortic repair. FU= folllow up. AAA= Aortic abdominal aneurysm. 
Fig. 1. Markov model for the course of abdominal aortic aneurysms 
The starting states of AAAs above the threshold for eligibility for elective surgery share the 
same decision pathway, except that ≥ 80 mm cannot grow to the next state. If the aneurysm 
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is symptomatic they will be referred to acute surgery following a similar protocol as 
described for the 55-59 mm AAA whereas if non-symptomatic, they will either be detected 
and referred for elective surgery or remain undetected in the state ( if no growth) or in the 
next disease state ( If growth). The size of the abdominal aneurysm is a universally 
recognised factor to forecast rupture, and the general consensus is that patients with a large 
aneurysm >5.5 cm should undergo surgical treatment. The real controversy surrounds the 
management of small aneurysm and large aneurysm in unfit patients. Indication for surgical 
treatment is deduced from the estimated risk of rupture, the estimated risk of the surgical 
procedure, and the estimated life expectancy of the patient. Fig 2: shows proposed 
management plan for asymptomatic abdominal aortic aneurysms. To be most effective, it 
should be performed when the rupture risk is high compared with operative risk, in 
patients who will live long enough to enjoy the long term benefit. It is assumed the elective 
treatment should be offered without waiting time (since there is no option for rupture while 
waiting for surgery). In practice, elective surgical treatment might not offered on the same 
days as indicated but give a 30 –day treatment guarantee in the Danish health care system 
and discretion of surgeons to prioritize the most sever candidates first this seemed a 
justified assumption in order to moderate the complexity of model structure.  
 
 
Fig. 2. proposed management of an asymptomatic abdominal aortic aneurysm. EVAR = 
endovascular repair of AAA. 
2.1 Risk of elective aneurysm repair 
Reported mortality rate related to elective AAA repair varies among hospitals and surgeons. 
Mean 30-days mortality rate has been reported between 1.1% and 7.0% (S. Shahidi et al. 
2008). Randomized EVAR 1 showed the overall 30days mortality, regardless of the risk 
factors after open surgery and endovascular repair (EVAR) was 4.6% and 1.5%, 
respectively.In 2009 the overall 30-days mortality rate in Denmark was 2.7% out of 310 open 
surgeries and 2.1% out of 196 EVAR. (www.karbase.dk). Most deaths resulting from the 
repair occurred in the so called high-risk patient. Factors of increased operative risk are 
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renal failure, chronic obstructive pulmonary disease, and most importantly myocardial 
ischemia. In this matter, analysis of the EVAR 2 trial data performed by the EVAR 
investigators did not show a significant difference in either all-cause or aneurysm-related 
mortality. Thus, outcomes of the EVAR 2 trial have not settled the choice between EVAR 
and no treatment in this scenario to everyone's satisfaction. In patients with large AAAs 
who are fit for open surgery, EVAR offers an initial mortality advantage over open, with a 
persistent reduction in AAA-related death at 4 years. However, EVAR offers no overall 
survival benefit, is more costly, and requires more interventions and indefinite surveillance 
with only a brief QOL benefit. It may or may not offer a mortality benefit over non-operative 
management in patients with large AAAs who are unfit for open repair, but the statistical 
significance of this comparison is inconclusive. In relation to growth rate /year, there will 
always be a relative concentration of patients unfit for open surgery in the follow-up 
program. It is thus assume that the risk of rupture is not affected from that and the high risk 
patients individually should spotted in the matter of rupture risk/ year and the risk of 
open/ EVAR treatment, if this is technically possible and acceptable. Patients, who have a 
very low restricted life expectancy estimated (0-4) year, suggest treating by non-operative 
management.  
3. Rupture abdominal aorta aneurysm, transition to AAA-related death 
Related death is defined as consequence of rupture or as consequence of undergoing 
surgery if death occurs within 30 days postoperatively. A certain proportion of patients with 
rupture will not reach the hospital alive for emergency surgery. Most patients (92%) with a 
rupture who reach the vascular clinic alive have a rupture of the posterolateral wall into the 
retroperitoneal space. Banke A et al, 2008.  
3.1 Risk of rupture 
The UK small aneurysm Trial 1998 and the US Veterans Administration study led to similar 
findings despite a lower operative mortality 2.7% vs.5.8%). The conclusion was, infra 
abdominal aorta aneurysms smaller than 5.5 cm in diameter is safe, where as early surgery 
is not associated with improved long-term survival. Today it is accepted that AAA diameter 
is the best predictor of rupture risk. The variability of estimates of rupture risk for particular 
AAA diameters cited in the literature reflects differences in other factors besides maximal 
diameter which may vary considerably from series to series, and illustrates that other factors 
in addition to absolute size must be taken into account in each individual case. It is clear that 
there is a substantial increase in rupture risk as AAA diameter increase from 5 cm to 6 cm. ( 
Nevit et al., 1989) reported no rupture during 5-years follow-up for AAA < 5 cm, but a 5% 
annual rupture risk for AAA> 5 cm at initial presentation. Similar estimates were obtained 
from the larger UK Small aneurysm Trial, where the annual rupture to be 0% (0-5%) for 
AAA< 4 cm. The long-term report from the UK small aneurysm has shown that the risk of 
rupture in women was nearly four times higher than in men. The studies of rapid expansion 
of AAA suggest the size of AAA is probably not the sole useful determinant for risk of 
rupture (Limet et al., 1991 & Gilmaker et al., 1991). Active investigations have been and still 
are being done to identify markers other than size that would predict a risk of rupture. The 
level of serum MMP-9 has been reported to be significantly higher in patients with AAA 
and also associated with the size expansion rate of these AAA (Sakalihasan et al., 1996). 
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Preliminary data obtained by PET Imaging of AAA have shown focal uptake of (18 F-FDG) is 
regarded as a functional image of inflammatory response and thus as a potential non-
invasive technique to identify unstable AAA that are prone to rupture Sakalihasan et al, 
2002. Probabilities of rupture were estimated from the literature. Estimates generated before 
year 2000 were considered to be outdated due to the introduction of medical treatment 
(Statin) in the beginning of 1990. After close examination of studies, the EVAR II was 
excluded since only patients fit for EVAR were included. Table 1 shows the estimated risk of 
rupture in AAA, as the function of AAA diameter size in centimetre.  
 
AAA diameter size, (cm) Rupture risk /year 
4,0-4,9 0,5-5,0% 
5,0-5,9 3-15 % 
6,0-6,9 10-20 % 
7,0-7,9 20-40 % 
Over 8 30-50 % 
Table 1. Estimated annual rupture risk in AAA.  
The simple observation that not all AAAs rupture at a specific diameter indicates that other 
patient- or aneurysm-variable also effect rupture risk. The risk of rupture is also correlated 
with co-morbidities as age, lung disease COPD,blood pressure, cardial disease, diabetes. The 
probability for rupture among high risk patients who are inoperable is likely to be higher 
than the equivalent in aneurysm-size matched patients. No estimates of ruptures in the 
group of high risk patients were found to be available in literature. Important information 
concerning AAA rupture from the UK Small Aneurysm Trial was that patients with 4.0-5.5 
cm AAAs , the relative risk of rupture was independently increased by female gender (3.0x), 
larger initial diameter (2.9x per cm.), current smoking (1,5x), age (1,3x per 4 years), worse 
COPD (0.6x per L ,FEVI), and higher mean arterial pressure ( 1.02x per mmHg). In addition 
to AAA size, many surgeons consider the ratio of diameter to the proximal normal aorta, a 5 
cm. AAA in a patient with a 1.5 cm native aortic diameter may or may not to be at greater 
risk of rupture compared with the same size AAA in a patient with a native aortic of 2.5 cm. 
The validity of this concept, however has not been proven. The relative comparison between 
aortic diameter and the diameter of the third lumbar vertebra reported to increase the 
accuracy for predicting rupture risk, by adjusting for differences in body size (Ouriel et al., 
1992). The improvement in prediction accuracy appears minimal, however, when compared 
with absolute AAA diameter. Although rapid AAA expansion is presumed to increase 
rupture risk, it is difficult to separate this effect from influence of expansion rate on absolute 
diameter, which alone could increase rupture risk. 
3.2 Open emergency repair of AAA 
The selection of patients with ruptured abdominal aortic aneurysms (RAAAs) for 
emergency repair can be a complex and emotionally charged process. Two possible broad 
approaches to patients with RAAA exist: an ‘‘all-comers’’ approach and a more ‘‘selective’’ 
approach. The all-comers approach offers surgical intervention in every patient, regardless 
of current status or presence of significant co morbidities. The selective approach would 
involve an assessment of operative risk predictors and co morbidities in an attempt to 
identify patients with an unrealistic expectation of a successful outcome. The epidemiology 
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renal failure, chronic obstructive pulmonary disease, and most importantly myocardial 
ischemia. In this matter, analysis of the EVAR 2 trial data performed by the EVAR 
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mortality. Thus, outcomes of the EVAR 2 trial have not settled the choice between EVAR 
and no treatment in this scenario to everyone's satisfaction. In patients with large AAAs 
who are fit for open surgery, EVAR offers an initial mortality advantage over open, with a 
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survival benefit, is more costly, and requires more interventions and indefinite surveillance 
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Preliminary data obtained by PET Imaging of AAA have shown focal uptake of (18 F-FDG) is 
regarded as a functional image of inflammatory response and thus as a potential non-
invasive technique to identify unstable AAA that are prone to rupture Sakalihasan et al, 
2002. Probabilities of rupture were estimated from the literature. Estimates generated before 
year 2000 were considered to be outdated due to the introduction of medical treatment 
(Statin) in the beginning of 1990. After close examination of studies, the EVAR II was 
excluded since only patients fit for EVAR were included. Table 1 shows the estimated risk of 
rupture in AAA, as the function of AAA diameter size in centimetre.  
 
AAA diameter size, (cm) Rupture risk /year 
4,0-4,9 0,5-5,0% 
5,0-5,9 3-15 % 
6,0-6,9 10-20 % 
7,0-7,9 20-40 % 
Over 8 30-50 % 
Table 1. Estimated annual rupture risk in AAA.  
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of AAA is changing. (Best et al., 2000) reported a persistent increase in the incidence of 
emergency AAA with an associated increase in age-adjusted AAA mortality. The recorded 
incidence of RAAA varies from region to region in Denmark. The national incidence of 
operated AAA and RAAA per year has increased in the last 10 years in Denmark: That for 
operated elective AAA is 6 to 7/100,000 and that for RAAA is 3.5 to 6/100,000 populations 
(S. Shahidi et al., 2009). 
Despite recent advances in anaesthetic, operative, and postoperative care, the high mortality 
figure has prompted many surgeons to question whether repairing RAAA should even be 
attempted in the subset of patients with poor physiological reserve. Although some decline 
has been reported over the years, the overall operative mortality is still in the range of 40-
50% (Fig.3). Elderly patients have a restricted life expectancy. In Denmark in 2005-2006, life 
expectancy for males aged 60, 65, 70, 75, 80, and 85 years old was 18,15.5, 11, 5, 6, and 4.8 
years, respective (S. Shahidi et al., 2009). For patients who undergo AAA repair, the 5-year 
survival rate is reduced compared to age and matched individuals (60-65%) (Barlow AP et 
al, .1989). Excess mortality in this patient group is substantially attributable to associated co 
morbidities, particularly coronary artery disease. In order to make this difficult decision 
more objective, a number of scoring systems have been constructed; however, none of them 
focuses on practical scores, which can be calculated preoperatively in an elderly surgical 
patient with RAAA. Is it pointless to operate on an elderly patient with RAAA? Can we 
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Fig. 3. Overall operative mortality after RAAA compared to background population, shows 
40-50% survival reduction in the first 30 days after rupture (www.karbase.dk). 
However, repair of RAAA in the elderly generally requires a careful assessment of life 
expectancy and of the impact of repair-related complications in this specific high-risk subset 
of patients. It may be still question, if would repair really be the best solution for the elderly 
patient? Should the patient be palliated? Would the resources we need to use be correctly 
addressed? These rhetorical questions and issues pose an increasing challenge and 
discussion for vascular-surgeons. In this respect, ethical problems and cost analysis can be 
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important components in the decision-making process. Some might claim that the health 
economy aspects are hardly relevant or that health economy has nothing to do with 
decision-making concerning the individual patient (at least not yet). Furthermore, some are 
of the opinion that the cost incurred during prolonged intensive treatment of elderly 
patients is substantial and that these resources, ideally, should not be wasted on futile 
endeavours. Currently, as clinicians are increasingly required to accept fiscal autonomy and 
budgetary responsibility, it is important that the use of health-care resources benefits not 
only the individual patient but also the wider group of all patients attempting to gain access 
to health care. This managerial role involves an increasing awareness of cost restraints 
within the health service, an awareness of the pressure to rationalize limited resources, and 
the need for awareness both in Denmark and worldwide of the realistic outcomes of a 
proposed treatment option. 
 
 
Fig. 4. Thirty-day mortality and survival after open repair of RAAA in the regions of age 
groups1:  S. Shahidi et al, 2009. 
In 2005, the policy of our department was to operate on all patients with an RAAA who 
reached the hospital alive, who did not refuse surgery, and who did not have a severe 
terminal malignancy. In some institutions, patients are selected for repair after consideration 
of age, presentation, and medical co morbidities. A recent survey showed that 97% of U.K. 
vascular surgeons practice a selective approach (Hewin DF et al., 1998). Many reports have 
attempted to identify independent predictors for mortality, but there is no ideal scoring 
system for preoperative assessment of elderly patients needing emergency RAAA surgery 
(Al Omran et al, 2004, S. Shahidi et al., 2009, 2010). Some preoperative scoring systems 
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provide approximate estimates of mortality risk, but none has proved sufficiently specific 
for use on elderly individuals. Among the 72 cases of infra- and juxtarenal open RAAA 
repair, 30-day mortality was markedly skewed around a median age in the region of 75-79 
years. The number of procedures in the different age groups according to 30-day mortality is 
presented in Figure 3. 2009. Out of 28 elderly patients (39%), eight (11%) were 75-80 years of 
age and 20 (28%) were aged 80 or more. The 30-day mortality was 75% for patients 75-80 
years of age and 50% for patients aged 80 years or more. The 30-day mortality rates for 
patients in the elderly group was 16 (57%, CI 48-72%), significantly higher than the mortality 
rate of 9 (20%, CI 12- 33%) in the younger group (p < 0.001) (Table 2). 
The significant risk factors identified by univariate analysis were then used in a multivariate 
analysis by means of simple logistic regression with death as the outcome to predict 
mortality. The logistic regression analysis was repeated to find significant independent risk 
factors in the elderly compared to the younger groups. As illustrated in Table 2, age ≥75 and 





Table 2. Multivariate analysis of 30 days mortality from (S. Shahidi et al; 2009). 
In this study the age range for 30-day mortality was a markedly skewed distribution around 
a median age in the region of 75-80 years (Fig. 1). The ROC analysis in our series showed 
that the age of 75 years gave the greatest area under the curve for predicting 30-day death 
postoperatively (a cut-off age). Of course, the sample size is small and this would be a bias; 
but with the above studies and the life expectancy of Danish males in mind, our study 
suggests that a male patient aged 75 years or more with an RAAA should be considered 
elderly. There are some other risk score systems.  
In another study, we compared of preoperative levels of Base deficit and Lactate in 
predicting outcome in patients with open repair after RAAA (S. Shahidi et al,. 2010). From 
January 2006 to December 2008, the medical records of 47 patients with RAAA were 
reviewed. Of the 47 patients enrolled in the study, 44 were men and 3 were women, with a 
median age of 71 (CI: 69-73), at admission. Patient’s demographics and underlying co-
morbidities are listed in Table 3. Twenty-five (53%) patients died within 30 days in the per-
operative period. Altogether, there were twelve (26%) on-table deaths; five (11%) patients 
died within 24 hours after surgery; 8 (17%) patients died of multi-organ failure. Survivors 
had a median age of 70(range 40-83), which is significantly younger than non-survivors 
75(range 59-85) (p=0.009). Pre-operative lactate (p=0.011), pre-operative base deficit 
(p<0.001), measured blood loss (p=0.002) are significant higher in non-survivors compared 
with survivors. These data suggest that pre-operative base deficit is a valuable marker better 
than pre-operative lactate for the identification of the per-operative death of patients with 
ruptured AAA. A threshold of level of -4.0 mmol/L of pre-operative base deficit had the 
highest combined sensitivity and specificity for the identification of per-operative death 
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after repair of ruptured AAA. The sensitivity and specificity of pre-operative base deficit <-4 
mmol/L was 80.0% and 86.3%, respectively. 
Receiver-operating-characteristic (ROC) curves were constructed to illustrate various cut-off 
values of pre-operative lactate, and base deficit. The mean ± SE area under the receiver-
operating-characteristic curve for pre-operative base deficit was 0.83±0.06 (95% confidence 
interval 0.71 to 0.95, p<0.001) among non-survivors. Pre-operative lactate level had a mean 
area under the curve of 0.72±0.08 (95% confidence interval 0.57 to 0.87, p=0.011) among non-
survivors. A cut-off value of -4 mmol/L of pre-operative base deficit has 80.0% sensitivity 
and 86.3% specificity respectively 
 
 
Table 3. Clinical variables in survivors and no survivors after open RAAA repair. 
 
 
Fig. 4. ROC analysys curve for base  
difficiet in our study. 
Fig. 5. Roc analysis curve for lactat in our 
study 
Fig. 4 & 5. Receiver operating characteristic curves of preoperative lactate (black), and base 
deficit (red).  
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4. Health economic finance 
The financing of Danish hospitals is through the national Diagnostic Related Group (DRG 
system). DRG is classified by diagnosis and surgical procedure according to this system and 
gives a value estimated by Danish health authorities. Since the majority of the procedures 
were complicated, the DRG with recorded complications was used. Based on these DRG 
values, the cost of each of the 30 days gained from surgical repair in these elderly patients 
could be estimated. The DRG value for the year 2005 was used for all patients. DRG is the 
average expenses, which depends on two parameters of the ICD-9 diagnosis, e.g., I.713 
(RAAA), and the treatment, e.g., KPDG10 (operation for AAA). The average estimated cost 
of in-hospital treatment of RAAA was €15,350 (DRG) in 2005 in Denmark In 2005, the 
Danish health authorities estimated the average cost of an operation for RAAA to be €15,350 
DRG compared to an elective AAA, which is €8,500 DRG. Concerning the age 75 years, our 
data show that the respective risk difference (RD) is approximately 0.38 (0.157-0.575), with 
an estimated NNT of 2.0 (1.74-6.34) (S. Shahidi et al., 2009). 
5. Discussion 
Decision-making in regard to elective repair of AAA requires careful assessment of factors 
that influence rupture risk, operative mortality and life expectancy. Individualizes 
consideration of these factors in each patient in each patient is essential, and role of patient 
preference is of increasing importance. The surgeon should be very aware that the elective 
treatment of AAA in every case and in any time is only a prophylactic treatment. It is not 
possible or appropriate to recommend a single threshold diameter for intervention which 
can be generalized to all patients. Based upon the best  available current evidence, 5.5 cm is 
the best threshold for repair in an “average” patient. However, subsets of younger, good-
risk patients or aneurysms at higher rupture risk may be identified in whom repair at 
smaller sizes id justified. I do believe that delaying in repair until larger diameter may be 
best for older, higher-risk patients, especially if endovascular repair is not possible. 
Intervention at diameter < 5.5 cm appears indicated in women with AAA and maybe in 
patients with rapid AAAs expansion. If a patient has suitable anatomy , endovascular repair 
should be considered, and it is most advantageous for older, higher-risk patients, who has 
acceptable life expectancy. The patient with a very low life expectancy should not under-go 
an invasive prophylactic repair. There is evidence for EVAR clearly reduced perioperative 
mortality, morbidity and recovery time, however, there is a higher reintervention rate, 
increased surveillance burden, and a small but ongoing risk of AAA rupture. In my 
knowledge there is no justification at present for different indications for EVAR , such as 
earlier treatment of smaller AAA. We are still waiting for long-term outcome of 
endoluminal repair is better defined and results of randamized trials available, the choice 
between EVAR and Open repair will continue heavily on patient preference and 
information.       
In the matter of RAAA and emergency repair of RAAA, there are many reports , as the 
report from the Mayo Clinic showed that advanced age, high Acute Physiology and Chronic 
Health Evaluation (APACHE II) score, low initial hematocrite, and preoperative cardiac 
arrest increased mortality rates (Goffi et al,. 1999). The APACHEII is commonly used to 
assess surgical patients in the ICU, where it was designed to predict outcome, but has 
seldom been used in preoperative assessment. The APACHE II scores appear to predict 
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outcome equally well when the age points are omitted. Goffi concluded that fit elderly 
persons should not be denied an emergency operation because of their age alone. (Hardman 
et al,. 1996) reviewed 154 patients and identified five independent preoperative risk factors 
that were associated with mortality: age >76 years, an ischemia electroencephalogram, Hb 
<9 g/dL, creatinine >0.19 mmol/L, and loss of consciousness. They also reported that all 
patients who presented three or more variables died. In addition, (Johnston et al., 1994) 
found that hypotensive patients with raised creatinine had only a 20% chance of survival. 
The Glasgow Aneurysm Score (GAS), first described in 1994, calculated a risk of mortality 
with RAAA using age in years: +17 for the presence of shock, +7 for myocardial disease, +10 
for cerebrovasculare disease, and +14 for renal disease (Sammy ak et al.). All of these 
findings strongly suggest that mortality is determined by the severity of physiological insult 
and the patient’s premorbid physiological reserve. Despite the findings of our studies and 
other studies, there is still no consensus on how to use these preoperative variables. While 
these clinical variables may prove useful, they must be interpreted with caution and should 
only act as an adjunct to clinical decision-making. A ruptured aneurysm is lethal in almost 
every case, unless the patient is operated successfully (Olsen P et al., 1991). That is why the 
scoring system should be able to differentiate those elderly patients who have no chance of 
survival from those who are likely to benefit from surgery (S. Shahidi et al., 2009 and 2010). 
The estimated cost per life after 30 days postoperatively was €40,409 (DRG) for the elderly 
patient in our cohort in 2005 compared to €18,880 (DRG) in the younger group. This can be 
compared to the cost per year of life gained by haemodialysis, which is estimated to be at 
least €50,000 (Winkel M.et al., 1999). Regarding the health economic aspect in RAAA 
patients, we found only one study. An interesting Norwegian study showed the total 
survival time of octogenarians treated for RAAA. Over a 20-year period, 53 patients aged 80 
years or older were operated for RAAA. The survival time was estimated and related to 
DRG values in order to estimate the cost of each year of life gained by operating on this type 
of patient (Aune et al., 2004). The authors concluded that the operative mortality for patients 
aged >80 years with RAAA is high (47%) but the price of each gained year of life is relatively 
low. The estimated cost per gained year of life was € 6,817. The accurate cost of each 
operation obviously varies and is difficult to calculate. That is why we have based our 
calculation on the DRG cost. There is some evidence of a significant reduction in mortality 
from AAA in men aged 65-79 years who undergo ultrasound screening. The cost-
effectiveness may be acceptable but needs further expert analysis (Mass study 2002). A Cost 
effectiveness analysis based on a probabilistic, enhanced economic decision analytical model 
from screening to death (MTV report) from Denmark(showed the estimated costs per 
quality adjusted life year (QALY) gained discounted at 3% per year over a lifetime for costs 
and QALYs was £43 485 (£54 852; £71 160). At a willingness to pay threshold of £30 000 
the probability of screening for abdominal aortic aneurysm being cost effective was less than 
30%. One way sensitivity analyses showed the incremental cost effectiveness ratio varying 
from £32 640 to £66 001 per QALY. Ehlers concluded screening for abdominal aortic 
aneurysm does not seem to be cost effective. Further research is needed on long term quality 
of life outcomes and costs (Ehlers et al., 2008). These findings still need careful consideration 
in judging whether a co-coordinated population-based screening program should be 
introduced. The screening program has been implemented in United Kingdom. In Denmark 
we are waiting for further expert analysis and approval from the Danish health authorities. 
The screening program would be discussed in other chapters. Open repair is still the 
predominant procedure for RAAA. Until today, there has been no high-quality evidence to 
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4. Health economic finance 
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possible or appropriate to recommend a single threshold diameter for intervention which 
can be generalized to all patients. Based upon the best  available current evidence, 5.5 cm is 
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outcome equally well when the age points are omitted. Goffi concluded that fit elderly 
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introduced. The screening program has been implemented in United Kingdom. In Denmark 
we are waiting for further expert analysis and approval from the Danish health authorities. 
The screening program would be discussed in other chapters. Open repair is still the 
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support the use of (EVAR) in the treatment of RAAA. However, evidence from prospective 
controlled studies without randomization, prospective studies, and retrospective case series 
suggests that EVAR is feasible in selected patients, with outcomes comparable to best 
conventional open surgical repair for the treatment of RAAA (AJAX trial still going on). The 
numbers of EVAR procedures for this group are small in Europe. The second VASCUNET 
data-base report from 2008 for 10 year operative outcome of more than 33.000 patients with 
aortic aneurysms in six countries, Denmark (DK), England (UK), New Zealand (NZ), 
Australia (AST), Sweden (SW) and Switzerland (SWZ), with participating of 202 hospitals, 
showed a much less use of EVAR in RAAA in these countries. The percentage of operation 
type according RAAA and EVAR in these six countries until 2009 was DK=1, UK=4, NZ= 7, 
SW= 22, AST=8 and SWZ=21 of all ruptures (S. Shahidi et al., 2009). The promising results 
for EVAR of ruptured abdominal aneurysms may have the potential to significantly lower 
the mortality in all RAAA patients. That is why the author suggest, all elderly high risk 
patients, patient with preoperative renal dysfunction and pre-operative base deficit < -
4mmol/L should be selected to EVAR, if this is technically possible. Had we chosen not to 
operate on elderly patients with preoperative serum creatinine 0.150 mmol/L, or elderly 
patients with a basis deficit -4.0 mol/ l, at least eleven patients would have been denied a 
life-saving operation. All of these eleven patients were successfully discharged from 
hospital (S. Shahidi et al., 2009 & 2010; Banke A., 2008). 
6. Conclusion and future 
The arbitrary setting of a single threshold diameter for elective AAA repair applicable to all 
patients is not appropriate, as the decision for repair must be individualized in each case.  
The most important thing in individual decision-making of this elective prophylactic 
treatment is the estimated risk of rupture, the estimated risk of the surgical procedure, and 
the estimated life expectancy of the individual case, and giving the competence to the out- 
patients for making decision along with the surgeon.  
 The ideal treatment of RAAA is prevention or to increase the probability of reaching 
hospital alive in case of rupture. In our experience, after 1-year follow-up, open repair has 
been life-saving in 77% of patients younger than 75 years, with a low price estimated at € 
18,880, and surgical repair has been life-saving in 33%of patients aged 75 years and older at 
a relatively low price for each life, estimated at € 40,409. The first goal in abdominal aortic 
aneurysm still is the prevention of rupture; hopefully the next aim in the future will be the 
prevention of abdominal aortic growth. 
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1. Introduction 
Abdominal Aortic Aneurysm (AAA) is defined as a localized and permanent dilatation of 
the abdominal aorta, beyond 50% of the normal aorta diameter (Schermerhorn, 2009). The 
prevalence of AAA ranges from 1.3% to 8.9% in men and 1% to 2.2% in women (Sakalihasan 
et al., 2005; Singh et al., 2001). Incidence of AAA is on the rise in parallel with a globally 
ageing population, higher clinical suspicion and improved accuracy of imaging methods 
(Best et al., 2003; Prisant & Mondy, 2004). AAA is an important problem for public health, 
since AAA rupture is the tenth leading cause of death in American white men 65 to 74 years 
of age (Upchurch & Schaub, 2006). Most AAA remain asymptomatic until rupture occurs. 
Half of the patients with a ruptured AAA reach the hospital alive, with an additional 
operative mortality of 30-60%. On the contrary, an elective AAA repair, recommended in 
most patients with an abdominal aortic diameter exceeding 50-55 mm or rapid growth (> 1 
cm/y), is associated with a mortality risk of 2% to 6% (Kurvers at al., 2003; Sakalihasan et 
al., 2005). Health organizations recently recommended one-time screening for AAA by 
ultrasonography for men aged between 65 and 75 years with a smoking history, thereby 
reducing AAA related mortality rates by 50% (Cosford & Leng, 2007; Ehlers et al., 2008; 
Ferket et al., 2011; Moxon et al., 2010; Takagi et al., 2010). However, they advised against 
screening in men below 65 and over 75 years, and in women, since the number of AAA-
related deaths that can be prevented by screening these populations is too small. AAA and 
atherosclerosis share several risk factors, such as male sex, age, smoking and arterial 
hypertension (Forsdahl et al., 2009). In population – based studies, AAA is independently 
associated with pre – existing coronary arterial disease (CAD) (Golledge et al., 2006; Kent et 
al., 2010). The high prevalence of CAD among patients with AAA is well known, with an 
impact on short term survival after AAA repair (Falk et al., 1997). Indeed, coronary 
investigation is often required prior to aortic surgery, finding a concomitant CAD 
prevalence of 31% to 90% (Kioka et al., 2002; Sukhija et al., 2004; Van Kuijk et al., 2009). In 
contrast, the opposite relationship, namely the prevalence of AAA among patients with 
CAD, has been explored only in some recent cohorts or in subgroups of patients. The 
possibility that AAA could be more prevalent in this population, as compared with the 
general population, has been suggested by these previous studies, with limited, incomplete 
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1. Introduction 
Abdominal Aortic Aneurysm (AAA) is defined as a localized and permanent dilatation of 
the abdominal aorta, beyond 50% of the normal aorta diameter (Schermerhorn, 2009). The 
prevalence of AAA ranges from 1.3% to 8.9% in men and 1% to 2.2% in women (Sakalihasan 
et al., 2005; Singh et al., 2001). Incidence of AAA is on the rise in parallel with a globally 
ageing population, higher clinical suspicion and improved accuracy of imaging methods 
(Best et al., 2003; Prisant & Mondy, 2004). AAA is an important problem for public health, 
since AAA rupture is the tenth leading cause of death in American white men 65 to 74 years 
of age (Upchurch & Schaub, 2006). Most AAA remain asymptomatic until rupture occurs. 
Half of the patients with a ruptured AAA reach the hospital alive, with an additional 
operative mortality of 30-60%. On the contrary, an elective AAA repair, recommended in 
most patients with an abdominal aortic diameter exceeding 50-55 mm or rapid growth (> 1 
cm/y), is associated with a mortality risk of 2% to 6% (Kurvers at al., 2003; Sakalihasan et 
al., 2005). Health organizations recently recommended one-time screening for AAA by 
ultrasonography for men aged between 65 and 75 years with a smoking history, thereby 
reducing AAA related mortality rates by 50% (Cosford & Leng, 2007; Ehlers et al., 2008; 
Ferket et al., 2011; Moxon et al., 2010; Takagi et al., 2010). However, they advised against 
screening in men below 65 and over 75 years, and in women, since the number of AAA-
related deaths that can be prevented by screening these populations is too small. AAA and 
atherosclerosis share several risk factors, such as male sex, age, smoking and arterial 
hypertension (Forsdahl et al., 2009). In population – based studies, AAA is independently 
associated with pre – existing coronary arterial disease (CAD) (Golledge et al., 2006; Kent et 
al., 2010). The high prevalence of CAD among patients with AAA is well known, with an 
impact on short term survival after AAA repair (Falk et al., 1997). Indeed, coronary 
investigation is often required prior to aortic surgery, finding a concomitant CAD 
prevalence of 31% to 90% (Kioka et al., 2002; Sukhija et al., 2004; Van Kuijk et al., 2009). In 
contrast, the opposite relationship, namely the prevalence of AAA among patients with 
CAD, has been explored only in some recent cohorts or in subgroups of patients. The 
possibility that AAA could be more prevalent in this population, as compared with the 
general population, has been suggested by these previous studies, with limited, incomplete 
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and often conflicting results. Accordingly, no specific recommendation is available on AAA 
screening in patients with advanced atherosclerosis. To our knowledge, we present the first 
systematic review, based on a thorough literature survey, which delineates the prevalence 
and predictive risk factors of AAA among CAD patients. We thus aim at identifying CAD 
patients at high risk for AAA development and discussing the usefulness of AAA screening 
in such subpopulations. 
2. Methods 
A systematic English-language literature search has been performed using the 
MEDLINE/Pubmed, Cochrane and Embase databases to identify all studies on the 
prevalence and risk factors of AAA among CAD patients, published from January 1985 to 
January 2011. The key words searched for were AAA and CAD. The title and relevant 
abstracts have been screened for studies which statistically analyzed prevalence data of 
AAA in CAD patients. In addition, the references of eligible papers were screened for 
further relevant studies. Two authors independently reviewed and extracted data from each 
article using a specific data extraction form: publication year, characteristics of study 
population including CAD severity, AAA definition, size, prevalence, associated risk factors 
and circulating biomarkers. Discrepancies were resolved by consensus.  
3. Characteristics of abdominal aortic aneurysm in coronary artery disease 
patients 
Seventeen studies (8308 patients) published between 1991 and 2010 were eligible, meeting 
the predetermined inclusion criteria (table 1). Study population ranged from 72 to 2819 
patients. For some studies, only the subgroup of CAD patients received our attention (Abela 
et al., 2009; Alcorn et al., 1996; Benzaquen et al., 2001; Bonamigo & Siqueira, 2003; Goessens 
et al., 2006; Jaussi et al., 1999; Nemati et al., 2009).  
In these studies, the prevalence or incidence of AAA among CAD patients oscillated 
between 0.48% and 18.2%, with 8 studies above 9% (upper limit of AAA prevalence in 
population – based studies). The prevalence of AAA eligible for surgical repair varied from 
0% to 5.2 % of the study population, and from 0% to 36.7% of the AAA population (table 2). 
AAA diameter in these studies ranged between 25 and 87 mm. Five studies included a 
control population, age and sex matched in most cases, and without angiographic CAD 
(Bergersen et al., 1998; Bonamigo & Siqueira, 2003; Madaric et al., 2005; Nemati et al., 2009; 
Wang et al., 2008). AAA prevalence in these control groups were always significantly below 
the prevalence in the CAD group, ranging from 0 to 3.3%.  
4. High heterogeneity of studies 
The wide variations in AAA prevalence among the precited 17 studies could be explained 
by differences in severity of CAD, AAA definition, age and sex distribution, geographical 
localisation, prevalence of associated risk factors and pre-existing atherosclerosis-related 
morbidity.  
Inclusion criteria clearly stated a wide range of CAD severity: current coronary 
angiographic data with various thresholds of significant coronary narrowing; data on 
previous coronary events; data on current or previous coronary revascularisation 
procedures whether endovascular or surgical. Nine out of the 17 studies included patients 
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Nevelsteen et al., 
1991 Post CABG, Belgium 100 (80) 11* 
Alcorn et al., 
1996 
Aged > 65 years, MI, angina, CABG, significant stenosis 
on coronary angiography, USA 1244 13.8 
Bergersen et al., 





Jaussi et al., 1999 Patients referred for Transthoracic Echocardiography with ischemic heart disease, Switzerland 72 15.3* 
Benzaquen et al., 
2001 Significant angiographic coronary stenosis, Canada 99 (75) 8.1* 
Bonamigo & 
Siqueira, 2003 
Male aged > 54 years, severe ischemic disease (stenosis > 
70%) and previous coronary surgery, or important lesions 
on cardiac catheterism, Brazil 
501 6.8* 
Monney et al., 
2004 Male aged > 60, Post CABG, Switzerland 395 10.1* 
Calderwood & 
Welch, 2004 CABG patients, United Kingdom 118 15.3 
Madaric et al., 
2005 
Age > 60 years, coronary narrowing ≥ 50%, Slovak 
Republic 109 (90) 
14.7 
(8.3*) 
Goessens et al., 
2006 
"SMART Study", MI, unstable angina or history of CAD 
or CABG/PCI, The Netherlands 1034 (83) 
3.7 
(2.2*) 
Wang et al., 2008 Age > 60 years, coronary narrowing ≥ 50%, China 209 (72.7) 0.48* 
Abela et al., 2009 Significant coronary stenotic lesions, United Kingdom 87 (77) 13.8 
Shirani et al., 
2009 Elective candidates for CABG, Iran 
2819 
(69.6) 2.09 
Nemati et al., 
2009 CAD (more than 50% constriction), Iran 184 4.3 
Dupont et al., 
2010 Post CABG, France 217 (87) 6.9 
Long et al., 2010 Acute coronary syndrome with coronary stenosis ≥ 50%, France 304 (77) 6.6* 
Poon et al., 2010 Elective patients for CABG, China 624 (79.9) 1.8 
Table 1. Summary of studies reporting prevalence or incidence (*) rates of abdominal aortic 
aneurysm (AAA) among coronary artery disease (CAD) patients. CABG: coronary artery 
bypass graft, MI: myocardial infarction, PCI: percutaneous coronary intervention 
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by differences in severity of CAD, AAA definition, age and sex distribution, geographical 
localisation, prevalence of associated risk factors and pre-existing atherosclerosis-related 
morbidity.  
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procedures whether endovascular or surgical. Nine out of the 17 studies included patients 
 
 
Abdominal Aortic Aneurysm in Patients with Coronary Artery Disease: A Review Article 
 
73 






Nevelsteen et al., 
1991 Post CABG, Belgium 100 (80) 11* 
Alcorn et al., 
1996 
Aged > 65 years, MI, angina, CABG, significant stenosis 
on coronary angiography, USA 1244 13.8 
Bergersen et al., 





Jaussi et al., 1999 Patients referred for Transthoracic Echocardiography with ischemic heart disease, Switzerland 72 15.3* 
Benzaquen et al., 
2001 Significant angiographic coronary stenosis, Canada 99 (75) 8.1* 
Bonamigo & 
Siqueira, 2003 
Male aged > 54 years, severe ischemic disease (stenosis > 
70%) and previous coronary surgery, or important lesions 
on cardiac catheterism, Brazil 
501 6.8* 
Monney et al., 
2004 Male aged > 60, Post CABG, Switzerland 395 10.1* 
Calderwood & 
Welch, 2004 CABG patients, United Kingdom 118 15.3 
Madaric et al., 
2005 
Age > 60 years, coronary narrowing ≥ 50%, Slovak 
Republic 109 (90) 
14.7 
(8.3*) 
Goessens et al., 
2006 
"SMART Study", MI, unstable angina or history of CAD 
or CABG/PCI, The Netherlands 1034 (83) 
3.7 
(2.2*) 
Wang et al., 2008 Age > 60 years, coronary narrowing ≥ 50%, China 209 (72.7) 0.48* 
Abela et al., 2009 Significant coronary stenotic lesions, United Kingdom 87 (77) 13.8 
Shirani et al., 
2009 Elective candidates for CABG, Iran 
2819 
(69.6) 2.09 
Nemati et al., 
2009 CAD (more than 50% constriction), Iran 184 4.3 
Dupont et al., 
2010 Post CABG, France 217 (87) 6.9 
Long et al., 2010 Acute coronary syndrome with coronary stenosis ≥ 50%, France 304 (77) 6.6* 
Poon et al., 2010 Elective patients for CABG, China 624 (79.9) 1.8 
Table 1. Summary of studies reporting prevalence or incidence (*) rates of abdominal aortic 
aneurysm (AAA) among coronary artery disease (CAD) patients. CABG: coronary artery 
bypass graft, MI: myocardial infarction, PCI: percutaneous coronary intervention 
Diagnosis and Treatment of Abdominal and Thoracic Aortic  







AAA > 50 mm % 
/ study population
AAA > 50 mm % 
/ AAA patients 
Nevelsteen et al., 1991 [30-65] 4 36.7 
Bergersen et al., 1998 43.6 (13.1), [25-70] 5.2 28.6 
Benzaquen et al., 2001 38 (14), [27-65]  1 12,5 
Monney et al., 2004 38.9 (13) 1.01 10 
Calderwood & Welch, 2004  4.2* 27.7* 
Madaric et al., 2005  4.6 31.2 
Goessens et al., 2006  0.09* 4.34* 
Abela et al., 2009 42 (19.6), [30-87]  1.1 11.1 
Shirani et al., 2009 30.70 (7.01), [25-61.7] 0.07* 3.4* 
Dupont et al., 2010 35.3 (9.1), [26-53]  0.9 13.3 
Long et al., 2010 33 (3.7), [30-45]  0 0 
Poon et al., 2010 [31.1-59.1] 0.3 18.2 
Table 2. Characteristics of abdominal aortic aneurysm (AAA) in coronary artery disease 
patients (*: >55 mm). 
who were candidates for CABG or in the post CABG period (table 1). AAA was diagnosed 
by abdominal ultrasound, by measurement of either transverse or antero-posterior, or both 
infrarenal aortic diameters. AAA is conventionally defined when infrarenal aortic diameter 
is ≥ 30 mm (Moll et al., 2011; Wanhainen et al., 2001; Wanhainen et al., 2008). In the present 
review, fifteen studies used this definition. However, some studies diagnosed AAA when 
infrarenal aortic diameter was > 26 mm (Calderwood & Welch, 2004) or ≥ 25 mm (Shirani et 
al., 2009), while others used additional criteria: infrarenal to suprarenal ratio > 1.2 (Alcorn et 
al., 1996) or > 1.5 (Dupont et al., 2010), infrarenal exceeding suprarenal aortic diameter by at 
least 5 mm (Bonamigo & Siqueira, 2003), to compensate for individual variation in the 
diameter of the adjacent aorta. While two studies exclusively included male patients 
(Bonamigo & Siqueira, 2004; Monney et al., 2004), the other studies recruited a female 
patient proportion varying from 10 to 34.4%. Because age is an important risk factor for both 
CAD and AAA in population – based studies, five studies restricted their study population 
to patients above 60 years. While most recruited patients had a mean age between 60 and 70 
years, some studies exhibited a wide age range (from 34 to 88 years; from 29 to 83 years; 
respectively) (Long et al., 2010; Poon et al., 2010). In contrast to a majority of CAD patients 
of Caucasian origin in these studies, we found two studies on prevalence of AAA in CAD 
patients of Chinese origin (Wang et al., 2008; Poon et al., 2010) and two on Iranian patients 
(Shirani et al., 2009; Nemati et al., 2009). These 4 studies reported the lowest AAA 
prevalence. It clearly appears that certain ethnic groups experience a disproportionately 
smaller burden of AAA (Salem et al., 2009). Emphasis should be done upon the fact that the 
size of abdominal aorta in these populations was quite smaller than in Caucasian 
population. Wang et al. and Poon et al. consistently found a mean maximal infrarenal aortic 
diameter inferior to studies of Caucasian population (Allison et al., 2008; Poon et al., 2010; 
Wang et al., 2008). Despite such heterogeneity between these observational cross – sectional 
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studies, one can fairly say that AAA prevalence among CAD patients exceeds that observed 
in population –based studies. It is also of interest that the prevalence of AAA in CAD 
patients was comparable to that reported in AAA screening studies of patients with 
peripheral vascular disease (7% -17%) and cerebrovascular disease (8.4% -20.2%) (Bentgsson 
et al., 1996; Kurvers et al., 2003; Palazzuoli et al., 2008; Simons et al., 1999). 
5. Abdominal aortic aneurysm risk factors in coronary artery disease patients 
We shall now stress on the association between AAA prevalence in CAD patients and the 
various coronary atherosclerosis risk factors or indicators which may be useful to identify 
patients at increased risk in a screening context. Of importance, some risk factors were 
examined in some studies but not in others (table 3). 
5.1 Gender 
Most studies including both male and female patients showed a trend towards a higher 
male prevalence among AAA cases (table 3) or detected AAA in male patients exclusively, 
in accordance with results of population – based studies (Dupont et al., 2010; Nemati et al., 
2009; Nevelsteen et al., 1991; Wang et al., 2008). Only one study showed a statistically 
significant association between male sex and AAA prevalence (table 3) (Shirani et al., 2009). 
 
 




al., 1998 1.78 (0.67-4.7)
5,7 (1,7-18,8)*, 
§ 7 (2,5-19,1)*,§   
Bonamigo & 
Siqueira, 2003  
1,09 (1,034-
1,152)*, § 0,96 (0,47-1,95) 1,29 (0,58-2,86) 1,53 (0,79-2,99) 
Monney et al., 





Madaric et al., 







Shirani et al., 
2009 
3,85 (1,65-
8,99)* age > 65: 1,79* 1,63* 2,32* 1,85* 
Nemati at al., 
2009  *    
Dupont et al., 
2010 NS 1.34 (0.47-3.83) infinity* 1,7 (0,58-4,99) 0,76 (0,26-2,22) 




age > 60: 2,74 
(1,07-7)*,§ 2,01 (0,65-6,18) 0,54 (0,18-1,66) 1,07 (0,42-2,7) 
Poon et al., 
2010 2.17 (0.49-9.52) 2.68 (0.74-8.96) NS NS NS 
Table 3. Odds ratio (95% confidence interval) obtained for association studies between 
abdominal aortic aneurysm presence and some atherosclerosis risk factors, among coronary 
artery disease patients. *: p< 0.05 by univariate analysis, §: p< 0.05 by multivariate analysis, 
NS: non significant 
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studies, one can fairly say that AAA prevalence among CAD patients exceeds that observed 
in population –based studies. It is also of interest that the prevalence of AAA in CAD 
patients was comparable to that reported in AAA screening studies of patients with 
peripheral vascular disease (7% -17%) and cerebrovascular disease (8.4% -20.2%) (Bentgsson 
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We shall now stress on the association between AAA prevalence in CAD patients and the 
various coronary atherosclerosis risk factors or indicators which may be useful to identify 
patients at increased risk in a screening context. Of importance, some risk factors were 
examined in some studies but not in others (table 3). 
5.1 Gender 
Most studies including both male and female patients showed a trend towards a higher 
male prevalence among AAA cases (table 3) or detected AAA in male patients exclusively, 
in accordance with results of population – based studies (Dupont et al., 2010; Nemati et al., 
2009; Nevelsteen et al., 1991; Wang et al., 2008). Only one study showed a statistically 
significant association between male sex and AAA prevalence (table 3) (Shirani et al., 2009). 
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Poon et al. exclusively detected AAA in male CAD patients when using the common AAA 
definition “infrarenal aortic diameter ≥ 30 mm” (Poon et al., 2010). However, when using an 
alternate definition “maximum infrarenal diameter 1.5 times the group mean infrarenal 
aortic diameter categorized by gender”, AAA prevalence was greater with 2 out of 19 in 
female patients (infrarenal aortic diameter of 24.1 mm and 25.1 mm). This goes along with 
the suggestion by Grootenboer et al. by which the definition of 30 mm in population based 
studies for the average women is probably inappropriate and leads to an underestimation of 
AAA prevalence (Grootenboer et al., 2009). In these studies on AAA prevalence in CAD 
patients, one also notes that infrarenal aortic diameter mean (standard deviation), when 
available, was significantly lower in female compared to male patients : 15.5 (2.2) mm versus 
18.8 (5.6) mm, p<0.0001 in Dupont et al. (Dupont et al., 2010), 16.8 (3.2) mm versus 20.2 (3.3) 
mm, p=0.004 in Nevelsteen et al. (Nevelsteen et al., 1991).  
5.2 Age 
Nine out of 17 studies reported a statistical evaluation of the association between age and 
AAA (table 3). Only 2 did not find an association (Dupont et al., 2010; Poon et al., 2010). Age 
was associated with AAA by multivariate analysis after adjustment for other known risk 
factors in 4 studies (table 3). In Nemati et al., ROC curve analysis showed that age of 
patients with CAD (67 years) predicted the presence of AAA with a sensitivity and 
specificity of 75% and 80%, respectively (Nemati et al., 2009). Although most guidelines 
contain recommendations that favour one time AAA screening for male patients 65 years or 
older in the general population, one can note that 6 out of the 17 studies gave data about 
AAA detection in men younger than 65 years (table 4).  
 
Reference AAA age 
Dupont et al., 2010 67.1 (9.8), [54-85] 
Goessens et al., 2006 68.8 (11,5), [45-79] 
Long et al., 2010 69 (11), [51-86] 
Calderwood et al., 2004 64.8, [60-72] 
Benzaquen et al., 2001 67.2 (5.4), [58-76] 
Abela et al., 2009 68.8 (11,5), [45-79] 
Nemati et al., 2009 68.2 (7,09) 
Table 4. Age distribution of abdominal aortic aneurysm (AAA) patients among coronary 
artery disease patients (mean (SD), [min-max]) 
Only the AAA that are vulnerable to rupture contribute to the benefit of screening at an 
earlier age (Ferket et al., 2011). As an example, in Dupont et al., 7 out of 15 AAA were 
detected in men aged 50 to 65 years with one of them exceeding 50 mm requiring surgical 
correction (Dupont et al., 2010). In Long et al., 7 out of 20 AAA were detected in CAD 
patients aged 50 to 60 years (Long et al., 2010). 
5.3 Smoking 
Over 90% of all AAA patients have a history of smoking, and nearly half are active smokers 
at the time of diagnosis (Powell et al., 1996). In population – based studies, smoking may be 
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more strongly associated with AAA than with CAD (3 fold) or with cerebrovascular disease 
(5 fold) (Lederle et al., 2003). It also was strongly associated with AAA progression and 
rupture (Badger et al., 2009) and the strength of its association with AAA persisted 
independently of the extent of atherosclerotic disease (coronary, peripheral artery disease) 
(Lee et al., 1997). Five out of the 17 studies on AAA prevalence in CAD patients showed 
smoking to be significantly associated with AAA by univariate analysis, 3 of them 
confirming this association by multivariate analysis (table 3). In Shirani et al., even more 
important was the duration of smoking as 8.6% of CAD patients with a history of smoking ≥ 
40 years had AAA compared to an AAA prevalence of 2.6% in their whole CAD population 
(Odd Ratio (OR): 3.49, p=0.0001) (Shirani et al., 2009). Similar results were found in 
population based studies (Singh et al., 2001). The effect of smoking cessation has been 
investigated as well, and showed a slow decrease in risk for AAA of 4% per year (95% 
confidence interval 2 to 6) (Wilmink et al., 1999). However, when adjusting for smoking 
duration, the risk of AAA even 20 years after cessation of smoking was not statistically 
different from the risk of current smokers (Singh et al., 2001). Nontheless, the recent AAA 
clinical practice guidelines of the European Society for Vascular Surgery recommend 
smoking cessation to reduce the risk of AAA growth (Moll et al., 2011). This relative slow 
decline in risk, after cessation of smoking, differs strongly between AAA and CAD. It would 
be interesting to evaluate the impact of smoking cessation on AAA prevalence and 
progression among CAD patients. 
5.4 Diabetes mellitus  
Among the 17 studies on AAA prevalence in CAD patients, only 7 did focus on the 
association between Diabetes Mellitus (DM) and AAA prevalence (table 3). Five out of these 
7 studies reported no association, while one showed an association by univariate analysis 
which was no more significant by multivariate analysis (Madaric et al. 2005). Shirani et al. 
reported a significantly higher frequency of AAA in diabetic patients compared with non 
diabetic ones (3.2% versus 1.4%, p=0.033) (Shirani et al., 2009). Of importance, Guijarro et al. 
studied 159 patients with CAD and found that microalbuminuria, but not DM, was a potent 
and independent predictor of AAA (OR: 7.56, 95% Confidence interval: 1.8-31.9) (Guijarro et 
al., 2006). DM, a strong coronary atherosclerosis risk factor, may therefore lack an 
association with AAA prevalence in CAD patients.  
5.5 Arterial hypertension 
Seven out of the 17 papers on AAA prevalence in CAD patients evaluated the association 
between AAA and arterial hypertension. Only Shirani et al. and Monney et al. confirmed a 
significant association (table 3) (Monney et al., 2004; Shirani et al., 2009). Arterial 
hypertension seems to be more positively associated with coronary heart disease and 
cerebrovascular disease than with aneurysm formation. These findings indicate that a 
history of hypertension should not be held as a significant risk factor for AAA among CAD 
patients.  
5.6 Lipid profile and obesity 
Most CAD patients receive a lipid modifying therapy including statins, fibrates and 
cholestyramine. In such populations, few studies did evaluate the association between 
serum lipoproteins levels or history of dyslipidemia and AAA prevalence (Dupont et al., 
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Poon et al. exclusively detected AAA in male CAD patients when using the common AAA 
definition “infrarenal aortic diameter ≥ 30 mm” (Poon et al., 2010). However, when using an 
alternate definition “maximum infrarenal diameter 1.5 times the group mean infrarenal 
aortic diameter categorized by gender”, AAA prevalence was greater with 2 out of 19 in 
female patients (infrarenal aortic diameter of 24.1 mm and 25.1 mm). This goes along with 
the suggestion by Grootenboer et al. by which the definition of 30 mm in population based 
studies for the average women is probably inappropriate and leads to an underestimation of 
AAA prevalence (Grootenboer et al., 2009). In these studies on AAA prevalence in CAD 
patients, one also notes that infrarenal aortic diameter mean (standard deviation), when 
available, was significantly lower in female compared to male patients : 15.5 (2.2) mm versus 
18.8 (5.6) mm, p<0.0001 in Dupont et al. (Dupont et al., 2010), 16.8 (3.2) mm versus 20.2 (3.3) 
mm, p=0.004 in Nevelsteen et al. (Nevelsteen et al., 1991).  
5.2 Age 
Nine out of 17 studies reported a statistical evaluation of the association between age and 
AAA (table 3). Only 2 did not find an association (Dupont et al., 2010; Poon et al., 2010). Age 
was associated with AAA by multivariate analysis after adjustment for other known risk 
factors in 4 studies (table 3). In Nemati et al., ROC curve analysis showed that age of 
patients with CAD (67 years) predicted the presence of AAA with a sensitivity and 
specificity of 75% and 80%, respectively (Nemati et al., 2009). Although most guidelines 
contain recommendations that favour one time AAA screening for male patients 65 years or 
older in the general population, one can note that 6 out of the 17 studies gave data about 
AAA detection in men younger than 65 years (table 4).  
 
Reference AAA age 
Dupont et al., 2010 67.1 (9.8), [54-85] 
Goessens et al., 2006 68.8 (11,5), [45-79] 
Long et al., 2010 69 (11), [51-86] 
Calderwood et al., 2004 64.8, [60-72] 
Benzaquen et al., 2001 67.2 (5.4), [58-76] 
Abela et al., 2009 68.8 (11,5), [45-79] 
Nemati et al., 2009 68.2 (7,09) 
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earlier age (Ferket et al., 2011). As an example, in Dupont et al., 7 out of 15 AAA were 
detected in men aged 50 to 65 years with one of them exceeding 50 mm requiring surgical 
correction (Dupont et al., 2010). In Long et al., 7 out of 20 AAA were detected in CAD 
patients aged 50 to 60 years (Long et al., 2010). 
5.3 Smoking 
Over 90% of all AAA patients have a history of smoking, and nearly half are active smokers 
at the time of diagnosis (Powell et al., 1996). In population – based studies, smoking may be 
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more strongly associated with AAA than with CAD (3 fold) or with cerebrovascular disease 
(5 fold) (Lederle et al., 2003). It also was strongly associated with AAA progression and 
rupture (Badger et al., 2009) and the strength of its association with AAA persisted 
independently of the extent of atherosclerotic disease (coronary, peripheral artery disease) 
(Lee et al., 1997). Five out of the 17 studies on AAA prevalence in CAD patients showed 
smoking to be significantly associated with AAA by univariate analysis, 3 of them 
confirming this association by multivariate analysis (table 3). In Shirani et al., even more 
important was the duration of smoking as 8.6% of CAD patients with a history of smoking ≥ 
40 years had AAA compared to an AAA prevalence of 2.6% in their whole CAD population 
(Odd Ratio (OR): 3.49, p=0.0001) (Shirani et al., 2009). Similar results were found in 
population based studies (Singh et al., 2001). The effect of smoking cessation has been 
investigated as well, and showed a slow decrease in risk for AAA of 4% per year (95% 
confidence interval 2 to 6) (Wilmink et al., 1999). However, when adjusting for smoking 
duration, the risk of AAA even 20 years after cessation of smoking was not statistically 
different from the risk of current smokers (Singh et al., 2001). Nontheless, the recent AAA 
clinical practice guidelines of the European Society for Vascular Surgery recommend 
smoking cessation to reduce the risk of AAA growth (Moll et al., 2011). This relative slow 
decline in risk, after cessation of smoking, differs strongly between AAA and CAD. It would 
be interesting to evaluate the impact of smoking cessation on AAA prevalence and 
progression among CAD patients. 
5.4 Diabetes mellitus  
Among the 17 studies on AAA prevalence in CAD patients, only 7 did focus on the 
association between Diabetes Mellitus (DM) and AAA prevalence (table 3). Five out of these 
7 studies reported no association, while one showed an association by univariate analysis 
which was no more significant by multivariate analysis (Madaric et al. 2005). Shirani et al. 
reported a significantly higher frequency of AAA in diabetic patients compared with non 
diabetic ones (3.2% versus 1.4%, p=0.033) (Shirani et al., 2009). Of importance, Guijarro et al. 
studied 159 patients with CAD and found that microalbuminuria, but not DM, was a potent 
and independent predictor of AAA (OR: 7.56, 95% Confidence interval: 1.8-31.9) (Guijarro et 
al., 2006). DM, a strong coronary atherosclerosis risk factor, may therefore lack an 
association with AAA prevalence in CAD patients.  
5.5 Arterial hypertension 
Seven out of the 17 papers on AAA prevalence in CAD patients evaluated the association 
between AAA and arterial hypertension. Only Shirani et al. and Monney et al. confirmed a 
significant association (table 3) (Monney et al., 2004; Shirani et al., 2009). Arterial 
hypertension seems to be more positively associated with coronary heart disease and 
cerebrovascular disease than with aneurysm formation. These findings indicate that a 
history of hypertension should not be held as a significant risk factor for AAA among CAD 
patients.  
5.6 Lipid profile and obesity 
Most CAD patients receive a lipid modifying therapy including statins, fibrates and 
cholestyramine. In such populations, few studies did evaluate the association between 
serum lipoproteins levels or history of dyslipidemia and AAA prevalence (Dupont et al., 
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2010; Monney et al., 2004; Shirani et al., 2009). None found a statistically significant 
association. Moreover, in view of current guidelines on atherosclerosis treatment, one 
cannot construct a study on association between basal lipid profile and AAA prevalence in 
CAD patients without lipid modifying therapy prescription. We can, therefore, not expect to 
withdraw conclusions in such a selective population. 
As far as obesity is concerned, 3 studies reported on the lack of association between AAA 
and BMI and/or body weight in CAD patients (Dupont at al., 2010; Long et al., 2010; 
Monney et al., 2004). A potential association between obesity and AAA or infrarenal aortic 
diameter in CAD patients requires evaluation by further studies. 
To date, in a CAD population, all evaluated potential AAA risk factors are also well – 
known CAD risk factors. Among these, only age and smoking seem to have a specific 
impact on AAA prevalence among CAD patients. Of importance, no known specific 
circulating biomarker of AAA in CAD patients is available. 
6. Atherosclerosis and abdominal aortic aneurysm 
6.1 Pathophysiology 
The pathogenesis of AAA is poorly understood. AAA has traditionally been thought to be 
caused by atherosclerosis. Recently, this atherosclerosis theory has been challenged on the 
basis of epidemiologic, genetic and biochemical information, questioning whether 
atherosclerosis is a “bystander” condition or an active participant in the development and 
progression of AAA disease (Golledge & Norman, 2010; Johnsen et al., 2010; Lee et al., 1997; 
Reed et al., 1992; Trollope & Golledge, 2011). As seen in previously described studies on 
AAA prevalence in CAD patients, not all patients with atherosclerotic disease do present an 
AAA. On the opposite, several studies reported many AAA patients lacking concomitant 
atherosclerotic vascular disease. The link between AAA formation and atherosclerosis is 
also not strong in animal models. Animals developing atherosclerosis by dietary or genetic 
means scarcely develop an AAA. Conversely, animal models of AAA, by intraluminal 
elastase infusion or adventitial application of calcium chloride, do not require the presence 
of atherosclerosis. There are both similarities and differences in the pathogenesis of AAA 
and atherosclerotic lesions whether coronary, carotid or peripheral arterial diseases. Both 
involve inflammation, macrophage infiltration, increased vascular smooth muscle cells 
turnover and thrombus formation. Whereas proliferation of vascular smooth muscle cells 
(VSMCs) is a typical feature of atherosclerosis affecting vascular media and intima, the 
density of these cells is low in media and adventitia of aneurismal wall due to apoptosis. 
Atherosclerosis is also characterized by migrating VSMCs and macrophages, foam cell 
formation, lipid deposition, leading to endothelial dysfunction and increased intima – media 
thickness (Palazzuoli et al., 2008). On the other hand, AAA involves dilation of all layers of 
the aortic wall, destructive remodeling of medial elastin and collagen fibers by matrix 
metalloproteinases released by activated aortic wall macrophages (Wassef et al., 2007). 
These different pathological features of CAD and AAA are further emphasized by the 
results of above mentioned observational studies. Indeed, some of the risk factors for CAD 
did emerge as being independently associated with AAA in severe CAD populations such 
as cigarette smoking and age. However, it is not possible to determine from these studies 
whether these risk factors did so through a pathway of promoting atherosclerosis, in turn 
increasing the risk of AAA, or if they promoted AAA further leading to CAD development. 
A third theory could be that both pathways act to some extent, subsequently stimulating the 
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development of the other. New integrative, hypothesis – driven, carefully designed human 
and animal studies should shed a light on the sequential development of AAA and coronary 
atherosclerosis.  
6.2 Severity of CAD and AAA 
Severity of CAD has been differently described in the aforementioned studies. Long et al. 
described a significant positive association between AAA and previous coronary events 
(previous acute coronary syndromes with proven coronary stenosis of 50% or greater, 
CABG or percutaneous coronary intervention), but not with the number of stenosed 
coronary vessels (Long et al., 2010). Nemati et al. as well as Shirani al. reported no 
association between AAA and number of stenosed coronary vessels or left main coronary 
vessel stenosis (Nemati et al., 2009; Shirani et al., 2009). Monney et al. confirmed these 
results regarding the lack of association between AAA and number of stenosed coronary 
vessels, NYHA classification of Angina Pectoris and number of bypass (Monney et al., 2004). 
Nevertheless, there was a reduced risk among patients with a single coronary vessel 
affection as compared to patients with CAD involving two or three vessels. Likewise, 
Dupont et al. did not detect an association between AAA and history of unstable/ stable 
angina, myocardial infarction, coronary angioplasty, and number of diseased coronary 
vessels (Dupont et al., 2010). Such an association or lack thereof between AAA and CAD 
severity has not been evaluated in population – based studies. It would also be important to 
assess the relationship between extent of coronary stenosis and infrarenal aortic diameter 
and/or risk of AAA rupture.  
6.3 Concomitant vascular disease to abdominal aortic aneurysm and coronary artery 
disease 
Atherosclerosis is a systemic inflammatory vascular disorder involving multiple arterial 
beds, so it makes sense to evaluate AAA prevalence among patients when Peripheral 
Arterial Disease (PAD) and/or Carotid Artery Stenosis (CAS) coexist with CAD. Patients 
with PAD seem to be at particularly high risk for AAA development with an overall 
prevalence greater than 10%, twice that of the general population (Barba et al., 2005; 
Galland, et al., 1991). In Barba et al., patients with tibial disease had a significantly higher 
AAA prevalence than those patients with aortoiliac or femoro-popliteal diseases. A 
systematic review of population based screening studies has shown a positive association of 
PAD with AAA (OR 2.5) (Palazzzuoli et al., 2008). The relationship between AAA and CAS 
is more difficult to apprehend. In patients aged above 65 years with severe CAD awaiting 
CABG, a recent study showed the presence of an AAA to be a significant predictor of  70% 
internal carotid artery stenosis by univariate analysis (Kiernan et al., 2009). Furthermore, a 
higher prevalence of AAA has been established in patients with CAS (Gratama et al., 2010; 
Kang et al., 1999; Karanjia et al., 1994; Kurverts et al., 2003). However, recent case control 
studies did not find any evidence for more carotid atherosclerosis in AAA patients (Cheuk 
et al., 2007; Palazzzuoli et al., 2008). In an attempt to better elucidate this relationship, 
Johnsen et al. reported significantly more carotid atherosclerosis in abdominal aortic 
aneurysm diameter  27 mm and in AAA (Johnsen et al., 2010). 
Among CAD patients, 5 studies appraised an association between AAA and PAD, while the 
association between AAA and CAS was analyzed in only 4 studies (table 5). Regarding 
PAD, Benzaquen et al. and Dupont et al. reported a significant association (Benzaquen et al., 
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2010; Monney et al., 2004; Shirani et al., 2009). None found a statistically significant 
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cannot construct a study on association between basal lipid profile and AAA prevalence in 
CAD patients without lipid modifying therapy prescription. We can, therefore, not expect to 
withdraw conclusions in such a selective population. 
As far as obesity is concerned, 3 studies reported on the lack of association between AAA 
and BMI and/or body weight in CAD patients (Dupont at al., 2010; Long et al., 2010; 
Monney et al., 2004). A potential association between obesity and AAA or infrarenal aortic 
diameter in CAD patients requires evaluation by further studies. 
To date, in a CAD population, all evaluated potential AAA risk factors are also well – 
known CAD risk factors. Among these, only age and smoking seem to have a specific 
impact on AAA prevalence among CAD patients. Of importance, no known specific 
circulating biomarker of AAA in CAD patients is available. 
6. Atherosclerosis and abdominal aortic aneurysm 
6.1 Pathophysiology 
The pathogenesis of AAA is poorly understood. AAA has traditionally been thought to be 
caused by atherosclerosis. Recently, this atherosclerosis theory has been challenged on the 
basis of epidemiologic, genetic and biochemical information, questioning whether 
atherosclerosis is a “bystander” condition or an active participant in the development and 
progression of AAA disease (Golledge & Norman, 2010; Johnsen et al., 2010; Lee et al., 1997; 
Reed et al., 1992; Trollope & Golledge, 2011). As seen in previously described studies on 
AAA prevalence in CAD patients, not all patients with atherosclerotic disease do present an 
AAA. On the opposite, several studies reported many AAA patients lacking concomitant 
atherosclerotic vascular disease. The link between AAA formation and atherosclerosis is 
also not strong in animal models. Animals developing atherosclerosis by dietary or genetic 
means scarcely develop an AAA. Conversely, animal models of AAA, by intraluminal 
elastase infusion or adventitial application of calcium chloride, do not require the presence 
of atherosclerosis. There are both similarities and differences in the pathogenesis of AAA 
and atherosclerotic lesions whether coronary, carotid or peripheral arterial diseases. Both 
involve inflammation, macrophage infiltration, increased vascular smooth muscle cells 
turnover and thrombus formation. Whereas proliferation of vascular smooth muscle cells 
(VSMCs) is a typical feature of atherosclerosis affecting vascular media and intima, the 
density of these cells is low in media and adventitia of aneurismal wall due to apoptosis. 
Atherosclerosis is also characterized by migrating VSMCs and macrophages, foam cell 
formation, lipid deposition, leading to endothelial dysfunction and increased intima – media 
thickness (Palazzuoli et al., 2008). On the other hand, AAA involves dilation of all layers of 
the aortic wall, destructive remodeling of medial elastin and collagen fibers by matrix 
metalloproteinases released by activated aortic wall macrophages (Wassef et al., 2007). 
These different pathological features of CAD and AAA are further emphasized by the 
results of above mentioned observational studies. Indeed, some of the risk factors for CAD 
did emerge as being independently associated with AAA in severe CAD populations such 
as cigarette smoking and age. However, it is not possible to determine from these studies 
whether these risk factors did so through a pathway of promoting atherosclerosis, in turn 
increasing the risk of AAA, or if they promoted AAA further leading to CAD development. 
A third theory could be that both pathways act to some extent, subsequently stimulating the 
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development of the other. New integrative, hypothesis – driven, carefully designed human 
and animal studies should shed a light on the sequential development of AAA and coronary 
atherosclerosis.  
6.2 Severity of CAD and AAA 
Severity of CAD has been differently described in the aforementioned studies. Long et al. 
described a significant positive association between AAA and previous coronary events 
(previous acute coronary syndromes with proven coronary stenosis of 50% or greater, 
CABG or percutaneous coronary intervention), but not with the number of stenosed 
coronary vessels (Long et al., 2010). Nemati et al. as well as Shirani al. reported no 
association between AAA and number of stenosed coronary vessels or left main coronary 
vessel stenosis (Nemati et al., 2009; Shirani et al., 2009). Monney et al. confirmed these 
results regarding the lack of association between AAA and number of stenosed coronary 
vessels, NYHA classification of Angina Pectoris and number of bypass (Monney et al., 2004). 
Nevertheless, there was a reduced risk among patients with a single coronary vessel 
affection as compared to patients with CAD involving two or three vessels. Likewise, 
Dupont et al. did not detect an association between AAA and history of unstable/ stable 
angina, myocardial infarction, coronary angioplasty, and number of diseased coronary 
vessels (Dupont et al., 2010). Such an association or lack thereof between AAA and CAD 
severity has not been evaluated in population – based studies. It would also be important to 
assess the relationship between extent of coronary stenosis and infrarenal aortic diameter 
and/or risk of AAA rupture.  
6.3 Concomitant vascular disease to abdominal aortic aneurysm and coronary artery 
disease 
Atherosclerosis is a systemic inflammatory vascular disorder involving multiple arterial 
beds, so it makes sense to evaluate AAA prevalence among patients when Peripheral 
Arterial Disease (PAD) and/or Carotid Artery Stenosis (CAS) coexist with CAD. Patients 
with PAD seem to be at particularly high risk for AAA development with an overall 
prevalence greater than 10%, twice that of the general population (Barba et al., 2005; 
Galland, et al., 1991). In Barba et al., patients with tibial disease had a significantly higher 
AAA prevalence than those patients with aortoiliac or femoro-popliteal diseases. A 
systematic review of population based screening studies has shown a positive association of 
PAD with AAA (OR 2.5) (Palazzzuoli et al., 2008). The relationship between AAA and CAS 
is more difficult to apprehend. In patients aged above 65 years with severe CAD awaiting 
CABG, a recent study showed the presence of an AAA to be a significant predictor of  70% 
internal carotid artery stenosis by univariate analysis (Kiernan et al., 2009). Furthermore, a 
higher prevalence of AAA has been established in patients with CAS (Gratama et al., 2010; 
Kang et al., 1999; Karanjia et al., 1994; Kurverts et al., 2003). However, recent case control 
studies did not find any evidence for more carotid atherosclerosis in AAA patients (Cheuk 
et al., 2007; Palazzzuoli et al., 2008). In an attempt to better elucidate this relationship, 
Johnsen et al. reported significantly more carotid atherosclerosis in abdominal aortic 
aneurysm diameter  27 mm and in AAA (Johnsen et al., 2010). 
Among CAD patients, 5 studies appraised an association between AAA and PAD, while the 
association between AAA and CAS was analyzed in only 4 studies (table 5). Regarding 
PAD, Benzaquen et al. and Dupont et al. reported a significant association (Benzaquen et al., 
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2001; Dupont et al., 2010). This was further confirmed by Guijarro et al. in 157 patients with 
CAD (angina, acute coronary syndromes, or myocardial infarction) out of a cohort of 269 
patients with symptomatic atherosclerosis (Guijarro et al., 2006). PAD was a potent and 
independent predictor of AAA (Odd Ratio: 6.0, 95% CI: 1.4-26.6). Of importance, in 
Benzaquen et al., difficulty advancing the catheter into the aorta during coronary 
catheterization was the only independent predictor of AAA presence by multivariate 
analysis (Odd Ratio: 11.1, 95% CI: 4.6-26.6) (Benzaquen et al., 2001). The association of AAA 
with concomitant lower extremity PAD may be due to the strong pathophysiologic 
association of both AAA and PAD with smoking. Both the aorta and lower extremity 
arteries are especially susceptible to injury by exposure to all forms of tobacco and cigarette 
smoking in particular (Baumgartner et al., 2008). As for CAS, its presence was associated 
with an increased risk of AAA in 3 out of 4 studies (table 5). In Shirani et al., AAA frequency 
was 10.8% in patients older than 65 years and CAS >50% (Shirani et al., 2009). In Dupont et 
al., severe CAD male patients aged below 75 years with a smoking history had an AAA 
prevalence of 24% when they also had PAD and/or CAS, versus 4.4% in the absence of 
either condition (p=0.007) (Dupont et al., 2010). 
 
Reference Carotid stenosis Peripheral arterial disease 
Benzaquen et al., 2001  4.7 (2.1-10.3)* 
Bonamigo & Siqueira, 2003  0,66 (0,21-2,1) 
Monney et al., 2004 0,9 (0,36-2,24) 1,88 (0,78-4,56) 
Madaric et al., 2005 3,11 (1,02-9,46)* 3,07 (0,91-10,38) 
Shirani et al., 2009 4,72*  
Dupont et al., 2010 4,88 (1,37-17,33)* 5,45 (1,77-16,78)* 
Table 5. Odds ratio (95% confidence interval) obtained for association studies between 
abdominal aortic aneurysm presence and carotid artery stenosis or peripheral arterial 
disease, among coronary artery disease patients. *: p< 0.05 by univariate analysis 
7. AAA screening 
AAA appears to meet many of the classic criteria of disease screening (Wilson & Jungner, 
1968). First, AAA is an important health problem disease with life – threatening 
consequences when rupture occurs. Its prevalence in cross sectional studies is on the rise, 
not only because of better case – finding by abdominal ultrasonography, but also due to 
ageing of the population. In carefully designed randomized controlled trials, it has been 
well established that AAA screening in men aged 65 to 74 years is effective and decreases 
the risk of aneurysm rupture by almost 50%. In this group, after a single abdominal 
ultrasonographic evaluation, death from aortic rupture is rare within the subsequent 10 
years (Ashton et al., 2002; Lindholt et al., 2002; Lindholt et al., 2005; Thompson et al., 2009; 
Wilmink et al., 2003). The evidence of clinical effectiveness was reinforced by a subsequent 
Cochrane Review—which estimated a 40% relative risk reduction in aortic rupture (absolute 
risk reduction from 0.27% to 0.16%)—and then by results from MASS after 7 years of follow-
up (Cosford & Leng, 2007; Kim et al., 2007). A second point is that abdominal 
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ultrasonography is an ideal method for AAA screening as it is safe, non – invasive, cheap, 
lasting only few minutes, with a high sensitivity and specificity (Lederle et al., 1988; 
Lindholt et al., 1999). Thirdly, the best therapy is pre-symptomatic elective surgery in 
appropriately selected individuals, with a mortality of 5% for elective surgery, one tenth the 
mortality of emergency interventions (Golledge & Norman, 2009). Accordingly, population-
based screening is currently being implemented in several countries (Scott et al., 2008; 
Wannheinen et al., 2005; Swedish council on technology assessment in health care, 2008). 
Most clinical practice guidelines contain recommendations in favor of one – time AAA 
screening for men 65 – 75 years old with a history of smoking using ultrasonographic scans 
(Ferket et al., 2011). However, this recommendation is poorly followed up in this target 
population, partly due to a lack of patients’ compliance with an acceptance rate around 65% 
(Boll et al., 1998; Collin et al., 1988; Lederle et al., 1997; Lindholt et al., 1997; Simoni et al., 
1995). Moreover, a recent study estimates that about half the patients with AAA were not 
eligible for screening under current guidelines and would have been missed (Kent et al., 
2010). A different approach, with screening of specific high-risk groups has been suggested 
(Derubertis et al., 2007) and is implemented within the Medicare programme in the United 
States (Lederle, 2008). No specific guidelines for AAA screening in CAD patients are 
available. In those articles dealing with AAA prevalence among CAD patients, we found a 
higher AAA prevalence among Caucasian patients (between 3.7 and 18.2%) compared to 
population – based studies, with a high prevalence of AAA above 50 mm, independently of 
CAD severity. Such prevalence seems to be higher, according to our review, when CAD 
patients have a smoking history and symptomatic atherosclerotic affection of other vascular 
beds (CAS and PAD). These data lend support to further urgent controlled randomized 
studies, dealing with AAA ultrasonographic screening in this specific subpopulation, with a 
longer follow up of included subjects. End goals would include cost effectiveness, AAA 
operability, long term survival, sufficiency of one – time screening and quality of life. The 
impact of cardiovascular co – morbidities has been implicated, by predictive scoring 
systems, to influence AAA prevalence in the subgroups of women and middle – aged men 
(50 to 65 years old) (Kent et al., 2010; Wanhainen et al., 2008). The screening of hospitalized 
CAD patients would be easily organized without adding administrative burden and of high 
efficiency, as evidenced by full attendance rates in studies of Monney et al. and Dupont et 
al.; as abdominal ultrasonography was proposed during hospitalization (Monney et al., 
2004; Dupont et al., 2010).  
8. Conclusion 
This review of literature shows, despite the limited number of studies, that CAD patients 
present with a higher AAA prevalence compared to population – based studies. Some 
classic atherosclerosis risk factors (history of smoking, age, associated atherosclerotic 
affection of other vascular beds) maintain an association with AAA in such CAD 
populations. This has a two-fold consequence: first, AAA may not simply be an 
atherosclerotic complication, as suggested by a recent work based on TROMSO study, 
warranting further studies in AAA pathogenesis (Johnsen et al., 2010). Secondly, specific 
CAD subgroups (those showing the above mentioned common risk factors) may be at risk 
for a higher AAA burden, strongly justifying the need for further studies to evaluate the 
impact of AAA screening in such patients subgroups. 
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2001; Dupont et al., 2010). This was further confirmed by Guijarro et al. in 157 patients with 
CAD (angina, acute coronary syndromes, or myocardial infarction) out of a cohort of 269 
patients with symptomatic atherosclerosis (Guijarro et al., 2006). PAD was a potent and 
independent predictor of AAA (Odd Ratio: 6.0, 95% CI: 1.4-26.6). Of importance, in 
Benzaquen et al., difficulty advancing the catheter into the aorta during coronary 
catheterization was the only independent predictor of AAA presence by multivariate 
analysis (Odd Ratio: 11.1, 95% CI: 4.6-26.6) (Benzaquen et al., 2001). The association of AAA 
with concomitant lower extremity PAD may be due to the strong pathophysiologic 
association of both AAA and PAD with smoking. Both the aorta and lower extremity 
arteries are especially susceptible to injury by exposure to all forms of tobacco and cigarette 
smoking in particular (Baumgartner et al., 2008). As for CAS, its presence was associated 
with an increased risk of AAA in 3 out of 4 studies (table 5). In Shirani et al., AAA frequency 
was 10.8% in patients older than 65 years and CAS >50% (Shirani et al., 2009). In Dupont et 
al., severe CAD male patients aged below 75 years with a smoking history had an AAA 
prevalence of 24% when they also had PAD and/or CAS, versus 4.4% in the absence of 
either condition (p=0.007) (Dupont et al., 2010). 
 
Reference Carotid stenosis Peripheral arterial disease 
Benzaquen et al., 2001  4.7 (2.1-10.3)* 
Bonamigo & Siqueira, 2003  0,66 (0,21-2,1) 
Monney et al., 2004 0,9 (0,36-2,24) 1,88 (0,78-4,56) 
Madaric et al., 2005 3,11 (1,02-9,46)* 3,07 (0,91-10,38) 
Shirani et al., 2009 4,72*  
Dupont et al., 2010 4,88 (1,37-17,33)* 5,45 (1,77-16,78)* 
Table 5. Odds ratio (95% confidence interval) obtained for association studies between 
abdominal aortic aneurysm presence and carotid artery stenosis or peripheral arterial 
disease, among coronary artery disease patients. *: p< 0.05 by univariate analysis 
7. AAA screening 
AAA appears to meet many of the classic criteria of disease screening (Wilson & Jungner, 
1968). First, AAA is an important health problem disease with life – threatening 
consequences when rupture occurs. Its prevalence in cross sectional studies is on the rise, 
not only because of better case – finding by abdominal ultrasonography, but also due to 
ageing of the population. In carefully designed randomized controlled trials, it has been 
well established that AAA screening in men aged 65 to 74 years is effective and decreases 
the risk of aneurysm rupture by almost 50%. In this group, after a single abdominal 
ultrasonographic evaluation, death from aortic rupture is rare within the subsequent 10 
years (Ashton et al., 2002; Lindholt et al., 2002; Lindholt et al., 2005; Thompson et al., 2009; 
Wilmink et al., 2003). The evidence of clinical effectiveness was reinforced by a subsequent 
Cochrane Review—which estimated a 40% relative risk reduction in aortic rupture (absolute 
risk reduction from 0.27% to 0.16%)—and then by results from MASS after 7 years of follow-
up (Cosford & Leng, 2007; Kim et al., 2007). A second point is that abdominal 
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ultrasonography is an ideal method for AAA screening as it is safe, non – invasive, cheap, 
lasting only few minutes, with a high sensitivity and specificity (Lederle et al., 1988; 
Lindholt et al., 1999). Thirdly, the best therapy is pre-symptomatic elective surgery in 
appropriately selected individuals, with a mortality of 5% for elective surgery, one tenth the 
mortality of emergency interventions (Golledge & Norman, 2009). Accordingly, population-
based screening is currently being implemented in several countries (Scott et al., 2008; 
Wannheinen et al., 2005; Swedish council on technology assessment in health care, 2008). 
Most clinical practice guidelines contain recommendations in favor of one – time AAA 
screening for men 65 – 75 years old with a history of smoking using ultrasonographic scans 
(Ferket et al., 2011). However, this recommendation is poorly followed up in this target 
population, partly due to a lack of patients’ compliance with an acceptance rate around 65% 
(Boll et al., 1998; Collin et al., 1988; Lederle et al., 1997; Lindholt et al., 1997; Simoni et al., 
1995). Moreover, a recent study estimates that about half the patients with AAA were not 
eligible for screening under current guidelines and would have been missed (Kent et al., 
2010). A different approach, with screening of specific high-risk groups has been suggested 
(Derubertis et al., 2007) and is implemented within the Medicare programme in the United 
States (Lederle, 2008). No specific guidelines for AAA screening in CAD patients are 
available. In those articles dealing with AAA prevalence among CAD patients, we found a 
higher AAA prevalence among Caucasian patients (between 3.7 and 18.2%) compared to 
population – based studies, with a high prevalence of AAA above 50 mm, independently of 
CAD severity. Such prevalence seems to be higher, according to our review, when CAD 
patients have a smoking history and symptomatic atherosclerotic affection of other vascular 
beds (CAS and PAD). These data lend support to further urgent controlled randomized 
studies, dealing with AAA ultrasonographic screening in this specific subpopulation, with a 
longer follow up of included subjects. End goals would include cost effectiveness, AAA 
operability, long term survival, sufficiency of one – time screening and quality of life. The 
impact of cardiovascular co – morbidities has been implicated, by predictive scoring 
systems, to influence AAA prevalence in the subgroups of women and middle – aged men 
(50 to 65 years old) (Kent et al., 2010; Wanhainen et al., 2008). The screening of hospitalized 
CAD patients would be easily organized without adding administrative burden and of high 
efficiency, as evidenced by full attendance rates in studies of Monney et al. and Dupont et 
al.; as abdominal ultrasonography was proposed during hospitalization (Monney et al., 
2004; Dupont et al., 2010).  
8. Conclusion 
This review of literature shows, despite the limited number of studies, that CAD patients 
present with a higher AAA prevalence compared to population – based studies. Some 
classic atherosclerosis risk factors (history of smoking, age, associated atherosclerotic 
affection of other vascular beds) maintain an association with AAA in such CAD 
populations. This has a two-fold consequence: first, AAA may not simply be an 
atherosclerotic complication, as suggested by a recent work based on TROMSO study, 
warranting further studies in AAA pathogenesis (Johnsen et al., 2010). Secondly, specific 
CAD subgroups (those showing the above mentioned common risk factors) may be at risk 
for a higher AAA burden, strongly justifying the need for further studies to evaluate the 
impact of AAA screening in such patients subgroups. 
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1. Introduction 
The incidence of Abdominal Aortic Aneurysms (AAA) has persistently increased over the 
past decades (Best et al., 2003). This is partly attributed to increased ageing of the 
population, improved diagnostic tools and the introduction of screening programmes 
(Sakalihasan et al., 2005). To date, AAAs are responsible for 1.3% of all deaths among men 
aged between 65-85 years in developed countries (Sakalihasan et al., 2005). This percentage 
is probably even higher due to underestimation of AAA related mortality, since AAAs 
generally exist without symptoms (Acosta et al., 2006). 
In patients with an identified AAA and abdominal and/or back pain in combination with 
pain at palpation of the aneurysm (a so called symptomatic AAA), pending rupture of the 
AAA is assumed. However, evidence for a symptomatic AAA representing pending rupture 
is lacking (Scott et al., 2005). When rupture occurs, the mortality rate is as high as 80% 
(Semmens et al., 2000; Veith et al., 2003; Gorham et al., 2004). Forty percent of the patients 
with a ruptured AAA do not reach the hospital alive (Semmens et al., 2000) and in patients 
reaching the hospital and undergoing surgery, the mortality rate is approximately 50% 
(Sayers et al., 1997). Despite progression in surgical techniques, anaesthetical management, 
vascular prostheses and perioperative care, there is only a gradual decline in operative 
mortality rate over the past decades (Heller et al., 2000; Bown et al., 2002).  
In 1991, a new minimally invasive technique was described by Parodi et al. to treat AAA, 
endovascular aneurysm repair (EVAR) (Parodi et al., 1991). In the elective setting, EVAR 
showed an absolute and relative mortality risk reduction of approximately 3 and 75%, 
respectively (Prinssen et al., 2004; EVAR-trial-participants 2005). In the acute setting, 
emergency EVAR (eEVAR) is a strategy that might allow for improvement in above 
mentioned poor prognosis. Since 1994 an increasing amount of publications of eEVAR to 
treat acute AAAs is published. Currently, eEVAR has become an accepted treatment option 
which is increasingly being performed to treat acute AAA. However, the potential reduction 
in peri-operative mortality of eEVAR compared to conventional open repair in patients with 
an acute AAA is still open to debate.  
in this chapter, we will discuss the role of endovascular AAA repair in patients with a 
ruptured AAA. 
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in this chapter, we will discuss the role of endovascular AAA repair in patients with a 
ruptured AAA. 
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2. Treatment options 
In patients presenting with a ruptured AAA, a choice can be made whether or not to offer 
treatment at all (selective treatment policy). When decided to perform an intervention, two 
treatment options are available; conventional “open” AAA repair or the minimally invasive 
EndoVascular Aneurysm Repair (EVAR). 
2.1 No intervention 
In order to identify patients with an unrealistic expectation of a successful outcome after 
surgery, operative risk predictors, comorbidities and estimated quality of life can be assessed. 
However, excluding selected patients from treatment is an awkward consideration (Hardman 
et al., 1996; Tambyraja et al., 2008), which is signified by the number of prediction models 
generated for risk stratification to support improvement of patient selection for surgical 
intervention (Samy et al., 1994; Hardman et al., 1996; Prytherch et al., 2001). The ‘Hardman 
Index’ and ‘Glasgow Aneurysm Score’ are the most commonly used prognostic scoring 
systems. The Hardman Index identifies five independent preoperative factors associated with 
mortality; age, blood creatinine level, loss of consciousness after arrival, blood haemoglobin 
level and electrocardiographic ischemia (Hardman et al., 1996). The Glasgow Aneurysm Score 
uses the following factors: age, shock, myocardial disease, cerebrovascular disease and renal 
disease (Samy et al., 1994). The validity of both scoring systems has been assessed using 82 
patients in the study of Tambyraja et al. from the year 2005 (Tambyraja et al., 2005). 
Unfortunately, both scoring systems seemed to be poor predictors for postoperative mortality 
in patients with a ruptured AAA. Two years later, Tambyraja et al. identified three risk factors 
which might form the basis of a new scoring system to predict the outcome of rAAA, the 
‘Edinburgh Ruptured Aneurysm Score’ (Tambyraja et al., 2007). Risk factors were: blood 
haemoglobin level, blood pressure, and Glasgow Coma Scale. Until this moment validation 
studies are still needed in order to assess its predictive value and clinical applicability. 
Due to modest validity and clinical applicability of present prognostic scoring systems, 
selecting patients for intervention remains a subjective consideration. Whenever possible, 
patients’ and families’ opinion as well as the opinion of the responsible medical doctor has 
to be included in the decision. 
2.2 Conventional ‘open’ ruptured AAA repair 
Conventional open repair of an AAA was performed for the first time in 1951, replacing the 
abdominal aortic aneurysm by a homograft (Dubost et al., 1951). Two years later, open 
repair was performed using synthetic grafts (DeBakey & Cooley 1953). The open procedure 
to treat ruptured as well as unruptured AAA has almost been consistent over time and 
known as being an invasive, but generally durable procedure. In patients who are often 
suffering from considerable hypovolemic shock, a laparotomy is performed immediately 
after induction of general anaesthesia. Subsequently, the aorta and/or iliacal arteries are 
clamped proximally and distally from the aneurysm. After clamping, the aneurysm is 
opened in order to provide access for placement of a polyester tube or bifurcated graft. The 
aneurysm sac is left in situ and secured around the graft in order to cover it.  
This major operation carries a significant mortality and morbidity, due to the combined 
effects of general anaesthesia, surgical exposure, haemorrhage, and aortic clamping with 
related lower torso ischaemia-reperfusion injury (Dillon et al., 2007). General anaesthesia is 
required which might lead to acute haemodynamical changes as a result of associated 
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inhibition of sympathetic arterial tone. The hypotension and subsequent inadequate 
oxygenation might induce or accelerate cerebral en cardiac ischemia, resulting in a poor 
clinical prognosis. Furthermore, loss of abdominal muscle tone can occur during the 
induction of general anaesthesia which might cause free rupture of the retroperitoneal 
haematoma with related haemodynamical consequences (Lachat et al., 2002). During 
surgical exposure, blood loss is generally extensive (Sadat et al., 2008). Hypotension and 
subsequent inadequate oxygenation might induce or accelerate cerebral en cardiac ischemia, 
resulting in poor clinical prognosis. Furthermore, after removing the clamps, considerable 
ischemia-reperfusion injury of the lower extremities and the intra-abdominal organs might 
occur (Bown et al., 2003). 
2.3 Minimally invasive endovascular ruptured AAA repair 
In 1991, Parodi et al described a less invasive alternative to conventional ‘open’ aneurysm 
repair for the treatment of AAA, Endovascular Aneurysm Repair (EVAR) (Parodi et al., 
1991). EVAR involves groin incisions in order to expose the femoral arteries. Using a 
catheter and guidewire a synthetic stentgraft is fed through the artery up to the AAA neck 
until positioned correctly just below the renal arteries and subsequently unfolded, excluding 
the aneurysm sac from blood flow and pressure. Control angiography is performed to 
assure correct placement of the endovascular stentgraft. Aorto-uni-iliac stentgrafts, reaching 
one of the common iliac arteries as well as bifurcated stentgrafts, reaching both iliac arteries 
are available. In case of aorto-uni-iliac stentgrafting, femoro-femoral bypass graft surgery 
has to be performed in order to restore blood flow to the contralateral leg. A controlateral 
endovascular occluder is used to stop retrograde bleeding up into the iliac artery into the 
aneurysm sac. Due to increasing expertise and continuous improvement of both stentgrafts 
and their delivery systems, increasing success rates and decreasing complications and 
reintervention rates are observed (Lovegrove et al., 2008). 
After several years of experience in EVAR for unruptured AAAs this technique has 
gradually extended its indication and is currently used to treat feasible patients with a 
ruptured AAA (Yusuf et al., 1994). However, the applicability for EVAR depends on several 
anatomical and logistic conditions. Anatomical suitability for EVAR is assessed on a 
preoperative CTA scan and evaluated for infrarenal aortic neck length, neck angulation and 
iliac and femoral access arteries that need to be large enough to accommodate the introducer 
system (Kapma et al., 2005). Approximately half of the ruptured AAAs is considered 
anatomically suitable for eEVAR according to the preoperative CTA scan (Hoornweg et al., 
2007). However, logistic problems are often reported which frequently led to the exclusion 
of EVAR-suitable patients for undergoing endovascular repair (Yilmaz et al., 2002; Reichart 
et al., 2003; Kapma et al., 2005; Franks et al., 2006; Peppelenbosch et al., 2006; Visser et al., 
2006; Acosta et al., 2007). Logistic criteria for EVAR in patients with a ruptured AAA are the 
instant availability of a CT-scanner, the 24/7 availability of an operating room that is 
adequately equipped to perform endovascular procedures as well as an endovascular 
trained staff. Financial burden is sometimes the availability of a large variety of ‘off-the-
shelf’ stent-grafts (Mehta et al., 2006).  
3. EVAR versus open surgery 
In a recent systematic review of 61 controlled and uncontrolled clinical studies of patients 
with an unruptured AAA, EVAR is described as a feasible and safe technique, showing 
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decreased mortality and morbidity rates compared to a conventional open procedure (Drury 
et al., 2005). Considering these benefits, EVAR has been generally accepted as the preferred 
treatment option.  
Since its first description in 1994 by Yusuf et al (Yusuf et al., 1994), over 400 reports of EVAR 
for patients with a ruptured AAA are available. The minimal invasive approach implies the 
opportunity to use local anaesthesia, which has been proven to be feasible and effective in 
EVAR (Henretta et al., 1999; Bettex et al., 2001). As described by Lachat et al in 2002, local 
anaesthesia is not attended with the acute haemodynamical changes which are normally 
seen during induction of general anaesthesia (Lachat et al., 2002). However, these benefits 
did not lead to standard application of local anaesthesia, since 19 comparative observational 
studies show considerable variation in the percentages of patients undergoing local 
anaesthesia (0-97%). Furthermore, eEVAR involves no crossclamping and minor surgical 
exposition compared to open surgery. 
The above mentioned advantageous consequences of the minimally invasive endovascular 
approach of acute AAA might reflect on perioperative mortality. Approximately 26 studies 
comparing EVAR with conventional open surgery in patients with a ruptured AAA can be 
identified (Ohki & Veith 2000; van Sambeek et al., 2002; Verhoeven et al., 2002; Yilmaz et al., 
2002; Reichart et al., 2003; Resch et al., 2003; Lee et al., 2004; Alsac et al., 2005; Brandt et al., 
2005; Kapma et al., 2005; Larzon et al., 2005; Vaddineni et al., 2005; Arya et al., 2006; Coppi et 
al., 2006; Dalainas et al., 2006; Dillavou et al., 2006; Franks et al., 2006; Greco et al., 2006; 
Hinchliffe et al., 2006; Peppelenbosch et al., 2006; Visser et al., 2006; Acosta et al., 2007; Anain et 
al., 2007; Moore et al., 2007; Ockert et al., 2007; Egorova et al., 2008). Twenty-four of these 
studies compared early mortality of EVAR compared to open surgery (Ohki & Veith 2000; van 
Sambeek et al., 2002; Verhoeven et al., 2002; Yilmaz et al., 2002; Reichart et al., 2003; Resch et 
al., 2003; Lee et al., 2004; Alsac et al., 2005; Brandt et al., 2005; Kapma et al., 2005; Larzon et al., 
2005; Vaddineni et al., 2005; Arya et al., 2006; Coppi et al., 2006; Dalainas et al., 2006; Franks et 
al., 2006; Greco et al., 2006; Hinchliffe et al., 2006; Peppelenbosch et al., 2006; Visser et al., 2006; 
Acosta et al., 2007; Anain et al., 2007; Moore et al., 2007; Ockert et al., 2007). One of these 
studies is a prospective randomised trial by Hinchliffe et al, which showed identical 30-day 
mortality rates in both treatment groups (9/17 in the open surgery group versus 8/15 in the 
EVAR group) (Hinchliffe et al., 2006). However, the study is underpowered and served as a 
pilot study for future randomised studies. The remaining 23 studies are observational studies 
of which 4 showed no reduction in early mortality compared to open surgery (Ohki & Veith 
2000; van Sambeek et al., 2002; Hinchliffe et al., 2006; Ockert et al., 2007). Using Review 
Manager 4.2.10, provided by the Nordic Cochrane centre, a forest-plots can be created (Figure 
1). The overall effect of EVAR compared to open surgery, taking 1 randomised controlled trial 
and 23 available observational studies into account, showed a 38% decrease in 30-day or 
hospital mortality rate (peto-odds ratio 0.62; 95% CI 0.52 to 0.74).  
Additionally, the 30-day, or hospital mortality is reported in five recent systematic reviews 
(Table 1) (Harkin et al., 2007; Visser et al., 2007; Mastracci et al., 2008; Rayt et al., 2008; Sadat 
et al., 2008). Two reviews only discuss the results of the endovascular procedure (Mastracci 
et al., 2008; Rayt et al., 2008) and three reviews compared the endovascular with the open 
procedure (Harkin et al., 2007; Visser et al., 2007; Sadat et al., 2008). The first review showed 
a pooled mortality rate after EVAR of 24% (95% CI 20-28%) across 31 studies concerning 982 
patients (Rayt et al., 2008). In 18 observational studies describing 436 people who underwent 
EVAR, the second review found a pooled mortality of 21% (95% CI 13-29%) (Mastracci et al., 
2008). According to two reviews comparing both treatment groups, pooled mortality is 18% 
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(Harkin et al., 2007) and 22% (Visser et al., 2007) in the EVAR group compared to 34% 
(Harkin et al., 2007) and 38% (Visser et al., 2007) in the open surgery group. In the fifth 
review, Sadat et al showed that EVAR is associated with a significant reduction in mortality 
with a pooled odds ratio of 0.62 (95% CI 0.52-0.75) (Sadat et al., 2008). Visser et al found 
similar results with an odds ratio of 0.45 (95% BI 0.28-0.72) (Visser et al., 2007). However, 
after adjustment for patients' hemodynamic condition, the odds ratio was 0.67 (95% CI 0.31-
1.44) and therefore no longer significant. 
 
Study  EVAR  open surgery  Peto OR  Peto OR
or sub-category  n/N  n/N  95% CI  95% CI
 Acosta et al              19/56              48/106           0.63 [0.33, 1.21]   
 Alsac et al                4/17              10/20            0.33 [0.09, 1.25]   
 Anain et al                5/30               4/10            0.27 [0.05, 1.47]   
 Arya et al                 4/17              16/34            0.38 [0.12, 1.24]   
 Brandt et al               0/11               2/13            0.15 [0.01, 2.49]   
 Coppi et al               10/33              42/91            0.52 [0.23, 1.17]   
 Dalainas et al             8/20               5/8             0.42 [0.08, 2.10]   
 Franks et al               2/21              12/23            0.15 [0.04, 0.51]   
 Greco et al              114/290           2627/5508          0.71 [0.56, 0.91]   
 Hinchliffe et al           8/15               9/17            1.02 [0.26, 3.99]   
 Kapma et al                5/40              64/213           0.41 [0.19, 0.88]   
 Larzon et al               2/5               12/26            0.79 [0.12, 5.21]   
 Lee et al                  1/13               1/4             0.21 [0.01, 6.08]   
 Moore et al                1/20               9/36            0.26 [0.06, 1.08]   
 Ockert et al               9/29               9/29            1.00 [0.33, 3.01]   
 Ohki et al                 2/20               0/5             3.69 [0.11, 126.93] 
 Peppelenbosch et al       17/49              20/51            0.83 [0.37, 1.85]   
 Reichart et al             1/6                4/13            0.50 [0.06, 4.26]   
 Resch et al                4/14               8/23            0.76 [0.19, 3.08]   
 Sambeek, van et al         0/6                0/6                Not estimable    
 Vaddineni et al            2/9                4/15            0.80 [0.12, 5.16]   
 Verhoeven et al            1/16               7/31            0.32 [0.07, 1.58]   
 Visser et al               8/26               9/29            0.99 [0.32, 3.07]   
 Yilmaz et al               4/24              13/40            0.45 [0.14, 1.40]   
Total (95% CI) 787                6351      0.62 [0.52, 0.74]
Total events: 231 (EVAR), 2935 (open surgery)
Test for heterogeneity: Chi² = 17.72, df = 22 (P = 0.72), I² = 0%
Test for overall effect: Z = 5.35 (P < 0.00001)
 0.001  0.01  0.1  1  10  100  1000
 Favours EVAR  Favours Open surgery  
Fig. 1. Forest plot of 30-day or hospital mortality in 24 studies comparing EVAR and open 
surgery in patients with a ruptured AAA. 
 
Review Studies Patients 30-day/in-hospital mortality 
 n n EVAR % (95% CI) 
Open 
% (95% CI) 
Odds ratio 
EVAR vs Open 
Rayt et al., 2008  31 982 24% (20-28) - - 
Mastracci et al., 2008  18 436 21% (13-29) - - 
Harkin et al., 2007  34 891 18% (0-53) * 34% (0-70) * - 
Visser et al., 2007  10 478 22% (16-29) 38% (32-45) 0.45 (0.28-0.78) 
Sadat et al., 2008  23 7040 - - 0.62 (0.52-0.75) 
CI = confidence interval, vs = versus, * = % (range of included studies) 
Table 1. 30-day or in-hospital mortality in patients treated with open or endovascular repair 
according to five systematic reviews. 
In addition, the systematic reviews showed that EVAR is associated with significant 
reduction in blood loss, reduced procedure time, reduction in systemical complications and 
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decreased mortality and morbidity rates compared to a conventional open procedure (Drury 
et al., 2005). Considering these benefits, EVAR has been generally accepted as the preferred 
treatment option.  
Since its first description in 1994 by Yusuf et al (Yusuf et al., 1994), over 400 reports of EVAR 
for patients with a ruptured AAA are available. The minimal invasive approach implies the 
opportunity to use local anaesthesia, which has been proven to be feasible and effective in 
EVAR (Henretta et al., 1999; Bettex et al., 2001). As described by Lachat et al in 2002, local 
anaesthesia is not attended with the acute haemodynamical changes which are normally 
seen during induction of general anaesthesia (Lachat et al., 2002). However, these benefits 
did not lead to standard application of local anaesthesia, since 19 comparative observational 
studies show considerable variation in the percentages of patients undergoing local 
anaesthesia (0-97%). Furthermore, eEVAR involves no crossclamping and minor surgical 
exposition compared to open surgery. 
The above mentioned advantageous consequences of the minimally invasive endovascular 
approach of acute AAA might reflect on perioperative mortality. Approximately 26 studies 
comparing EVAR with conventional open surgery in patients with a ruptured AAA can be 
identified (Ohki & Veith 2000; van Sambeek et al., 2002; Verhoeven et al., 2002; Yilmaz et al., 
2002; Reichart et al., 2003; Resch et al., 2003; Lee et al., 2004; Alsac et al., 2005; Brandt et al., 
2005; Kapma et al., 2005; Larzon et al., 2005; Vaddineni et al., 2005; Arya et al., 2006; Coppi et 
al., 2006; Dalainas et al., 2006; Dillavou et al., 2006; Franks et al., 2006; Greco et al., 2006; 
Hinchliffe et al., 2006; Peppelenbosch et al., 2006; Visser et al., 2006; Acosta et al., 2007; Anain et 
al., 2007; Moore et al., 2007; Ockert et al., 2007; Egorova et al., 2008). Twenty-four of these 
studies compared early mortality of EVAR compared to open surgery (Ohki & Veith 2000; van 
Sambeek et al., 2002; Verhoeven et al., 2002; Yilmaz et al., 2002; Reichart et al., 2003; Resch et 
al., 2003; Lee et al., 2004; Alsac et al., 2005; Brandt et al., 2005; Kapma et al., 2005; Larzon et al., 
2005; Vaddineni et al., 2005; Arya et al., 2006; Coppi et al., 2006; Dalainas et al., 2006; Franks et 
al., 2006; Greco et al., 2006; Hinchliffe et al., 2006; Peppelenbosch et al., 2006; Visser et al., 2006; 
Acosta et al., 2007; Anain et al., 2007; Moore et al., 2007; Ockert et al., 2007). One of these 
studies is a prospective randomised trial by Hinchliffe et al, which showed identical 30-day 
mortality rates in both treatment groups (9/17 in the open surgery group versus 8/15 in the 
EVAR group) (Hinchliffe et al., 2006). However, the study is underpowered and served as a 
pilot study for future randomised studies. The remaining 23 studies are observational studies 
of which 4 showed no reduction in early mortality compared to open surgery (Ohki & Veith 
2000; van Sambeek et al., 2002; Hinchliffe et al., 2006; Ockert et al., 2007). Using Review 
Manager 4.2.10, provided by the Nordic Cochrane centre, a forest-plots can be created (Figure 
1). The overall effect of EVAR compared to open surgery, taking 1 randomised controlled trial 
and 23 available observational studies into account, showed a 38% decrease in 30-day or 
hospital mortality rate (peto-odds ratio 0.62; 95% CI 0.52 to 0.74).  
Additionally, the 30-day, or hospital mortality is reported in five recent systematic reviews 
(Table 1) (Harkin et al., 2007; Visser et al., 2007; Mastracci et al., 2008; Rayt et al., 2008; Sadat 
et al., 2008). Two reviews only discuss the results of the endovascular procedure (Mastracci 
et al., 2008; Rayt et al., 2008) and three reviews compared the endovascular with the open 
procedure (Harkin et al., 2007; Visser et al., 2007; Sadat et al., 2008). The first review showed 
a pooled mortality rate after EVAR of 24% (95% CI 20-28%) across 31 studies concerning 982 
patients (Rayt et al., 2008). In 18 observational studies describing 436 people who underwent 
EVAR, the second review found a pooled mortality of 21% (95% CI 13-29%) (Mastracci et al., 
2008). According to two reviews comparing both treatment groups, pooled mortality is 18% 
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(Harkin et al., 2007) and 22% (Visser et al., 2007) in the EVAR group compared to 34% 
(Harkin et al., 2007) and 38% (Visser et al., 2007) in the open surgery group. In the fifth 
review, Sadat et al showed that EVAR is associated with a significant reduction in mortality 
with a pooled odds ratio of 0.62 (95% CI 0.52-0.75) (Sadat et al., 2008). Visser et al found 
similar results with an odds ratio of 0.45 (95% BI 0.28-0.72) (Visser et al., 2007). However, 
after adjustment for patients' hemodynamic condition, the odds ratio was 0.67 (95% CI 0.31-
1.44) and therefore no longer significant. 
 
Study  EVAR  open surgery  Peto OR  Peto OR
or sub-category  n/N  n/N  95% CI  95% CI
 Acosta et al              19/56              48/106           0.63 [0.33, 1.21]   
 Alsac et al                4/17              10/20            0.33 [0.09, 1.25]   
 Anain et al                5/30               4/10            0.27 [0.05, 1.47]   
 Arya et al                 4/17              16/34            0.38 [0.12, 1.24]   
 Brandt et al               0/11               2/13            0.15 [0.01, 2.49]   
 Coppi et al               10/33              42/91            0.52 [0.23, 1.17]   
 Dalainas et al             8/20               5/8             0.42 [0.08, 2.10]   
 Franks et al               2/21              12/23            0.15 [0.04, 0.51]   
 Greco et al              114/290           2627/5508          0.71 [0.56, 0.91]   
 Hinchliffe et al           8/15               9/17            1.02 [0.26, 3.99]   
 Kapma et al                5/40              64/213           0.41 [0.19, 0.88]   
 Larzon et al               2/5               12/26            0.79 [0.12, 5.21]   
 Lee et al                  1/13               1/4             0.21 [0.01, 6.08]   
 Moore et al                1/20               9/36            0.26 [0.06, 1.08]   
 Ockert et al               9/29               9/29            1.00 [0.33, 3.01]   
 Ohki et al                 2/20               0/5             3.69 [0.11, 126.93] 
 Peppelenbosch et al       17/49              20/51            0.83 [0.37, 1.85]   
 Reichart et al             1/6                4/13            0.50 [0.06, 4.26]   
 Resch et al                4/14               8/23            0.76 [0.19, 3.08]   
 Sambeek, van et al         0/6                0/6                Not estimable    
 Vaddineni et al            2/9                4/15            0.80 [0.12, 5.16]   
 Verhoeven et al            1/16               7/31            0.32 [0.07, 1.58]   
 Visser et al               8/26               9/29            0.99 [0.32, 3.07]   
 Yilmaz et al               4/24              13/40            0.45 [0.14, 1.40]   
Total (95% CI) 787                6351      0.62 [0.52, 0.74]
Total events: 231 (EVAR), 2935 (open surgery)
Test for heterogeneity: Chi² = 17.72, df = 22 (P = 0.72), I² = 0%
Test for overall effect: Z = 5.35 (P < 0.00001)
 0.001  0.01  0.1  1  10  100  1000
 Favours EVAR  Favours Open surgery  
Fig. 1. Forest plot of 30-day or hospital mortality in 24 studies comparing EVAR and open 
surgery in patients with a ruptured AAA. 
 
Review Studies Patients 30-day/in-hospital mortality 
 n n EVAR % (95% CI) 
Open 
% (95% CI) 
Odds ratio 
EVAR vs Open 
Rayt et al., 2008  31 982 24% (20-28) - - 
Mastracci et al., 2008  18 436 21% (13-29) - - 
Harkin et al., 2007  34 891 18% (0-53) * 34% (0-70) * - 
Visser et al., 2007  10 478 22% (16-29) 38% (32-45) 0.45 (0.28-0.78) 
Sadat et al., 2008  23 7040 - - 0.62 (0.52-0.75) 
CI = confidence interval, vs = versus, * = % (range of included studies) 
Table 1. 30-day or in-hospital mortality in patients treated with open or endovascular repair 
according to five systematic reviews. 
In addition, the systematic reviews showed that EVAR is associated with significant 
reduction in blood loss, reduced procedure time, reduction in systemical complications and 
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reduced intensive care and hospital stay compared to open surgery (Harkin et al., 2007; 
Visser et al., 2007; Mastracci et al., 2008; Sadat et al., 2008). 
4. Discussion 
Theoretically, both the endovascular and the conventional open technique have benefits. 
During open repair the aorta is clamped short after the initiation of the procedure, ceasing 
the blood loss. During endovascular repair on the other hand, the ruptured aneurysm 
remains part of the circulation until the entire endograft is deployed and correctly 
positioned without major endoleak.  
Reported results of reduced early mortality after EVAR for the treatment of a ruptured AAA 
compared to open surgery seems conclusive (table 1). However, the currently available, 
mainly observational, studies are small and add considerable heterogeneity and 
methodological limitations (Yilmaz et al., 2002; Reichart et al., 2003; Resch et al., 2003; Lee et 
al., 2004; Alsac et al., 2005; Brandt et al., 2005; Castelli et al., 2005; Hechelhammer et al., 2005; 
Kapma et al., 2005; Larzon et al., 2005; Vaddineni et al., 2005; Arya et al., 2006; Coppi et al., 
2006; Franks et al., 2006; Hinchliffe et al., 2006; Peppelenbosch et al., 2006; Visser et al., 2006; 
Acosta et al., 2007; Ockert et al., 2007). Heterogeneity is signified by the broad range in 
percentages of patients treated with EVAR (15-50%) and in percentage of haemodynamical 
unstable patients (33-73% in the eEVAR group). Even the definition of haemodynamical 
instability varied between the studies from a systolic blood pressure below 50 mmHg to 100 
mmHg. Furthermore, the comparative studies reported so far are flawed by methodological 
inadequacies such as high potential of selection bias and lack of randomisation (Dillon et al., 
2007). Selection bias is created by selecting patients for EVAR constituting a lower-risk 
category, presuming they need to be haemodynamically more stable for preoperative 
imaging and have a more favourable (EVAR-suitable) anatomic configuration. In a previous 
report, though not randomized, we eliminated selection bias due to inadequate patient 
matching by reporting a comparison of EVAR and open surgery in patients who all had the 
same preoperative imaging protocol, irrespective of haemodynamic condition, and who 
were all anatomically suitable for EVAR (Ten Bosch et al., 2010). This study showed a 
significant reduction in 30-day and 6-month mortality of EVAR compared to open ruptured 
AAA repair. However, a larger conducted prospective randomised trial such as the 
Amsterdam Acute Aneurysm Trial, which is currently performed in the Netherlands, is 
needed to identify possible benefits of EVAR over open surgery in patients with a ruptured 
AAA. The pilot study of Hinchliffe et al showed the possibility to recruit patients with a 
ruptured AAA to a randomised trial of open surgery and EVAR (Hinchliffe et al., 2006). 
However, a RCT might give ethical concerns, given the accumulation of superior results 
with EVAR based on the available observational studies. In addition, a RCT in an acute, 
severe condition like a ruptured AAA, appears difficult to perform (Hinchliffe et al., 2006). 
Furthermore, long term effects on outcome still need further investigation. 
In case randomised trials demonstrate a clinically relevant reduction in mortality and 
morbidity for endovascular repair, consequences for care organisation will be major. 
Treatment of ruptured AAAs has to be performed in hospitals that are able to guarantee 
permanent availability of endovascular trained staff, implicating regionalisation and 
centralisation of acute AAA care. 
 




The minimally invasive endovascular procedure (EVAR) is theoretically likely to reduce 
early mortality in patients with a ruptured AAA. The majority of observational studies show 
a clear trend toward an improved short term effect of EVAR and a significant reduction in 
early mortality compared to conventional open surgery. Therefore, EVAR has become a 
generally accepted treatment option for ruptured AAAs. However, studies comparing 
EVAR with conventional open surgery have to be interpreted with caution due to the 
likelihood of methodological inadequacies such as selection bias, heterogeneity, and lack of 
randomisation. Can endovascular repair of the ruptured AAA be considered as the 
treatment option of first choice? This question has not been answered yet. Further research 
in terms of randomised controlled trials with adequate follow-up will be required in order 
to clarify the role of endovascular repair as treatment option for ruptured abdominal aortic 
aneurysms. 
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reduced intensive care and hospital stay compared to open surgery (Harkin et al., 2007; 
Visser et al., 2007; Mastracci et al., 2008; Sadat et al., 2008). 
4. Discussion 
Theoretically, both the endovascular and the conventional open technique have benefits. 
During open repair the aorta is clamped short after the initiation of the procedure, ceasing 
the blood loss. During endovascular repair on the other hand, the ruptured aneurysm 
remains part of the circulation until the entire endograft is deployed and correctly 
positioned without major endoleak.  
Reported results of reduced early mortality after EVAR for the treatment of a ruptured AAA 
compared to open surgery seems conclusive (table 1). However, the currently available, 
mainly observational, studies are small and add considerable heterogeneity and 
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mmHg. Furthermore, the comparative studies reported so far are flawed by methodological 
inadequacies such as high potential of selection bias and lack of randomisation (Dillon et al., 
2007). Selection bias is created by selecting patients for EVAR constituting a lower-risk 
category, presuming they need to be haemodynamically more stable for preoperative 
imaging and have a more favourable (EVAR-suitable) anatomic configuration. In a previous 
report, though not randomized, we eliminated selection bias due to inadequate patient 
matching by reporting a comparison of EVAR and open surgery in patients who all had the 
same preoperative imaging protocol, irrespective of haemodynamic condition, and who 
were all anatomically suitable for EVAR (Ten Bosch et al., 2010). This study showed a 
significant reduction in 30-day and 6-month mortality of EVAR compared to open ruptured 
AAA repair. However, a larger conducted prospective randomised trial such as the 
Amsterdam Acute Aneurysm Trial, which is currently performed in the Netherlands, is 
needed to identify possible benefits of EVAR over open surgery in patients with a ruptured 
AAA. The pilot study of Hinchliffe et al showed the possibility to recruit patients with a 
ruptured AAA to a randomised trial of open surgery and EVAR (Hinchliffe et al., 2006). 
However, a RCT might give ethical concerns, given the accumulation of superior results 
with EVAR based on the available observational studies. In addition, a RCT in an acute, 
severe condition like a ruptured AAA, appears difficult to perform (Hinchliffe et al., 2006). 
Furthermore, long term effects on outcome still need further investigation. 
In case randomised trials demonstrate a clinically relevant reduction in mortality and 
morbidity for endovascular repair, consequences for care organisation will be major. 
Treatment of ruptured AAAs has to be performed in hospitals that are able to guarantee 
permanent availability of endovascular trained staff, implicating regionalisation and 
centralisation of acute AAA care. 
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evaluation of the thoracic aorta and great vessels without exposure to ionizing radiation or 
iodinated contrast agents. Because MRA does not require the use of ionizing radiation, it can 
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contrast-enhanced MRA uses a lesser volume of intravenous contrast agents, and is much 
less likely to result in contrast-induced in nephropathy compared with CT with iodine 
contrast, which may be particularly relevant since patients with aortic disease are often old, 
and frequently suffer from some extent of renal insufficiency. Another benefit that is 
intrinsic to MRI is the exquisite contrast resolution and the ability to perform a variety of 
techniques based on different physical principles. For example, for patients at risk of 
nephrogenic systemic fibrosis (NSF), non-contrast-enhanced MRA techniques may be 
considered, generally with good morphologic assessment. Not every MRA technique yields 
equivalent results in similar situations, and therefore, it is important to understand the 
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advantages and limitations of each technique. Furthermore, based on the intrinsic sensitivity 
to flow and motion, MRI offers the possibility of acquiring functional information that is of 
incremental value to the morphological MRA study. 
The utility of MRA has been further improved by the addition of new intravenous contrast 
agents and the proliferation of post processing techniques, many of which are largely 
automated on commercially available workstations.  
 In this chapter we will discuss the current role of MRI in the assessment of the thoracic 
aorta; the available imaging techniques, and illustrate the application of these techniques to 
the diagnosis of acute thoracic syndrome related to the aorta. 
2. MRA techniques 
Magnetic resonance imaging (MRI) can use several different techniques for the evaluation of 
the aorta, each with advantages and disadvantages. Therefore examinations often require 
different and complementary approaches, according to the patient and clinical condition. 
Magnetic resonance imaging of the aorta and pulmonary arteries is mainly dependent on a 
morphological evaluation, either alone or combined with a functional evaluation. The goals 
of the morphological evaluation are to provide information on the vessel location, diameter, 
wall characteristics, lumen patency and anatomical relations, including adjacent tissues and 
vessel branches. Unlike CT, MR can additionally provide vascular functional assessment, 
which can be useful in selected clinical settings. Many advanced practices are converging 
toward a subset of techniques that are fast, reliable, and reproducible. In the subheadings 
below, the authors will describe in more detail the different imaging approaches that can be 
used in the study of the thoracic aorta. 
2.1 Gadolinium-enhanced MR angiography techniques 
The use of gadolinium-based contrast agents (GBCA) has dramatically expanded the clinical 
utility of MRA. Gadolinium-enhanced MR angiography techniques can be highly spatially 
resolved, usually called contrast enhanced-MRA (CE-MRA), or highly temporally resolved, 
also called Time-resolved MRA (TR-MRA). 
Many of the important advances in vascular MR imaging have involved evolution of CE- 
MRA, resulting in high-quality images in a single breath-hold (Sodickson, 2000; Lohan 
2008). The most commonly used approach for CE-MRA is a 3D gradient echo (3D-GRE), 
allowing thin contiguous image partitions to be obtained during a single breath-hold. CE-
MRA using a heavily T1-weighted 3D-GRE technique has become the mainstay of MR study 
of the vascular abnormalities of the thoracic aorta (Prince, 1993, 1996; Krinsky 1996, 1997; 
Sakamoto, 2010) (Fig1).  
After the intravenous injection of a bolus of a GBCA, there is a T1-shortening of blood so 
that the blood appears bright irrespective of flow patterns or velocities. Usually, a standard 
dose (0.1 mL/kg bodyweight) of a GBCA is administered at a flow rate of 2-5 mL per 
second, followed by a saline flush of 20 mL injected at the same flow rate immediately after 
contrast administration, to achieve a compact bolus. Because signal enhancement and 
overall image quality of CE-MRA depends on the intra-arterial concentration of the GBCA, 
the correct timing of imaging after contrast material injection is fundamental (Sakamoto, 
2010). Nevertheless, gadolinium has a larger window of visibility than iodine on CT images, 
which renders timing of data acquisition less critical than on CT.  
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Fig. 1. A 6cm x 4cm saccular aneurysm at the aortic arch is depicted using the black blood 
technique (a). Black-blood imaging allows visualization of the involved aortic wall, 
facilitating accurate luminal and wall-to-wall diameter measurement. Source image of 3D 
parasagital CE-MRA acquisition (b) did not allow confident depiction of the aneurysm. Note 
the reduced signal from background (stationary) tissue, as there is insufficient time for 
recovery of longitudinal magnetization. Post processing MRA techniques like volume 
rendering (c) with multiple projections allowed a confidant diagnosis of this process. 
Several methods are used to determine the optimal delay between the start of intravenous 
contrast material injection and the start of image acquisition, including injection of a test 
bolus using a small amount of contrast material, automatic triggering, and MR fluoroscopy 
(Sakamoto, 2010; Hany, 1997; Foo, 1997; Riederer, 2000). More recently, all major MRI 
system vendors have introduced real-time bolus monitoring software packages and these 
are now considered the state-of-the art for CE-MRA. Real-time bolus monitoring allows the 
operator to inject the total volume of contrast material, and to proceed with the 3D CE-MRA 
acquisition when the desired signal enhancement in the arterial bed of interest has been 
detected by the MR system, or by visual feedback by the operating technologist. Real-time 
MR fluoroscopic technique also integrates a monitoring phase and an imaging phase into a 
single pulse sequence. With the MR fluoroscopic method, monitoring is performed by using 
a continuous fast two-dimensional (2D) gradient-echo pulse sequence with imaging 
centered over the vascular bed.  
The dose of contrast necessary to perform thoracic aorta CE-MRA varies by scanner, type of 
gadolinium-based contrast agent and operator experience. Thoracic aorta CE-MRA can be 
adequately performed with approximately 20mL or less of GBCA. MultiHance® (gadobenate 
dimeglumine) has greater T1 shortening than the purely extracellular GBCAs currently 
available, leading some centers like ours, to use this agent at a lower dose (half-dose or 
0.5mmol/KG) than would be used with typical extracellular agents. An additional attractive 
feature of Multihance is mild protein-binding that increases intravascular dwell time.  
a 
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Fig. 2. Aortic pseudoaneurysm in a 48 year-old man, a complication of a previous repair of 
an aortic aneurysm. Axial black-blood spin-echo (a) and single-shot SSFP (b) images showed 
a left pseudoaneurysm at the level of the aortic arch. Coronal MPR showed direct 
communication with the true aortic lumen (c). MIP and volume-rendered full-thickness 
from CE-MRA examination (d, e) displays the morphology and location of the 
pseudoaneurysm. 
2.1.1 Steady-state contrast enhanced MRA and blood pool contrast agents 
Besides dynamic imaging of the arterial-dominant phase after single bolus injection of an 
extracellular GBCA (first-pass MRA), extended imaging during the steady state of the 
contrast agent can be performed: this is called steady-state contrast enhanced MRA (Klessen, 
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used, blood-pool agents, allowing imaging acquisition up to one hour after contrast 





Fig. 3. Oblique sagittal images from a time-resolved MRA of the chest in a 83 year-old male 
with a Stanford type B aortic dissection. Using a TR-MRA technique it is possible to 
demonstrate delayed filling of the false lumen (a). There is a dissection flap originating in 
the aortic arch distal to the origin of the left subclavian artery.  Arch vessels that arise from 
the true lumen and are not involved by dissection. Delayed phases show the distal extent of 
the false lumen (b, c), with late higher overall enhancement compared to the true lumen (c). 
The anatomic details of the dissected aorta are somewhat difficult to recognize on volume 
rendered images (e). Parasagittal reformatted TR-MRA and bSSFP (asterisk, a, d) images 
clearly depict the intimal flap and also the entry site. Black-blood images (f) show a 
compressed true lumen due to a dilated false lumen. 
b c a 
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Blood pool contrast agents have a prolonged intravascular phase, which means that a wide 
window of opportunity exists for imaging the blood vessels after contrast agent 
administration. Gadofosveset trisodium (Ablavar®, Vasovist®) is the first blood pool 
contrast agent FDA approved for routine clinical use. Gadofosveset is characterized by a 
lipophilic side chain, which leads to a transient, reversible and non-covalent binding to 
serum albumin (Lauffer, 1998). The transient protein interaction increases T1-relaxtivity four 
to five times compared to standard extracellular gadolinium chelates at 1.5 T (Nissen, 2009; 
Rohrer, 2005; Caravan, 2007), resulting in prolonged blood pool enhancement, which is 
particularly beneficial for vascular imaging. This can be utilized for higher spatial resolution 
scanning and greater anatomic coverage. Maximum signal enhancement using this contrast 
agent on MRA is independent of the injection rate used (Nissen, 2009). Nevertheless, first-
pass arterial phase imaging should be performed when possible to avoid interference from 
venous structures, with steady-state CE-MRA used as a complementary acquisition. 
Gadofosveset can be used for these two types of CE-MRA with a single dose. It remains 
longer in the intravascular compartment, allowing several repetitions of the CE-MRA 
sequences after the initiation of contrast injection. It is possible then to choose the 
acquisition (both in time and imaging plane) that best displays the vessels of interest for 
image interpretation. 
2.1.2 MRA Post-processing and imaging planes 
Interpretation of MR images usually is done with the aid of a computer workstation on 
which individual source images are analyzed and postprocessing techniques, such as 
maximum intensity projection (MIP) reformation, volume rendering and multiplanar 
reformation of the images are performed (Fig 2). MIP images can be obtained quickly, and 
permit a 3D appreciation of anatomy, which can be useful both for the radiologist and for 
the clinician, as these resemble catheter angiograms, and are therefore the most widely used 
post-processing technique. MIP reconstruction involves display of the highest signal 
intensity voxels within each projection ray to create pixels on the final image. These images 
must be viewed in multiple projections to detect findings that might be otherwise obscured 
by overlapping structures with higher signal intensity. Volume rendering uses the entire 
volume of data for image reconstruction. Volume rendering assigns groups of voxels an 
opacity score from 0% (transparent) to 100% (completely opaque).  
Multiplanar (MPR) and curved reformations allow rapid assessment of MRA data in any 
plane avoiding problems with vessel overlap and background projection. MPR compresses 
the full volume of data in a single plane. 
Comprehensive thoracic aortic evaluation necessitates that images are acquired in several 
complementary planes, such that the entire course is fully evaluated. Direct coronal and 
sagittal images may address shortcomings of true axial views, a parasagittal oblique plane 
to the ascending, transverse, and descending aorta, is recommended such that subtle 
abnormalities of the arch may be confidently excluded. This imaging plane also is beneficial 
in aortic dissection, demonstrating the extent of intimal dissection flaps and their 
relationship to the origins of the supra-aortic branch vessels. In the presence of aortic 
dissection or aneurysmal dilatation, particularly when involving the ascending portion of 
the thoracic aorta, cine imaging of the left ventricular outflow tract represents an essential 
component to the evaluation of the effect of such pathology on ventricular function. 
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Fig. 4. Ascending aortic aneurysm. Axial black-blood imaging of the aorta through the 
upper mediastinum at the level of the right pulmonary artery (a). There is homogeneous 
suppression of luminal blood signal, increasing the conspicuity of the vessel wall.  
2.1.3 Time-resolved MR angiography (TR-MRA) 
If dynamic information related to direction or rate of vascular enhancement is considered 
necessary, Time-resolved MR angiography (TR-MRA) techniques can provide this temporal 
resolution during the vascular phases of enhancement, with a compromise regarding spatial 
resolution. These techniques are widely available on modern equipments and have become 
routinely used in many medical centers; TR-MRA can have a complementary or alternative 
role to conventional CE-MRA and has been advocated by some authors when a 
comprehensive evaluation of the thoracic vasculature is warranted (Lohan, 2008b). 
Dedicated time-resolved MRA sequences such as TRICKS (time-resolved imaging of 
contrast kinetics), TWIST (time-resolved angiography with stochastic trajectories), or 4D 
Track (4D time-resolved MRA with Keyhole), can be used to collect data continuously after 
GBCA injection during a single breath-hold. TR-MRA represents a powerful complement to 
conventional 3-D CE-MRA. A complementary TR-MRA allows dynamic evaluation of 
circulatory patency, confidant separation of the arterial and venous phases of luminal 
enhancement (Lohan, 2008). Patients who have severe respiratory disease and very limited 
breath-hold capabilities can be examined (Lohan, 2008; Griffin, 2009). Time-resolved CE-
MRA is independent of the bolus timing, because the contrast injection and the MR imaging 
sequence are started simultaneously. TR-MRA may be of particular value in the evaluation 
of inhomogeneous aortic flow and dissections, showing the opacification of true and false 
lumens on multiple phases of enhancement (Fig3) (Lohan, 2008; Schoenberg, 1999).  
2.1.4 Patient preparation for contrast-enhanced MRA 
Patient preparation used has been described elsewhere (Schneider, 2005): In addition to 
screening for the usual contraindications for MR scanning (e.g. pacemakers) and for the use 
of GBCA (e.g. pregnancy), patients scheduled for a CE-MRA examination should also be 
asked about underlying pulmonary disease and their ability to hold their breath. If 
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necessary, proper coaching is performed in advance and breath holding is optimized by the 
use of supplemental oxygen and hyperventilation (Marks, 1997). Patients should also be 
asked about prior interventions, especially vascular or endovascular procedures. 
Knowledge of extra-anatomic bypass grafts or stent grafts will ensure proper scan 
prescription and planning. 
Patients are checked for venous access. Ideally, for CE-MRA, the intravenous catheter is 
placed in the antecubital fossa and should be sufficiently large (i.e. at least 22 gauge) to 
support a bolus rate of at least 2 mL/sec. When imaging the aortic arch and great vessel 
origins, it is preferable to place the intravenous catheter in the right arm, as left sided 
venous contrast administration can cause T2* artifacts due to the high concentration of the 
GBCA within the left brachiocephalic vein en route to the right heart. This can be mistaken 
for a proximal great vessel stenosis (Lee, 2000). 
2.2 Gadolinium-based contrast agents and nephrogenic systemic fibrosis (NSF) 
MRA using a GBCA has become the mainstay of high-quality MR imaging of the thoracic 
vasculature. This reflects its high spatial and temporal resolution, and avoidance of ionizing 
radiation and of nephrotoxicity related to iodine-based contrast agents, which are utilized in 
CT. There are however, specific safety conditions that are related to the use of GBCA, such 
as high-risk patients for nephrogenic systemic fibrosis (NSF), or pregnant patients. Limited 
intravenous access also may obviate contrast use. Considering NSF and gadolinium, it has 
been shown that not all agents have the same risk for NSF, and that volume of contrast and 
cumulative dose influenced the presence and severity of NSF. The use of stable GBCAs are 
recommended such as macrocyclic agents (eg:  Prohance, Gadovist, Dotarem) or ionic Linear 
with partial hepatobiliary elimination and high T1 relaxation (Gadofosveset or  Gadobenate 
dimeglumine) at risk patients (Wertman, 2008; Altun, 2009a, 2009b; Martin, 2009). Reducing 
the dose, while maintaining diagnostic information, is also important (Altun, 2009b).  Half-
dose (0,5mmol/Kg) Gadobenate dimeglumine has been shown to provide diagnostic quality 
examinations in abdominal studies, including vascular imaging. It is the authors’ experience 
that the same diagnostic results can be achieved in thoracic imaging, when higher doses are 
not recommended for safety concerns.  
Recently, the use of quarter-dose (0,025mmol/Kg) Gadobenate dimeglumine at 3T has been 
associated with diagnostic images in the abdomen (De Campos, 2011). It is likely that this can 
also be achieved in thoracic vascular imaging, providing vascular diagnostic imaging of the 
thorax, either alone or in combination with other techniques, such as TR-MRA and/or 
noncontrast-enhanced MRA, in selected cases. It should be noted that the relative risk for 
developing contrast induced nephropathy with iodinated contrast agents in patients with 
chronic renal failure generally far exceeds the risk of NSF. There is no measurable risk of NSF 
occurring in patients with mild to moderate (stage 3) chronic renal failure using GBCAs, 
whereas these patients are at risk for contrast induced nephropathy (Altun, 2009b, Martin 2009). 
2.3 Noncontrast-enhanced MR angiography 
Over the last decade, contrast-enhanced MR angiography (CE-MRA) techniques (Prince, 
1996; Krinsky, 1999; Korosec, 1996) have largely replaced unenhanced MRA techniques for 
the evaluation of the thoracic aorta because of their high spatial resolution and reliability. In 
recent years, with the concern about NSF, along with concerns about ionizing radiation and 
nephrotoxicity of iodinated contrast agents, non-contrast MRA, have re-emerged as 
important techniques, especially bright blood steady state free precession techniques. 
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2.3.1 “Bright blood” MR angiography 
Non-contrast enhanced “bright blood” vascular imaging includes Steady-state free-
precession (SSFP), Time-of-flight (TOF) and Phase-contrast (PC) MR angiography.  
Steady-state free-precession (SSFP) sequence (TrueFISP, balanced FFE, FIESTA) is a bright 
blood technique, with short TE and TR sequences, that has become widely available 
(Sakamoto, 2010;Earls, 2002; Pereles, 2002). With SSFP, intraluminal signal generally is very 
high and homogenous even in cases of turbulent flow because this sequence depends 
mainly on a function of the T2/T1 ratio (Sakamoto, 2010). 
SSFP images can be acquired in both breath-hold and free-breathing manners, either with or 
without ECG-gate and Navigator/ respiratory triggered (Bi, 2005; Amano, 2008). SSFP can 
provide rapid bright-blood images with high-contrast resolution, free-breathing real-time 
steady-state free precession techniques allow for a fast non-ECG gated, non–contrast 
enhanced MRA that may be useful in critically ill patients (Pereles, 2002; Gebker, 2007; 
Kluge, 2004). A rapid morphologic assessment can be achieved in urgent situations, such as 
demonstrating aortic abnormalities in unstable patients, for example intimal flaps and false 
lumens in aortic dissection (Pereles, 2002; Gebker, 2007). Free-breathing cardiac and 
respiratory-gated 3D SSFP MRA has also been shown valuable in the evaluation of thoracic 
vessels (Fuchs, 2003; Tomasian, 2008; Krishnam, 2008, 2010), and represents an alternative 
for free-breathing SSFP MRA. 
SSFP sequences can also be acquired in a cine mode, and have become the foundation for 
cine imaging. Advantages are the higher SNR, shorter imaging duration, and freedom from 
the reliance on inflow effects for signal generation (Carr, 2001; Lohan, 2008). This sequence 
has benefited from the application of parallel imaging techniques, allowing high temporal 
resolution, large FOV imaging of the thoracic aorta, and left ventricular outflow during 
acceptable breath-holds as low as 5 to 6 seconds. The inherently high blood signal achieved 
using SSFP throughout a cine acquisition period has been shown to aid evaluation of aortic 
mural and valvular characteristics and  allowing exclusion of the presence of aortic 
dissection, (Pereles, 2002; Kunz, 2004). SSFP is the most promising of the “bright-blood” 
non-contrast enhanced MR angiography techniques (Fig2 and 3).  
Other techniques, such as time-of-flight (TOF) and phase-contrast (PC) are seldom use for 
non–contrast-enhanced MR angiography of the thorax because of sensitivity to respiratory 
and cardiac motions, in-plane saturation, and the need for wide coverage (Prince, 
1993;Amano, 2008; McCauley, 1994). These sequences are also time- consuming and 
susceptible to artifacts. Possible applications exist when vascular flow quantification is 
warranted.  
PC-MRA is an inherently quantitative technique, unlike TOF or CE MRA., allowing for the 
calculation of flow velocity. With PC-MRA, the signal intensity of blood is proportional to 
its flow velocity and the direction of flow can be determined on the basis of the direction of 
the phase shift (Schneider, 2005). 
2.3.2 ‘‘Black-blood” MR  
These techniques are termed black-blood because signal void is created in flowing blood.  
They consist of either conventional or echo-train spin-echo techniques, usually with ECG-
gating, exploiting the contrast between rapidly flowing blood and the aortic wall (Sakamoto, 
2010; Czum, 2005; Fattori, 1999; Russo, 2006; Bradley, 1985). Black-blood MRA may be 
useful for the depiction of intraluminal abnormalities such as dissection flaps and tumor  
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Fig. 5. Two patients with type A dissection. Slow/ turbulent flow may produce high signal in 
the aortic lumen, artificially simulating wall disease. A simple method of reducing errors is to 
compare with other sequences. In the first case (a) there is moderate high signal intensity in the 
false lumen, which correlates with high signal intensity on the bSSFP images (b), associated 
with slow flow. On the other example (c), the higher signal intensity saw on the spin-echo 
sequence (black-blood image) correlates with a partial thrombus in the false lumen as low 
signal intensity on the bSSFP images (d). A simple method of reducing intravascular signal on 
a black-blood technique is to increase the TE, allowing more time for intravoxel dephasing and 
for moving excited protons to exit the slice before the refocusing pulse.  
thrombus. When vessel wall analysis is desirable, as in aortic conditions such as mural 
hematoma, black-blood techniques may at times provide a better wall depiction than CE-
MRA (Potthast, 2010; Litmanovich, 2009).  The goal of black-blood techniques is to eliminate 
a b 
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as much signal as possible from flowing blood in the vessels lumen (Fig4). Luminal signal  
void occurs because intravascular protons only produce signal if they are exposed to both a 
90-degree excitation pulse and subsequent refocusing pulse while travelling through the 
image slice. Therefore, low flow and entry/exit slice phenomena may produce high signal in 
the aortic lumen (Fig5), artificially simulating wall disease (Sakamoto, 2010). Echo-train 
spin-echo techniques are favoured, because of rapid data acquisition (usually in a single 
breath hold) and improved image resolution (Matsunaga, 2003). T2-weighted single-shot 
echo-train spin-echo sequences can be obtained as a black blood technique, which may be 
useful in patients who cannot comply with the necessary breath-holds for alternative 
imaging (Stehling, 1996; Winterer, 1999). 
Usually, black-blood techniques are used in combination with other imaging sequences, 
most often CE-MRA and/or non-contrast enhanced “bright-blood techniques”. 
3. Comprehensive thoracic evaluation on vascular MR studies 
Although the above-described techniques, especially CE-MRA, can achieve high-quality 
diagnostic imaging of the thoracic vessels, evaluation of comprehensive chest structures 
may be necessary. If clinically necessary, the complementary use of T2 weighted single-shot 
echo-train spin echo and pre-contrast 3D-GRE sequences in axial and coronal planes will 
provide such information with minimally added time (Fig 6). A basic MRA protocol can be 
supplemented with additional sequences, based on the suspected clinical condition or 
pathologic process. Post contrast 3D-GRE MRI visualizes not only the aorta, but also the 
lungs and other organs and structures in the chest (Bader, 2002; Karabulut, 2002; Altun, 
2010) and is usually acquired after the MRA. Blood-pool contrast agents can be beneficial in 
this setting, allowing for persistently high signal in vessels on delayed acquisition. 
4. Clinical conditions 
An increasing number of clinical indications for gadolinium-enhanced MRA/MRI have 
been described, including congenital syndromes, functional imaging of flow and direction, 
and acquired disease of the aorta. A detailed description of all these indications is beyond 
the scope of this chapter, and can be found elsewhere (Schneider, 2005). In this review, the 
authors will focus on some common indications for MRA/MRI imaging of the aorta, aortic 
aneurysms, and acute aortic syndrome will be discussed. Usually, in these settings, CT is 
more commonly used than MR, due to its high spatial resolution rapid acquisition, 
resistance to patient motion, adequate diagnostic capability, and availability of the 
technique (Bhargavan, 2010; Jha, 2010). Nevertheless, in selected cases, MR may be 
preferred, such as in young patients, pregnant patients, renal failure, allergy to iodine 
contrast, or lack of adequate intravenous access. Another setting in which MR is 
recommended, is in studying patients that will undergo sequential follow up examinations, 
as a follow-up to initial CT or MR studies, as in the follow-up of aneurysms. In specific 
conditions, MR can be superior to CT, for example when differentiating false from true 
lumen in an aortic dissection, using cine-imaging if needed, or when differentiating acute 
aortic hematoma from atherosclerotic plaque and chronic thrombus (Yucel, 1990). 
A combination of morphological assessment techniques and vascular patency techniques is 
sufficient for most acute conditions. In selected cases, dynamic imaging, usually using TR- 
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Fig. 6. A 62 year-old male with small cell lung cancer with pleural involvement. Axial 
double IR black-blood spin-echo MR (a) and coronal T2-weighted single-shot fast spin-echo 
(b) images clearly showed a pulmonary mass in the right upper lobe. Post contrast T1-
weighted 3D-GRE images (c, d) defined the lesion’s vascular characteristics and as well as 
pleural involvement.  
MRI or Cine-SSFP can be added to the study, as described below. Using comprehensive 
imaging protocols provides information, not only on the disease process in question, but 
other diseases as well. For example, a comprehensive protocol evaluating suspected acute 
pulmonary embolism can also detect aortic dissection.  
4.1 Aortic aneurysm 
The normal dimensions of the aorta have been defined based on normative measurements 
performed in large patient populations (Litmanovich, 2009). An ascending aortic diameter 
equal to or greater than 4 cm (in individuals younger than 60 years old) and a descending 
aortic diameter larger than 3 cm is usually considered to indicate dilatation and a diameter 
equalling or exceeding 1.5 times the expected normal diameter is considered an aneurysm 
(Litmanovich, 2009). The prevalence of thoracic aortic aneurysms increases with age, with 
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(Bickerstaff, 1982; Litmanovich, 2009). In up to one third of cases, the abdominal aorta is also 




Fig. 7. A 77-year-old male with diffuse long-standing atherosclerotic thoraco-abdominal 
aneurysm. MIP CE-MRA (a) and TR-MRA (b) images clearly depict the diffuse thoracic 
aorta dilatation with mural thrombus in the descending aorta (asterisk, A, B) and irregular 
contour due to severe atherosclerosis. These features are also well appreciated in the bSSFP 
images (c). Characterization of the aortic wall and thrombus is better preformed with a 
black-blood sequence (d) like a double inversion spin-echo techniques. With volume 
rendering (e) the entire volume of data is used in data reconstruction.  
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atherosclerotic (Tatli, 2004; Litmanovich, 2009). Infection, inflammation, syphilis, and cystic 
medial necrosis are other causes for aortic aneurysms, the last being the most common cause 
of an aneurysm isolated to the ascending aorta. Cystic medial necrosis is usually associated 
with Marfan syndrome but can also be idiopathic (Litmanovich, 2009). In Marfan syndrome, 
the classic imaging features include a pear-shaped aneurysmal ascending aorta with smooth 
tapering to a normal aortic arch (Litmanovich, 2009) (Fig 8). Thoracic aortic aneurysms can 




Fig. 8. Fusiform ascending aortic aneurysm in a patient with Marfan syndrome, depicted on 
CE-MRA (a), bSSFP (b) and on black blood (c) images. Phase contrast flow quantification at 
the level of the aortic valve (d) shows the characteristic fish-mouth appearance of bicuspid 
aortic valve, a common addition of aortic aneurysm.  
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features. In true aneurysms, all layers of the aortic wall are involved. A pseudoaneurysm 
represents enlargement of the artery resulting from blood accumulating beyond the intimal 
layer and typically trapped within the serosa or outer layer of the arterial wall (Fig2). 
Aetiology may be related to ruptured atheroma, dissection, or trauma. When resulting from 
trauma, the aortic isthmus is more frequently affected by pseudoaneurysms, whereas 
penetrating aortic ulcer usually occurs in the descending aorta (Litmanovich, 2009;  
Boiselle, 2007). 
True aortic aneurysms are usually fusiform in shape, involving the entire circumference of 
the aorta, and often extend over a significant length of the vessel, although saccular 
aneurysms can occasionally be found (Fig1). Pseudoaneurysms are usually saccular, with a 
narrow neck at the origin in the aorta. The presence of a wide neck in a saccular aneurysm 
suggests a mycotic origin. These aneurysms have a tendency to involve the ascending aorta, 
likely because of its proximity to the heart and suspected extension from endocarditis 
(Boiselle, 2007). 
It is important to evaluate eventual extension of thoracic aortic aneurysms to the abdominal 
aorta, as there are therapeutic implications (Yu, 2007). Thoraco-abdominal aneurysms 
include Type I (involving the descending thoracic aorta below the origin of the left 
subclavian artery and the upper abdominal aorta); Type II (involving both the thoracic 
descending aorta and most of the abdominal aorta); Type III (lower portion of the thoracic 
aorta) and Type IV (begins at the diaphragm and extends caudally) (Crawford, 1986; 
Litmanovich, 2009). 
When imaging an aortic aneurysm, it is important to exactly evaluate the maximal diameter, 
the length of the aneurysm, and involvement of major branch vessels (Bonser, 2000). Also, 
the most frequent complications of aortic aneurysm - mass effect, dissection, and rupture - 
are related to size. The mean rate of dilatation for thoracic aortic aneurysm is 0.12 cm per 
year (Coady, 1997). The risk of rupture increases with increasing aortic diameter, with a 
high risk of complications (rupture and dissection) at 6 cm for the ascending and 7 cm for 
the descending thoracic aorta (Elefteriades, 2002, 2005). CE-MRA/MRI is generally suitable 
for this evaluation. It allows the study of the extent of an aneurysm and its relationship to 
the aortic branches, with reproducible results (Prince, 1996; Krinsky, 1997; Debatin, 1998; 
Neimatallah, 1999). Breath-hold non ECG-gated CE-MRA is nevertheless more prone to 
motion artifacts and blurring at the aortic root, with potential implications for treatment 
planning (Potthast, 2010; Cigarroa, 1993). Non-contrast enhanced ECG-gated 3D-SSFP has 
shown good results in aneurysm imaging, providing good assessment of diameter, lumen 
patency and topographic evaluation, including the aortic root (Krishnam, 2008; Potthast, 
2010). It can also be used as a cine technique allowing for evaluation of the aortic valve in 
patients with ascending aortic aneurysms, providing crucial information for treatment 
planning (Sakamoto, 2010). 
Use of the sagittal or oblique sagittal plane allows accurate assessment of the location and 
extent of the aneurysm and avoids partial volume effects. With CE-MRA, aneurysm 
measurements should be obtained from source images where the vessel wall is visible, 
because MIP images represent a cast of the lumen alone, and therefore, underestimates 
aneurysm dimensions (Sakamoto, 2010). Standard spin echo images and precontrast 3D-
GRE also are helpful in evaluating changes in the aortic wall and periaortic structures. Areas 
of high signal intensity on spin echo images within the thrombus and aortic wall may 
indicate instability of the aneurysm (Sakamoto, 2010; Russo, 2006b). High signal is 
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Fig. 8. Fusiform ascending aortic aneurysm in a patient with Marfan syndrome, depicted on 
CE-MRA (a), bSSFP (b) and on black blood (c) images. Phase contrast flow quantification at 
the level of the aortic valve (d) shows the characteristic fish-mouth appearance of bicuspid 
aortic valve, a common addition of aortic aneurysm.  
d c 
a b 
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features. In true aneurysms, all layers of the aortic wall are involved. A pseudoaneurysm 
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emphasized by using fat suppressed T1-weighted sequences. Also, contrast enhanced MRA, 
using time resolved techniques, allows visualization of the Adamkiewicz artery (Bley, 2010), 
providing information that is important in planning the surgical repair of an aneurysm, thus 
avoiding postoperative neurologic deficit secondary to spinal cord ischemia (Nijenhuis, 
2006; Yoshioka, 2006). 
4.2 Acute aortic syndrome 
Acute Aortic Syndrome includes dissection, intramural hematoma, and penetrating ulcer. In 
all three conditions, MRI may have a role with similar diagnostic capability or advantages 
over CT. 
4.2.1 Aortic dissection 
Aortic dissection is a life-threatening condition requiring prompt diagnosis and treatment. 
This condition occurs when blood dissects into the media of the aortic wall through an 
intimal tear. Classification of aortic dissections has been based traditionally on anatomic 
location and time from onset. The 14-day period after onset has been designated as the acute 
phase, because morbidity and mortality rates are highest (15%–25%), and surviving patients 
typically stabilize during this period. The Stanford classification distinguishes aortic 
dissection into type A or B, whether the ascending aorta is involved or spared, respectively. 
This classification is based fundamentally on prognostic factors: type A dissection 
necessitates urgent surgical repair, but most type B dissections can be managed 
conservatively. Hence, accurate recognition with imaging of anatomic details of the 
dissection is essential for successful management (Cigarroa, 1993). The diagnostic goals of 
imaging are a clear anatomic delineation of the intimal flap and its extension and the 
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Aortic root dilatation with severe aortic insufficiency (50%) is noted (b) on axial heart three chambers 
view bSSFP images. This sentence belongs to figure 9 legend. 
Fig. 9. ECG gated bSSFP (a, b, c) and 3D contrast-enhanced MR angiography of aortic 
dissection (d, e, f). Sequelae of prior surgical repair of the ascending aorta with stable type A 
aortic dissection with thrombosis of the false lumen (asterisk, a, f) at the level of the arch and 
with a persistent but unchanged dissection flap originating in the aortic arch near to the left 
subclavian takeoff.  The arch vessels arise from the true lumen and the left subclavian artery 
is involved by dissection. The distal arch and thoracic aorta are dilated and retrograde fill of 
the false lumen is depicted on CE-MRA (d, e). The dissection flap extends throughout the 
thoracic and abdominal aorta and into the right common and external iliac arteries. 
c d 
e f 
Diagnosis and Treatment of Abdominal and Thoracic Aortic  
Aneurysms Including the Ascending Aorta and the Aortic Arch 
 
116 
emphasized by using fat suppressed T1-weighted sequences. Also, contrast enhanced MRA, 
using time resolved techniques, allows visualization of the Adamkiewicz artery (Bley, 2010), 
providing information that is important in planning the surgical repair of an aneurysm, thus 
avoiding postoperative neurologic deficit secondary to spinal cord ischemia (Nijenhuis, 
2006; Yoshioka, 2006). 
4.2 Acute aortic syndrome 
Acute Aortic Syndrome includes dissection, intramural hematoma, and penetrating ulcer. In 
all three conditions, MRI may have a role with similar diagnostic capability or advantages 
over CT. 
4.2.1 Aortic dissection 
Aortic dissection is a life-threatening condition requiring prompt diagnosis and treatment. 
This condition occurs when blood dissects into the media of the aortic wall through an 
intimal tear. Classification of aortic dissections has been based traditionally on anatomic 
location and time from onset. The 14-day period after onset has been designated as the acute 
phase, because morbidity and mortality rates are highest (15%–25%), and surviving patients 
typically stabilize during this period. The Stanford classification distinguishes aortic 
dissection into type A or B, whether the ascending aorta is involved or spared, respectively. 
This classification is based fundamentally on prognostic factors: type A dissection 
necessitates urgent surgical repair, but most type B dissections can be managed 
conservatively. Hence, accurate recognition with imaging of anatomic details of the 
dissection is essential for successful management (Cigarroa, 1993). The diagnostic goals of 
imaging are a clear anatomic delineation of the intimal flap and its extension and the 







Magnetic Resonance Imaging of the Thoracic Aorta: A Review of Technical and  





Aortic root dilatation with severe aortic insufficiency (50%) is noted (b) on axial heart three chambers 
view bSSFP images. This sentence belongs to figure 9 legend. 
Fig. 9. ECG gated bSSFP (a, b, c) and 3D contrast-enhanced MR angiography of aortic 
dissection (d, e, f). Sequelae of prior surgical repair of the ascending aorta with stable type A 
aortic dissection with thrombosis of the false lumen (asterisk, a, f) at the level of the arch and 
with a persistent but unchanged dissection flap originating in the aortic arch near to the left 
subclavian takeoff.  The arch vessels arise from the true lumen and the left subclavian artery 
is involved by dissection. The distal arch and thoracic aorta are dilated and retrograde fill of 
the false lumen is depicted on CE-MRA (d, e). The dissection flap extends throughout the 
thoracic and abdominal aorta and into the right common and external iliac arteries. 
c d 
e f 
Diagnosis and Treatment of Abdominal and Thoracic Aortic  
Aneurysms Including the Ascending Aorta and the Aortic Arch 
 
118 
With current technology, MR imaging is the most accurate tool for detection of these 
features of the dissection (Prince, 1993; LaRoy, 1989; Roberts, 2001; Shiga, 2006). 
Occasionally MR can also demonstrate “aortic cobwebs”, which are fibroelastic bands 
formed during the dissection process that project from the false lumen wall (Williams, 1994). 
Detection of these bands facilitates the distinction of the false from the true lumen, as they 
are located in the false lumen. On spin-echo images, flow in the true lumen is usually signal 
void, whereas flow in the false lumen can be signal void or high in signal intensity 
depending upon the velocity of blood flow. Slow flow in the false lumen of a dissection may 
be difficult to differentiate from thrombosis on spin-echo images (Fig5). 
The role of conventional spin-echo imaging is limited because CE MRA/MRI imaging are all 
fast, accurate, and reproducible techniques for the demonstration of dissection. CE-
MRA/MRI techniques reliably differentiate slow flow, which is high in signal intensity on 
these images, from thrombus, which is low to intermediate in signal intensity. Breath - hold 
CE-MRA images provide sharp detail and demonstrate the full extent of dissection, the 
entry site, the location of the intimal flap. The entry site, intimal flap, and branch vessel 
origins are better shown on individual sections than on 3D MIP reconstructions. The serial 
acquisition of two data sets provides dynamic flow information, which often demonstrates 
lack of opacification on early post contrast images followed by delayed enhancement of the 
false lumen, which is apparent in cases with slow flow. TR-MRA can also be used. Its 
temporal resolution allows a confident distinction between the true and false lumen (Fig3).  
4.2.2 Penetrating aortic ulcers and intramural dissecting hematoma 
Penetrating aortic ulcers result from ulcerated atherosclerotic plaques that penetrate the 
internal elastic lamina and may lead to hematoma formation within the media of the aortic 
wall, false aneurysm, and may progress to transmural rupture of the aorta. 
Intramural hematoma (Fig10) usually results from spontaneous rupture of the aortic wall 
vasa vasorum, from a penetrating atherosclerotic ulcer. Extensive atherosclerotic changes 
are usually present in the aorta in the latter condition (Welch, 1990). The diagnostic MR 
imaging findings in penetrating atherosclerotic ulcer is a craterlike outpouching extending 
beyond the contour of the aortic lumen (Yucel, 1990; Hayashi, 2000; Macura, 2003). Mural 
thickening with high or intermediate signal intensity T1-weighted fat suppressed gradient- 
or on spin-echo sequences indicates the formation of intramural hematoma. Intramural 
hematoma most frequently involves the ascending or proximal descending aorta. The 
clinical presentation is similar to dissection: severe chest pain radiating to the back. Because 
of the similarity between the two entities, intramural hematoma is classified in the same 
way as aortic dissection: type A when the ascending aorta is involved and type B when 
involvement is limited to the descending aorta. (Litmanovich, 2009; Nienaber, 1995). The 
importance of intramural hematoma is that it can be a precursor of aortic dissection, 
representing either an early stage or a variant of dissection (Litmanovich, 2009; Nienaber, 
1995; Cho, 2004). Complete resolution of the aortic hematoma is seen occasionally, but 
complications such as fluid extravasation with pericardial, pleural, and periaortic hematoma 
or aortic rupture may occur at the time of the onset or during the follow-up period. 
Progression of intramural hematoma to overt dissection and rupture has been reported in 
32% of the cases, particularly when the ascending aorta is involved (Sakamoto, 2010). 
Intramural hematoma can be identified as crescentic thickening of the aortic wall with 
abnormal signal intensity. Intramural hematoma is high in signal intensity on both T1 - and 
T2-weighted images and can be differentiated from chronic mural thrombus, which is low in  
Magnetic Resonance Imaging of the Thoracic Aorta: A Review of Technical and  









Fig. 10. Double inversion recovery spin echo MR imaging of intramural hematoma (a, b). On 
a T1-weighted spin echo MR image, intramural hematoma of the ascending thoracic aorta 
shows a crescentic local wall thickening with high signal intensity (arrow, a) caused by the 
presence of methemoglobin (subacute stage). Two-chamber view oblique sagittal bSSFP (c) 
shows in the same topography, a crescentic low signal intensity area.  
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With current technology, MR imaging is the most accurate tool for detection of these 
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formed during the dissection process that project from the false lumen wall (Williams, 1994). 
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4.2.2 Penetrating aortic ulcers and intramural dissecting hematoma 
Penetrating aortic ulcers result from ulcerated atherosclerotic plaques that penetrate the 
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signal intensity (Yucel, 1990). The combination of CE-MRA images to define the aortic 
lumen and 3D-GRE images to demonstrate the wall thickness in deep aortic ulcers may be 
the most effective means for evaluating this entity. Fat suppression images can be helpful in 
differentiating high-signal intramural hematoma from surrounding mediastinal fat. T1-
weighted spin echo MR imaging (black blood techniques), can also be used to evaluate the 
aortic wall (Sakamoto, 2010; Litmanovich, 2009).  
5. Future perspectives and challenges 
There is growing concern among clinicians for the necessity of diagnostic, cost effective and 
safe imaging, with ionizing radiation being a major concern in some patients (Picano, 2007). 
At present, the routine use of MR angiography/MRI in the emergency setting for acute 
aortic syndrome is not established, reflecting lesser availability than CT and greater 
problems with motion artifacts compromising some studies. Nevertheless, there are 
increasing indications of MRI, such as young individuals, pregnant patients, and high-risk 
to iodinated contrast agent nephropathy. CE-MRA and 3D-GRE MRI with gadolinium have 
been shown to be a reliable and safe method for imaging the aorta. Motion artifacts remain 
the major cause for study compromise if patients are not able to comply with breathholding. 
Recent developments, such as 3D-GRE with a radial K-space acquisition (Azevedo, 2011), 
have been shown to provide adequate motion resistant imaging in the abdomen. This 
sequence may also provide diagnostic images in the chest, in combination with a blood 
contrast agent such as gadofosveset trisodium, probably allowing motion-resistant steady-
state contrast enhanced MRA of the chest. Other techniques, such as non-contrast enhanced 
real-time SSFP can also provide rapid acquisition, motion resistant images in critically ill 
patients. Newer scanner with greater numbers of channels will also permit higher parallel 
imaging acquisition sequences with considerably shorter acquisition, in general important 
for patients who are critically ill. 
6. Conclusion 
In conclusion, MRI can provide a comprehensive evaluation of the aorta, using different 
and often complementary approaches, with protocols tailored individually to the clinical 
question, including morphological and functional evaluation. It is the authors’ opinion 
that the recent development of MRI hardware and software facilitating faster imaging 
with the growing concern of safety, regarding ionizing radiation will further increase the 
importance of MRI in the study of vascular thoracic pathology, in the emergency 
department setting. 
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1. Introduction  
Extensive pathologies of the aorta are a major challenge in terms of its surgical treatment. In 
principle, complex pathologies of the aorta are divided into type A aortic dissection 
according to the Stanford classification, and aneurysmatic changes involving the aortic arch.  
The first successful operations in the ascending aorta and the aortic arch were described by 
Denton Cooley, Michael DeBakey and Stanley Crawford (DeBakey et al. 1955, Cooley et al. 
1956, Cooley et al. 1955). Several advancements made since this time have led to 
improvements in the surgical treatment of the ascending aorta (Bentall &De Bono 1968, Starr 
et al. 1963, David & Feindel 1992, Yacoub et al. 1998).  
Surgical procedures focused on dissections of the proximal portion of the descending aorta 
and the distal aortic arch have received increasing attention in the last few years and been 
subjected to several modifications. Especially the development of interventional radiological 
endovascular techniques that reduce the invasive nature of surgery as well as complication 
rates led to rapid advancements. 
In the following, a combined surgical and endovascular procedure for the treatment of 
complex aortic diseases will be presented. It is advancement on the methods used thus far. 
The development and performance of the method and results obtained by its application in 
patients at the Department of Cardiovascular Surgery, Hietzing Hospital -Vienna, as well as 
with reference to the European register will be summarised.  
2. Background  
Type A aortic dissection and aneurysms in the ascending aorta involving the aortic arch and 
the descending aorta are diseases that pose a major challenge for the surgeon. The classical 
approach of two-step surgery involves, as the first step, replacement of the ascending aorta 
and the aortic arch through a median sternotomy, which is then concluded after an interval 
of a few weeks by performing the second step. The latter consisted of replacement of the 
descending aorta through a left-lateral thoracotomy and connection with the vascular 
prosthesis inserted at the first session.  
However, this procedure is associated with a high risk of morbidity and mortality; the 
cumulative risk may be as high as 20%. A further important aspect is the waiting period of 
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several weeks between the two surgical steps, which is associated with a mortality risk of 
10% due to rupture. Restrictions for this laborious procedure are the patient's age and 
comorbidities. In fact, up to 30% of the patients do not live long enough to undergo the 
second step of the procedure (Kouchoukos, 2001). The aim of the method presented here is 
to render this complex treatment procedure simpler and safer. 
Based on Borst’s (Borst et al. 1983) description, the first part of the classical approach is 
named the "elephant trunk" operation and was developed further because of the setbacks 
reported after its application. The combination of open surgery and implantation of a stent 
graft opened new perspectives in the treatment of extensive changes in this sensitive portion 
of the aorta (Fleck et al. 2002, Mizuno et al. 2002, Jazayeri et al. 2003, Karck et al. 2005). 
This combination of surgery and a stent-assisted procedure, which is partly performed 
simultaneously, may avoid or simplify further interventions. Besides, the occurrence of type 
I endoleaks can be avoided by this approach. A type I endoleak in cases of implanted 
endoprostheses is defined as a leak at the proximal docking site. 
The results of this modified and combined surgical procedure have been analysed in the 
studies published thus far. In patients who underwent aortic dissection, the behaviour of the 
false lumen during the postoperative observation period was also analysed. 
3. Material and methods  
3.1 Patients 
3.1.1 Primary analysis  
Between August 2005 and December 2006, the first seven patients were treated at the 
Department of Cardiovascular Surgery, Hietzing Hospital Vienna (5 were men and 2 were 
women). Five patients had an aortic dissection; two of these were acute type A dissections 
and two were extensive complex chronic aneurysms of the aorta. The patients' median age 
was 62 years (Gorlitzer et al. 2007).  
Thirty-one patients were treated with this combined method in our department until 
December 2010. After primary analysis all consecutive patients were included into the 
international E-vita Open Register. 
3.1.2 E-vita open register 
One hundred and twenty-eight patients were included in the international E-vita Open 
Register (IEOR) between January 2005 and March 2009. Five European centres (Hietzing 
Hospital Vienna, Western Germany Heart Centre Essen, University of Bologna, Na Homolce 
Hospital in Prague, and the University of Barcelona) participated in this multicentre trial 
(Tsagakis et al.  2011). Fifty-five of them had been operated on for an acute type A 
dissection, 51 for a chronic dissection, and 22 because of extensive aneurysms. Of these, nine 
patients had a Marfan syndrome (Tsagakis et al. 2010).  
3.1.3 Follow-up: transformation of the false lumen 
Our own series of patients were evaluated between August 2005 and February 2009 as 
regards transformation of the false lumen after treatment of aortic dissection. The mean 
observation period was 43 months. A control CT-angiography was performed immediately 
post-surgery, after 3, 6, and 12 months, and thereafter at yearly intervals. In all, 14 type A 
dissections were followed. The combined surgical and interventional procedure had been 
used in all 14 patients (Gorlitzer et al., 2010).  
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Ninety-three patients were followed in the course of the IEOR investigation: 49 after acute 
dissection and 44 after chronic dissection (Tsagakis et al., 2010).  
3.2 Hybrid stent graft 
Replacement of the ascending aorta, the aortic arch, and the proximal portion of the 
descending aorta can be performed by the use of the E-vita open prosthesis in a single-stage 
operation. This recently developed prosthesis consists of a 70-mm-long woven "classical" 
Dacron portion which is directly connected to a polytetrafluoroethylene-covered stent 
prosthesis via Z-shaped nitinol rings. (Figure 1) The rings are not connected to each other. 
Thus, two things are ensured: optimal flexibility of the stent graft, and ideal adaptation to 
the course of the proximal descending aorta (Gorlitzer et al., 2007). Self-expandable stents 
measuring 13 cm in length and 32mm, 34 mm or 36 mm in diameter were used. A spiral CT 
angiography of the thoracic aorta was performed preoperatively to assess the extent of the 




Fig. 1. E vita open graft 
3.3 Surgical technique 
For cerebral protection and extracorporeal circulation we use a classical heart-lung machine 
with alternative arterial cannulation via the axillary artery, moderate hypothermic 
circulatory arrest, and selective antegrade bilateral cerebral perfusion. The arterial cannula is 
introduced via a short 8-mm Dacron prosthesis, which is anastomosed to the right axillary 
artery. This permits the surgeon to subsequently perform a safe sternotomy on the one 
hand, and a means of achieving antegrade cerebral perfusion during circulatory arrest on 
the other (Strauch et al. 2005, Shimazaki et al. 2004, Numata et al. 2003, Okita et al. 
2001).(Figure 2) 
After median sternotomy, a venous two-step cannula is placed in the right atrium and the 
patient is cooled to 25°C at the heart-lung machine in order to achieve moderate 
hypothermia (Minatoya et al. 2008, Pacini et al. 2007). In contrast to deep hypothermia, 
moderate cooling offers the advantages of a lower risk of haemorrhage, shorter operating 
times, and a lower likelihood of inflammatory signs secondary to haemostasis (Kamiya et al. 
2007). 
During the cooling phase, the left ventricle has to be vented via the right upper pulmonary 
vein or the apex of the heart. Once the core temperature of 25° C has been achieved, the 
ascending aorta and the concave portion of the aortic arch are resected in a state of 
circulatory arrest. Selective antegrade cerebral perfusion with 10 ml/kg/min cold blood is 
achieved via a catheter in the left carotid artery and the cannula in the right axillary artery 
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after clamping the brachiocephalic artery (Mazzola et al. 2002). Oxygen saturation is 
measured by infrared spectroscopy during cerebral perfusion (Harrer et al. 2010). 
 
 
Fig. 2. Arterial cannulation of axillary artery 
In cases of aortic dissection, the true lumen is identified by insertion of a stiff transfemoral 
guidewire which can be placed prior to commencement of the operation. 
The E-vita open stent graft is introduced into the descending aorta via the open aortic arch, 
and is then adapted. The point of orientation for placement of the stent is the site of origin of 
the subclavian artery. (Figure 3) 
 
 
Fig. 3. Insertion if combined stentgraft 
The proximal part of the stent lies one centimetre distal to this point of origin. To avoid 
potential endoleaks - as initial experience in the use of this procedure showed - the 
integrated Dacron prosthesis is pulled out slightly and fixed to the proximal descending 
aorta by the use of sutures supported with Teflon strips. (Figure 4) 
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Fig. 4. Replacement the ascending aorta and hemiarch with a separate prosthesis   
Two methods were used for replacement of the aortic arch: complete aortic arch 
replacement with reinsertion of the supra-aortic branches (Di Eusanio et al. 2004), or 
reconstruction of the aortic arch with preservation of the convex portion by way of "light 
arch replacement" (Gorlitzer et al. 2007). When using the latter approach, the supra-aortic 
branches are not isolated and need not be reimplanted individually. (Figure 5) 
 
 
a b  
Fig. 5. Replacement of the aortic arch with preservation of its convexity 
The ascending aorta and the concave portion of the aortic arch are replaced with an 
additional coated Dacron prosthesis, and anastomosed to the reconstructed descending 
aorta. Additionally - if necessary - this access may be used to replace the aortic valve or 
create aortocoronary bypasses. 
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4. Results  
4.1 Results of hospital hietzing 
In our own series, implantations of the antegrade stent in the descending aorta as well as 
replacement of the ascending aorta and the aortic arch were successfully achieved in all 
patients. All patients survived the intervention. The duration of time on the heart-lung 
machine (HLM) was 197±29.9 minutes, that of hypothermic circulatory arrest 60±15.5 
minutes, and aortic clamping 88±33.2 minutes. Implantation of the stent in the descending 
aorta took 10 minutes (range, 8 to 12 minutes). The duration of stay at the intensive care unit 
was 6.8 days (range, 2 to 21 days) while the overall hospital stay had a duration of 20 days 
(range, 8 to 35 days).  
One patient had a transient neurological deficit postoperatively. Another patient had to be 
drained on the 11th postoperative day because of a pericardial effusion. 
In one patient with a Marfan syndrome, thoraco-abdominal replacement of the aorta had to 
be performed five months later. At this operation, a direct proximal anastomosis to the stent 
graft could be performed. In a further patient, the stent had to be lengthened into the distal 
descending aorta. These operations involved no complications and did not require 
circulatory arrest (Gorlitzer et al. 2007). 
4.2 Results of international E-vita open registry 
In the course of the investigation of the International E-vita Open Registry (IEOR), 106 
patients with acute (n=55) and chronic (n=51) aortic dissection were evaluated (see Table 1). 
The duration of time on the HLM, aortic clamping and hypothermic circulatory arrest were 
242±64, 144±44 and 75±23 minutes, respectively. 
 
Clinical status preoperatively of Aortic dissections 






Emergency < 24h 49 (46) 47 (86) 2 (4) 
Inotropics preoperatively 23 (22) 21 (38) 2 (4) 
Cardiac tamponade 13 (12) 13 (24) 0 
Intubated prior to 
admission 14 (13) 12 (22) 2 (4) 
Malperfusion    
  Cardiac 9 (9) 9 (16) 0 
  Cerebral 13 (12) 13 (24) 0 
  Spinal cord 4 (4) 4 (7) 0 
  Visceral 7 (7) 7 (13) 0 
  Renal 9 (9) 8 (15) 1 (2) 
  Peripheral 9 (9) 8 (15) 1 (2) 
Aortic valve regurgitation 57 (54) 37 (67) 20 (39) 
AD= Aortic dissection; IEOR= International E-vita Open Registry  
Table 1. Clinical status of patients of the International E-vita Open Register 
The techniques of reconstruction of the aortic arch and associated procedures, such as 
replacement of the aortic valve and the mitral valve or aortocoronary bypass, are 
summarised in Table 2. Stent implantation was successful in 99% of cases. In one case the 
distal end of the stent was in the false lumen. 
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Cannulation site (n)    
  Axillary artery 70 (66) 34 (62) 36 (71) 
  Proximal aorta 22 (21) 17 (31) 5 (10) 
  Femoral artery 1 (1) 1 (2) 0 
  Previous prosthesis 11 (10) 1 (2) 10 (20) 
  Others 2 (2) 2 (4) 0 
Intraoperative values (min)    
  CPB-time 242±64 239±59 246±70 
  Cross-clamp Time 144±44 139±40 150±47 
  SACP time 75±23 67±19 83±24 
  HCA-time 8±6 9±7 7±6 
Antegrade stent grafting (n)    
  Stent-graft size (mm) 29±5 28±4 30±5 
  Oversizing > 10% 17 (16) 10 (18) 7 (14) 
  Use of guidewire 71 (67) 30 (55) 41 (80) 
Arch replacement    
  Total 95 (90) 48 (87) 47 (92) 
  Subtotal 11 (10) 7 (13) 4 (8) 
Supra-aortic vessels (n)    
  Island 67 (63) 42 (76) 25 (49) 
  Separate 39 (37) 13 (24) 26 (51) 
Ascending aorta replacement   
  E-vita open prosthesis 9 (9) 3 (5) 6 (12) 
  Other prosthesis 82 (77) 51 (93) 31 (61) 
Aortic valve intervention    
  Bentall 14 (13) 6 (11) 8 (16) 
  Isolated valve replacement 10 (9) 3 (5) 7 (14) 
  Resuspension 20 (19) 20 (36) 0 
  Repair 5 (5) 5 (9) 0 
Mitral valve repair 2 (2) 0 2 (4) 
CABG 17 (16) 12 (22) 5 (10) 
AD= Aortic dissection; IEOR= International E-vita Open Registry; CPB= cardiopulmonary 
bypass;  
SACP= selective antegrade cerebral perfusion; CABG= coronary artery bypass grafting 
Table 2. Intraoperative variables of the International E-vita Open Register 
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distal end of the stent was in the false lumen. 
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Intraoperative variables (mean±SD; no (%)  
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  Repair 5 (5) 5 (9) 0 
Mitral valve repair 2 (2) 0 2 (4) 
CABG 17 (16) 12 (22) 5 (10) 
AD= Aortic dissection; IEOR= International E-vita Open Registry; CPB= cardiopulmonary 
bypass;  
SACP= selective antegrade cerebral perfusion; CABG= coronary artery bypass grafting 
Table 2. Intraoperative variables of the International E-vita Open Register 
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The median duration of stay at the intensive care unit was 6 days while that of the entire 
hospital stay was 21 days. 
Mortality rates were 11% /6/55) for acute dissection and 14% (7/51) for chronic dissection; 
p=0.77. Of these, one patient died due to rupture of the abdominal aorta. Other causes of 
death were heart failure (n=3), visceral malperfusion (n=2), haemorrhage (n=2), sepsis (n=2), 
cerebrovascular accident (n=1) and lung failure (n=2). The incidence of postoperative 
cerebrovascular accident was 5%. Damage to the spinal cord occurred in three patients (3%). 
Of these, one had paraplegia and two had paraparesis (see Table 3).  
 




(n=55) Chronic AD (n=51) p-value 
In-hospital mortality 13 (12) 6 (11) 7 (14) 0.77 
Intubation time 72 h 36 (34) 22 (40) 14 (28) 0.21 
Re-exploration 20 (19) 11 (20) 9 (18) 0.80 
LOS 9 (9) 6 (11) 2 (6) 0.49 
Visceral ischemia 4 (4) 3 (5) 1 (2) 0.61 
Stroke 5 (5) 4 (7) 1 (2) 0.36 
Spinal cord injury 3 (3) 0 3 (6) 0.10 
AD= Aortic dissection; LOS= low 
output syndrome    
Table 3. Postoperative results of the Evita open Registry 
Eleven patients (10%) had to undergo a second intervention in the aorta during their 
hospital stay: 10 stent elongations (acute dissection 4/55, 7% vs. chronic dissection 6/51, 
12%; p= 0.52). Open replacement of the descending aorta was performed in one patient. 
Ten patients (11%) died in the observation period of 20±11 months. As regards overall 
survival after 36 months, no significant difference was registered between acute and chronic 
dissections (79% vs. 87%; p=0.69) (Figure 6). 
 
 
Fig. 6. Survival rates after the hybrid operation (left: all patients; right: after acute and 
chronic aortic dissection) 
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An additional intervention in the aorta could be avoided in 91% of patients after 12 months, 
and in 87% after 36 months (Figure 7) (Tsagakis et al. 2011). 
 
 
Fig. 7. Avoidance of additional surgery in the aorta (left: all patients; right: after acute and 
chronic aortic dissection) 
 
 
Fig. 8. The points measured in the aorta: A= Point of origin of the left subclavian artery, B= 
Pulmonary arteries, C= End of the stent, D= Diaphragm 
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4.3 Fate of the false lumen 
In our own series of patients, the false lumen thrombosed completely at the level of the stent 
graft within two weeks in 86% of patients, while complete thrombosis at the level of the 
stent graft was observed after three months in all patients. The diameter of the aorta was 
measured at four points: the point of origin of the left subclavian artery, the level of the 








Fig. 9. CT scans preoperatively (a), 10 days (b) and 6 months postoperatively (c) (false lumen 
marked with arrow) 
Combined Surgical and Endovascular Approach for  
the Treatment of Complex Thoracic Aortic Pathologies 
 
137 
A significant reduction in the overall diameter of the aorta was observed at the level of the 
subclavian artery (3.9±0.45 cm vs. 3.6±0.39 cm; p=0.011), and a significant reduction in the 
diameter of the false lumen was noted in all portions of the stent graft. 
No significant changes were observed in the untreated part of the aorta at the diaphragm 
(Gorlitzer et al 2010).  
These observations concur with those of the IEOR, according to which 93% of patients 
developed a complete thrombosis in the region of the stent (Tsagakis et al. 2011). (Figure 9). 
5. Conclusion 
The treatment of complex aortic diseases by the use of the combined surgical and 
endovascular procedure is of a single-step operation which can be performed safely and is 
associated with a low rate of complications. Preservation of the convexity of the aortic arch 
(so-called light arch replacement) permits shorter, more visible suture line and reduces the 
duration of circulatory arrest. 
Thrombosis of the false lumen in the region of the stent graft causes re-structuring of the 
descending aorta in its proximal portion. Our results are confirmed by those of the 
multicenter trial of the International E-vita Open Register. 
Subsequent operations can be avoided or markedly reduced by this method without 
increasing the risk for the patient. 
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1. Introduction 
The thoracic aorta begins at the lower border of the fourth thoracic vertebra, descends from 
the aortic arch, and ends at the level of the lower border of the twelfth thoracic vertebra. 
After passing through the aortic hiatus, it becomes the abdominal aorta. 
The volume and pressure of blood through the thoracic aorta are greater than those of all 
other vascular structures. Consequently, diseases and complications of the thoracic aorta are 
extremely problematic. Emergencies such as aortic dissection, trauma, ruptured thoracic 
aortic aneurysms, penetrating aortic ulcers, thoracic aortic tears, aortobronchial fistulas, and 
any other condition where the integrity of the thoracic aorta is disrupted can have fatal 
consequences.  
One of the most difficult emergencies of the thoracic aorta is acute aortic syndrome,  
which encompasses classic aortic dissection, intramural hematoma, and penetrating aortic 
ulcers.  
Emergency open repair of lesions in the thoracic aorta is associated with very high surgical 
risk. Even with the use of cardiopulmonary bypass, profound hypothermia, circulatory 
arrest, spinal cord protection, and intensive care unit support, operative mortality rates for 
open repair have been reported to range from 8% to 20% for elective cases and from 60% to 
70% following aortic rupture or aortic emergencies (Saratzis et al., 2008; Cowley et al.; 1990). 
Some series report mortality rates to be as high as 40-50% for open surgical repair of the 
thoracic aorta in emergency situations (Kaya et al., 2009; Schermerhorn et al., 2008). 
Other postoperative complications, such as cardiac conditions, paraplegia, pulmonary 
conditions, or renal failure are observed in 12% to 45% of patients undergoing open surgical 
repair (Kaya et al., 2009; Schermerhorn et al., 2008; Achneck et al., 2007; Bozinovski & 
Coselli, 2008; Rousseau et al., 2005; Buz et al., 2008; Demetriades et al., 2008). 
Endovascular repair, on the other hand, is associated with lower morbidity and mortality 
(Schermerhorn et al., 2008). Moreover, patients considered unsuitable for surgery because of 
severe comorbid conditions may benefit from this less invasive technique.  
In this chapter, we present our experience with endovascular approaches to a series of 
thoracic aortic emergencies: aortic dissection, ruptured thoracic aneurysms, aortobronchial 
fistula, aortoesophageal fistula, subclavian symptomatic pseudoaneurysm, and blunt aortic 
disruption. We also review previous publications on this important vascular pathology. 
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2. Clinical cases 
2.1 Material and methods  
We present our experience with thoracic aortic emergencies. From May 2003 to September 
2010, more than 200 patients were evaluated in our hospital for various emergencies 
affecting the entire aorta. Many patients required laparotomy or thoracotomy due to 
hemodynamic instability.  
From January 2000 to September 2010, we treated 80 patients using endovascular stent 
grafting, both in elective and in emergency repair. Endovascular procedures were 
performed in 25 patients for emergency lesions between May 2003 and September 2010. 
In this section, we describe the cases, procedures, and outcome.  
At our institution, we divide aortic emergencies into 5 groups:  
 Acute aortic syndrome: aortic dissection (5), penetrating aortic ulcer (2), intramural 
hematoma (2)  
 Ruptured thoracic aneurysm (5) 
 Symptomatic thoracic aortic pseudoaneurysm (3) 
 Traumatic (blunt) aortic disruption (4)  
 Aortobronchial fistula (1), aortoesophageal fistula (2) 
 Subclavian symptomatic pseudoaneurysm (1) 
The indications for treatment were aortic rupture in 5 patients (20%), persistent or recurrent 
pain in 8 patients (32%), hypotension or shock in 9 patients (36%), hemoptysis in 2 patients 
(8%), and acute renal failure in 1 patient (4%).  
Baseline characteristics and cardiovascular risk factors of our patients are given in Table 1. 
 
Age, years 60 (range, 26-80) 
Gender (male: female) 21:4 (84%: 16%) 
Hypertension 20 (80%) 
Diabetes mellitus 7 (28%) 
Dyslipidemia 9 (36%) 
Smoking  16 (64%) 
Coronary artery disease 4 (16%) 
Previous cardiac surgery/coronary 
intervention  
5 (20%) 
Renal insufficiency 3 (12%) 
Chronic obstructive pulmonary disease 5 (21%) 
Aortic disease  
- Aortic dissection  5 
- Penetrating aortic ulcer 2 
- Intramural hematoma 2 
- Ruptured thoracic aneurysm 5 
- Symptomatic thoracic aortic pseudoaneurysm 3 
- Traumatic (blunt) aortic disruption 4 
- Aortobronchial fistula  1 
- Aortoesophageal fistula 2 
- Subclavian symptomatic pseudoaneurysm 1 
 n=25 
Table 1. Patient characteristics and comorbidities 
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Five patients (20%) had already undergone aortic surgery and five (20%) had undergone 
cardiac surgery. Two patients had undergone open repair of the abdominal aorta for 
abdominal aortic aneurysm. 
The mean diameter of the thoracic aorta in patients with ruptured thoracic aortic aneurysms 
was 79 ± 18 mm (range, 70-92 mm). Mean diameter including all patients with thoracic 
aortic aneurysms and pseudoaneurysms (11 patients) was 77 mm (range, 40-110 mm). 
The median interval between onset of symptoms and the endovascular procedure was 0.7 
days (range, 0- 6). 
We used four commercially available thoracic stent-graft prostheses: Talent® (n=12, 48%), 
Valiant®, (Medtronic Vascular, Santa Rosa, California, USA) (n=6, 24%), Relay® (Bolton 
Medical, Florida, USA) (n=6, 24%), and AneuRx® (Medtronic AVE, Cupertino, California, 
USA) (n=1, 4%).  
Each endoprosthesis consisted of a self-expanding nitinol stent, covered externally by a 
Dacron graft. The type of stent graft was selected depending on availability and surgeon 
preference. 
Data were collected on case report forms and checked for inconsistencies by two of the 
authors (R.L, P. JL). 
2.2 Preprocedural diagnosis  
Sizing of the endoprosthesis was based on centerline diameter measurements from contrast 
enhanced computed tomography (CT) angiography and three-dimensional image 
reconstructions; 10-20% oversizing was applied when selecting the stent graft diameter. 
Trans-esophageal echocardiography was used in all cases of acute aortic syndrome 
(Stanford type B acute aortic dissection, intramural hematoma, penetrating aortic ulcer) and 
in the patient with an aortobronchial fistula. 
Intravascular ultrasound was used in 3 of the patients with aortic dissection and for 
deployment of the stent graft in the patient with aortobronchial fistula.  
2.3 Procedures 
All surgical procedures were performed under general anesthesia in an operating room with 
angiographic and fluoroscopic equipment. Each patient received a single dose of antibiotic 
therapy (cefazolin) and 5000 units of heparin (except in ruptured aneurysms or head 
injuries). Cerebrospinal fluid (CSF) was drained in 8 hemodynamically stable patients (n=8). 
CSF pressure was monitored and maintained at 10 mmHg. CSF drainage was continued for 
48 hours after surgery unless complications occurred. Hypotension was induced before 
device deployment when patients were stable.  
Intravascular access was by transfemoral insertion in one groin. An ultrastiff 0.035-inch 
Amplatz SuperStiff™ guidewire (Boston Scientific, Miami, Florida, USA) or Lunderquist 
ExtraStiff wire (Cook, Inc., Bloomington, Illinois, USA) was directed into the ascending aorta 
via a transverse arteriotomy. Using a percutaneous contralateral approach, a soft Terumo 
guidewire (Terumo Medical, Somerset, New Jersey, USA) and 6-F pigtail catheter (Cordis, 
Johnson and Johnson, Warren, New Jersey, USA) were directed into the ascending aorta. 
Intraoperative angiogram was then performed in a left anterior oblique view at 40º-60º. The 
stent graft delivery system was inserted through the access artery. After marking the left 
subclavian artery, the endoprosthesis was delivered and deployed. During deployment, 
systolic blood pressure was usually maintained below 80 mmHg.  
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A prosthetic conduit was used from the common iliac artery (2 cases) when the diameter of 
the femoral or iliac vessels was very small (under 7 mm) or the vessels were very calcified or 
tortuous.  
Completion angiography was performed at the end of the procedure to assess accurate 
placement of the endoprosthesis and exclusion of pathology.  
Table 2 shows the diagnosis, patient´s age and endovascular procedure details. 
 
CASES DIAGNOSIS AGE (years) PROCEDURE 
1 DISSECTION 67 Thoracic endoprosthesis 
2 DISSECTION 39 Thoracic endoprosthesis 
3 DISSECTION 65 Thoracic endoprosthesis 
4 DISSECTION 74 Thoracic endoprosthesis 
5 DISSECTION 33 Thoracic endoprosthesis 
6 PENETRATING AORTIC 
ULCER  61 Thoracic endoprosthesis 
7 PENETRATING AORTIC 
ULCER 66 Thoracic endoprosthesis 
8 INTRAMURAL 
HEMATOMA 64 Thoracic endoprosthesis 
9 INTRAMURAL 
HEMATOMA 69 Thoracic endoprosthesis 
10 RUPTURED TAA 80 Thoracic endoprosthesis 
11 RUPTURED TAA 56 Thoracic endoprosthesis 
12 RUPTURED TAA 69 Thoracic endoprosthesis 
13 RUPTURED TAA  72 Thoracic endoprosthesis 
14 RUPTURED TAA 76 Thoracic endoprosthesis 
15 PSEUDOANEURYSM 74 Thoracic endoprosthesis 
16 PSEUDOANEURYSM 44 Thoracic endoprosthesis 
17 PSEUDOANEURYSM 46 Thoracic endoprosthesis 
18 TRAUMATIC AORTIC 
DISRUPTION 64 Thoracic endoprosthesis 
19 TRAUMATIC AORTIC 
DISRUPTION 55 Thoracic endoprosthesis 
20 TRAUMATIC AORTIC 
DISRUPTION 30 Thoracic endoprosthesis 
21 TRAUMATIC AORTIC 
DISRUPTION 26 Thoracic endoprosthesis 
22 AORTOBRONHCIAL 
FISTULA  55 Thoracic endoprosthesis 
23 AORTOESOPHAGEAL 
FISTULA 74 Thoracic endoprosthesis 
24 AORTOESOPHAGEAL 
FISTULA 68 Thoracic endoprosthesis 
25 SUBCLAVIAN 
PSEUDOANEURYSM 65 
Thoracic endoprosthesis and 
Amplatzer plug 
Table 2. Diagnosis, age and endovascular procedure details. 
 




2.4.1 Cases 1-9. Acute aortic syndrome (9) 
Five patients were treated during this period for symptomatic type B aortic dissection, 2 for 
symptomatic penetrating aortic ulcer and 2 for intramural hematoma. Median age was 60 
years (range, 33- 74 years). 
Seven patients were treated for persistent pain. One patient was treated for uncontrolled 
hypertension. One patient was treated for onset of acute renal failure (due to the dissection) 
and persistent pain. 
One patient was a 33-year-old male with Marfan syndrome who was treated for a 
symptomatic huge growth of a distal thoracic aorta dissection (10 cm in diameter) with a 
postdissection thoracoabdominal aneurysm (Figure 1). He presented at the emergency 
department with interscapular pain. The patient underwent a hybrid surgical procedure in a 
2-stage intervention involving placement of a thoracic endoprosthesis (34 x 34 x 200 mm 
Valiant-Medtronic®) followed 2 days later by open repair of his visceral aorta using an 
aorto-aortic bypass Dacron graft with reimplantation of the 4 visceral vessels. He was 
discharged 32 days after the second procedure.  
Another patient was a 60-year-old male who presented with acute-onset intense thoracic 
interscapular pain and hypertension. CT scan revealed an intramural hematoma 
complicated with penetrating aortic ulcers (Figure 2). A 46 x 42 x 110-mm Talent® stent-graft 
was deployed. Four days later, CT scan revealed a type I proximal endoleak. A proximal 
stent graft (46 x 46 x 130-mm Talent) was successfully delivered and deployed. The patient 




Fig. 1. Case 5. Left: Chest computed tomography scan showing sac growth (11 cm in 
diameter) in the descending thoracic aorta. Right: Dissection of the distal thoracic aorta and 
visceral aorta, with a huge thoracic postdissection sac.  
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Fig. 2. Case 6. Left: Computed tomography scan revealing a 20 x 10-mm penetrating aortic 
ulcer with an intramural hematoma. Right: Aortography showing 3 penetrating ulcers in the 
descending thoracic aorta.  
2.4.2 Cases 10-17. Ruptured thoracic aneurysms and symptomatic pseudoaneurysms 
(8) 
Five patients were treated during this period for ruptured thoracic aneurysms and 3 patients 
for symptomatic thoracic pseudoaneurysms. Median age (all 8 patients) was 65 years (range, 
44-80 years). Mean thoracic aorta diameter in patients with ruptured thoracic aortic 
aneurysms was 79 mm (range, 70- 92 mm) (Figure 3). On admission, 7 patients were 
hemodynamically unstable. One patient presented with hemoptysis.  
As an unusual presentation, we describe the case of a 46-year-old HIV-infected woman 
(stage B2) coinfected with hepatitis C virus and tuberculosis. She presented with persistent 
hemoptysis (ongoing for 3 days), interscapular pain, and fever. CT scan revealed a 40-mm 
upper thoracic pseudoaneurysm in close contact with the left bronchus (Figure 4). The 
patient became hemodynamically unstable and went into cardiopulmonary arrest. After 
cardiopulmonary resuscitation and stabilization in the intensive care unit, she underwent 
successful exclusion of the lesion with a 26 x 26 x 155-mm Relay® endoprosthesis placed 
distal to the origin of the left common carotid artery and covering the ostium of the left 
subclavian artery. The postoperative period was uneventful and she was discharged 11 days 
after surgery. 
Follow up was scheduled at 1, 3, 6, and 12 months. Her latest CT scan (36 months) showed 
patency of the endoprosthesis with no endoleaks. Her latest physical examination revealed 
no vascular abnormalities.  
Mortality in this group was very high (3 of 8 patients). Three of the 5 patients who died 
during their stay were in this group. 
 




Fig. 3. Case 16. Chest computed tomography scan showing a ruptured (contained) 




Fig. 4. Case 17. Left: Chest computed tomography scan showing a mycotic pseudoaneurysm 
(arrow) in the descending thoracic aorta. Right: Computed tomography scan demonstrating 
correct position of the stent graft.  
2.4.3 Cases 18-21. Traumatic (blunt) aortic disruption (4)  
In this group, all the patients were young (median age, 40 years [range, 26-58 years]) and 
were treated for hypotension or shock.  
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Fig. 3. Case 16. Chest computed tomography scan showing a ruptured (contained) 




Fig. 4. Case 17. Left: Chest computed tomography scan showing a mycotic pseudoaneurysm 
(arrow) in the descending thoracic aorta. Right: Computed tomography scan demonstrating 
correct position of the stent graft.  
2.4.3 Cases 18-21. Traumatic (blunt) aortic disruption (4)  
In this group, all the patients were young (median age, 40 years [range, 26-58 years]) and 
were treated for hypotension or shock.  
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In all cases, the lesion was located at the aortic isthmus. 
A 26-year-old woman was admitted after a fall from 15 meters. CT scan revealed a blunt 
aortic disruption at the level of the proximal thoracic aorta (aortic isthmus), slightly distal to 
the left subclavian artery. The patient was unstable and therefore immediately transferred to 
the operating room. She underwent successful endovascular stent grafting (22 x 22 x 150 
mm Relay® endoprosthesis) of the ruptured thoracic aorta. The patient had multiple 
fractures, as well as hemothorax and liver contusion. She was discharged 54 days after 
surgery.  
2.4.4 Cases 22-24: Aortobronchial fistula (1) and aortoesophageal fistula (2) 
The patient with the aortobronchial fistula presented with massive (>400 cc) hemoptysis and 
hypotension. The other 2 patients were evaluated for hematemesis, malaise, and sudden 
hypotension.  
A 55-year-old male was referred to our hospital for evaluation of massive hemoptysis. CT 
with intravenous contrast revealed a ruptured para-anastomotic pseudo-aneurysm in the 
descending thoracic aorta. Intra-operative angiography confirmed the presence of an 
aortobronchial fistula at the site of the pseudo-aneurysm (Figure 5).  
 
 
Fig. 5. Case 22. A, Aortography showing an aortobronchial fistula (arrow) at the site of a 
thoracic pseudoaneurysm. B, Computed tomography scan showing accurate placement of 
endoprosthesis with successful exclusion of the aortobronchial fistula (B).  
A 74-year-old man was referred to our hospital for evaluation of massive hematemesis and 
hypotension. Preoperative assessment was with blood samples and chest X-ray. A CT scan 
revealed a descending thoracic aneurysm measuring 100 mm in diameter. This aneurysm 
was displacing the esophagus (Figures 6 and 7). In the emergency department, the patient 
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became hemodynamically unstable and was transferred to the operating room. He 
underwent successful endovascular stent grafting (36 x 36 x 200 and 36 x 36 x 145-mm 
Relay® endoprostheses). The patient died of a massive myocardial infarction on the third 
day after surgery.  
 
 
Fig. 6. Case 23. A, Chest computed tomography scan showing complete contact between a 
thoracic aortic aneurysm (10 cm in diameter) and the esophagus (arrow), causing an 
aortoesophageal fistula. B, Computed tomography scan showing accurate placement of 
endoprosthesis (postoperative day 2), with successful exclusion of the aortoesophageal 
fistula and aneurysm.   
 
 
Fig. 7. Case 23. Upper: Chest computed tomography scan (transverse view) showing the 
thoracic aortic aneurysm measuring 10 cm in diameter. Lower: Computed tomography scan 
in a coronal view.  
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2.4.5 Case 25: Subclavian symptomatic pseudoaneurysm (1) 
A 70-year-old Chinese man with a significant history of hypertension and smoking was 
referred to our hospital for evaluation of intermittent hemoptysis. On admission, he presented 
hemoptysis (>300 cc) and dyspnea. CT scan revealed a pseudoaneurysm measuring 30 mm x 
20 mm at the origin of the left subclavian artery and in contact with the left pulmonary apex 
(Figure 8). The patient experienced 2 new episodes of massive hemoptysis with progressive 
anemia and was transferred immediately to the operating room. A Relay® covered self-
expandable thoracic endoprosthesis (36 mm x 36 mm x 145-mm) was successfully placed distal 
to the origin of the left common carotid artery and covering the left subclavian artery. A 16-
mm Amplatzer® vascular plug (AGA Medical Corporation, Plymouth, Minnesota, USA) was 
inserted through the left brachial artery to occlude the left subclavian artery without covering 
the left vertebral artery. Serology and culture studies were negative. 
The patient was discharged 13 days after the endovascular procedure. Follow-up was 
scheduled at 1, 6, and 12 months, and yearly thereafter. His latest examination revealed the 
recovery of left brachial and distal pulses.  
 
 
Fig. 8. Case 25. Left: Computed tomography scan revealing a pseudoaneurysm measuring 
30 mm x 20 mm (arrow) at the origin of the left subclavian artery. Right: Computed 
tomography scan revealing accurate placement of endoprosthesis and 16-mm Amplatzer 
plug, with successful exclusion of the pseudoaneurysm (right).  
3. Results  
A total of 41 endografts were implanted. Median diameter and length were 36 mm (range, 
22-46 mm) and 135 mm (range, 100-200 mm), respectively. The characteristics of the 
endografts and types of lesion are described in Table 3.  
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Lesions were excluded by 1 stent graft in 15 patients (60%, table 2), by 2 stent grafts in 4 
patients (16%), and 3 stent grafts in 6 patients (24%). 
The stent grafts were all deployed at the intended position, which was predominantly in the 
distal aortic arch or proximal descending aorta, necessitating complete coverage of the 
ostium of the left subclavian artery in 6 of 25 patients (24%). 
 
 





      
1 TALENT 36 x 36 200 1 Yes 
2 VALIANT 34 x 34 150 1 Yes 
3 TALENT 36 and 34 112 and 115 2 No 
4 TALENT 34, 38, and 42 115, 114, 113 3 No 
5 VALIANT 30, 32, and 34 200, 150, 120 3 Yes 
6 TALENT 46 x 42 110 1 No 
7 TALENT 34 x 34 100 1 No 
8 TALENT 46 and 42 113 2 No 
9 TALENT 36, 38, and 38 115, 115, 115 3 Yes 
10 VALIANT 38, 38, and 38 150, 100, 100 3 No 
11 VALIANT 36 and 32 150 and 150 2 No 
12 RELAY 38, 36, and 32 200, 130, 130 3 No 
13 RELAY 34 x 34 200 1 No 
14 VALIANT 38 x 38 200 1 No 
15 TALENT 34 x 34 130 1 No 
16 VALIANT 42, 44, and 46 150, 100, 100 3 No 
17 RELAY 26 x 26 155 1 Yes 
18 ANEURX 40 x 40 120 1 No 
19 TALENT 28 x 24 113 1 No 
20 RELAY 22 x 22 150 1 No 
21 TALENT 24 x 24 113 1 No 
22 TALENT 30 x 30 130 1 No 
23 RELAY 36 and 36 200 and 145 2 No 
24 TALENT 34 x 34 150 1 No 
25 RELAY 36 x 36 145 1 Yes 
      
Table 3. Stent graft and endovascular procedure 
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LSA: Left subclavian artery.  
Technical success, defined as correct stent placement and accurate coverage of the affected 
site, was achieved in all 25 patients (100%). 
One patient required a proximal extension for a proximal type I endoleak 4 days after the 
procedure. One patient with a traumatic (blunt) aortic disruption required a proximal 
extension 20 days after the endovascular procedure for a proximal type I endoleak.  
Intraoperative mortality was 4% (1 patient who was in severe shock before surgery and died 
during stent graft implantation from a ruptured thoracic aneurysm).  
There was no conversion to open thoracotomy and no incidence of paraplegia after surgery. 
Median length of hospital stay was 18 days (range, 6-60 days). 
3.1 Mortality 
Overall hospital and 30-day mortality was 20% (n = 5). One patient (4%) died during 
surgery.  
Two patients died during their hospital stay due to multiorgan failure (after 17 and 80 days, 
respectively). One patient died of cardiorespiratory failure (postoperative day 15). One 
patient (treated for an aortoesophageal fistula) died on the third day after surgery of a 
massive myocardial infarction.  
3.2 Follow-up 
Follow-up was scheduled at 1, 6, and 12 months and yearly thereafter. Patients with 
endoleaks (type II) were followed closely at 3 to 6 months. Mean follow-up was 51 months 
(range, 4-96 months). Nineteen patients were followed up, 1 was lost to follow-up, and 5 
died in hospital.  
Two patients (8%) died after discharge from hospital. 
One patient died of a cerebral hemorrhage after 8 months, the other died of an 
aortoesophageal fistula 4 months after discharge.  
Overall survival at 1 year was 72%. At the time of writing, 17 patients are still alive, with no 
evidence of new leaks, device migration, or other complications.  
One patient treated for an acute type B dissection required a proximal stent graft extension 
for a type I endoleak after 12 months. One patient (previously treated for an acute type B 
dissection) required a left renal angioplasty and stent for renal stenosis and hypertension 
after 13 months. One patient (treated for an intramural hematoma) required a distal stent 
graft after 48 months to repair postdissection sac growth.  
Although we had to cover the ostium of the left subclavian artery in 6 of 25 patients (24%), it 
was not necessary to revascularize the left subclavian artery, as no arm ischemia or vertebro-
basilar ischemia was detected.   
According to the definitions of Chaikof et al. (Chaikof et al, 2002), primary technical success 
was 80%.  
Table 4 shows results in terms of mortality and follow up. 
4. Discussion 
Vascular lesions and injuries to the thoracic aorta are associated with very high morbidity 
and mortality. Many patients with severe injuries die at the scene of the accident before 
being diagnosed or are severely ill on arrival at the emergency department.  
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1 DISSECTION No No 48 
2 DISSECTION No No 72 
3 DISSECTION No No 72 
4 DISSECTION No No 72 
5 DISSECTION No No 8 
6 PENETRATING ULCER No No 84 
7 PENETRATING ULCER No No 72 
8 INTRAMURAL HEMATOMA No No 72 
9 INTRAMURAL HEMATOMA No No 60 
10 RUPTURED TAA No No 60 
11 RUPTURED TAA Yes Yes  
12 RUPTURED TAA No No 4 
13 RUPTURED TAA No No 12 
14 RUPTURED TAA No Yes- Day 80  
15 PSEUDOANEURYSM No Yes- Day 17  
16 PSEUDOANEURYSM No No 36 
17 PSEUDOANEURYSM No No 36 
18 TRAUMATIC DISRUPTION No No 84 
19 TRAUMATIC DISRUPTION No No 72 
20 TRAUMATIC DISRUPTION No No 36 
21 TRAUMATIC DISRUPTION No No 6 
22 AORTOBRONHCIAL FISTULA No No 96 
23 AORTOESOPHAGEAL FISTULA No 
Yes- Day 
15  
24 AORTOESOPHAGEAL FISTULA No Yes- Day 3  
25 SUBCLAVIAN PSEUDOANEURYSM No No 20 
Table 4. Intra- postoperative mortality and follow up. 
Endovascular repair of a ruptured thoracic aorta was initiated in the mid-nineties. Dake et 
al. presented one of the first series of endovascular stent grafts for the treatment of 
descending thoracic aortic aneurysms in 1994 (Dake et al., 1994).  
Since then, several authors have reported successful endovascular treatment of both chronic 
and acute lesions of the thoracic aorta (Dake, 2001; Kato et al., 1997; Fujikawa et al., 2001; 
Lachat et al., 2002; Czermak et al., 2002; Amabile et al., 2004; Dunham et al., 2004; Hoornweg 
et al., 2006; Alsac et al., 2008; Kaya et al., 2009).  
Despite advances in surgical techniques, surgery for acute thoracic aortic rupture is 
associated with high morbidity and mortality rates (Doss et al., 2003; Dake et al., 1994). 
Open thoracic aortic repair carries the risk of severe complications affecting the heart, lungs, 
kidneys, and nervous system (spinal cord ischemia), with frequencies as high as 50% 
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(Lachat et al., 2002). Mortality rates for elective open surgical repair of descending thoracic 
aortic aneurysm have been reported at 3-12%. Most reports, however, are from high-volume 
centers of excellence and national referral centers; therefore, the results may not reflect the 
actual experience worldwide (Schermerhorn et al., 2008). 
Ruptured descending thoracic aortic aneurysm (rDTAA) is a cardiovascular catastrophe, 
associated with high morbidity and mortality. The vast majority of patients who suffer from 
rDTAA die before they reach hospital (Johansson et al., 1995). rDTAA is less common than 
aortic dissection and traumatic aortic rupture, and the treatment of choice in most centers is 
thoracic endovascular aortic repair (TEVAR) .  
Open surgical repair of rDTAA presents very high mortality rates and is only feasible in 
referral centers. Mortality rates for open surgery vary from 30% to 60% depending on the 
series (Jonker et al., 2011).  
Patients with rDTAA treated with TEVAR present lower mortality rates, although 
morbidity is also high. Recent reports present 30-day mortality rates of 15%-20%. Only 
highly specialized centers have reported mortality rates of between 25% and 30% after open 
repair of rDTAA (Jonker et al., 2010; Estrera et al., 2001). A recent comparative study by 
Patel and colleagues showed a 30-day mortality of 11.4% after TEVAR compared with 26.5% 
after open repair of ruptured thoracic aortic dissections and aneurysms (Patel et al., 2009). In 
endovascular repair of descending thoracic aortic aneurysms, the incidence rates of 
paraplegia and stroke usually range from 1% to 6% and from 2.5% to 5%, respectively. The 
risk of neurological complications may increase after endovascular repair of rDTAA, 
although it is still lower than that of open repair. The incidence of paraplegia and stroke 
after conventional surgical treatment of rDTAA may be as high as 12.5% and 25% (Jonker et 
al., 2011; Barbato et al., 2007), providing even greater support for endovascular treatment of 
rDTAA. 
Although TEVAR is currently the most appropriate approach for the management of this 
often-fatal lesion, endovascular repair of rDTAA is still associated with considerable rates of 
neurological complications and procedure-related complications such as endoleak. 
In our series, mortality for thoracic endovascular aortic repair in the ruptured thoracic 
aneurysm group was high (2 patients out of 5: 40%). Previous medical comorbidities and 
severe preoperative shock were determinant factors.   
The prevalence of intramural hematoma in patients with acute aortic syndrome is 10%-20%, 
and approximately 10% of patients with symptomatic intramural hematoma develop aortic 
rupture. The signs of disease progression include aortic diameter ≥40 mm and thickening of 
the aortic wall ≥10mm. Close surveillance in these patients is critical (Geisbüsch et al., 2008).  
The prevalence of penetrating aortic ulcer among patients presenting with acute aortic 
syndrome is about 2%-8%. Although frequently causing the same symptoms, penetrating 
aortic ulcer and classic aortic dissection must be distinguished, as they differ in their natural 
course. The rupture rate in symptomatic penetrating aortic ulcer is reported to be as high as 
40% compared to 4% in Stanford type B dissection. Therefore, urgent repair is required in 
symptomatic cases (Geisbüsch et al., 2008; Tittle et al., 2002; Coady et al., 1996; Ganaha et al., 
2002). Signs of progression of this condition include aortic ulcer diameter >20 mm and ulcer 
depth >10 mm. Close surveillance is essential.  
Early mortality after TEVAR in penetrating aortic ulcer is reported at 0%-11%. Medium-
term outcomes have been published, with 1-, 3-, and 5- year survival rates of 85%, 75%, and 
60%, respectively (Geisbüsch et al., 2008; Botta et al., 2008; Demers et al., 2004). 
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In 2007, Estrera et al. published their series of 159 patients treated for acute type B aortic 
dissection. They concluded that mortality associated with complicated dissection was 17%. 
In contrast, 53% of patients with uncomplicated dissection were managed medically, with a 
mortality rate of only 1.2% (Estrera et al., 2007).  
TEVAR should now be considered the gold standard for complicated acute type B thoracic 
dissections and symptomatic penetrating ulcers.  
In our series, the acute aortic syndrome group was quite homogeneous as regards age, 
initial presentation, postoperative period, and outcome. There was no in-hospital mortality, 
with 90% of patients alive during a mean follow-up of 62 months (range, 8-84 months). 
Traumatic aortic injury is the second commonest cause of death in patients after blunt 
injury; autopsy reveals that 15%-30% of deaths from blunt trauma involve aortic transection 
(Thompson & Morgan., 2009; Shorr, 1987). Traumatic thoracic aortic rupture is a potentially 
lethal injury and leads to immediate death in 75%-90% of cases. Only about 10%-20% of 
victims reach the hospital alive.  
The most common site of aortic injury is the isthmus, where the relatively mobile thoracic 
aorta joins the fixed arch. Aortic rupture occurs at this site in 80% of pathological series and 
in 90% of the clinical series Thompson & Morgan., 2009).  
Despite advances in surgical techniques, in emergency settings, open surgical repair of 
aortic rupture is still associated with a mortality rate of 18%-67% (Steingruber et al., 2007, 
Karmy-Jones et al. 2003; Richens et al., 2002; Williams et al., 1994).  
Most series report the technical success of TEVAR to be 81.1-100%, with a paraplegia rate of 
0%. These series present low mortality and morbidity rates, with accompanying injuries as 
primary causes of morbidity and mortality (Urgnani et al., 2009, Neuhauser et al., 2004; 
Rousseau et al., 2005).  
Our results revealed considerable age differences between the traumatic (blunt) aortic 
rupture group and the other groups. This is due to the type of injury, which commonly 
occurs in young patients after high velocity trauma such as car accidents or falls from great 
heights. These patients commonly present multiple extremity and other fractures, vertebral 
or spinal cord injuries, and lung and visceral contusions, thus increasing the already high 
postoperative mortality.  
In spite of the many benefits in the short and medium terms, the long-term results of 
endovascular repair of traumatic aortic rupture remain a major issue in these relatively 
young patients. In the future, we expect to see the development and use of stent grafts 
specifically designed to treat aortic trauma.  
We present our experience with endovascular repair of thoracic aortic emergencies. Some of 
the cases we report are very unusual and therefore challenging, in terms of both diagnosis 
and treatment. 
In several cases the presenting symptom was hemoptysis. In patients with massive 
hemoptysis, lesions in the intrathoracic large vessels, including the supra-aortic arteries, 
must be considered in the differential diagnosis. Moreover, in patients with previous aortic 
surgery and hemoptysis, the physician must have a high index of suspicion (Kopp et al., 
2009).   
Aortobronchial fistula and aortoesophageal fistula can be difficult to diagnose and 
extremely complex to treat. These conditions are often devastating, and the results of 
surgery are usually very poor. Endovascular repair provides an alternative to very complex 
open surgical repair. Very few series in the literature analyze endovascular repair of these 
complex lesions, and data are mostly from case reports or small series.  
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Open surgery entails high morbidity and mortality, and mortality rates range from 25% to 
60% (Thompson et al., 2002; Piciche et al., 2003; Liu et al., 2004). 
As regards endovascular repair of aortobronchial fistula, a review of the literature revealed 
less than 60 cases treated using endovascular repair. These were all from small series 
(Wheatley et al., 2007; Pirrelli et al., 2006; Ribé et al., 2010). 
Initial results are encouraging, with 30-day mortality rates below 10%; however, larger 
series with longer-term follow-up are still required (Pirrelli et al., 2006). 
Both our results and those published in the literature indicate that endovascular repair of 
thoracic aortic emergencies is a promising approach.  
In some acute conditions, such as complicated type B thoracic dissections or ruptured 
thoracic aortic aneurysms, endovascular repair must be considered the treatment of choice. 
Larger series and longer follow-up are required for future assessment of these conditions.  
5. Conclusion 
Endovascular therapy may now be considered the first-line treatment for thoracic aortic 
emergencies, especially for ruptured thoracic aortic aneurysms and acute complicated 
dissections.  
Endovascular procedures reduce morbidity and mortality in patients with acute thoracic 
aortic lesions, and must therefore be considered the gold standard in these situations.  
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1. Introduction 
The bicuspid aortic valve (BAV), the most common congenital cardiac malformation, is 
associated with ascending thoracic aneurysms and appears to reflect a common 
developmental defect. (Hahn et al., 1992; Roberts, 1970) The average time of patients with 
BAV undergoing surgery (of the aortic valve and/or because of complications associated 
with it) is a decade earlier than patients with a normally developed aortic valve. 
Accordingly, it is contended that if a diseased BAV must be replaced because of a diseased 
BAV, the aneurysmal ascending aorta should also be replaced. Valve replacement surgery 
without replacing the aorta would simplify the surgical intervention and shorten the time of 
operation. In contrast, an enlarged ascending aorta represents an increased likelihood of the 
patient undergoing the same surgical procedure after a few years. Replacing the aortic valve 
in patients with BAV does not prevent the progressive dilation of the aortic root and 
ascending aorta. (Yasuda et al., 2003) 
Cellular and extracellular processes are involved in the pathogenesis of the ascending  aortic 
aneurysms in patients with BAV. (Bonderman et al., 1999; Mohamed et al., 2010; 
Nataatmadja et al., 2003; Tang et al., 2005) Many studies have demonstrated the 
abnormalities of matrix metalloproteinases (MMPs) and tissue inhibitors of 
metalloproteinases (TIMPs) in aneurysmal tissues. (Boyum et al., 2004; Koullias et al., 2004; 
Longo et al., 2002) Using tissue microarray techniques, Koullias et al. detected a significantly 
higher MMP-2 and MMP-9 levels in BAV compared with normal tricuspid aortic valves 
(TAV), and even significantly higher MMP-2, MMP-9 and TIMP-1 levels compared with all 
other tissues (control and TAV together). LeMaire et al. observed a lack of inflammatory 
processes and an increased MMP-2 level and normal MMP-9, TIMP-1 and TIMP-2 
expression levels in aneurysmal tissues obtained from patients with BAV. In contrast, in 
aneurysmal tissues obtained from patients with TAV, they observed increased inflammatory 
processes and MMP-9 levels. (Lemaire et al., 2005) Furthermore, they showed an increased 
incidence of cultured vascular smooth muscle cell (VSMC) loss in BAV and Marfan 
syndrome (MFS) compared with control samples and suggested that a link between the up-
regulation of MMP-2 and VSMC apoptosis may exist in MFS. Certainly, there are similarities 
between the histology of the aneurysmal tissue of the aorta in MFS and that BAV. (Longo et 
al., 2002) In MFS, a mutation in the gene encoding for the extracellular matrix protein 
fibrillin-1 can be observed; this mutation leads to dysregulation of the transforming growth 
factor-beta (TGF-b) signaling. (Dietz et al., 2005) In this chapter, we review the present 
knowledge for elucidating the ascending aortic aneurysm pathogenesis, particularly in 
patients with BAV.  
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We will discuss the genetic basis and basic pathology underlying BAV and ascending aortic 
aneurysms. We used a simultaneous detection system for MMPs and TIMPs in two different 
areas of aortic aneurysms to quantify protein levels. Light and transmission electron 
microscopy were performed in some cases. 
2. The aorta and its basic structure  
The aorta transports oxygenated blood from the heart to the organs of the body. It plays a 
major role in the biomechanics of the circulatory system. The high velocity pulsatile flow of 
the ascending aorta changes into a low velocity steady flow when entering the arterioles and 
capillaries where metabolic processes such as gaseous and nutrient exchange occur. (Lohff, 
1999; Olufsen and Nadim, 2004) A healthy aorta has a flexible vasculature and specific size, 
which correlates with age and gender. Located near the left ventricle, the ascending aorta 
along with the aortic root forms a unique shape and displays mechanical properties to 
influence left ventricle workload and coronary blood flow.  (Davies et al., 2008; El-Hamamsy 
and Yacoub, 2009) Similar to all other arterial walls, the ascending aorta comprises three 
basic layers: the innermost layer, tunica intima that adjoins the blood vessel lumen with an 
endothelial lining; the middle layer, tunica media that contains muscular elastic fibers; and 
the outer layer, tunica adventitia. The internal and external elastic laminae (thick elastic 
fibers) separate these layers from each other. The lamellar unit of the media is the 
fundamental structural and functional unit of the aortic wall providing viscoelastic 
properties to the aorta. It is composed of vascular smooth muscle cells between two layers of 
elastin fibers, which comprise microfibrils and proteoglycans that form the extracellular 
matrix. (El-Hamamsy and Yacoub, 2009; Wolinsky and Glagov, 1967) 
3. Present knowledge of genetics of BAV and thoracic aortic aneurysms 
Remodeling, processing, and degradation of extracellular matrix proteins are regulated by 
MMPs and tissue inhibitors of TIMPs. MMPs are a family of zinc-dependent proteolytic 
enzymes with five major members categorized according to substrates. These members 
include collagenases, gelatinases, stromelysins, matrilysins, and membrane-type MMPs. 
(Brauer, 2006; Folgueras et al., 2004) Imbalances in MMP and/or TIMP synthesis have been 
linked to changes in the aortic wall and formation of aortic aneurysms. (Coady et al., 1999; 
Davis et al., 1998; Isselbacher, 2005) Although the involvement of MMPs or TIMPs in the 
pathogenesis of abdominal aortic aneurysms is clarified to a great extent, MMP or TIMP 
levels in ascending aortic aneurysms have shown different results. (Davis et al., 1998; 
Goodall et al., 2001; Raffetto and Khalil, 2008) In particular, the elevation of MMPs and 
TIMPs occurs in ascending aneurysms in BAV. BAV, which was probably first depicted 
more than 400 years ago in Leonardo da Vinci’s sketches, is a genetic disorder. (Clementi et 
al., 1996; Cripe et al., 2004; Friedman et al., 2008; Huntington et al., 1997; Roberts, 1970) The 
high heritability of BAV was estimated to be 0.89. Family-based genome-wide analysis 
revealed linkage of BAV to the chromosomal regions 5q, 13q, and 18q in an autosomal 
dominant inheritance with reduced penetrance and a non-Mendelian pattern. (Cripe et al., 
2004; Huntington et al., 1997; Ward, 2000) Mutations were detected in the transmembrane 
receptor NOTCH1 (gene mapped to a locus on chromosome 9q) in familiar and sporadic 
cases of BAV. (Garg et al., 2005; McKellar et al., 2007; Mohamed et al., 2006) Moreover,  
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mutations in the vascular smooth muscle cell alpha actin gene (mapped to chromosome 10q) 
have also been identified in patients with BAV and aortic aneurysms. (Milewicz et al., 2008) 
The ubiquitin fusion degradation 1-like gene (mapped to chromosome 22q), which is highly 
expressed in the outflow tract during embryogenesis, was down-regulated in the cusps of 
patients with BAV compared with those of control patients. (Mohamed et al., 2005) 
Furthermore, BAV can manifest as a type of a group of left ventricular outflow tract 
abnormalities such as aortic coarctation, arch hypoplasia, and supravalvular and mitral 
valve stenosis. The homeobox gene (mapped to a locus on chromosome 5q in humans) Nkx2-5 
deficient heterozygous mice are at a higher risk of developing BAV. (Biben et al., 2000; 
Wessels et al., 2005) A male predominance of more than 3:1 has been reported for BAV, and 
this anomaly is very frequent in the X0 Turner’s syndrome, with an incidence rate of 22%–
34%, suggesting an X-linked etiology. (Miller et al., 1983; Tadros et al., 2009) Analysis of a 
subpopulation with Anderson syndrome described 4 members (4/41) with BAV. In 
Anderson syndrome a mutation in the potassium inwardly-rectifying channel, subfamily J, 
member 2 (mapped to chromosome 17q) was observed. (Andelfinger et al., 2002) Endothelial 
nitric oxide synthase (eNOS; located on chromosome 7q in humans) knockout is associated 
with the development of BAV in mice. (Lee et al., 2000) Kuhlencordt et al. detected a higher 
incidence of aortic aneurysms in eNOS/apolipoprotein E double-knockout mice. 
(Kuhlencordt et al., 2001) Aicher et al. reported a significant decrease in the amount of the 
eNOS protein in BAV aortic tissue compared with that in TAV aortic tissue. (Aicher et al., 
2007) The expression and activity of eNOS in aortic endothelial cells is controlled by 
hemodynamic wall shear stress. Recent studies have indicated that aortic wall shear stress 
differs locally between BAV and control patients, when examined by magnetic resonance 
imaging. (Barker et al., 2010; Weigang et al., 2008) Furthermore, we have provided evidence 
that VSMCs show different apoptotic behavior in the convex and opposite concave portions 
of the dilated aorta (Fig. 1). Inhibition of caspase-3 protected cultured cells derived from the 
tunica media of the concavity to a greater extent than those derived from the convexity of 
the aorta. (Mohamed et al., 2010) These observations that compare of convex and concave 
ascending aortic sites are extremely important, not only necessarily from a genetic 
standpoint but also from the standpoint of differential pressures experienced (or more 
specifically dP/dt) at every site. Early in development, the growth of the embryonic outflow 
tract (OFT, descendant of the second heart field) shortens at specific stages according to 
programmed cell death (apoptosis). (Fisher et al., 2000) During cardiac valve formation, 
when the heart is a simple tube, invaded the extracellular matrix to build the endocardial 
cushions in the OFT. Migratory cells from pharyngeal arches, i.e., neural crest cells, 
participate and differentiate into VSMCs that populate the walls of the ascending aorta, 
aortic arch, head vessels, and interior of semilunar valves. Transient and moderate activities 
of caspase-3 promote stem cell differentiation; in OFT, only cells with moderate caspase-3 
activity undergo smooth muscle differentiation. (bdul-Ghani and Megeney, 2008) It is also 
our personal belief that dysregulation of apoptosis during valvulogenesis may lead to 
failure in separating valve leaflets from each other like in BAV. (Zhang et al., 2010). 
This present knowledge of ascending aortic aneurysms in patients with BAV reflects only a 
part of the complex entity of the pathogenesis. BAV occurs at an incidence rate of 1%–2% in 
the general population, and almost 50% of the anomaly is associated with ascending 
aneurysms that can lead to aortic dissection or rupture. (Roberts, 1970b; Siu and Silversides, 
2010) Therefore, further investigations to understand the pathogenesis of ascending 
aneurysms are required. 
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2010) Therefore, further investigations to understand the pathogenesis of ascending 
aneurysms are required. 
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Fig. 1. Schematic representation of ascending aneurysms. Rescted tissue of the concave and 
convex aortic sites for analysis. 
4. Simultaneous detection of MMPs and TIMPs in thoracic aortic aneurysms  
The mutiplex system (Bio-Plex, BioRad Laboratories, Hercules, CA, USA)) analyses  were 
used to determine the concentrations of MMP-1, MMP -2, MMP -8, MMP -9, MMP -12, and 
MMP -13 in pg/ml as well as those of TIMP-1, TIMP -2, TIMP -3, and TIMP -4 in two areas 
of the dilated aorta ascendens (Fig. 1). The Human MMP Fluorokine MultiAnalyte Profiling 
(FMAP) Base Kit and the respective kits to this panel of targets obtained from R&D Systems 
(Minneapolis, MN, USA), applied according to the manufacturer's instructions. 
Forty-one patients were included in the analysis, the concave and convex aortic sites were 
identified from overall cases. The group of 31 patients with BAV consisted of 24 male (77%) 
and 7 female patients, while 7 of the 10 patients with TAV were male (70%). The distribution 
of age was considerably different between the two groups. Patients with BAV featured a 
mean age of 50.9 ± 12.9 years and were therefore significantly younger than patients with 
TAV having a mean age of 63.2 ± 8.2 years (P = 0.006). On the other hand, the means of 
aortic diameters are comparable (52.7 ± 4.9 mm vs. 56.7 ± 6.6 mm). There were differences in 
the aortic valve disease between the two groups. While the BAV group contained 10 patients 
with aortic valve insufficiency (32%), 3 patients with stenosis (10%), and 18 patients with a 
combination of both diseases (58%), the TAV group comprised patients who only suffered 
from aortic valve insufficiency. 
The overall detection of MMPs and TIMPs using the multiplex system revealed significantly 
higher MMP-8 and MMP-9 levels in the convex aortic site than in the opposite area 
(concave) in all patients (P = 0.001; P =.007). On the other hand, MMP-2 and TIMP-3 levels 
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were elevated in the concave aortic site (P = 0.04, P = 0.0007; Table 1). Patients with TAV 
have a higher TIMP-3 level in the concave aortic site than in convex aortic site (P = 0.008).  
4.1 Elevation of MMPs and TIMPs with age 
Within the BAV group the age group below and including 51 years displayed a significantly 
lower expression of TIMP-3 in the convex aortic site in contrast to convex aortic site (10.35 ± 
3.4 pg/ml; P = 0.01). The convex area of older patients featured significantly higher MMP-8 
and TIMP-2 levels than that of the younger group (10.84 ± 13.92 pg/ml, P = 0.02; 141.91 ± 
34.29 pg/ml, P = 0.05). 
4.2 Elevation of MMPs and TIMPs based on the diameter of aortic aneurysm 
To classify patients according to the diameter of aortic aneurysms, the threshold was chosen 
to be located between 54 and 55 mm, as the mean diameter was 53.7 ± 5.6 mm. Most of the 
TAV associated aneurysm was larger in diameter than the BAV associated aneurysm. 
Therefore, all patients with TAV were selected in the group of greater than or equal to 55 
mm. 
The aortic convex area of patients with BAV suffering from an aneurysm of 54 mm diameter 
or less, showed a higher MMP-8 and MMP-9 levels compared with the concave area (2.78 ± 
2.76 pg/ml, P = 0.04; 9.61 ± 9.78 pg/ml, P = 0.05). The expression of TIMP-3 and TIMP-4 on 
the other hand is significantly lower in the convex area (11.51 ± 3.81 pg/ml, P = 0.004; 0.25 ± 
0.07 pg/ml, P = 0.004). Patients with BAV and an aneurysm with greater than or equal to 55 
mm displayed considerably higher MMP-8 and MMP-9 levels in the convex aortic site when 
compared the concave aortic site (12.30 ± 15.20 pg/ml, P = 0.01, 28.29 ± 41.80 pg/ml, P = 
0.04). The TAV group exhibited a higher TIMP-3 expression in the concave when compared 
with the convex aortic site (10.03 ± 3.50 pg/ml, P = 0.05). 
4.3 Elevation of MMPs and TIMPs based on gender 
Comparison of male and female patients with BAV resulted in a significantly higher TIMP-1 
concentration in area 23II of female patients (P = 0.03). 
Analyses of the male BAV group resulted in significantly increased MMP-8 and MMP-9 
levels in the convex aortic site than in the concave aortic site (P = 0.005; P = 0.01). The 
concave aortic site showed an elevated TIMP-3 concentration (P = 0.03). 
4.4 Elevation of MMPs and TIMPs based on aortic valve disease 
The classification of patients depending on their aortic valve disease was restricted by the 
low number of patients with isolated stenosis. Therefore, only patients with BAV with aortic 
valve insufficiency or a combination of insufficiency and stenosis were considered. 
The TAV group comprised patients who only suffered from aortic valve insufficiency.  
The BAV group with aortic valve insufficiency showed increased TIMP-3 in the convex 
aortic site in contrast to concave aortic site (P = 0.02).  
The BAV group with a combination of aortic valve disease showed significantly elevated 
MMP-8 and MMP-9 levels in the convex aortic site (P = 0.004; P = 0.007). 
5. Light and transmission electron microscopy  
In light microscopy, we studied the histopathological features of ascending aortic 
aneurysms in 15 patients with BAV and 6 with TAV. Convex and concave aortic sites were 
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0.07 pg/ml, P = 0.004). Patients with BAV and an aneurysm with greater than or equal to 55 
mm displayed considerably higher MMP-8 and MMP-9 levels in the convex aortic site when 
compared the concave aortic site (12.30 ± 15.20 pg/ml, P = 0.01, 28.29 ± 41.80 pg/ml, P = 
0.04). The TAV group exhibited a higher TIMP-3 expression in the concave when compared 
with the convex aortic site (10.03 ± 3.50 pg/ml, P = 0.05). 
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valve insufficiency or a combination of insufficiency and stenosis were considered. 
The TAV group comprised patients who only suffered from aortic valve insufficiency.  
The BAV group with aortic valve insufficiency showed increased TIMP-3 in the convex 
aortic site in contrast to concave aortic site (P = 0.02).  
The BAV group with a combination of aortic valve disease showed significantly elevated 
MMP-8 and MMP-9 levels in the convex aortic site (P = 0.004; P = 0.007). 
5. Light and transmission electron microscopy  
In light microscopy, we studied the histopathological features of ascending aortic 
aneurysms in 15 patients with BAV and 6 with TAV. Convex and concave aortic sites were 
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graded according to the severity of seven histopathological features: fibrosis, atherosclerosis, 
medionecrosis, cystic medial necrosis, smooth muscle cell orientation, elastic fiber 
fragmentation, and inflammation. (de Sa et al., 1999) The most prominent feature is elastic 
fiber fragmentation (Fig. 2). Aortic ascending abnormalities were more severe in TAV than 
in BAV. Nonetheless, it became obvious that histological grading of the convex aortic site 
was generally more severe in BAV, which is associated with the aortic diameter of the 
convex and not concave aortic sites (Fig. 2). These results correlated with the previous 
observations of Bechtel et al. (Matthias Bechtel et al., 2003). 
 
 
Fig. 2. Elastic fragmentation detected in two sites (concave and convex) of ascending 
aneurysms of 15 patients with BAV and 6 with TAV. The histopathological evaluation after 
de SA et al. The histological grading was copared with the aortic diameter (AoAsc; in 
millimetres) of the concave aortic site in A) and convex aortic site B). Elastica van Gieson 
staining is demonstrated in paraffin section  of aneurysmatic tissue obtained from a 46 year-
old-male with BAV thoracic aortic aneurysms (original magnification, x100). In C) the 
concave aortic site, in D) grade 2 elastic fragmentation of the presence of foci elastic 
fragmentation in more than five neighboring elastic lamellae of the convex aortic site. 
The transmission electron microscopy analysis of the examined slides of aneurysmal tissues 
obtained from patients with BAV lacks any well known typical structure of the aortic wall. 
This texture mingles the whole aortic wall as well as the adventitia; the typical build up 
layer of an aortic wall is not recognisable (Fig. 3A).  
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In the intima, the endotheliums still possess a single layered consistent coating of plain cells 
that are aligned parallel to the bloodstream with their longitudinal axis. 
The subendothelial layer of the examined specimen exhibits partial extensive differences. 
This layer contains few cells, at the most long thin stretched processes of fibrocytes, muscle 
cells are rare. A rather broad layer with a variously running bundle of collagen fibers is 
attached. The transition to the media is marked through fibrocytes processes, followed by 
strong bundles of collagen fibers with different orientation. The typical structure of the 
dense elastic membrane is completely abolished within the media. Bizarre shaped fibrocytes 
among bundles of collagen fibers, small parts of elastic membranes, and few vascular 
smooth muscle cells dominate, together with strikingly wide and empty appearing matrix 
spaces in the TEM. Among all compounds of this series, calcium concrements in all layers of 
the aortic wall exist as round eosinophilic granules (Fig. 3B). 
  
 
Fig. 3. The transmission electon micropy analysis of the tunica media of the aneurysmal 
tissue obtained from 15-year-old patient with BAV thoracic aortic aneurysm. In A, the 
electron micrograph demonstration of the lamellar structure and many broken VSMCs 
(arrows) with different elongations. In B, a fibaroblast with osmiophilic granules and space 
vacuoles is demonstrated. 
6. Discussion 
BAV is associated with ascending aneurysms that can lead to acute aortic dissection.  
(Januzzi et al., 2004) Acute aortic dissection is a life-threatening condition with high 
morbidity and mortality rates and is generally an unpredictable event. (Abbara et al., 
2007; Januzzi et al., 2004; Mohamed et al., 2008; Mohamed et al., 2009; Park et al., 2004; 
Wheat, Jr., 1987) People commonly at risk of this disease include those with connective 
tissue disorders such as Marfan syndrome, Ehlers-Danlos syndrome, Erdheim–Gsell 
medial necrosis, and BAV. (Beroukhim et al., 2006; Dietz et al., 1994; Silverman et al., 
1995) The exact genetic cause of BAV is unknown. Patients with BAV present a wide 
spectrum of heterogeneous morphological phenotypes of fused cusps. (Sievers and 
Schmidtke, 2007)  
The normal aorta is a large elastic artery with a wall consisting of the intima and a 
prominent internal elastic lamina between the intima and media. The media has a markedly 
layered structure, in which fenestrated layers of elastic lamellae alternate with interlamellar 
Diagnosis and Treatment of Abdominal and Thoracic Aortic  
Aneurysms Including the Ascending Aorta and the Aortic Arch 
 
166 
graded according to the severity of seven histopathological features: fibrosis, atherosclerosis, 
medionecrosis, cystic medial necrosis, smooth muscle cell orientation, elastic fiber 
fragmentation, and inflammation. (de Sa et al., 1999) The most prominent feature is elastic 
fiber fragmentation (Fig. 2). Aortic ascending abnormalities were more severe in TAV than 
in BAV. Nonetheless, it became obvious that histological grading of the convex aortic site 
was generally more severe in BAV, which is associated with the aortic diameter of the 
convex and not concave aortic sites (Fig. 2). These results correlated with the previous 
observations of Bechtel et al. (Matthias Bechtel et al., 2003). 
 
 
Fig. 2. Elastic fragmentation detected in two sites (concave and convex) of ascending 
aneurysms of 15 patients with BAV and 6 with TAV. The histopathological evaluation after 
de SA et al. The histological grading was copared with the aortic diameter (AoAsc; in 
millimetres) of the concave aortic site in A) and convex aortic site B). Elastica van Gieson 
staining is demonstrated in paraffin section  of aneurysmatic tissue obtained from a 46 year-
old-male with BAV thoracic aortic aneurysms (original magnification, x100). In C) the 
concave aortic site, in D) grade 2 elastic fragmentation of the presence of foci elastic 
fragmentation in more than five neighboring elastic lamellae of the convex aortic site. 
The transmission electron microscopy analysis of the examined slides of aneurysmal tissues 
obtained from patients with BAV lacks any well known typical structure of the aortic wall. 
This texture mingles the whole aortic wall as well as the adventitia; the typical build up 
layer of an aortic wall is not recognisable (Fig. 3A).  
 
Ascending Aneurysms in Bicuspid Aortic Valve 
 
167 
In the intima, the endotheliums still possess a single layered consistent coating of plain cells 
that are aligned parallel to the bloodstream with their longitudinal axis. 
The subendothelial layer of the examined specimen exhibits partial extensive differences. 
This layer contains few cells, at the most long thin stretched processes of fibrocytes, muscle 
cells are rare. A rather broad layer with a variously running bundle of collagen fibers is 
attached. The transition to the media is marked through fibrocytes processes, followed by 
strong bundles of collagen fibers with different orientation. The typical structure of the 
dense elastic membrane is completely abolished within the media. Bizarre shaped fibrocytes 
among bundles of collagen fibers, small parts of elastic membranes, and few vascular 
smooth muscle cells dominate, together with strikingly wide and empty appearing matrix 
spaces in the TEM. Among all compounds of this series, calcium concrements in all layers of 
the aortic wall exist as round eosinophilic granules (Fig. 3B). 
  
 
Fig. 3. The transmission electon micropy analysis of the tunica media of the aneurysmal 
tissue obtained from 15-year-old patient with BAV thoracic aortic aneurysm. In A, the 
electron micrograph demonstration of the lamellar structure and many broken VSMCs 
(arrows) with different elongations. In B, a fibaroblast with osmiophilic granules and space 
vacuoles is demonstrated. 
6. Discussion 
BAV is associated with ascending aneurysms that can lead to acute aortic dissection.  
(Januzzi et al., 2004) Acute aortic dissection is a life-threatening condition with high 
morbidity and mortality rates and is generally an unpredictable event. (Abbara et al., 
2007; Januzzi et al., 2004; Mohamed et al., 2008; Mohamed et al., 2009; Park et al., 2004; 
Wheat, Jr., 1987) People commonly at risk of this disease include those with connective 
tissue disorders such as Marfan syndrome, Ehlers-Danlos syndrome, Erdheim–Gsell 
medial necrosis, and BAV. (Beroukhim et al., 2006; Dietz et al., 1994; Silverman et al., 
1995) The exact genetic cause of BAV is unknown. Patients with BAV present a wide 
spectrum of heterogeneous morphological phenotypes of fused cusps. (Sievers and 
Schmidtke, 2007)  
The normal aorta is a large elastic artery with a wall consisting of the intima and a 
prominent internal elastic lamina between the intima and media. The media has a markedly 
layered structure, in which fenestrated layers of elastic lamellae alternate with interlamellar 
Diagnosis and Treatment of Abdominal and Thoracic Aortic  
Aneurysms Including the Ascending Aorta and the Aortic Arch 
 
168 
VSMCs, collagen, and fine elastic fibers. This arrangement is regular so that each elastic 
lamella and adjacent interlamellar zone is reported as a lamellar unit of the media. In 
addition to collagen and elastic fibers, the adventitia contains flattened fibroblasts with 
extremely long processes, macrophages and mast cells, nerve bundles, and lymphatic 
vessels. On examining the tissue samples of ascending aortic aneurysms of patients with 
BAV, we observed that the spatial structure of the aortic wall is totally destroyed. This 
structure was also partly observed during immunohistochemical analysis performed for 
Marfan syndrome. (Guo et al., 2009) The lamellar units of the media were disintegrated, and 
the VSMCs were atrophied and wrinkled in a bizarre shape. Between these wrinkled muscle 
cells, existed thick bundles of collagen fibrils. In some cases of the thoracic aortic aneurysms 
we detected dramatic changes in the distribution of collagen fibrils in the media with 
different diameters, and fibroblasts with long and thin processes between the enormous 
collagen bundles. However, the most striking observation was the lack of elastic fibers. In 
the adventitia, we observed dysplastic collagen fibrils, which had a flower-like appearance 
in transverse sections. In addition, accumulations of lipid droplets and eosinophilic 
granules, probably proteoglycan granules or calcium concrements were observed. 
In the literature, different reports exist about matrix protein expression in aneurysmal 
tissues. In accordance with the published data, we observed the profile of six MMPs and 
their four inhibitors using a simultaneous detection system in two different areas 
(concave/convex) of ascending aneurysms. Using this method, we detected and quantified 
the elevation of MMP-2, MMP-8, MMP-9, and TIMP-1, TIMP-2, TIMP-3, and TIMP-4 in 
aneurysmal tissues obtained from the concave and opposite convex aortic sites. 
Concentrations of MMP-1, MMP-12, and MMP-13 were extremely low in these tissues and 
were therefore omitted. The areas of concave and convex aortic sites were combined in 41 
patients (31 BAV and 10 TAV). The patients were divided into group on the basis of age, 
ascending aneurysm diameter, gender, and valve malformation. 
When complete patient data were considered, increased MMP-2 and TIMP-3 levels in the 
area of the concave (inner curves) aortic site became apparent. The convex area (outer 
curves) of the ascending aortic aneurysm showed significantly raised MMP-8 and MMP-9 
levels. Younger patients (≤51 years) revealed an elevated TIMP-3 level in the inner curves. In 
addition to the TIMP-3 level, older patients (≥52 years) showed an increase in MMP-2 level 
in the area of the concave aortic site, and an increase in MMP-8 and MMP-9 levels in the 
area of the convex aortic site.  
Patients with an ascending aneurysm diameter of less than or equal to 54 mm were showed 
elevated TIMP-3 and TIMP-4 levels in the area of the concave aortic site, whereas 
aneurysmal convexity showed higher MMP-8 and MMP-9 levels. A aneurysm diameter of 
greater than or equal to 55 mm was associated with elevated MMP-8 and MMP-9 levels in 
the ascending aortic wall of the dilated convexity. Comparisons of gender and aortic valve 
disease groups revealed no significant differences.  
In patients with Marfan syndrome, a mutation was observed in the gene encoding ECM 
protein fibrillin-1 (Dietz and Pyeritz, 1995) and further analysis in this regard may facilitate 
diagnosis and treatment of this syndrome. The situation differs in patients with BAV 
because haemodynamics can also play a role, and no defect can be detected in the gene 
encoding fibrillin-1. Although many studies support the genetic origin of BAV, the genetic 
pathomechanism of BAV is probably far more complicated possibly due to mutations in 
different genes.  
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7. Conclusions and future directions 
To the best of our knowledge, simultaneous detection of six matrix protein levels was 
performed for the first time. This method is as accurate as old methods and minimizes the 
errors that occurred with those methods. Although we did not measure these proteins in 
blood or body liquids, the results obtained demonstrated that MMPs and matrix proteins 
can be differently elevated in ascending aortic aneurysms in BAV.  
Many factors, such as hemodynamics, environmental factors, and genetic factors (in part) 
appear to be involved in this process. Other modern technologies such as whole genome 
screening may identify additional risk factors (single nucleotide polymorphisms); however, 
these risk factors must also be considered on the basis of their functionality. Another 
interesting topic for the near future is the microRNAs (miRNAs). miRNAs, small 
approximately 22 nucleotides in length noncoding nucleotide RNAs, have been shown to 
modulate mRNA stability and translation. (Cordes and Srivastava, 2009; van and Olson, 
2007a; van and Olson, 2007b) In a pervious study, miR-26a was down-regulated in a fused 
aortic valve. (Nigam et al., 2010) Recently, this miR-26a was also found to be down-
regulated in aneurysms. (Leeper et al., 2011) 
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curves) of the ascending aortic aneurysm showed significantly raised MMP-8 and MMP-9 
levels. Younger patients (≤51 years) revealed an elevated TIMP-3 level in the inner curves. In 
addition to the TIMP-3 level, older patients (≥52 years) showed an increase in MMP-2 level 
in the area of the concave aortic site, and an increase in MMP-8 and MMP-9 levels in the 
area of the convex aortic site.  
Patients with an ascending aneurysm diameter of less than or equal to 54 mm were showed 
elevated TIMP-3 and TIMP-4 levels in the area of the concave aortic site, whereas 
aneurysmal convexity showed higher MMP-8 and MMP-9 levels. A aneurysm diameter of 
greater than or equal to 55 mm was associated with elevated MMP-8 and MMP-9 levels in 
the ascending aortic wall of the dilated convexity. Comparisons of gender and aortic valve 
disease groups revealed no significant differences.  
In patients with Marfan syndrome, a mutation was observed in the gene encoding ECM 
protein fibrillin-1 (Dietz and Pyeritz, 1995) and further analysis in this regard may facilitate 
diagnosis and treatment of this syndrome. The situation differs in patients with BAV 
because haemodynamics can also play a role, and no defect can be detected in the gene 
encoding fibrillin-1. Although many studies support the genetic origin of BAV, the genetic 
pathomechanism of BAV is probably far more complicated possibly due to mutations in 
different genes.  
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7. Conclusions and future directions 
To the best of our knowledge, simultaneous detection of six matrix protein levels was 
performed for the first time. This method is as accurate as old methods and minimizes the 
errors that occurred with those methods. Although we did not measure these proteins in 
blood or body liquids, the results obtained demonstrated that MMPs and matrix proteins 
can be differently elevated in ascending aortic aneurysms in BAV.  
Many factors, such as hemodynamics, environmental factors, and genetic factors (in part) 
appear to be involved in this process. Other modern technologies such as whole genome 
screening may identify additional risk factors (single nucleotide polymorphisms); however, 
these risk factors must also be considered on the basis of their functionality. Another 
interesting topic for the near future is the microRNAs (miRNAs). miRNAs, small 
approximately 22 nucleotides in length noncoding nucleotide RNAs, have been shown to 
modulate mRNA stability and translation. (Cordes and Srivastava, 2009; van and Olson, 
2007a; van and Olson, 2007b) In a pervious study, miR-26a was down-regulated in a fused 
aortic valve. (Nigam et al., 2010) Recently, this miR-26a was also found to be down-
regulated in aneurysms. (Leeper et al., 2011) 
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1. Introduction 
The aim of surgical interventions in type A aortic dissections (TAAD) is to manage the 
potentially fatal complications associated with it. These are: intra-pericardial rupture and 
tamponade, malperfusion phenomena (coronary, neurological, visceral) and acute aortic 
valve regurgitation. Despite excellent results from individual surgeons and expert centres, 
operative outcomes for TAAD have remained static with mortality rates from large 
databases that perhaps better reflect “real-world” practice still around 15 to 30% [Ergin et al, 
1996, Fann et al, 1991, Hagl et al, 2003, Kouchoukos et al, 1991, Mazzucotelli et al, 1993, 
Nienaber et al, 2003a, 2003b, von Segesser et al, 1996]. 
Since the past decade, the reimplantation aortic valve sparing technique (David I) has been 
proposed as an alternative to supra commissural replacements or to modified Bentall-
deBono procedures for repair of TAAD, based upon the principle of totally resecting the 
aortic root, but leaving in place a macroscopically intact aortic valve [Kallenbach et al, 2004]. 
Since the sinuses are very frequently involved in the dissection, in opposition to the aortic 
leaflets, this technique seems to be very appealing. Yet, in most of the cardiac centres, 
reimplantation valve sparing techniques are done by experienced surgeons, most often in 
elective ascending aortic aneurysms. These same surgeons are not those who deal routinely 
with aortic dissections, and it can be easily understandable that young assistants set as a 
gold standard in aortic dissection surgery a living patient better than an intellectually 
satisfying surgery.  
For all these reasons, we have carried in our department a prospective study over a 5 years 
period to evaluate whether a reimplantation valve sparing technique could be associated 
with an increased perioperative morbidity or mortality when done routinely. The aims of 
this study were multiple: to proof efficacy and feasibility, to confirm long term reliability of 
the technique, and to demystify this approach still considered for too many surgeons as a 
technical challenge. 
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2.1 Preoperative data 
Between February 2005 and April 2010, 51 consecutive patients (40 male/11 female) who 
underwent surgery for TAAD were analyzed prospectively. Mean age was 65±11 years. 
Mean logistic Euroscore was 23.3±15.3. Past medical history was marked by severe 
pulmonary disease in 8 patients, multivascular disease in 5, clopidogrel/anti K vitamin 
treatment in 4, cerebral stroke in 6, alcohol addiction in 1, and pulmonary Rendu-Ossler 
disease in 1. Cardiovascular risk factors were severe arterial hypertension (88%) and 
smoking (27%). None of the patients had previous cardiac surgery.  
Diagnosis of type A aortic dissection, defined as involvement of the ascending aorta 
regardless to the distal extension of the lesions, was assessed by echocardiography, and 
confirmed in 46 cases by CT-scan. All of the diagnoses were done in external hospitals 
before transfer to our institution. All the patients had tricuspid aortic valve. Preoperative 
morphologic and hemodynamic data are represented in table 1. In two cases, the patients 
presented with a preoperative collapse needing intubation, inotropic support and fluid 
venous filling. Two other patients had an aortic rupture at the onset of the surgery. Eleven 
patients had one or more preoperative malperfusion syndromes (limbs 8, cerebral 4, 
digestive 4 and coronary 5). A 38-year-old woman had a complete coronary artery network 
dissection in association with the TAAD. Among these patients, 45 underwent a 
reimplantation valve sparing technique, 2 a modified Bentall-DeBono and 4 a supra 
commissural replacement. 
 
Imaging assessement  n % 
 TEE 51 100 
 CT-scan 46 90.2 
Anatomical findings    
 Aortic insufficiency >2/4 9 17.6 
 Ascending aortic diameter >50mm 22 43.1 
Hemodynamic status    
 Shock (alone) 4 7.8 
 Malperfusion (alone) 11 21.6 
 Both 7 13.7 
Table 1. Preoperative data TEE: transesophageal echocardiography. 
2.2 Surgical technique in case of reimplantation valve sparing technique 
All the procedures were performed under general anaesthesia, standard tracheal intubation 
and transesophageal echocardiography (TEE) monitoring. Two catheters were inserted into 
the right radial and the left femoral arteries for continuous blood pressure monitoring. 
Bispectral index was used for cerebral monitoring. After exposition of the heart and the 
great vessels, venous cannulation was done into the right atrium using a double stage 
cannula. In twelve cases, arterial cannulation was performed into the right femoral artery 
before sternotomy. For 38 patients, the arterial cannulation was made directly in the 
concavity of the aorta, at the junction between the ascending segment and the arch. In one, 
canulation of the brachiocephalic trunck was performed. After the cardiopulmonary bypass 
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(CPB) was started, we began general cooling to reach a rectal temperature of 30°C if an arch 
replacement was planned. The aortic root was dissected free from the pulmonary artery, the 
right ventricle and the left atrium. After cross clamping, the aorta was opened transversally 
and cold crystalloid cardioplegia (Celsior®, Imtix Sangstat, Wien, Austria) was infused 
directly into the coronary ostia and repeated when necessary. The coronary ostia were 
dissected, leaving two coronary buttons of approximately 1cm diameter, as well as the 
sinuses, up to a remnant of 3 to 4mm. The tops of the aortic commissures were suspended 
with one U-stitch of 4-0 polypropylene each. The diameter of the aortic annulus was 
assessed using a Hegar dilator to determine the size of the Dacron™ tube. Six threads of 2-0 
coated polyester fibre were passed in a U-fashion underneath the aortic annulus from inside 
to outside in a horizontal way. These threads secured a Valsalva shaped Dacron™ Tube 
(Gelweave Valsalva graft, Vascutek, Ann Harbor, Mi) to the aortic annulus. The tops of the 
aortic commissures were then attached inside the tube. The aorta remnant layers forming 
three cuffs were reimplanted into the tube using three 4-0 polypropylene running sutures, 
without glue. The coaptation of the three cusps was then examined carefully to determine 
any residual leakage. In this case, additional leaflet plasty was performed by the mean of 
free margin running suture using CV-7 PTFe. 
 





Age (years) 65±2 64±4 0.73 
Cross clamping (min) 109±5 86±8 0.01 
CPB (min) 136±6 138±24 0.91 
Lowest temperature (°C) 29.1±0.5 34.7±0.5 <0.0001 
Table 2. Comparative data between patients with or without arch replacement 
At that moment, rectal temperature usually reached 30°C. In case of aortic arch replacement, 
a brief circulatory arrest was performed and the aortic arch was resected, totally or partially, 
in order to remove as much arch tissue as possible. Two manually inflatable retrograde 
cardioplegia cannulas (Medtronic™, Minneapolis, Mn) mounted on a Y-shaped injection 
line were inserted into the lumen of the brachiocephalic trunk and the left carotid artery to 
provide continuous cerebral antegrade perfusion at a temperature of 30°C and a flow rate of 
1.2 to 1.6l/min (10 to 15ml/kg). The adequate perfusion was determined regarding to the 
right arterial radial pressure and to the lateral pressure line on the left carotid artery 
cannula. Another Dacron™ prosthesis was anastomosed to the aortic isthmus with a 4/0 
polypropylene running suture, after instillation of fibrin glue (Tissucol®, Baxter™, 
Maurepas, France) between the two layers of the descending aorta. An aortic cuff, including 
the three cerebral trunks, was anastomosed on the top side of the graft. At the end of the 
suture, the cerebral perfusion cannulas were removed, and a new cannulation was 
performed directly into the arch tube through a small incision and secured using a snare. 
The CPB was started slowly in order to de-air the tube before clamping and re warming. 
The two coronary buttons (left then right) were anastomosed on the lateral side of the 
Valsalva tube at the level of the skirt-like segment. Finally, the two Dacron™ tubes 
(ascending aorta and arch) were anastomosed end-to-end with a 3-0 polypropylene running 
suture. For the patients without arch replacement, the ascending tube was directly 
anastomosed underneath the arterial brachiocephelic trunk. The aorta was declamped after 
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de-airing, and the CPB was weaned in a standard manner. Two temporary epicardial pacing 
wires were placed on the right ventricle. Pericardial drainage was made using two Ch16 
redon catheters with high depression (-700mmHg) [Farhat et al, 2003]. 
2.3 Follow-up 
Postoperative follow-up was done by the surgeon at the hospital, after 1, 6, 12 months and 
every year. A transthoracic echocardiography (TTE) and a CT-scan were done before each 
outcome visit. Aortic regurgitation was assessed semi quantitatively between 0 and IV/IV. 
Thrombosis of the false lumen of the descending aorta was noted as well. Clinically, general 
dyspnoea was calculated using the New York Heart Association classification (NYHA). 
3. Results 
3.1 Operative data 
We didn’t note any intraoperative mortality. Mean cross clamping, cerebral perfusion and 
CPB times were respectively 102±31, 24±10 and 137±58min. Mean low temperature was 
30.7±3.8°C. There was a significant difference in cross clamping times and lowest 
temperatures between patients with or without arch replacement, but surprisingly not in 
CPB times (table 2). 
 
 Alive, n=43 Dead, n=8 p value 
 N=43 N=8  
Age (mean standard deviation) 63 (11) 72 (13) 0.12 
Type 1 DeBakey Dissection (%) 32 (74%) 7 (88%) 0.66 
Hypertension 38 (88%) 7 (88%) 1 
Preoperative malperfusion 14 (33%) 4 (50%) 0.43 
Preoperative shoc 8 (19%) 3 (38%) 0.35 
Preoperative AI>2 18 (42%) 2 (25%) 0.46 
Aorta diameter > 50 mm 19 (44%) 3 (38%) 1 
Arch repair 30 (70%) 6 (75%) 1 
Table 3. Comparative data between alive and dead patient in the perioperative period AI: 
aortic insufficiency. 
The overall cooling time was less than 20 minutes. The surgical sequence that we used allowed 
us in each case to reach the ideal temperature at aortic declamping. In two cases, the aortic 
cannulation was directly made into the false lumen. At the aortic cross clamping, the radial 
pressure dropped dramatically attesting of the hypoperfusion of the true lumen. A brief CPB 
arrest was performed in a Trendelenburg position. The aortic clamp was released, and a 
surgical fenestration of the intimal flap was made in the aortic arch. The CPB was restarted 
after recalmping the aorta re-establishing a homogenous perfusion within the two lumen. 
Among all patients, 36 had an arch replacement, including one elephant trunk distal suture. 
Five patients had associated coronary artery bypasses during surgery, four for coronary 
occlusions and one for coronary dissections. Another patient had an extracorporeal life 
support (ECLS) at the end of the surgical procedure because of biventricular failure 
(preoperative left main coronary trunk dissection). 
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3.2 Early postoperative course 
3.2.1 Postoperative mortality 
Eight patients died in the early postoperative period (15.7%). One patient died on 
postoperative day (POD) 8 during a tracheal aspiration. No diagnostic autopsy was 
performed. Two patients presenting with a preoperative coma died respectively on POD 3 and 
4. Two patients died from myocardial infarction respectively on POD 1 and 13. One patient 
died on POD 56 due to severe pneumopathy. One patient died on POD 27 from multiple organ 
failure. The last patient died one day from discharge without clear reason (non contributive 
autopsy). There was no statistical difference in between alive and dead patients regarding age, 
distal extension of the dissection, preoperative hypertension, preoperative malperfusion or 
shock, preoperative severe aortic insufficiency, aortic diameter or arch repair (table 3). 
 
With malperfusion (4 death) Survival 78% (95%CI : 61-100) 
Without malperfusion (4 death) Survival 87% (95%CI : 76-100) 
Log-rank p=0.36 
With preoperative shock (3 death) Survival 73% (95%CI : 51-100) 
Without preoperative shock (5 death) Survival 87% (95%CI : 77-99) 
Log-rank p=0.23 
Table 4. Survival in patients with or without preoperative malperfusion 
Moreover, postoperative survival was not affected by preoperative malperfusion (OR=2.07 
[0.45-9.52] p=0.35), shock (OR=2.63 [0.52-13.32] p=0.24, table 4) or age (OR=2.21 [0.96-5.05] 
p=0.06). To refine the analysis of preoperative risk factors for postoperative mortality, we 
have defined as severity factor patients presenting with malperfusion, shock or both. In this 
case, there was no difference in between patients with (5 death) or without (3 death) severity 
criteria regarding mortality (OR=2.55 [0.54-12.08] p=0.24). After analysing the population of 
patients over 70 years old, the results were also comparable (OR=5.54 [0.63-48.44] p=0.12). 
 
  Value 
Total transfusion    
 RBC 4.4±5.1 
 FFP 3.6±3.6 
 Platelets 0.6±0.8 
Aortic insufficiency   
 Grade 0 43 
 Grade 1 2 
Table 5. Early postoperative data. 
Regarding anatomical findings, preoperative aortic insufficiency >2/4 (2 vs 6 deaths, 
OR=0.46 [0.08-2.56] p=0.38) was not related to increased mortality, neither was an aortic 
diameter >50mm (3 vs 5 deaths, OR=0.76 [0.16-3.58] p=0.72). Patients with a preoperative 
AI>2/4 had better survival comparably to others but without reaching statistically 
significant difference (90% vs 80%, p=0.32), as well as patients with an aortic diameter 
>50mm (86% vs 82%, p=0.72) when compared with patients with aortic diameter <=50mm. 
Finally, survival in case of reimplantation technique (7 deaths) was comparable to other 
approaches (1 death, respectively 84% vs 83%, p=0.94, OR=0.92 [0.09-9.13]) 
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de-airing, and the CPB was weaned in a standard manner. Two temporary epicardial pacing 
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CPB times were respectively 102±31, 24±10 and 137±58min. Mean low temperature was 
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 Alive, n=43 Dead, n=8 p value 
 N=43 N=8  
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Hypertension 38 (88%) 7 (88%) 1 
Preoperative malperfusion 14 (33%) 4 (50%) 0.43 
Preoperative shoc 8 (19%) 3 (38%) 0.35 
Preoperative AI>2 18 (42%) 2 (25%) 0.46 
Aorta diameter > 50 mm 19 (44%) 3 (38%) 1 
Arch repair 30 (70%) 6 (75%) 1 
Table 3. Comparative data between alive and dead patient in the perioperative period AI: 
aortic insufficiency. 
The overall cooling time was less than 20 minutes. The surgical sequence that we used allowed 
us in each case to reach the ideal temperature at aortic declamping. In two cases, the aortic 
cannulation was directly made into the false lumen. At the aortic cross clamping, the radial 
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support (ECLS) at the end of the surgical procedure because of biventricular failure 
(preoperative left main coronary trunk dissection). 
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3.2 Early postoperative course 
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autopsy). There was no statistical difference in between alive and dead patients regarding age, 
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patients over 70 years old, the results were also comparable (OR=5.54 [0.63-48.44] p=0.12). 
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3.2.2 Postoperative morbidity 
Eleven patients (21.6%) underwent revision for bleeding. Four were previously treated with 
clopidogrel, and one was under ECLS. No surgical causes were noted on reintervention. 
Eight patients (15.7%) had postoperative neurological deficit, completely regressive within 
24 hours. Cerebral CT-scan didn’t show ischemic signs. One patient with preoperative leg 
malperfusion presented with postoperative mesenteric ischemia needing surgical abdominal 
aortic fenestration on POD 1. One patient had on POD 7 an implantation of a descending 
aortic covered stent graft (Talent™, Medtronic) for a pre-existing penetrating aortic ulcer 
(PAU) located 10 cm above the celiac trunk. This procedure was done under epidural 
analgesia because of severe COPD. 
Mean troponin I level at 24 hours was 15±20μg/l. Mean bleeding at 24 hours was 
846±825ml. Mean intubation and ICU times were respectively 9.2±17.2 and 10.7±14.2 days. 
Yet, twelve patients with severe preoperative comorbidities (malperfusion, alcohol 
addiction, pulmonary Rendu-Ossler disease, preoperative shock) had prolonged 
ventilations (range from 14 to 48 days). Other postoperative data are represented in table 5. 
ICU stay was analyzed regarding preoperative risk factors. Malperfusion (13.9 days if 
malperfusion vs 9.0 if not, p=0.33) or preoperative shock (7.14 if shock vs 11.7 if not, p=0.13) 
were not found to be predictive factors of prolonged ICU stay. Analyzing the postoperative 
neurological deficit, neither arch repair (8/36 vs 0/15, p=0.08) nor direct aortic canulation 
(6/38 vs 2/13, p=1) were found to be risk factors. 
3.3 Late postoperative course 
Mean follow up was of 34±25 months and was completed in all cases. Actuarial survival rate 
at 1 year was 84.3% (figure 1). We didn’t have any reintervention on the aorta during the 
follow up period. 42 patients presented in NYHA I class while 1 was in NYHA II (COPD). 
TTE control didn’t show any aortic insufficiency greater then grade I. CT-scan control 
showed neither false aneurysm on the proximal or distal anastomosis, nor malperfusion 
syndrome. In 6 cases, CT-scan showed a complete thrombosis of the descending aortic false 
lumen. For all patients, we could note the Valsalva shaped aspect of the aortic root (figure 2) 
with a non modified geometry of the cusps coaptation. 
4. Discussion 
The surgical approach of type A aortic dissection remains questionable for many reasons. 
First, this pathology represents one of the major life-threatening emergency situations in 
cardiovascular diseases, due to the risk of aortic rupture into the pericardium, and to the 
consequences of malperfusion (cerebral, digestive, limbs) that can higher morbidity or 
mortality even if the surgical management of the ascending aorta itself is optimal [Nienaber 
et al, 2003a]. Second, type A aortic dissection presents the very bad habit of being a “mid-
night pleasure”! Thus, a big majority of the surgeons tend to privilege a fast and easy 
technique. Third, the absence of dilatation of the aortic root is very often present, and in this 
case, total aortic root replacement (regardless to valve preservation or not) is difficult to 
justify because of a potentially higher surgical risk. Finally, and in many institutions, 
reimplantation techniques in scheduled patients are reserved for confirmed surgeons. 
Unfortunately, all of the surgeons who deal with type A aortic dissection in the middle of 
the night are not always used to this approach. 
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Time (months) 14 26 36 67 
Patients at risk (n) 38 30 22 10 
Fig. 1. Actuarial survival curve for patients with type A aortic dissection treated by 
reimplantation valve sparing technique according to David in association or not with arch 
replacement. Early mortality is included. 
Supracommissural tube graft replacement in conjunction with reconstruction of the sinuses 
with glue is the easiest way to treat type A aortic dissection [Fann et al, 1991, Kouchoukos et 
al, 1991, Mazzucotelli et al, 1993]. This technique allows in almost 90% of the patients the 
restoring of the geometry of the aortic sinuses and subsequently the valve competence 
which is failing in many cases. If this surgical treatment brings entire satisfaction in 
immediate postoperative course, the long term outcome remains controversial. 
Supracommissural replacement has been proven by some authors inasmuch as the freedom 
for reoperation for aortic valve dysfunction was elevated after 10 years of follow-up (up to 
91%) [Casselman et al, 2000, Driever et al, 2004]. Yet, others underscore that the progression 
of the disease, regardless to a pre-existing aortic aneurysm, could lead to aortic insufficiency 
by the absence of coaptation between the three leaflets. Simon et al found that 29% of the 
patients with supracommissural tube graft for type A aortic dissection developed a sinus of 
Valsalva aneurysm within 44±22 months after surgery [Simon et al, 1994]. Three reasons are 
often evoked as an explanation: first, the supracommissural replacement of the aorta  
leads to increased shear stress in the sinuses because of the absence of elasticity of the 
Dacron™, especially during diastole, thereby transferring the diastolic pressure  
to the only sinuses [Simon et al, 1999]. Second, a long aortic root remnant has by itself a 
dilatation risk due to cystic medial necrosis that is diffusely present in the aortic structure 
and which is the primary reason for aortic dissection [Marsalese et al, 1990]. Third, the use 
of gelatine-resorcinol-formaldehyde has been incriminated in a higher incidence of false 
aneurysms or re-dissections, particularly in the proximal part of the aorta [Kirsch et al, 2002]. 
For all these reasons, some authors have strongly recommended total aortic root 
replacement by a composite graft, subsequently to eliminate the entire diseased aortic root 
[Ergin et al, 1996, Hagl et al, 2003]. Yet, solving a problem was to create another one: 
biological tubes lead to valve failure, and mechanical ones to lifetime anticoagulation. Thus, 
the valve preserving techniques (remodelling/reimplantation) have gained more interest 
these past years in type A aortic dissection treatment along with their development in  
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syndrome. In 6 cases, CT-scan showed a complete thrombosis of the descending aortic false 
lumen. For all patients, we could note the Valsalva shaped aspect of the aortic root (figure 2) 
with a non modified geometry of the cusps coaptation. 
4. Discussion 
The surgical approach of type A aortic dissection remains questionable for many reasons. 
First, this pathology represents one of the major life-threatening emergency situations in 
cardiovascular diseases, due to the risk of aortic rupture into the pericardium, and to the 
consequences of malperfusion (cerebral, digestive, limbs) that can higher morbidity or 
mortality even if the surgical management of the ascending aorta itself is optimal [Nienaber 
et al, 2003a]. Second, type A aortic dissection presents the very bad habit of being a “mid-
night pleasure”! Thus, a big majority of the surgeons tend to privilege a fast and easy 
technique. Third, the absence of dilatation of the aortic root is very often present, and in this 
case, total aortic root replacement (regardless to valve preservation or not) is difficult to 
justify because of a potentially higher surgical risk. Finally, and in many institutions, 
reimplantation techniques in scheduled patients are reserved for confirmed surgeons. 
Unfortunately, all of the surgeons who deal with type A aortic dissection in the middle of 
the night are not always used to this approach. 
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leads to increased shear stress in the sinuses because of the absence of elasticity of the 
Dacron™, especially during diastole, thereby transferring the diastolic pressure  
to the only sinuses [Simon et al, 1999]. Second, a long aortic root remnant has by itself a 
dilatation risk due to cystic medial necrosis that is diffusely present in the aortic structure 
and which is the primary reason for aortic dissection [Marsalese et al, 1990]. Third, the use 
of gelatine-resorcinol-formaldehyde has been incriminated in a higher incidence of false 
aneurysms or re-dissections, particularly in the proximal part of the aorta [Kirsch et al, 2002]. 
For all these reasons, some authors have strongly recommended total aortic root 
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Fig. 2a. and 2b. CT-scan showing transverse (a) and sagittal (b) views of the aorta and aortic 
leaflets. The sinuses’ diameter is 20 to 25% larger than the annulus diameter. The three 
leaflets are well identified and coaptation can be assessed 
elective cases, such as aortic root aneurysms. Kallenbach et al have reported that the aortic 
valve preservation techniques can be performed with favourable functional results 
regardless to the underlying aortic lesion (type A aortic dissection or aneurysm) [Kallenbach 
et al, 2004]. Yet, Leyh et al, from the same team, noted a higher failure rate in aortic root 
remodelling, in patients with type A aortic dissection, comparatively to a reimplantation 
technique [Leyh et al, 2002]. These results can be easily understandable: the remodelling is 
based upon the suture of a Dacron™ tube, which is previously three folded, directly to the 3 
to 4mm remnants of the sinuses of Valsalva. This suture is made on a diseased tissue, 
without any protection against further dilatation of the aortic annulus. 
Our prospective series was carried on to find out whether a near systematic performance of 
a reimplantation technique is accompanied with a higher mortality or morbidity risk. Post 
operative death proportion in our series is comparable to what we can find all along the 
literature. Yet, many points are remarkable in this series. In opposition to what previously 
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described in the literature, preoperative malperfusion, shock or age of the patients were not 
found to be risk factors of perioperative mortality. Arch replacement, as well as direct aortic 
cannulation, didn’t emphasize the postoperative risk of stroke. 
Different points are to be discussed in our global strategy. First, we did direct aortic 
cannulation into the dissected aorta for 38 patients. This technique was first described by Lijoi 
et al, who performed two cases of aortic replacement in type A aortic dissection, with direct 
aortic cannulation and deep hypothermia [Lijoi et al, 1998]. Minatoya et al reported a series of 
14 patients with direct aortic cannulation, without rupture or peroperative malperfusion 
[Minatoya et al, 2003]. The difference with the Lijoi description is that the arch replacement is 
performed under mild (28°C) hypothermia and antegrade cerebral perfusion, like reported in 
our series. Beside the aortic rupture risk, the elective perfusion of the false lumen is the other 
pitfall of this technique. This problem can only be tracked down at cross clamping, when the 
proximal intimal aortic tear is excluded and doesn’t anymore constitute an entry site for the 
perfusion of the true lumen. This complication can be suspected easily while the right radial 
pressure drops (along with a preservation of the pressure in the femoral artery), witnessing of 
a malperfusion of the arterial brachiocephalic trunk. Minatoya et al have also reported this 
complication. We propose a simple fenestration of the intima in the arch, that is to recreate a 
downstream re-entry site and to perfuse adequately the true lumen. The second point of our 
technique is the arch replacement under mild hypothermia with selective antegrade cerebral 
perfusion. Minatoya et al have recently reported the absence of difference upon neurological 
outcome with antegrade cerebral perfusion, comparatively between three groups with a body 
temperature of 20, 24 and 28°C [Minatoya et al, 2005]. Karck et al performed prolonged 
circulatory arrest times (up to 62±14min) in combined aortic arch and descending aortic 
replacement, using a 28°C antegrade cerebral perfusion, without major cerebral complications 
[Karck et al, 2005]. This technique brings the advantage of shortening the CPB time, reducing 
the platelets dysfunction and subsequently the postoperative bleeding. Regarding the 
postoperative neurological events, direct aortic canulation and arch replacement were not 
found to be risk factors when considered alone. The third point of our approach is the use of a 
Gelweave Valsalva™ prosthesis for the root replacement. This tube was designed to reproduce 
the anatomic and physiologic features of the normal aortic root. The root of the tube, shaped as 
a skirt, has vertical crimps, allowing it to expand transversally along with the cardiac systole 
and diastole, contrarily to the body of the tube, which has horizontal crimps. In a normal aortic 
root, the sinuses of Valsalva create eddy currents, first described by DaVinci, with a major 
importance in the aortic leaflets motion: on valve opening, they prevent the cusps’ edges from 
impacting the aortic wall, and they participate to the initiation of the aortic valve closure 
[Hopkins et al, 2003, Kunzelman et al, 1994, Leyh et al, 2003]. One of the suggested reasons for 
mid term failure of the reimplantation technique is the use of a straight Dacron™ tube without 
any stretching structure allowing the transversal expansion during systole. The consequence is 
repetitive impaction of the cusps’ free edges on the tube’s walls, leading to a progressive 
fibrotic retraction of the cusps with subsequent coaptation default. We believe that the 
Valsalva shaped tube prevents from this evolution by recreating the anatomy and the 
haemodynamic of a normal aortic root. Along with the progression of the series, we noticed 
during echographic control that the Valsalva segment was far from the free edge of the cusps 
during systole. 
Follow up was done for 34±25 months and was completed in all cases. We didn’t observe 
any evolution towards aortic insufficiency in any patient, and previous aortic aneurysm 
didn’t constitute a risk factor for aortic repair failure [Leyh et al, 2003]. None of the patients 
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had anticoagulant treatment. Mean aortic gradients and effective permeability index were 
acceptable, without difference between the postoperative period and follow-up. CT-scan 
reconstructions allowed a perfect visualization of the aortic root, showing the shape of the 
Valsalva skirt. In 9 patients, we noted a thrombosis of the false lumen. The persistence of 
perfusion in the other patients is probably related to the re-entry sites situated distally on 
the descending and abdominal segments. One patient presented an evolution to dilatation 
of the descending aorta, without reaching surgical criteria. 
5. Conclusion 
Based upon our experience in the management of type A aortic dissection, the 
reimplantation valve sparing technique could be performed systematically without 
emphasizing perioperative risk. Our results during follow-up, along with other results 
published by many authors, seem to be encouraging, and push up to keep on performing 
this technique routinely in type A aortic dissection. Preoperative malperfusion or shock 
shouldn’t push the surgeon to counter indicate the patients to undergo surgery. We also 
think that the use of a Valsalva tube grandly contributes to these mid term good results. 
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root, the sinuses of Valsalva create eddy currents, first described by DaVinci, with a major 
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mid term failure of the reimplantation technique is the use of a straight Dacron™ tube without 
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during systole. 
Follow up was done for 34±25 months and was completed in all cases. We didn’t observe 
any evolution towards aortic insufficiency in any patient, and previous aortic aneurysm 
didn’t constitute a risk factor for aortic repair failure [Leyh et al, 2003]. None of the patients 
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had anticoagulant treatment. Mean aortic gradients and effective permeability index were 
acceptable, without difference between the postoperative period and follow-up. CT-scan 
reconstructions allowed a perfect visualization of the aortic root, showing the shape of the 
Valsalva skirt. In 9 patients, we noted a thrombosis of the false lumen. The persistence of 
perfusion in the other patients is probably related to the re-entry sites situated distally on 
the descending and abdominal segments. One patient presented an evolution to dilatation 
of the descending aorta, without reaching surgical criteria. 
5. Conclusion 
Based upon our experience in the management of type A aortic dissection, the 
reimplantation valve sparing technique could be performed systematically without 
emphasizing perioperative risk. Our results during follow-up, along with other results 
published by many authors, seem to be encouraging, and push up to keep on performing 
this technique routinely in type A aortic dissection. Preoperative malperfusion or shock 
shouldn’t push the surgeon to counter indicate the patients to undergo surgery. We also 
think that the use of a Valsalva tube grandly contributes to these mid term good results. 
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1. Introduction 
Thoracoabdominal aortic aneurysm (TAAA) repair still remains a challenging operation 
since it necessitates extended exposure of the aorta and reimplantation of the vital aortic 
branches. Among possible postoperative complications, spinal cord injury (SCI) seems 
one of the most formidable morbidities. Even by experts who have championed in TAAA 
repair the incidence of SCI remained as high as 16% in the early 1990s (Svensson et al., 
1993). Thanks to numerous experimental investigations and technical advances or 
modifications, it has improved up to 3.6%-4.6% in the worldwide largest centers with a 
contemporary strategy (i.e. aggressive use of distal aortic perfusion) (Safi et al., 2003, 
Coselli et al., 2007, Zoli et al., 2010). However, this incidence of SCI should vary according 
to the extent of aortic involvement. In 1986, Crawford and his colleagues proposed 
classification of TAAA into four groups according to the extent of aortic involvement and 
clearly showed that this classification could predict late death and neurological deficit 
(Crawford et al., 1986). Their classification is as following; group I involves most of the 
descending thoracic and upper abdominal aorta. Group II involves most of the 
descending thoracic aorta and most or all of the abdominal aorta. Group III involves the 
distal descending thoracic aorta and varying segments of abdominal aorta. Group IV 
involves most or all of the abdominal aorta including the segment from which the visceral 
vessels arise. Later, Safi and his co-workers advocated additional group V that involves 
below the sixth intercostal space to just above the renal arteries (Safi et al., 1998, 1999, 
2003) (Figure 1). As shown later in Table 3, this classification correlates well with 
postoperative SCI still in contemporary era, thus it has been used widely to date. In the 
most extended type of TAAA (type II), SCI still occurs in 4.2-15.8% despite with 
experienced hands in the last decade (Safi et al., 2003, Jacobs et al., 2006, Coselli et al., 
2007, Conrad et al., 2007, Acher et al., 2008, Zoli et al., 2010). Thus spinal cord protection 
during TAAA repair has emerged as great clinical importance. The primary aim of this 
review is to provide a better appreciation and understanding of the mechanisms and 
pathophysiology of SCI after TAAA repair.  
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Fig. 1. Crawford/Safi’s cllasification of the extent of aortic involvement (From; Safi, et al., 
1999 ). 
2. Mechanisms of spinal cord injury 
Underlying mechanisms of SCI after TAAA repair are multifactorial, however, they can be 
primarily summarized into three key processes; 1) the duration and degree of ischemia, 2) 
failure to re-establish blood flow to the spinal cord after repair, and 3) a biochemically 
mediated reperfusion injury (Svensson 1997). 
2.1 The duration and degree of ischemia 
To reduce the duration and degree of spinal cord ischemia, either oxygen supply should be 
enhanced or oxygen demand attenuated. For these purposes, multi-segmental sequential 
clamping technique combined with mild hypothermic distal aortic perfusion has favorably 
been used in many institutions. When sequential clamping is not feasible, deep hypothermic 
circulatory arrest should be applied.  
2.1.1 Distal aortic perfusion 
Pioneers have used simple cross-clamping technique and reported acceptable outcomes 
(Crawford et al., 1986) (Schepens et al., 1994). Nowadays, majority of surgeons use distal 
aortic perfusion to reduce ischemia of the distal organs and cardiac afterload. Surprisingly, 
distal shunt was already used in a half century ago and has been applied with some 
modifications (Etheredge et al., 1955, Gott 1972, Cambria et al., 1998). Distal shunt has some 
advantages such as its simplicity and mild heparinization, but has also some disadvantages. 
Distal blood flow depends largely on proximal blood pressure and it is difficult to manage 
massive bleeding. On the other hand, left heart bypass using a centrifugal pump can 
provide flexible control of distal blood flow, thus it is currently used widely. Many experts 
have demonstrated that left heart bypass could significantly reduce the incidence of SCI 
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especially in extended TAAA (type II) repair (Safi et al., 1997) (Coselli et al., 1999, 2003). We 
have favorably used a partial cardiopulmonary bypass (CPB) through the femoral artery 
and vein. This alternative has some advantages in case with cardiopulmonary instability or 
massive bleeding. Some disadvantages such as acceleration of bleeding tendency has been 
resolved by reduction of heparin dosage using a fully heparin-coated closed-loop CPB 
system with a soft reservoir bag (Shiiya et al., 2005, 2006). 
2.1.2 Multi-segmental sequential clamping 
Blood flow of the anterior spinal artery is primarily supplied by some radicular arteries. The 
radicular artery has a rich collateral network between adjacent intercostal/lumbar arteries. 
Therefore it may be beneficial to maintain this collateral blood flow during reattachment of 
the intercostals/lumbar arteries. Especially in patients with degenerative aortic aneurysm, 
occlusion or stenosis of the intercostals/lumbar arteries may alter and complicate this 
collateral pathway, which may emphasize the importance to preserve it. In addition, during 
reattachment of the intercostals/lumbar arteries, back bleeding from adjacent one may 
accelerate steal phenomenon (Christiansson et al., 2001). The Mount Sinai group 
emphasized importance of avoiding steal phenomenon. They sacrificed all involved 
intercostals/lumbar arteries outside of the aorta to avoid steal phenomenon in 100 cases and 
experienced only 2% SCI (Etz et al., 2006). Their findings have a great implication for 
extensive deployment of endocasvular stentgraft. 
On the other hand, the anterior spinal artery has a narrow critical zone at around T4 level, 
where the spinal cord is susceptible to ischemia (Dommisse 1974, Svensson et al., 1986). 
Thus an ascending blood flow through the anterior spinal cord artery alone is not enough to 
feed this area. These mechanisms may explain why distal aortic perfusion alone was not 
beneficial to prevent SCI in the early era (Crawford et al., 1988). Therefore segmental 
sequential clamping seems advantageous to preserve collateral blood flow to the spinal cord 
during reattachment of the critical intercostals/lumbar arteries (Kuniyoshi et al., 2003). 
Trend has become toward clamping shorter segments (multi-segmental sequential 
clamping). We experienced no postoperative SCI when less than two pairs of 
intercostals/lumbar arteries were involved between segmental clamping. We identified that 
multi-segmental sequential clamping in combination with distal aortic perfusion was the 
only significant predictor for SCI after type I and II TAAA repair in multivariate analysis 
(Shiiya et al., 2005). The fact that a previous abdominal aortic aneurysm repair is a 
significantly high risk for postoperative SCI may support this collateral network concept 
(Svensson 2005). 
2.1.3 Hypothermia 
It has been widely accepted that mild hypothermia is clinically effective to prevent SCI. A 
reduction in temperature of 3C provides a 2-fold increase of the tolerable ischemic interval 
in rabbit (Vacanti et al., 1984) and a 5C reduction does a 2.5-fold increase in pig (Strauch et 
al., 2004). Therefore almost all aortic surgeon currently use mild hypothermia (32-34C) 
using heat-exchanger or permissively in combination of distal aortic perfusion. Whenever 
the aorta cannot be safely clamped, use of deep hypothermic circulatory arrest should be 
warranted. Clinically, moderate to profound hypothermia was proved to prolong tolerable 
ischemic interval, which enables secure reconstruction of the aorta for aortic surgeons 
(Svensson et al., 2003) (Fig. 2).  
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Fig. 2. Relationship between interval of spinal cord ischemia and risk of neurological deficit 
stratified by systemic temperature (Svensson 2005). 
Kouchoukos and his colleagues have aggressively performed TAAA repair under profound 
hypothermia and reported its substantial protective effect against SCI (2.9% paraplegia) 
(Kouchoukos et al., 2003). Using deep hypothermic circulatory arrest Coselli and his co-
workers could reduce the incidence of SCI up to 1%, however on the other hand, it increased 
morbidity and mortality rate (Coselli et al., 2008). Therefore this alternative is currently 
limited to selected cases (large or extensive aneurysm, friable aortic tissue, high risk of 
embolization, complex repair, redo cases), principally due to risk of coagulopathy, 
pulmonary dysfunction, and massive fluid sift. Accordingly some experts have proposed 
regional epidural or intrathecal cooling (Black et al., 2003, Shimizu et al., 2010). Although 
conceptually promising, this alternative currently lacks the support of prospective 
randomized data in larger cohort.   
2.2 Failure to re-establish blood flow to the spinal cord after repair 
2.2.1 Preoperative identification of critical intercostals artery 
There are some surgeons who will blindly re-attach every intercostal/lumbar arteries to 
secure spinal cord protection (so-called onlay patch methods) (DeAnda et al., 2005). 
However, this technique seems unrealistic because longer ischemic time is definitively 
associated with higher risk of SCI (Safi et al., 1998). In addition, considerable extent of 
aneurismal aortic wall remains to exist. To re-establish blood flow to the spinal cord, 
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therefore, it is crucial to identify critical intercostals artery to the spinal cord. This is 
normally the largest radiculomedullary artery; so-called “the Adamkiewicz artery”. 
Preoperatively, it used to be identified by angiography, however, it appears rather invasive 
and difficult in case with large, thrombosed, or kinky aorta (Kiefer et al., 2002). Since we 
have visualized Adamkiewicz artery using multi-detector row computed tomography in 
2003 (Maruyama et al., 2003), numerous reports have demonstrated that it is feasible in over 
80% of cases by both computed tomography and magnetic resonance angiography 






Fig. 3. Identification of the Adamkiewicz artery by 3D volume-rendered computer 
tomography. 1: Intercostal and lumbar arteries with their posterior (2) and anterior (3) 
branches, 4: Radiculomedullary artery and muscular branch (5), 6: the Adamkiewicz artery, 
7: the anterior spinal artery. (Uotani et al., 2008) 
The majority of the Adamkiewicz artery proved to originate from T8-L1 level with left 
dominancy, which was consistent with angiographic findings and cadaver study (Koshino 
et al., 1999, Kiefer et al., 2002) (Table 2, Fig 4-5).   
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Table 1. Preoperative identification rate of the Adamkiewicz artery using different 
modalities. *child cases (7.5 +/- 5 years old), I.A. or I.V.: intra arterial or venous injection of 
contrast materials, respectively. 
 
 Rt Lt Total 
Th7 - 1 1 
Th8 2 3 5 
Th9 1 4 5 
Th10 1 6 7 
Th11 2 1 3 
TH12 3 4 7 
L1 - 4 4 
L2 - 2 2 
L3 - 1 1 
L4~ 1 - 1 
 10 27 37 
 (27%) (73%)  
Table 2. Our experience to detect the Adamkiewicz artery in 48 cases using a computer 
tomography between 2001 and 2004. Detection rate was 77% and 86% of the Adamkiewicz 
artery originated from T8-L1 
 




Fig. 4. Identification of the origin of the Adamkiewicz artery using an angiography (Kiefer et 
al., 2002 with modification) 
 
 
Fig. 5. Identification of the origin of the Adamkiewicz artery from 90 cadavers.  (Koshino et 
al., 1999 with modification) 
2.2.2 Intraoperative identification of critical intercostals artery 
To identify the Adamkiewicz artery intraoperatively, traditionally we used to apply evoked 
spinal cord potential, which required two electrodes placed in the epidural space and 
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published its usefulness to prevent SCI (Matsui et al., 1994, Shiiya et al., 1995). However, this 
method is more or less invasive and technical demanding, and although rare, complications 
related to epidural catheter are catastrophic. Therefore majority of surgeon are currently 
using motor evoked potentials (Jakobs et al., 2006). Nonetheless, these electrophysiological 
examinations have some disadvantages such as time delay or effect of electric noise, 
anesthetic agents, peripheral ischemia, and hypothermia. Therefore we have tried to 
measure immediate information of spinal cord oxygenation noninvasively using 
transcutaneous or transesophageal near-infrared spectrophotometry (Kunihara et al., 1998, 
Kunihara et al., 2004). Further studies and technical advance will be essential toward its 
clinical use.   
2.3 A biochemically mediated reperfusion injury 
2.3.1 Clinical siginificance of cerebrospinal fluid drainage 
Cerebrospinal fluid (CSF) drainage (CSFD) may be one of the most promising procedures to 
prevent SCI. Its usefulness has already advocated in 1960 (Miyamoto et al., 1960). Acher and 
associates have reported that combined use of CSFD and naloxone hydrochloride 
(naloxone), an opioid receptor antagonist, reduces the risk of SCI in patients undergoing 
TAAA repair in 1994 (Acher et al., 1994). In 2002, CSFD itself proved to be beneficial to 
reduce the risk of SCI after TAAA repair in prospective randomized clinical trial (Coselli et 
al., 2002). Meta-analysis of three randomized controlled trials and five cohort studies 
revealed beneficial effect of CSFD on paraplegia (Fig 6) (Cinà et al., 2004). Although rare 
(0.2%), CSFD-associated complications are catastrophic (subdural hematoma, intracranial 
bleeding, meningitis), so that CSFD should currently be reserved for extended aneurysm 
(type I and II) or patient at high risk (Cinà et al., 2004, Wynn et al., 2009). 
 
 
Fig. 6. Meta-analysis showing beneficial effect of cerebrospinal fluid drainage on paraplegia  
(Cinà et al., 2004). 
2.3.2 Clinical siginificance of cerebrospinal fluid drainage 
However, underlying mechanisms of CSFD to reduce SCI seems still unclear and it has not 
been investigated whether naloxone can alone attenuate the risk of SCI clinically like CSFD. 
Experimental studies have revealed that CSF pressure rises during aortic clamping, leading 
to decrease of spinal cord perfusion pressure (mean distal aortic pressure – CSF pressure) 
(Kaplan et al., 1995) (Fig. 7).   
 




Fig. 7. Relationship between intracranial pressure (ICP), mean distal aortic pressure 
(DISTAL PAo), and spinal cord perfusion gradient (DISTAL PAo - ICP) during aortic 
clamping (Kaplan et al., 1995). 
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It has been believed that CSFD may restore spinal cord blood flow by decompressing spinal 
compartment syndrome caused by spinal cord edema in relation to ischemia-reperfusion 
injury (Safi et al., 1997) (Fig. 8). This speculation is supported by the clinical consequence 
that delayed-onset paraplegia could be successfully reversed by reducing CSF pressure 
(Cheung et al., 2002).  
 
 
Fig. 8. Speculated mechanism of beneficial effect of cerebrospinal fluid drainage on spinal 
cord injury (Safi et al., 1997). 
2.3.3 Role of cerebrospinal fluid drainage in ischemia-reperfusion injury 
On the other hand, it has been well known that ischemia-reperfusion injury mediates 
some negative neurotrophic substances. Indeed, we showed that pro- and anti-
inflammatory cytokines were generated in the rabbit spinal cord after ischemic SCI and 
they were clearly reversed by 21-aminosteroids (lazaroids) (Kunihara et al., 2000). Thus 
we have speculated that another key role of CSFD might be removal of negative 
neurotrophic substances. Actually, we revealed pro-inflammatory cytokines and S-100 
protein were predominantly generated in CSF than in serum after TAAA repair and their 
levels were more pronounced and prolonged in patients with SCI (Kunihara et al., 2001, 
Kuniharat et al., 2001) (Fig. 9, 10). Moreover, CSF levels of excitatory amino acids in 
patients with postoperative SCI was significantly higher that those in patients without 
SCI. These elevated CSF levels of excitatory amino acids could be significantly 
antagonized by intraoperative continuous intravenous administration of naloxone 
(Kunihara et al., 2004) (Fig. 11).  
 










Fig. 9. Changes in serum and cerebrospinal fluid (CSF) interleukin-8 (IL-8) levels in overall 
patients (left). Changes in CSF IL-8 levels in patients with or without (w/o) paraplegia 






Fig. 10. Postoperative time course of S-100 protenin levels in the serum and CSF (Kunihara 
et al., 2001). 
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Fig. 11. Postoperative time course of CSF glutamete levels (Kunihara et al., 2004). 
2.3.4 Pharmacological intervention 
2.3.4.1 Naloxone hydrochloride 
Numerous pharmacological interventions have been tried to attenuate postoperative SCI, 
however, no compound has become popular for a wide standardized clinical use. Above all, 
naloxone, the opiate antagonist, has gained increased attention since a report by Acher and 
associates was published in 1994, as described before (Acher et al., 1994). In general, 
excessive synaptic accumulation of excitatory amino acids during ischemia is associated 
with neuronal cell damage, which is mediated through overactivation of their receptors (i.e. 
N-methyl-D-aspartate receptor) followed by excessive influx of calcium. It has been shown 
that high concentration of naloxone attenuates N-methyl-D-aspartate-mediated 
neurotoxicity in an animal model (Kim et al., 1987). Clinically, Acher and his colleagues 
disclosed that the addition of naloxone resulted in a 30% reduction in the SCI rate (Acher et 
al., 2010). The important findings of our study that CSF excitatory amino acids were 
significantly suppressed by naloxone up to 72 hours after TAAA repair may have great 
implication because neurotoxicity mediated by excitatory amino acids is supposed to be a 
late-onset process (Nakamura et al., 1994) (Fig. 11). Therefore Acher and his colleagues 
recommended intravenous continuous administration of naloxone up to 48 hours 
postoperatively (Acher et al., 2010). We have experienced no side effect of naloxone at a rate 
of 1µg/kg/h even at postoperative period.  
2.3.4.2 Other glutamate inhibitors 
With the same mechanism, beneficial effects of other glutamate antagonists have been 
reported. Rokkas and his colleagues reported that Dextrorphan, a noncompetitive N-
methyl-D-aspartate receptorantagonist, inhibited the release of excitatory amino acids in the 
spinal cord during ischemia (Rokkas et al., 1994). However, this agent is no longer used 
 
Prevention of Spinal Cord Injury After Thoracoabdominal Aortic Aneurysm Repair 
 
199 
clinically because of an unfavorable tolerance profile (Albers et al., 1995, Rokkas & 
Kouchoukos, 2001). Instead, other antiglutamate compounds such as Riluzole (Lang-
Lazdunski et al., 2000), Memantine (Ehrlich et al., 1999), MK-801 (Cho et al., 2005) or 
Magnesium sulfate (Lang-Lazdunski et al., 2000) have been evaluated to have a 
neuroprotective effect after ischemia reperfusion of the spinal cord, although further 
evaluation should be necessary for their wide clinical use.  
2.3.4.3 Steroid 
In the early 1980’s, beneficial effects of intravenous methylprednisolone (30 mg/kg) on 
experimental SCI have been confirmed (Hall & Braughler, 1982, Braughler & Hall, 1983, 
Laschinger et al., 1984). It has been believed that steroid act as cellular and lysosomal 
membrane stabilizers. Since the Second National Acute Spinal Cord Injury Study reported 
in 1990 that methylprednisolone improved neurologic recovery after acute SCI when it was 
given in the first eight hours, methylprednisolone has become a clinical mainstay in the 
treatment of acute SCI (Bracken et al. 1990). In the field of aortic surgery, 
methylprednisolone has been given in many institutions with various dosages (7 mg/kg: 
kouchoukus et al., 2003, 30 mg/kg: Hollier et al., 1992, Acher C. 2010) although its effect is 
still controversial. We have routinely administered 1g methylprednisolone intravenously 
prior to aortic cross-clamping and another 1g into CPB circuit (Kunihara et al., 2004). A 
drawback of steroid use such as postoperative hyperglycemia, disadvantageous to spinal 
cord protection, should be aggressively normalized. Recently, a new series of 21-
aminosteroids (i.e. Lazaroids) have emerged as remarkable protective compounds against 
various ischemia-reperfusion injury model through the inhibition of irondependent lipid 
peroxidation (Sasaki et al., 1996, Holzgrefe et al., 1990, Johnson & Lefer, 1990). As was 
written above, these agents have also been shown beneficial effects of attenuating 
postischemic SCI (Fowl et al., 1990, Kunihara et al., 2000). Further examination will be 
required for clinical application.  
2.3.4.4 Vasodilators 
The other beneficial mechanisms against postischemic SCI include enhancing collateral 
blood flow to the jeopardized spinal cord. Systemic administration of vasodilators (i.e. 
nitroprusside) has been believed to decrease spinal cord perfusion pressure by reducing 
distal aortic pressure and increasing cerebrospinal fluid pressure, thus it should be avoided 
or combination with CSFD is recommended (Shine & Nugent, 1990, Marini et al., 1997). On 
the other hand, local use (i.e. intrathecal) of vasodilators can avoid reducing distal aortic 
pressure, thus may be beneficial for spinal cord protection. Svensson and his colleagues 
administered papaverine intrathecally and showed significant increase in spinal cord blood 
flow (Svensson 2005) and significant reduction of SCI clinically (Svensson et al., 1998) 
(Figure 12). 
Prostaglandin E1 (PGE1) has also emerged as one of the promising compounds to enhance 
collateral blood flow to the spinal cord (Grabitz et al., 1993), however, it has also a dilemma 
to reduce distal aortic pressure. To avoid PGE1-induced hypotension in clinical use, 
Alprostadil, PGE1 incorporated in lipid microspheres to minimize metabolization and 
inactivation in the lung (Yone et al., 1999), has been examined to have the beneficial effect on 
ischemic SCI. In an experimental spinal cord ischemia model, we detected beneficial 
pharmacological effect of intravenous Alprostadil on the spinal cord oxygenation using 
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near-infrared spectrophotometry, which was not detected by spinal cord evoked potentials 
(Figure 13) (Kunihara et al., 2008). Thus Alprostadil can be given systemically, which may 
facilitate intraoperative management.  
 
 
Fig. 12. Risk of spinal cord injury according to aortic cross-clamp time with no cooling or 
papaverine. cerebrospinal fluid drainage with intrathecal papaverine (CSFD+IP), active 
cooling with the combination. (Svensson et al., 1998) 
 
 
Fig. 13. Time course of mean %change of oxygenated hemoglobin (oxy-Hb) in the spinal 
cord measured by near-infrared spectrophotometry. AXC: aortic cross-clamping. (Kunihara 
et al., 2008) 
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2.3.4.5 Other drugs 
Other numerous promising pharmacological interventions such as superoxide dismutase 
(Agee et al., 1991), allopurinol (Qayumi et al., 1994), calcium-channel blockers (Schittek et 
al., 1992), Adenosine (Seibel t al., 1993) or Adenosine A2A agonist (ATL-146e) (Reece et al., 
2004) have been tested. We have seriously published beneficial effects of nicorandil (an 
adenosine triphosphate-sensitive potassium channel opener) (Wakamatsu et al., 2001), 
immunophilin ligands FK506 or cyclosporine A (Tachibana et al., 2005) on transient spinal 
cord ischemia in rabbits. However, their protective effects on SCI seem still controversial 
and may require further evaluations. 
3. Clinical results 
With a better appreciation and understanding of the mechanisms and pathophysiology of 
SCI and with many clinical evidences the neurological outcomes after TAAA repair have 
dramatically improved. Table 3 illustrated postoperative SCI stratified by the extent of aortic 
involvement reported from institutions with large case volume. 
 
 
Table 3. Spinal cord injury after thoracoabdominal aortic aneurysm repair stratified by the 
extent of aortic involvement reported from institutions with large case volume. DAP: distal 
aortic perfusion. Conrad/Cambria*: only major paraplegia is demonstrated. 
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near-infrared spectrophotometry, which was not detected by spinal cord evoked potentials 
(Figure 13) (Kunihara et al., 2008). Thus Alprostadil can be given systemically, which may 
facilitate intraoperative management.  
 
 
Fig. 12. Risk of spinal cord injury according to aortic cross-clamp time with no cooling or 
papaverine. cerebrospinal fluid drainage with intrathecal papaverine (CSFD+IP), active 
cooling with the combination. (Svensson et al., 1998) 
 
 
Fig. 13. Time course of mean %change of oxygenated hemoglobin (oxy-Hb) in the spinal 
cord measured by near-infrared spectrophotometry. AXC: aortic cross-clamping. (Kunihara 
et al., 2008) 
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2.3.4.5 Other drugs 
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manuscript briefly. From these considerable experimental and clinical evidences, we have 
evolved our strategy for TAAA repair over time as shown in Table 4 (Shiiya et al., 2005). We 
believe this may be the best and reasonable approach to prevent SCI after TAAA repair at 
the present moment. Nonetheless, Jacobs and his colleagues described; “despite all available 
measures, complete prevention of paraplegia in type II aneurysms seems to be unrealistic” 
(Jacobs et al. 2006). Our multidisciplinary effort to prevent SCI after extensive TAAA repair 
may be never ending  
 
Mild hypothermic distal aortic perfusion or deep hypothermic circulatory arrest 
Multi-segmental sequential clamping 
Preoperative identification of the Adamkiewicz artery and reimplantation of  responsible 
intercostal arteries  
Without information, reconstruction of the intercostal arteries at Th8-L1 left 
Avoidance of steal phenomenon during reconstruction of the intercostal arteries  
Electrophysiological monitoring of the spinal cord function   
Cerebrospinal fluid drainage 
Intravenous administration of naloxone and methylprednisolone. 
Table 4. Our strategy to prevent spinal cord injury. 
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This book considers diagnosis and treatment of abdominal and thoracic aortic 
aneurysms. It addresses vascular and cardiothoracic surgeons and interventional 
radiologists, but also anyone engaged in vascular medicine. The book focuses amongst 
other things on operations in the ascending aorta and the aortic arch. Surgical 
procedures in this area have received increasing attention in the last few years 
and have been subjected to several modifications. Especially the development of 
interventional radiological endovascular techniques that reduce the invasive nature 
of surgery as well as complication rates led to rapid advancements. Thoracoabdominal 
aortic aneurysm (TAAA) repair still remains a challenging operation since it 
necessitates extended exposure of the aorta and reimplantation of the vital aortic 
branches. Among possible postoperative complications, spinal cord injury (SCI) seems 
one of the most formidable morbidities. Strategies for TAAA repair and the best and 
most reasonable approach to prevent SCI after TAAA repair are presented.
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